TW593305B - Processes for preparation of 9,11-epoxy steroids and intermediates useful therein - Google Patents

Processes for preparation of 9,11-epoxy steroids and intermediates useful therein Download PDF

Info

Publication number
TW593305B
TW593305B TW86118698A TW86118698A TW593305B TW 593305 B TW593305 B TW 593305B TW 86118698 A TW86118698 A TW 86118698A TW 86118698 A TW86118698 A TW 86118698A TW 593305 B TW593305 B TW 593305B
Authority
TW
Taiwan
Prior art keywords
group
formula
alkyl
compound
hydrogen
Prior art date
Application number
TW86118698A
Other languages
Chinese (zh)
Inventor
Chin Liu
Dennis K Anderson
Jon P Lawson
Sastry A Kunda
Leo J Letendre
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of TW593305B publication Critical patent/TW593305B/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Multiple novel reaction schemes, novel process steps and novel intermediates are provided for the synthesis of epoxymexrenone and other compounds of formula I, wherein: -A-A- represents the group -CHR4-CHR5- or -CR4=CR5-; R3, R4 and R5 are independently selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl, lower alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, aryloxy, R1 represents an alpha-oriented lower alkoxycarbonyl or hydroxyalkyl radical, -B-B- represents the group -CHR6-CHR7- or an alpha- or beta-oriented group, where R6 and R7 are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano, aryloxy, and R8 and R9 are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano, aryloxy, or R8 and R9 together comprise a carbocyclic or heterocyclic ring structure, or R8 or R9 together with R6 or R7 comprise a carbocyclic or heterocyclic ring structure fused to the pentacyclic D ring, wherein the intermediates include compounds of formula D, E, F, 211, 210, 209, 208, 207, 206, 205, 204 and 203 as defined in claims 34 to 57.

Description

593305 五、發明説明( 發明背景 本發明係關於製備9,u_環氧類固醇化合物之新類方法, 特別是那些2 0 螺氧垸(响⑽咖)的系列及其類似物,使用 在孩類固醇化合物之製備中的新穎中間物,及製備這 减中間物的万法。最特別的是,本發明係針對製備9山“ 環氧]7α-經基-3_氧代孕留_4_烯〜,2ι_二羧酸氯甲酉匕 ,r -内醋(艾皮樂雷諾(epleren〇ne);環氧美克斯雷諾)的: 和有利之方法。 在美國專利第4,559,332號中描述了製備2〇·螺氧燒系 合物的方法。根據,3 3 2專利之方法產製的化合物,具有 列通式之打開的含氧環E : 下 C請先聞讀背面之注意事項再填寫本頁』 Φ593305 5. Description of the invention (BACKGROUND OF THE INVENTION The present invention relates to a new class of methods for the preparation of 9, u_epoxy steroids, especially those of the 20 spiroxo (sounding coffee) series and their analogs, used in children steroids Novel intermediates in the preparation of compounds, and methods for preparing the intermediates. Most particularly, the present invention is directed to the preparation of 9- "epoxy] 7α-Aceto-3_oxopregnancy_4_ene ~ , 2-methylene chloride dicarboxylate, r-lactone (eplerenone; epoxy mexenolide): and an advantageous method. Preparation is described in US Patent No. 4,559,332 20 · Spiro-oxygen-based compound. The compound produced according to the method of 332 patent has an oxygen ring that is open in the formula E: Please read the precautions on the back before filling in this Page 』Φ

IA -訂 其中 經濟部中央標準局員工消費合作社印製 -A-A-代表基團-CH2-CH2-或_CH=CH-, R1代表方位的低碳數烷氧羰基或羥羰基基團, -Β_Β-代表基團-CH2-CH2-或或方位之基團, ^CH-IA-Ordered by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs -AA- represents the group -CH2-CH2- or _CH = CH-, R1 represents a low-carbon alkoxycarbonyl or hydroxycarbonyl group, -B_Β -Represents a group -CH2-CH2- or a group of orientation, ^ CH-

-CH •C Η* CH--CH • C Η * CH-

III -4- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 經濟部中央標準局員工消費合作社印製 A7 ____ B7 五、發明説明(2 ) R6和R7爲氫, X代表兩個氫原子或氧, γ1和Y2 一起代表氧擒_〇_,或 Y1代表羥基,且 Y2代表羥基、低碳數烷氧基,或如果χ代表H2,也可代 表低碳數烷醯氧基, 以及這類化合物的鹽類,其中χ代表氧且¥2代表輕基, 也就是相當於17/? •羥基_2ΐ-羧酸。 二土 美國專利弟4,559,332號描述了許多製備環氧美克斯雷語 及相關之式1Α化合物的方法。環氧美克斯雷諾新顆和擴大 (臨床用途的到來,產生了料製造這種和其他相關類固 醇之改良方法的需求。 發明概述 本發明的王要目標是提供製備具有共同結構特徵之環氧 美克斯雷諾、其他20-螺氧烷及其他相關類固醇的改良方法 。在本發明特定目標中的有:提供以高產量來產製式^之產 物及其他相關化合物的改良方法;提供涉及最少分離步驟 的這類方法;並提供可利用合理的資金消費來實行,並以 合理的轉換成本來操作的這類方法。 因此,本發明係針對有關環氧美克斯雷諾一連串的合成 計劃;在製造艾皮樂雷諾時用到之中間物;以及這類& 中間物的合成。 、 、在較佳之具體實施例的説明中,詳細地描述了新穎的合 成計劃。在本發明的新穎中間物之中,將在下文中立即^ 本紙張尺度顧悄_縣(CNS) #丨| (讀先閱讀背面之注意事項再填寫本頁)III -4- This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210X 297 mm) 593305 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 ____ B7 V. Description of the invention (2) R6 and R7 are hydrogen, X Represents two hydrogen atoms or oxygen, γ1 and Y2 together represent oxygen _〇_, or Y1 represents a hydroxyl group, and Y2 represents a hydroxyl group, a low-carbon alkoxy group, or if χ represents H2, a low-carbon alkane can also be used. Oxygen, and salts of such compounds, where χ represents oxygen and ¥ 2 represents a light group, which is equivalent to 17 /? Hydroxy_2ΐ-carboxylic acid. Second Earth U.S. Patent No. 4,559,332 describes a number of methods for preparing epoxy Mexley and related compounds of formula 1A. The advent of new epoxy resins and expansion of clinical use (Mexico Reynolds) has created a need for improved methods of manufacturing this and other related steroids. SUMMARY OF THE INVENTION The primary objective of the present invention is to provide the preparation of epoxy resins with common structural characteristics Improved methods of mexanol, other 20-spiroxane, and other related steroids. Among the specific objectives of the present invention are: to provide improved methods for producing products of formula ^ and other related compounds in high yields; This method of separation steps; and provides such methods that can be implemented with reasonable capital consumption and operated at reasonable conversion costs. Therefore, the present invention is directed to a series of synthetic plans related to Epoxy Rex; Intermediates used in the production of Epileur Reynolds; and the synthesis of such & intermediates. In the description of the preferred embodiment, a novel synthesis scheme is described in detail. The novel intermediate in the present invention Among them, it will be immediately in the following ^ This paper size Gu quiet_ 县 (CNS) # 丨 | (Read the precautions on the back before filling this page)

、1T 1· 593305 ΑΊΒ7 五、發明説明(3 ) 述那些。 式IV化合物符合下列結構:1T 593305 ΑΊΒ7 V. Description of the invention (3) Those mentioned. The compound of formula IV conforms to the following structure:

IV 其中 -Α·Α-代表基團 _CHR4_CHR5·或_Cr4 = cr5_ R3、R4和R5分別選自包括氫、_素、禮基、低碳數燒基、 低碳數烷氧基、羥烷基、烷氧烷基、羥羰基'氰基、芳氧 基’ R1代表方位之低碳數烷氧羰基或羥羰基基團, R2爲11 釋離基,它的除去有效地在9_* u_碳原子之 間產生一個雙鍵; -B-B -代表基團-CHR6_CHR7-或從-或方位之基團: (請先閱讀背面之注意事項再填寫本頁j 、-口 Γ 經濟部中央標準局員工消費合作社印製 VCH- -CH — C Hj •CH I •CH-IV where -Α · Α- represents a group _CHR4_CHR5 · or _Cr4 = cr5_ R3, R4, and R5 are respectively selected from the group consisting of hydrogen, hydrogen, ceryl, low-carbon alkyl, low-carbon alkoxy, and hydroxyalkane Group, alkoxyalkyl, hydroxycarbonyl 'cyano, aryloxy' R1 represents a low-carbon alkoxycarbonyl or hydroxycarbonyl group, R2 is an 11-releasing group, and its removal is effective at 9_ * u_ There is a double bond between the carbon atoms; -BB-represents the group -CHR6_CHR7- or the group from-or orientation: (Please read the notes on the back before filling in this page j,-口 Γ Staff of the Central Standards Bureau of the Ministry of Economic Affairs Printed by Consumer Cooperatives VCH- -CH — C Hj • CH I • CH-

III 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基、醯 基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧羰基、醯氧 烷基、氰基、芳氧基,且 R8和R9分別選自包括氫、鹵素、低碳數统氧基、醯基、 6- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五、發明説明(4 羥烷基、烷氧烷基、羥羰基、烷基、烷氧羰基、醯氧烷基 、氰基、芳氧基,或是…和尺9一起包含一碳環或雜環之 結構,或是R8或…與…或尺7一起包含—碳環或雜環結構 ’融合成五每·之Γ)環。 式IV A化合物相當於其中R8和R9以環碳將其附接在一起 形成下列結構的式IV化合物: Χ,π • A·】III wherein R6 and R7 are selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, fluorenylalkyl, cyano, Aryloxy, and R8 and R9 are selected from the group consisting of hydrogen, halogen, low carbon number oxygen, fluorenyl, 6- This paper size is applicable to China National Standard (CNS) A4 specifications (210X297 mm) 593305 A7 B7 V. Description of the Invention (4-Hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, alkoxyalkyl, cyano, aryloxy, or ... containing a carbocyclic or heterocyclic ring Structure, or R8 or… together with… or feet 7-carbocyclic or heterocyclic structure 'fused into five per Γ) ring. The compound of formula IV A is equivalent to the compound of formula IV in which R8 and R9 are attached together with a ring carbon to form the following structure: χ, π • A ·]

XXXIV 其中X、Y1、Y2和C(l7)均如同上文之定義。 式IVB化合物相當於其中R8和R9 一起形成χχχιπ之結 構的式IVA化合物: Λ XXXII工 經濟、部中央標準局員工消費合作社印製 式IVC、IVD和IVE之化合物,分別相當於其中每個-A_ A-和-B-B·分別爲-CH2_CH2-,R3爲氫且R1爲烷氧羰基,最 好是甲氧羰基的任何式IV、IV A或IV B。在式IV範園中 的化合物,可藉著使低碳數烷基磺醯基化或醯基化試劑, 或是產生卣化物之試劑與在式V之範圍内的相對應化合物反 應來製備之。 式V化合物符合下列結構: 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)XXXIV where X, Y1, Y2 and C (l7) are as defined above. The compound of formula IVB is equivalent to the compound of formula IVA in which R8 and R9 together form a structure of χχχιπ: Λ XXXII The compounds of formula IVC, IVD, and IVE printed by the Industrial Cooperative, Ministry of Standards, and Consumer Cooperatives, respectively, are equivalent to each of -A_ A- and -BB. Are -CH2-CH2-, R3 is hydrogen and R1 is an alkoxycarbonyl group, preferably any of formula IV, IV A or IV B of methoxycarbonyl. Compounds in the formula IV range can be prepared by reacting a low-carbon alkylsulfonyl or sulfonating reagent, or a reagent that generates a halide with a corresponding compound in the range of formula V . The compound of formula V conforms to the following structure: This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page)

593305 A7 B7 五、發明説明(593305 A7 B7 V. Description of the invention (

V 其中-A_A-、-B-B-、R1、R3、R>R9如同在式…中之定義。 式V A化合物相當於其中R8和R9以環碳將其附接在一起, 形成下列結構的式V化合物: (請先閱讀背面之注意事項再填寫本頁) \ //\17>V wherein -A_A-, -B-B-, R1, R3, R > R9 are as defined in the formula ... The compound of formula V A is equivalent to the compound of formula V in which R8 and R9 are attached together with a ring carbon to form the following structure: (Please read the precautions on the back before filling this page) \ // \ 17 >

CH τ j) tCH τ j) t

XXXIV 其中X、Y1、γ2和C(l7)均如同上文之定義。 式VB化合物相當於其中R8和R9 一起形成式χχχιπ之結構 的式VA化合物: 訂 〇 Λ 經濟部中央標準局員工消費合作社印掣XXXIV where X, Y1, γ2, and C (l7) are as defined above. The compound of formula VB is equivalent to the compound of formula VA in which R8 and R9 together form a structure of formula χχχιπ: Λ Λ Printed by the staff consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

XXXIII 式VC、VD和VE之化合物,分別相當於其中每個-A-A- 和·Β·Β·分別爲-CH2-CH2-,R3爲氫且R1爲烷氧羰基,最好是 甲氧談基的任何式V、VA或VB。在式V範圍中的化合物, 可藉著使驗金屬烷氧化物與相對應的式VI化合物反應來製 備之。 式VI化合物符合下列結構: 本紙張尺度適财_家轉(CNS) M規格(2iGX297公襲) 593305 A7 B7XXXIII Compounds of formula VC, VD and VE are equivalent to each of -AA- and · Β · Β · are -CH2-CH2-, R3 is hydrogen and R1 is alkoxycarbonyl, preferably methoxyl Of any formula V, VA or VB. Compounds in the range of formula V can be prepared by reacting a metal alkoxide with a corresponding compound of formula VI. The compound of formula VI conforms to the following structure: This paper is suitable for financial use _ Jia Zhuan (CNS) M specification (2iGX297 public attack) 593305 A7 B7

〇 五、發明説明(6〇 5. Description of the invention (6

VI 其中_Α-Α-、-Β-Β-、R3、R8和R9如同在SIV中之定義。 式VIA化合物相當於其中R8和R9以環碳將其附接在一起 ’形成下列結構的式VI化合物: γ,\ / f* /\ίΤ)VI where _Α-Α-, -Β-Β-, R3, R8, and R9 are as defined in SIV. The compound of formula VIA is equivalent to the compound of formula VI in which R8 and R9 are attached together with a ring carbon to form the following structure: γ, \ / f * / \ ίΤ)

XXXIV 其中Χ'Υ1、Υ2和C(17)均如同上文之定義。 式vIB化合物相當於其中…和以9 一起形成式χχχιπ之 結構的式VIΑ化合物: 〇 Λ XXXI工工 式VIC、VID和VIE之化合物’分別相當於其中每個 -A-A-和 -B-B-分別爲-CH2-CH2-且R3爲氫的任何式VI、via*ViB。 式V!、VIA、VIB和V!C係分別藉著水解相當於式νπ、 VIIA、VIIB或VIIC的化合物來製備之。 式VII化合物符合下列結構: 本紙張尺度適用中國國家標準(CNS ) A4規格( (讀先閱讀背面之注意事項再填寫本頁)XXXIV where X′Υ1, Υ2 and C (17) are as defined above. A compound of formula vIB is equivalent to a compound of formula VIA in which ... and a structure of formula χχχιπ are formed together: 〇Λ XXXI compounds of formulas VIC, VID, and VIE are equivalent to each of -AA- and -BB- -CH2-CH2- and any of Formula VI, via * ViB, where R3 is hydrogen. Formulas V !, VIA, VIB and V! C are prepared by hydrolyzing compounds corresponding to formula νπ, VIIA, VIIB or VIIC, respectively. The compound of formula VII conforms to the following structure: This paper size applies to the Chinese National Standard (CNS) A4 specification ((Read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印製 593305 A7 B7 五、發明説明(Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 B7 V. Description of Invention (

VII 其中-A_A、-B-B-、R3、R8和R9如同在式IV中之定義。式VIIA化合物相當於其中R8和R9以環碳將其附接在 ,形成下列結構的式VII化合物: 起 (請先閱讀背面之注意事項再·填寫本頁)VII wherein -A_A, -B-B-, R3, R8 and R9 are as defined in formula IV. The compound of formula VIIA is equivalent to the compound of formula VII in which R8 and R9 are attached to the ring carbon to form the following structure: (Please read the precautions on the back before filling in this page)

(CH(CH

XXXIV 其中Χ、γΐ、γ2和C(17)均如同上文之定義。式VIIB化合物相當於其中R8和R9 —起形成式XXXIII之結 構的式VIIA化合物: 經濟部中央標準局員工消費合作社印製 〇 Λ XXX工工工 式VIIC、VIID和VIIE之化合物,分別相當於其中每個- A-A、-B-B-分別爲-CH2_CH2-且R3爲氫的任何式VII、VIIA或 VIIB。在式VII範圍内的化合物,可藉著在式VIII範圍内之化 -10- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五、發明説明(8 ) 合物的氰化作用來製備之。 式VIII化合物符合下列結構:XXXIV where X, γΐ, γ2 and C (17) are as defined above. The compound of formula VIIB is equivalent to the compound of formula VIIA in which R8 and R9 together form the structure of formula XXXIII: printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, ΛΛXXX compounds of formula VIIC, VIID and VIIE, which are equivalent to them respectively Each -AA, -BB- is -CH2-CH2-, and R3 is any of formula VII, VIIA or VIIB, respectively. Compounds in the range of formula VII can be converted by the formula VIII-10- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 A7 B7 V. Description of the invention (8) Cyanation to prepare it. The compound of formula VIII conforms to the following structure:

其中-A-A、-B-B-、R3、R8和R9如同在式IV中之定義。Wherein -A-A, -B-B-, R3, R8, and R9 are as defined in Formula IV.

VIII 式VIIIA化合物相當於其中R8和R9以環碳將其附接在一起 形成下列結構的式VIII化合物:VIII A compound of formula VIIIA is equivalent to a compound of formula VIII in which R8 and R9 are attached together as a ring carbon to form the following structure:

γ\/ I 义 17> 丨Iim (ch2) 2 ·〇_χγ \ / I meaning 17 > 丨 Iim (ch2) 2 · 〇_χ

\ XXXIV 其中X、Υ1、Υ2和C(17)均如同上文之定義。 式VIIIB化合物相當於其中R8和R9—起形成式XXXIII之結 構的式VIIIA化合物: 〇\ XXXIV where X, Υ1, Υ2, and C (17) are as defined above. The compound of formula VIIIB corresponds to the compound of formula VIIIA in which R8 and R9 together form the structure of formula XXXIII:

(請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

XXXIII 經濟部中央標準局員工消費合作社印製 式VIIIC、VIIID和VIIIE之化合物,分別相當於'其中每個-A-A-和-B-B-分別爲-CH2-CH2·且R3爲氫的任何式VIII、 VIIIA或VIIIB。在式VIII範圍内的化合物,可藉著氧化包括 如同在下文中描述之式XXX化合物的受酶質,經由發酵作用 有效地將11-#呈基基團以α -方位導入該受酶質來製備之。 -11 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 593305 A7 B7 五、發明説明(9 式XIV化合物符合下列結構:XXXIII The compounds of formulas VIIIC, VIIID, and VIIIE printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs are equivalent to any formula VIII, where each of -AA- and -BB- are -CH2-CH2, and R3 is hydrogen, respectively. VIIIA or VIIIB. Compounds in the range of formula VIII can be prepared by oxidizing the enzymatic substance including the compound of formula XXX as described below, and efficiently introducing an 11- # group into the enzymatic substance in an α-position via fermentation. Of it. -11 This paper size applies to Chinese National Standard (CNS) A4 specification (210 × 297 mm) 593305 A7 B7 5. Description of the invention (9 The compound of formula XIV conforms to the following structure:

AXIV 其中-A-A-、-B-B-、R3、R8和R9如同在式IV中之定義。 式XIVA化合物相當於其中R8和R9以環碳將其附接在一 起,形成下列結構的式XIV化合物:AXIV wherein -A-A-, -B-B-, R3, R8 and R9 are as defined in Formula IV. The compound of formula XIVA is equivalent to the compound of formula XIV in which R8 and R9 are attached together with a ring carbon to form the following structure:

I Υ\/ ί C( 1 7) mill ( CH2) z . o-xI Υ \ / ί C (1 7) mill (CH2) z. O-x

/ \ XXXIV 其中X、Y1、Y2和C(17)均如同上文之定義。 式XIVB化合物相當於其中R8和R9以環碳將其附接在一起, 形成式XXXIII之結構的式XIVA化合物: 經濟部中央標準局員工消費合作社印製/ \ XXXIV where X, Y1, Y2, and C (17) are as defined above. The compound of formula XIVB is equivalent to the compound of formula XIVA in which R8 and R9 are attached together with a ring carbon to form a structure of formula XXXIII: Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

(請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

XXXIII 式XIVC、XIVD和XIVE之化合物,分別相當於其中每 個-A-A-和-B-B·分別爲- CH2-CH2_且R3爲氫的任何式XIV、 XIVA或XIVB。在式XIV範圍内的化合物,可藉著水解在式 XV範圍内的相對應化合物來製備之。 -12- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7XXXIII The compounds of the formulae XIVC, XIVD and XIVE are equivalent to any of the formulae XIV, XIVA or XIVB in which each of -A-A- and -B-B is -CH2-CH2_ and R3 is hydrogen, respectively. Compounds in the range of formula XIV can be prepared by hydrolyzing the corresponding compounds in the range of formula XV. -12- This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 593305 A7 B7

五、發明説明(1G 式XV化合物符合下列結構V. Description of the invention (1G compound of formula XV conforms to the following structure

AXV •其中、-B-B-、R3、R8和R9如同在式…中之定義。 式XVA化合物相當於其中R8和R9以環碳將其附=在一起 ,形成下列結構的式XV化合物: (請先閱讀背面之注意事項再填寫本頁) \ / C( 1 7) mill ( ch2) 2. ό-χAXV • where -B-B-, R3, R8, and R9 are as defined in the formula ... A compound of formula XVA is equivalent to a compound of formula XV in which R8 and R9 are attached together with a ring carbon to form the following structure: (Please read the precautions on the back before filling this page) \ / C (1 7) mill (ch2 ) 2. ό-χ

XXXIV 、-口 經濟部中央標準局員工消費合作社印製XXXIV 、 -port Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

XXXIII 其中X、Υ1、Υ2和c(17)均如同上文之定義。 式XVB化合物相當於其中R8和R9以環碳將其附接在一起 ,形成式XXXIII之結構的式XVA化合物: 〇 Λ ',πιι/ 式XVC、XVD和XVE之化合物,分別相當於其中每個〜 A和-B-B·分別爲-CHyCH2-且R3爲氲的任何式χν、χνΑ XVB。在式XV範圍的化合物,可藉著在式χνι範圍内之 對應化合物的氰化作用來製備之。 -13- +紙張尺度適用中國國家標準(CNS ) A4規格( 593305 經濟部中央標準局員工消費合作社印製 A7 _B7 五、發明説明(11 ) 式XXI化合物符合下列結構:XXXIII where X, Υ1, Υ2 and c (17) are as defined above. A compound of formula XVB is equivalent to a compound of formula XVA in which R8 and R9 are attached together with a ring carbon to form a structure of formula XXXIII: 〇Λ ', πιι / Compounds of formula XVC, XVD, and XVE, respectively corresponding to each of them ~ A and -BB · are any of the formulas χν, χνΑ XVB which are -CHyCH2- and R3 is 氲, respectively. Compounds in the range of formula XV can be prepared by cyanation of the corresponding compounds in the range of formula χνι. -13- + Paper size applies to Chinese National Standard (CNS) A4 specifications (593305 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A7 _B7 V. Description of the invention (11) The compound of formula XXI conforms to the following structure:

XXI 其中_A-A-、-B-B_、R3、R8和R9如同在式IV中之定義。 式XXIA化合物相當於其中R8和R9以環碳將其附接在一 起,形成下列結構的式XXI化合物: νι « Y\/ r /C^t7) ,,M,* (CH2)2 .〇-x xxxiv 其中X、Y1、Y2和c(17)均如同上文之定義。 式XXIB化合物相當於其中R8和R9 一起形成式 結構的式ΧΧΙΑ化合物:XXI where _A-A-, -B-B_, R3, R8, and R9 are as defined in Formula IV. The compound of formula XXIA is equivalent to the compound of formula XXI in which R8 and R9 are attached together with a ring carbon to form the following structure: νι «Y \ / r / C ^ t7) ,, M, * (CH2) 2 .〇- x xxxiv where X, Y1, Y2, and c (17) are as defined above. A compound of formula XXIB is equivalent to a compound of formula XXIA where R8 and R9 together form a formula:

QQ

式XXIC、XXID和ΧΧΙΕ之化合物,分別相當於其中每 個-Α-ΑϋΒ_分別爲-Ch2-Ch2•且R3爲氫的任何式χχι、 XXIA或XXIB。在式xxm圍内的化合物,可藉著水解在 式X X11範圍内的相對應化合物來製備之。 -14- 本紙張尺度適用巾S國家標準(CNS ) A4規格(2I0X 297公釐)" (請先閱讀背面之注意事項再填寫本頁)The compounds of the formulae XXIC, XXID and XXIXE respectively correspond to any of the formulas χχι, XXIA or XXIB in which each of -A-ΑϋΒ_ is -Ch2-Ch2 • and R3 is hydrogen. Compounds in the range of formula xxm can be prepared by hydrolyzing the corresponding compounds in the range of formula X X11. -14- The national standard (CNS) A4 size (2I0X 297 mm) of this paper size applies (Please read the precautions on the back before filling this page)

593305 A7 B7 五、發明説明(12 式X X Π化合物符合下列結構:593305 A7 B7 5. Description of the invention (12 compounds of formula X X Π conform to the following structure:

XXII 其中-A-A-、-B_B_、R3、R8和R9如同在式IV中之定M 式XXIIA化合物相當於其中R8和R9以環碳將其附接在一 起,形成下列結構的式X X11化合物: r\ / I C( 1 7) mill ( CH“复· ό_)XXII where -AA-, -B_B_, R3, R8, and R9 are as defined in Formula IV. A compound of formula XXIIA is equivalent to a compound of formula X X11 in which R8 and R9 are attached together with a ring carbon to form the following structure: r \ / IC (1 7) mill (CH “复 · ό_)

XXXIV 其中Χ'Υ1、Υ2和C(17)均如同上文之定義。 式XXIIB化合物相當於其中R8和R9—起形成式χχχιη 之結構的式XXIIΑ化合物: (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 Λ \im/ XXX工工工 式XXIIC、XXIID和XXIIE之化合物,分別相當於其中 每個- A-A-和-Β·Β-分別爲-CH2-CH2-且R3爲氫的任何式 XXII、XXIIA或XXIIB。在式XXII範圍内的化合物,可 藉著在式XXIII範圍内之相對應化合物的氰化作用來製備之。 -15- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五、發明説明(13 式XXIII化合物符合下列結構:XXXIV where X′Υ1, Υ2 and C (17) are as defined above. The compound of formula XXIIB is equivalent to the compound of formula XXIIΑ in which R8 and R9 form a structure of formula χχχιη: (Please read the precautions on the back before filling out this page) Printed by the Consumers Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Λ \ im / XXX 工Compounds of the formulae XXIIC, XXIID and XXIIE are equivalent to any of formula XXII, XXIIA or XXIIB in which each -AA- and -B · B- are -CH2-CH2- and R3 is hydrogen, respectively. Compounds in the range of formula XXII can be prepared by cyanation of corresponding compounds in the range of formula XXIII. -15- The dimensions of this paper are applicable to Chinese National Standard (CNS) A4 (210X297 mm) 593305 A7 B7 V. Description of the invention (13 The compound of formula XXIII conforms to the following structure:

XXIII 其中、-B-B_、R3、R8和R9如同在SIV中之定義。1 式XXIIIA化合物相當於其中R8和R9以環碳將其附接在 一起,形成下列結構的式X X111化合物: \ / Π mm ( ch2)XXIII where -B-B_, R3, R8 and R9 are as defined in SIV. 1 The compound of formula XXIIIA is equivalent to the compound of formula X X111 in which R8 and R9 are attached together with a ring carbon to form the following structure: \ / Π mm (ch2)

XXXIV 其中X、Y1、Y2和C(17)均如同上文之定義。 式XXIIIB化合物相當於其中R8和R9—起形成式χχχπι 之結構的式ΧΧΠΙΑ化合物:XXXIV where X, Y1, Y2 and C (17) are as defined above. The compound of formula XXIIIB is equivalent to the compound of formula XXIIIA where R8 and R9 together form a structure of formula χχχπι:

(請先閲讀背面之注意事項再填寫本頁}(Please read the notes on the back before filling this page}

訂 經濟部中央標準局員工消費合作社印製 XXXIII 式XXIIIC、XXIIID和XXIIIE之化合物,分別相當於 其中每個-A-A-和-B-B·分別爲-CH2-CH2-且R3爲氫的任何式 XXIII、XXIIIA或XXIIIB。在式XXIII範圍内的化合物 ,可藉著在式XXIV範圍内之相對應化合物的氧化作用來製 備之,如同在下文中的描述。 式1 0 4之化合物符合下列結構: -16- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公楚) 593305 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(14 ΟIt is required to print compounds of formula XXXIII of formula XXIIIC, XXIIID, and XXIIIE by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, which are equivalent to any formula XXIII in which each -AA- and -BB · are -CH2-CH2- and R3 is hydrogen XXIIIA or XXIIIB. Compounds in the range of formula XXIII can be prepared by oxidation of the corresponding compounds in the range of formula XXIV, as described below. The compound of formula 104 conforms to the following structure: -16- This paper size applies to the Chinese National Standard (CNS) A4 specification (210X297 Gongchu) 593305 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (14 〇

104 其中_A_A_、_B_B_和R3如同在式以中之定義,且r11爲Ci至q 燒基。 式104A之化合物’相當於其中每個_a_a_*_b_b_分別爲_ CH^CH2-且R3爲氯的式1〇4之化合物。在式1〇4範圍内的化合物 ,可藉著在式103之化合物的熱分解作用來製備之。 式1 0 3之化合物符合下列結構: 〇104 where _A_A_, _B_B_, and R3 are as defined in the formula, and r11 is Ci to q alkyl. The compound of formula 104A 'is equivalent to a compound of formula 104 in which each of _a_a _ * _ b_b_ is _CH ^ CH2- and R3 is chloro. Compounds in the range of Formula 104 can be prepared by thermal decomposition of compounds in Formula 103. The compound of formula 103 has the following structure:

CO〆 103 其中-A-A-、-B-B·和R3和R11如同在式1〇4中之定義。 式103A之化合物,相當於其中每個_a_a_*_b_b_分別爲-CI^-CH2-且R3爲氫的式1〇3之化合物。在式1〇3範圍内的化 合物,可藉著式102之相對應化合物與丙二酸二烷基酯,在 (請先閱讀背面之注意事項再填寫本頁)CO <103> wherein -A-A-, -B-B ·, and R3 and R11 are as defined in Formula 104. The compound of formula 103A is equivalent to the compound of formula 103 in which each of _a_a _ * _ b_b_ is -CI ^ -CH2- and R3 is hydrogen. For compounds in the range of Formula 103, the corresponding compound of Formula 102 and dialkyl malonate can be used (Please read the precautions on the back before filling this page)

-17- 593305 R3-17- 593305 R3

其中-Am、R3和RU如同在式1〇4中之定義。 〇Where -Am, R3 and RU are as defined in Formula 104. 〇

經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(IS ) 諸如驗金狀氧化物之㈣的存在下反應來製備之 式1 0 2之化合物符合下列結構: 102 式102A之化合物,相當於其中每個_a_a_*_b_b_分別 爲- CH^CH2-且R3爲氫的式1〇2之化合物。在式1 〇2範圍内的 化合物,可藉著式1〇1之相對應化合物與三烷基锍,在鹼的 存在下反應來製備之。 式1 0 1之化合物符合下列結構· 101 其中 Α-Α_、·Β-Β-、R3和R11如同在式1〇4中之定義。 式101Α之化合物,相當於其中每個-α_α*_β_β_分別爲 CH^CH2-且R3爲氫的式1〇丨之化合物。在式1〇丨範園内的价 合物,可藉著1 1 “ 羥基雄留烯_3,17_二酮或其他的^ XXXVI化合物與原甲酸三烷基酯,在酸的存在下反應來^ 備之。 〜 -18- 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇χ 297公釐) (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (IS) The compound of formula 102 prepared by the reaction in the presence of osmium oxide, such as a gold test compound, conforms to the following structure: 102 Compound of formula 102A, Corresponding to a compound of formula 102 in which each of _a_a _ * _ b_b_ is -CH ^ CH2- and R3 is hydrogen. A compound in the range of Formula 102 can be prepared by reacting a corresponding compound of Formula 101 with a trialkylphosphonium in the presence of a base. The compound of the formula 101 corresponds to the following structure: 101 where Α-Α_, Β-Β-, R3 and R11 are as defined in the formula 104. The compound of formula 101A is equivalent to the compound of formula 10 in which each of -α_α * _β_β_ is CH ^ CH2- and R3 is hydrogen. The valence compound in the formula 10 can be reacted with trialkyl orthoformate in the presence of an acid by means of 1 1 "hydroxyandrostene-3,17_dione or other ^ XXXVI compounds ^ Be prepared. ~ -18- This paper size applies Chinese National Standard (CNS) Α4 size (21〇χ 297 mm) (Please read the precautions on the back before filling this page)

593305 A7 B7 五、發明説明(16 ) 式XL之化合物符合下列結構:593305 A7 B7 5. Description of the invention (16) The compound of formula XL conforms to the following structure:

9090

XL 其中-E-E-係選自下列之中 、R”| XL工工工 (請先閱讀背面之注意事項再填寫本頁) :c - c-XL where -E-E- is selected from the following, R "| XL workers (please read the precautions on the back before filling this page): c-c-

XLIV ·〆4 、βμΙ C— cXLIV · 〆4, βμΙ C— c

XLV ONIC, 經濟部中央標準局員工消費合作社印製XLV ONIC, printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

:lc—R XLVI y 和 XLV工工 19-本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五 發明説明(17 汉“爲…至^烷基,或是Rl8〇_基團—起形成_ 境基橋,R”、R”和R”分別選自氫、燒基、南素乳:: 和氰基’ R24it自氫和低碳數燒基’ r8&gt;r9()分別選自二 和包括R和R (如同上文之定義,參照式…),和如同在式 104中定義之-A-A-、-B-B-、R3的取代基。 ’ 式XL A之化合物相當於其中r2i、r22和r23分別選自氣 、鹵素和低碳數烷基的式XL。 工 式XLB之化合物相當於其中_E_E_符合式XLU、 、又1^¥或又1^¥11的式乂1^八。式又1^之化合物相當於其中_ E-E_符合式XLV的式XLB。式XLD之化合物相當於其中_ E-E-符合式XLVII的式XLB。 式XIE之化合物相當於其中r8Q和r9❶與附接於其上之環 碳原子一起,包括酮或: \/, I 7) mm ( ch8) ^ . 〇m): lc—R XLVI y and XLV workers 19- This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297 mm) 593305 A7 B7 Five invention descriptions (17 Han "is ... to ^ alkyl, or Rl8 〇_Group—from the formation of the _environmental bridge, R ", R" and R "are selected from the group consisting of hydrogen, alkynyl, and sulfonamide: and cyano 'R24it from hydrogen and low carbon number alkynyl' r8> r9 () Are selected from di and include R and R (as defined above, with reference to formula ...), and substituents -AA-, -BB-, R3 as defined in formula 104, respectively. 'Compounds of formula XL A Equivalent to formula XL in which r2i, r22 and r23 are selected from the group consisting of gas, halogen, and low-carbon alkyl, respectively. Compounds of formula XLB are equivalent to _E_E_ which conform to formula XLU,, and 1 ^ ¥ or 1 ^ ¥ 11 The compound of the formula 乂 1 ^ 八. The compound of the formula 1 又 is equivalent to the formula XLB where _E-E_ conforms to the formula XLV. The compound of the formula XLD corresponds to the formula XLB where EE- complies with the formula XLVII. The compound of the formula XIE is equivalent In which r8Q and r9❶ are together with the ring carbon atom attached thereto, including a ketone or: \ /, I 7) mm (ch8) ^. 〇m)

XXXIV (請先閱讀背面之注意事項再填寫本頁) •举, 11 經濟部中央標準局員工消費合作社印f 其中Χ'Υ1、γ2和c(17)均如同上文之定義 式 XLF、XLG、XLH、XLJ、XLM 和 XLN 之化合物, 分別相當於其中_ A-A-和-B-B-和R3如同上文之定義的式xl、 XLA、XLB、XLC、XLD和XLE 〇 式XL I之化合物符合下列結構:XXXIV (Please read the notes on the back before filling out this page) • For example, 11 The Consumer Cooperatives' Seal of the Central Standards Bureau of the Ministry of Economic Affairs f where X′Υ1, γ2, and c (17) are the same as defined above. XLF, XLG, The compounds of XLH, XLJ, XLM and XLN are equivalent to _ AA- and -BB- and R3, respectively, as defined above. The compounds of formula xl, XLA, XLB, XLC, XLD and XLE. The compounds of formula XL I conform to the following structure. :

(參見計劃9 ) XLI 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 五 、發明説明(I8 其中-E-E-選自包括: R*s 、Re,| 0*— C- :C - c— t1〇R24 、Rm| C—Q—,u OR \l c~ 24 A7 B7 xLXli XLiv(See plan 9) XLI This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) V. Description of the invention (I8 where -EE- is selected from the group consisting of: R * s, Re, | 0 * — C-: C-c— t1〇R24, Rm | C—Q—, u OR \ lc ~ 24 A7 B7 xLXli XLiv

XLV 和XLV and

•L XLVi :cfibR- XLVI i 經濟部中央榡準局員工消費合作社印製• L XLVi: cfibR- XLVI i Printed by the Consumers' Cooperative of the Central Government Bureau of the Ministry of Economic Affairs

Rl8爲Cl至C4烷基,或是R18〇 &amp;基橋,R21、R22和r23分別選自氫、減、齒素 和最基’ r24選自氫和低碳數燒基,r8〇和r9G分別選自 和包括R和化9(如同上文之定義,參照式IV),和如同在 104中定義之-A-A-、-B-B_、R3的取代基。 式XLIA之化合物相當於其中、R22和R23分別選自 、鹵素和低碳數烷基的式XLI。 、 式XLIB之化合物相當於其中符合式XLIn、 、XLV 或 XLVII 的式 XLIA。 XLIC之化合物相當於其中和r9〇與附接於其上的 基團一起形成〇,〇R18 is Cl to C4 alkyl, or R18O &amp; base bridge, R21, R22 and r23 are selected from hydrogen, minus, halogen, and radical, respectively; r24 is selected from hydrogen and low carbon number alkyl, r80 and r9G And a substituent selected from and including R and R 9 (as defined above, with reference to Formula IV), and -AA-, -B-B_, and R3 as defined in 104, respectively. The compound of the formula XLIA is equivalent to the formula XLI in which R22 and R23 are selected from the group consisting of halogen, and a lower alkyl group, respectively. The compound of the formula XLIB corresponds to the formula XLIA in which the formula XLIn, XXL or XLVII is met. The compound of XLIC is equivalent to that in which r9 is formed together with the group attached to it.

(請先閲讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

593305 A7 B7 五、發明説明(I9 ) 碳原子一起,含有酮或下式的式XL 1: \ / ] 7) mu, ( 〇h8) f .593305 A7 B7 V. Description of the invention (I9) Carbon atoms together, containing ketones or the following formula XL 1: \ /] 7) mu, (〇h8) f.

XXXIVXXXIV

其中X、Y1、Y2和C(l7)均如同上文之定義。 式XL ID之化合物相當於其中取代基χχχΙν符合結構 XXXIII 之式 XLID r\ / f /〈in mm (ch2)2X, Y1, Y2, and C (l7) are as defined above. The compound of the formula XL ID is equivalent to the formula XLID r \ / f / <in mm (ch2) 2 in which the substituent χχχΙν conforms to the structure XXXIII

XXXIV 广讀先聞讀背面1注意事項真填寫本fo 式XL IE之化合物相當於其中R8〇和R9〇 一起形成酮的式 XL。 式 XLIF、XLIG、XLIH、XLIJ、xlim 和 XLIN 之化合 物’分別相當於其中- A- A_、-和R3如同上文之定義 的式 XLI、XLIA、XLIB、XLIC、xlid 和 XLIE。在式 XLI範圍内的化合物,可藉著如同下文定義之式又乙之相對 應化合物的水解作用來製備之。 式XLII之化合物符合下式: --訂 經濟部中央標準局員工消費合作社印製XXXIV Read extensively first and read the back 1 Note that the compounds of formula XL IE that are really filled in are equivalent to formula XL in which R80 and R90 together form a ketone. The compounds of the formulas XLIF, XLIG, XLIH, XLIJ, xlim and XLIN are equivalent to the formulas XLI, XLIA, XLIB, XLIC, xlid and XLIE, respectively, where -A-A_,-and R3 are as defined above. Compounds in the range of formula XLI can be prepared by hydrolysis of the corresponding compounds of formula B and B as defined below. The compound of formula XLII conforms to the following formula:-Ordered by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

.η • 0 XL·工工 -22- 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 593305 A7 B7 五、發明説明(2〇 c—c- :C - c-.η • 0 XL · Gonggong -22- The paper size applies to Chinese National Standard (CNS) A4 (21 OX 297 mm) 593305 A7 B7 V. Description of the invention (20 c-c-: C-c-

XLIII XLIV if -c— 24XLIII XLIV if -c— 24

XLV OR24,、i— R41XLV OR24, i— R41

XLVI 和 經濟部中央標準局員工消費合作社印製Printed by XLVI and the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

f XLVII R21、R”和R23分別選自氫、烷基、齒素、硝基和氰基、 Rj4選自氫和低碳數烷基,R8〇*R9G分別選自酮和可包括 R和R ,且·Α-Α-、-Β-Β_、Ι13如同在式ι〇4中之定義的 取代基。 式XLIIA之化合物相當於其中R2!、尺22和尺23分別選自 氫、卣素和低碳數烷基的式XL j j。 式XLIIB之化合物相當於其中-Ε·Ε_符合式XLni、 XLIV、XLV 或 XLVII 之式 XLIIA。 &lt; 式XLIIC之化合物相當於其中r8〇和r9〇與附接於其上之 環碳原子一起,含有酮或下式的式XLII: γι 慶 Y\ / τmm ( che) t XXXIV 23- 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) (請先閱讀背面之注意事項再填寫本頁)f XLVII R21, R "and R23 are selected from hydrogen, alkyl, halo, nitro and cyano, Rj4 is selected from hydrogen and low-carbon alkyl, R80 * R9G is selected from ketone and may include R and R And Α-Α-, -Β-Β_, Ι13 are the same as the substituents defined in formula ι04. The compound of formula XLIIA is equivalent to wherein R2 !, 22 and 23 are selected from hydrogen, halogen and A low-carbon alkyl group of the formula XL jj. A compound of the formula XLIIB corresponds to the formula XLIIA where -E · E_ conforms to the formula XLni, XLIV, XLV or XLVII. &Lt; A compound of the formula XLIIC corresponds to where r80 and r90 are equal to The ring carbon atom attached to it contains a ketone or the following formula XLII: γι Qing Y \ / τmm (che) t XXXIV 23- This paper size applies to the Chinese National Standard (CNS) A4 specification (21 OX 297) Li) (Please read the notes on the back before filling this page)

593305 A7 B7 五、發明説明(21 其中X'Y1、Y2和C(17)均如同上文之定義。 式XL I ID之化合物相當於其中取代基XX XIV符合結構 XXXIII 之式 XLIID 〇593305 A7 B7 V. Description of the invention (21 where X'Y1, Y2, and C (17) are as defined above. The compound of formula XL I ID is equivalent to the formula in which the substituent XX XIV conforms to the structure XXXIII XLIID 〇

XXXII工 式XLIIE之化合物相當於其中R8〇和r9G 一起形成酮的式 XLIID。式 XLIIF、XLIIG、XLIIH、XLIIJ、XLIIM 和 XLIIN之化合物,分別相當於其中_Α_ΑϋΒ_分別爲_CH2_ CH2,且爲氫的式 XLII、XLIIA、XLIIB、XLIIC、 XLIID和XLIIE。在式XLII範圍内的化合物,可藉著式 X LI之相對應化合物的脱保護作用來製備之。 式XLIX之化合物符合下列結構:The compound of the XXXII formula XLIIE is equivalent to the formula XLIID in which R80 and r9G together form a ketone. The compounds of the formulas XLIIF, XLIIG, XLIIH, XLIIJ, XLIIM and XLIIN are respectively equivalent to the formulas XLII, XLIIA, XLIIB, XLIIC, XLIID and XLIIE where _Α_ΑϋΒ_ is _CH2_ CH2, respectively, and is hydrogen. Compounds in the range of formula XLII can be prepared by deprotecting the corresponding compounds of formula X LI. The compound of formula XLIX conforms to the following structure:

R ·

XLIX (讀先閱讀背面之注意事項再填寫本頁) _^.XLIX (Read the precautions on the back before filling this page) _ ^.

、1T 經濟部中央標準局員工消費合作社印製 其中-E-E-如同在式XL中之定義,且_a_a_、_b_b. 、R1、R3、R8和R9如同在式V中之定義。 式XLIXA之化合物,相當於其中附接於其上的 環碳一起形成下列結構之式XLIX: -E-E· \ ^CM7) -24-, 1T Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs where -E-E- is defined as in Formula XL, and _a_a_, _b_b., R1, R3, R8, and R9 are defined as in Formula V. The compound of formula XLIXA is equivalent to the formula XLIX in which the ring carbons attached thereto form the following structure together: -E-E · \ ^ CM7) -24-

XXXIV 593305 A7 B7 五、發明説明(22 其中X、Y 、Y2和C(17)如同上文之定義。 式XLIXB之化合物相當於其中r8和r9 一起形成式 XXXIII之結構的式XLIXA: Λ 'mu/ XXX工工工 式XLIXC、XLIXD、XLIXE之化合物,分別相當於其中 每個分別爲-CIVCH2·,R3爲氫,且Ri爲烷氧羰 基,最好是甲氧羰基的任何式XLIX、xlixa或XLIXB。 在式XLIX範圍内的化合物,可藉著使含醇或含水的溶劑與 式VI之相對應化合物,在適當之鹼的存在下反應來製備之。 式A2 0 3之化合物符合下列結構:XXXIV 593305 A7 B7 V. Description of the invention (22 where X, Y, Y2 and C (17) are as defined above. The compound of formula XLIXB is equivalent to the formula XLIXA where r8 and r9 together form the structure of formula XXXIII: Λ 'mu / XXX Compounds of the formula XLIXC, XLIXD, XLIXE are equivalent to any of the formulas XLIX, xlixa or XLIX, xlixa or XLIXB. Compounds in the range of formula XLIX can be prepared by reacting an alcohol-containing or water-containing solvent with the corresponding compound of formula VI in the presence of a suitable base. The compound of formula A203 has the following structure:

[A203] (請先閱讀背面之注意事項再填寫本頁} .轉· -訂 其中選自包括: 經濟部中央標準局員工消費合作社印製[A203] (Please read the precautions on the back before filling out this page}. · · · Orders selected from the following: Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

• R” 、RI1I C—Q. / I I XLIII R21 XLIV 25 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五、發明説明(23 • 1〇R 、R*1| c~*• R ”, RI1I C—Q. / II XLIII R21 XLIV 25 This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 A7 B7 V. Description of the invention (23 • 1〇R, R * 1 | c ~ *

XLV OR24 Rai %—i— / I»XLV OR24 Rai% —i— / I »

XLVI 和XLVI and

XLVI I 經濟部中央標準局員工消費合作社印製 R18選自C!至C4烷基,R21、尺22和尺23分別選自氫、烷美 、鹵素、硝基和氰基,R24選自氫和低碳數烷基,且 、-B-B-、R3如同在式1〇4中之定義。 式A203A之化合物相當於其中r2i、尺22和尺23分別選自 氫、鹵素和低碳數烷基的式A203。 式A203B之化合物相當於其中_E_E_符合式XLIII、 XLIV、XLV 或 XLVII 的式 A203A。 式A203C、A203D和A203E之化合物,分別相當於其中 每個- A-A和-B-B-分別爲- CH2-CH2-,且R3爲氫的式A203、 A203A或203B。在式A203範圍内的化合物,可精著還原如同 下文定義之式A2 02的化合物來製備之。 式A 2 0 4之化合物符合下列結構:XLVI I Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs R18 is selected from C! To C4 alkyl groups, R21, feet 22 and feet 23 are selected from hydrogen, alkyl, halogen, nitro and cyano, and R24 is selected from hydrogen and Low carbon number alkyl, and -BB-, R3 have the same meanings as defined in Formula 104. The compound of formula A203A is equivalent to formula A203 in which r2i, feet 22, and feet 23 are selected from hydrogen, halogen, and lower carbon alkyl, respectively. The compound of formula A203B is equivalent to formula A203A in which _E_E_ conforms to formula XLIII, XLIV, XLV or XLVII. The compounds of the formula A203C, A203D and A203E respectively correspond to the formula A203, A203A or 203B in which each of -A-A and -B-B- is -CH2-CH2-, and R3 is hydrogen. Compounds in the range of formula A203 can be prepared by careful reduction of compounds of formula A202 as defined below. The compound of formula A 2 0 4 conforms to the following structure:

[A204] (請先閱讀背面之注意事項再填寫本頁} -、-=-口 - Γ 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 式A204C、A204D和A204E之化合物,分別相當於其中 每個-A-A-和-B-B-分別爲-CH2-CH2-,且r3爲氫的式A2〇4 、A204A和A204B。在式A204範圍内的化合物,可藉著 式A 2 0 3之相對應化合物的水解作用來製備之。 式A 2 0 5之化合物符合下列結構:[A204] (Please read the notes on the back before filling in this page}-,-=-口-Γ This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 type A204C, A204D and A204E Compounds corresponding to formulas A204, A204A, and A204B in which each -AA- and -BB- are -CH2-CH2-, and r3 is hydrogen. Compounds in the range of formula A204 can be obtained by formula A It is prepared by hydrolysis of the corresponding compound of 203. The compound of formula A 205 conforms to the following structure:

經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(24 其中 R19 爲 1至(:4 烷基,且 _E_E_、_a_a_、_b_b_*r3 如同 在式2〇3中之定義。 式A2 04A之化合物,相當於其中、R22*R23分別選 自氫、鹵素和低碳數烷基之式A2 04。 式A204B之化合相當於其中_E_E符合式XLm、xuv 、XLV 或式 XLVII 之式 A204A。 [A205] 其中 R 0爲(^至匕燒基’且- 、R19、·Α-Α-、-B_b&gt;^r3 如同在式203中之定義。 式A205 A之化合物,相當於其中r2i、r22和r23分別選 自氫、鹵素和低碳數烷基之式A2 05。 , 式A205B之化合物相當於其中_E_E_符合式XLIII、 XLIV、XLV 或式 XLVII 之式 A205A。 式A205C、A205D和A20 5E之化合物,分別相當於其中 每個-A-A-和-B-B·分別爲&lt;η2-(:Η2…且R3爲氫的式 -27· 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁jPrinted by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (24 of which R19 is 1 to (: 4 alkyl), and _E_E_, _a_a_, _b_b_ * r3 are as defined in Formula 203. Formula A2 The compound of 04A is equivalent to the formula A2 04 in which R22 * R23 is selected from hydrogen, halogen and low-carbon alkyl, respectively. The compound of formula A204B is equivalent to the formula A204A in which _E_E conforms to the formulas Xlm, xuv, XLV or XLVII. [A205] wherein R 0 is (^ to stilbyl) and-, R19, · A-A-, -B_b &gt; ^ r3 are as defined in formula 203. A compound of formula A205 A is equivalent to r2i, r22 and r23 are respectively selected from the group consisting of hydrogen, halogen and low-carbon alkyl formula A205. The compound of formula A205B is equivalent to formula A205A in which _E_E_ conforms to formula XLIII, XLIV, XLV or formula XLVII. Formulas A205C, A205D and The compounds of A20 5E are equivalent to each of -AA- and -BB, which are &lt; η2-(: Η2 ..., and R3 is hydrogen, respectively. -27 · This paper size applies Chinese National Standard (CNS) A4 specifications ( 210X 297 mm) (Please read the notes on the back before filling in this page j

593305 A7 B7 五、發明説明(25 ) A205、A205A和A205B。在式A205範圍内的化合物 藉著式A204之相對應化合物與鏈烷醇和酸的反應來製備之。 式A 2 0 6之化合物符合下列結構: 可 2 0593305 A7 B7 5. Description of the invention (25) A205, A205A and A205B. Compounds in the range of Formula A205 are prepared by reacting the corresponding compound of Formula A204 with an alkanol and an acid. The compound of formula A 2 0 6 conforms to the following structure: may 2 0

[A206] B-B -和R3如同在式205 經濟部中央標準局員工消費合作社印製 其中R19、R 中之定義。 式A206A之化合物,相當於其中R21、R22和R23分別選 自氫、鹵素和低碳數燒基之式A206。 式八2066之化合物相當於其中-£-£-符合式又1^111、 XLIV、XLV 或式 XLVII 之式 A206A。 式A206C 、A206D和A206E之化合物,分另】J相當於其中 每個-A-A-和-B-B-分別爲-CH2-CH2·,且R3爲氫的式 A206、A206A和A206B。在式A206範圍内的化合物,可 藉著在式A2 0 5範圍内之相對應化合物與鹵化三烷基锍的反 應來製備之。 式A2 0 7之化合物符合下列結構: 〇[A206] B-B-and R3 are the same as those printed in 205 in the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, where R19 and R are defined. The compound of the formula A206A is equivalent to the formula A206 in which R21, R22 and R23 are selected from hydrogen, halogen and a low carbon number group, respectively. The compound of formula eight 2066 is equivalent to the formula A206A in which-£-£-conforms to formula 1 ^ 111, XLIV, XLV or formula XLVII. Compounds of formulas A206C, A206D and A206E, respectively, J are equivalent to formulas A206, A206A and A206B in which each of -A-A- and -B-B- is -CH2-CH2 · and R3 is hydrogen. A compound in the range of Formula A206 can be prepared by reacting a corresponding compound in the range of Formula A205 with a trialkylphosphonium halide. The compound of formula A2 0 7 conforms to the following structure:

COffR2i [A207] f請先閱讀背面之注意事項再填寫本頁j 1«· -訂· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7COffR2i [A207] f Please read the notes on the back before filling in this page j 1 «· -Order · This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) 593305 A7 B7

to 經濟部中央標準局員工消費合作社印製 五、發明説明(26 其中 R25 爲(^至!^ 烷基,且-E-E-、R19、R20、-A-A-、 和R3如同在式A205中之定義。 式A207A之化合物,相當於其中r2i、R22和R23分別選 自氫、鹵素和低碳數烷基之式A207。 式A207B之化合物相當於其中-E-E-符合式XLIII、 XLIV、XLV 或式 XLVII 之式 A207A。 式A207C、A207D和A207E之化合物,分別相當於其中 每個- A-A -和- B-B分別爲_CH2-CH2-,且R3爲氫的式 A207、A207A和A207B。在式A207範圍内的化合物,可 藉著式A2 0 6之相對應化合物與丙二酸二烷酯的反應來製備 之 式A 2 0 8之化合物符合下列結構 [A208] 其中-E-E-、R80和R%如同在式又£11中之定義,且_A_A_ B-B-、R3如同在式1〇4中之定義。r19、r20、_八仏_ 和R3如同在式205中之定義。 式A20 8A之化合物,相當於其中R2i*R22分別選自氫 鹵素和低碳數烷基之式A208。 式A20 8B之化合物相當於其中_E-E_符合式XLln、 (請先閱讀背面之注意事項再填寫本百c〕Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the invention (26 where R25 is (^ to! ^ alkyl, and -EE-, R19, R20, -AA-, and R3 are as defined in Formula A205). The compound of formula A207A is equivalent to the formula A207 in which r2i, R22 and R23 are selected from hydrogen, halogen and a low-carbon alkyl group, respectively. The compound of formula A207B is equivalent to -EE- in accordance with formula XLIII, XLIV, XLV or XLVII. Formula A207A. Compounds of Formula A207C, A207D, and A207E are equivalent to Formula A207, A207A, and A207B, each of which -AA- and -BB are _CH2-CH2-, and R3 is hydrogen. Within the scope of Formula A207. The compound of formula A 2 0 8 can be prepared by reacting the corresponding compound of formula A 2 0 6 with dialkyl malonate. The compound of formula A 2 0 8 has the following structure [A208] where -EE-, R80 and R% are as in The formula is as defined in £ 11, and _A_A_ BB- and R3 are as defined in formula 104. r19, r20, _octadecane, and R3 are as defined in formula 205. The compound of formula A20 8A is equivalent In which R2i * R22 is selected from the group consisting of hydrogen halide and low-carbon alkyl, respectively, formula A208. The compound of formula A20 8B is equivalent to _EE _Compliant XLln, (Please read the precautions on the back before filling this hundred c)

29- 593305 A7 B729- 593305 A7 B7

QQ

五、發明説明(27 XLV或式XLVII之式A208A。 式A208C之化合物,相當於其中R8G和r9G與附接於其上 的環碳一起,含有酮或下式的式A20 8:V. Description of the invention (27 XLV or formula A208A of formula XLVII. The compound of formula A208C is equivalent to R8G and r9G, together with the ring carbon attached to it, containing a ketone or formula A20 8 of the formula:

XXXIV 其中Χ'Υ1、Υ2和C(17)如同上文之定義。 式A208D之化合物相當於其中取代基χχχιν符合式 XXXIII之結構的式A2 0 8D:XXXIV where X′Υ1, Υ2 and C (17) are as defined above. The compound of formula A208D is equivalent to formula A2 0 8D in which the substituent χχχιν conforms to the structure of formula XXXIII:

XXXIII 式 A208E、A208F、A20 8G、A208H 和 A208J 之化合 物,分別相當於其中每個_A-A-和-B-B-分別爲-CH2-CH2-, 且R3爲氫的式A208、A208A、A208B、A208C或A208D。在式 A208範圍内的化合物,可藉著式A2 07之相對應化合物的 熱分解作用來製備之。 式A2 0 9之化合物符合下列結構: (請先閱讀背面之注意事項再填寫本頁}XXXIII Compounds of the formula A208E, A208F, A20 8G, A208H and A208J, respectively equivalent to the formulas A208, A208A, A208B, A208C, or _AA- and -BB-, respectively, and R3 is hydrogen A208D. Compounds in the range of formula A208 can be prepared by thermal decomposition of the corresponding compounds of formula A2 07. The compound of formula A2 0 9 conforms to the following structure: (Please read the precautions on the back before filling this page}

經濟部中央標準局員工消費合作社印製 FT ,ΦΟPrinted by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, ΦΟ

R· [A209] 其中118()和119()如同在式;^1中之定義,且44-、-八-八-、 -30- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五、發明説明(28 ) -B-B-和R3如同在式205中之定義。 式A2 09 A之化合物,相當於其中R21和R22分別選自礼、 鹵素和低碳數烷基之式A209。 式A2 0 9B之化合物相當於其中-E-E·符合式XLIII、 XLIV、XLV或式XLVII之式A209A。 式A209C之化合物相當於其中- E-E-符合式XLIV之式 A209B 〇 式A209D之化合物,相當於其中R8G和r9g與附接於其上 的環碳一起,含有酮或下式的式A2 09: Y,\ / f /C\7) ,,,,N -0-ΧR · [A209] where 118 () and 119 () are the same as in the formula; ^ 1, and 44-, -eight-eight-, -30- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 (Mm) 593305 A7 B7 5. Description of the Invention (28) -BB- and R3 are as defined in Formula 205. The compound of the formula A2 09 A is equivalent to the formula A209 in which R21 and R22 are selected from the group consisting of Li, halogen, and lower alkyl. The compound of the formula A2 0 9B is equivalent to the formula A209A in which -E-E · conforms to the formula XLIII, XLIV, XLV or XLVII. The compound of formula A209C is equivalent to -EE-complying with formula A209B of formula XLIV. 0 The compound of formula A209D is equivalent to where R8G and r9g, together with the ring carbon attached thereto, contain a ketone or formula A2 09: Y \ / F / C \ 7) ,,,, N -0-Χ

XXXIV 其中X、Υ1、γ2和c(17)如同上文之定義。 式A209E之化合物相當於其中取代基χχΧΙν符合式 又又又111之結構的式八209〇:XXXIV where X, Υ1, γ2, and c (17) are as defined above. The compound of formula A209E is equivalent to the formula 8209 in which the substituent χχχΙν conforms to the structure of formula 111.

xxici工工 經濟部中央標準局員工消費合作社印繁 (請先閱讀背面之注意事項再填寫本頁) 式 A209F、A209G、A209H、A209J、A209L 和 A209M 之 化合物’分別相當於其中每個-A_A-和分別爲_Ch2_ CH2-,且R3爲氫的式A209、A209A、A209B、A209C、A209D 和A209E。在式A209範圍内的化合物,可藉著式A208之 相對應化合物的水解作用來製備之。 式A 2 1 0之化合物符合下列結構: -31- 本紙張尺度適财關家;f縳(CNS ) A規格(210X297公嫠) 593305 A7 B7 五、發明説明(29 R η·〇xxici Ministry of Industry, Economy, Trade and Industry, Central Standards Bureau, Employees' Consumer Cooperatives, India (please read the precautions on the back before filling this page) The compounds of formula A209F, A209G, A209H, A209J, A209L and A209M are equivalent to each of them -A_A- And formulas A209, A209A, A209B, A209C, A209D, and A209E, which are _Ch2_CH2- and R3 is hydrogen, respectively. Compounds in the range of formula A209 can be prepared by hydrolysis of the corresponding compound of formula A208. The compound of formula A 2 1 0 conforms to the following structure: -31- The paper size is suitable for financial and family care; f bound (CNS) A specification (210X297 gong) 593305 A7 B7 V. Description of the invention (29 R η · 〇

[Α210] 其中R80和R90如同在式XLI中之定義,且取代基_α_α_、 Β-、R3如同在式1〇4中之定義。 式Α210Α之化合物,相當於其中和r9〇與附接於其上 的環碳一起,含有酮或下式的式A2 10: Β- (請先閲讀背面之注意事項再填寫本頁) 丨丨丨丨丨丨[A210] wherein R80 and R90 are as defined in Formula XLI, and the substituents _α_α_, B-, and R3 are as defined in Formula 104. The compound of formula A210A is equivalent to the formula A2 10 which contains ketone or r9〇 and the ring carbon attached to it: Β- (Please read the precautions on the back before filling this page) 丨 丨 丨丨 丨 丨

XXXIV 訂 經濟部中央標準局員工消費合作社印製 Λ 'iim/ 其中X、Y1、Y2和C(17)如同上文之定義。 式A2 1 0B之化合物相當於其中取代基χχχιV符合式 XXXIII之結構的式A210A: XXXIII _ 式A2 10C之化合物相當於其中和r9〇 一起形成酮的式 A210A 。 式A2 1 0D、A210E、A210F和A210G之化合物,分別相去 於其中每個-A-A-和-B-B-分別爲-CH^CH2·,且R3爲氫的式 -32- 593305 A7 B7 五、發明説明(3〇 A210、A21〇a、A210B 和 A210C。在式 A210範圍内的 化合物,可藉著其中-E_E•爲〉C-CH_之式209化合物的環 氧化作用來製備之。 式A2 1 1之化合物符合下列結構:XXXIV Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs Λ 'iim / where X, Y1, Y2, and C (17) are as defined above. The compound of the formula A2 1 0B corresponds to the formula A210A in which the substituent χχχιV conforms to the structure of the formula XXXIII: XXXIII _ The compound of the formula A2 10C corresponds to the formula A210A in which ketone is formed together with r90. Compounds of formula A2 1 0D, A210E, A210F, and A210G, respectively, are eliminated by each of the formulas -32- 593305 A7 B7 where -AA- and -BB- are -CH ^ CH2 · and R3 is hydrogen (30A210, A21〇a, A210B, and A210C. Compounds in the range of Formula A210 can be prepared by the epoxidation of a compound of Formula 209 where -E_E • is> C-CH_. Formula A2 1 1 The compound conforms to the following structure:

fTfT

[A211] 其中-A-A-、_Β_Β·和R3如同上文之定義。 式Α211Α之化合物,相當於其中尺8〇和尺9〇 一起含有酮或 •下式的式A 2 1 1 : r\ / J 17) min[A211] wherein -A-A-, _Β_Β · and R3 are as defined above. The compound of the formula A211Α is equivalent to the rule wherein the ruler 80 and the ruler 9 together contain a ketone or the formula: A 2 1 1: r \ / J 17) min

XXXIV (請先閱讀背面之注意事項再填寫本頁} 經濟部中央標準局員工消費合作社印製 其中χ、γΐ、Y2和c(17)如同上文之定義。 式A2 1 1B之化合物相當於其中取代基χχχιν符合式 XXXIII之結構的式Α211Α: 口’XXXIV (Please read the precautions on the back before filling this page} Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, where χ, γΐ, Y2, and c (17) are as defined above. The compound of formula A2 1 1B is equivalent to it The substituent χχχιν conforms to the formula A211A of the structure of formula XXXIII:

XXXIII 式Α2 1 1C之化合物相當於其中和r9〇 一起形成酉同 A210A 〇 -33 593305 Α7 Β7 五、發明説明(31 ) 式A211D、A211E、A211F和A211G之化合物,分別相當 於其中每個-A-A-和-B-B-分別爲-CHrCHr,且R3爲氫的式 A211、A211A、A211B和A211C。在式A211範圍内的化合物, 可藉著多A210之相對應化合物的氧化作用,或是在其中^^一爲 &gt;^-crM 之式A209之相對應化合物的環氧化作用當中 ’以下文描述的方法.將其轉變爲式11化合物,來製備之。 式L之化合物符合下列結構: (請先閱讀背面之注意事項再填寫本頁} 訂XXXIII Compounds of formula A2 1 1C are equivalent to form together with r90. They are the same as A210A 0-33 593305 A7 B7 V. Description of the invention (31) Compounds of formula A211D, A211E, A211F and A211G are equivalent to each of -AA -And -BB- are the formulas A211, A211A, A211B, and A211C, each of which is -CHrCHr and R3 is hydrogen. Compounds in the range of formula A211 can be oxidized by the corresponding compound of A210 or in the epoxidation of the corresponding compound of formula A209 where ^^ is &gt; ^-crM 'as described below It is converted into a compound of formula 11 to prepare it. The compound of formula L conforms to the following structure: (Please read the notes on the back before filling this page}

經濟部中央標準局員工消費合作社印製 其中 R 爲 Ci 至 C4坑基’且-A-A-、-B-B_、R1、R2、r3、 和R9如同上文之定義。 式L A之化合物相當於其中R8和R9與附接於其上的碳原子 一起的式L,包括: YI t γ\ / f /C\7} Π,,Π ί -ό^χPrinted by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economics where R is Ci to C4 Pit ’and -A-A-, -B-B_, R1, R2, r3, and R9 are as defined above. The compound of formula L A is equivalent to formula L where R8 and R9 are together with the carbon atom attached to it, including: YI t γ \ / f / C \ 7} Π ,, Π ί -ό ^ χ

XXXIV 其中X'Y1和Y2如同上文之定義。XXXIV where X'Y1 and Y2 are as defined above.

式LB之化合物相當於其中R8和R9符合式之式L 〇The compound of formula LB is equivalent to formula L where R8 and R9 conform to formula.

593305 A7 ------ B7_ 五、發明説明(32 ) ' &quot; 式LC、LD、LE之化合物,分別相當於其中·Α-Α·和-&amp; B-各自爲- CHrCH2-,且R3爲氫的式L、LA和LB。 (請先閲讀背面之注意事項再填寫本頁) 以如同在下文中陳述的特定反應計劃之揭示内容爲基礎 ’對於特殊反應計劃最實用的這些化合物將是顯而易見的 。本發明化合物的用途,可用來做爲環氧美克斯雷諾及其 他類固醇的中間物。 其他的目標和特徵一部份是顯而易見的,一部份將在後 文中指出。 Μ片説明 圖1是康雷諾(canrenone)或康雷諾衍生物轉變爲相對靡之 1 1 α _羥基化合物之生物轉變方法的計劃流程圖; 圖2爲康雷語或康雷諾衍生物之-羥基化作用之生物 轉變較佳方法的計劃流程圖; 圖3爲康雷語或康雷諾衍生物之1 1 _ α -輕基化作用之生物 轉變特佳方法的計劃流程圖; 圖4顯示根據圖2之方法製備之康雷諾的特定尺寸分布;且 圖5顯示根據圖3之方法’在轉化發酵桶中殺菌之康雷諾 的特定尺寸分布。 經濟部中央標準局員工消費合作社印製 相對應之參考特徵指出在整個圖片中相符合的部份。 較佳具體實施例的説明 根據本發明,爲了製備環氧美克斯雷諾及其他符合式工之 化合物,已經想出各種新穎的方法計劃: -35- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 叫〇5 A7 B7 五 '發明説明(33593305 A7 ------ B7_ V. Description of the invention (32) '&quot; Compounds of the formula LC, LD, and LE are equivalent to · A-Α · and-& B- are each -CHrCH2-, and R3 is a formula L, LA and LB of hydrogen. (Please read the notes on the back before filling out this page) Based on the disclosure of a specific reaction plan as stated below ’These compounds that are most useful for a particular reaction plan will be obvious. The use of the compound of the present invention can be used as an intermediate of epoxy mexrenol and other steroids. Other goals and characteristics are partly obvious and part will be pointed out later. Description of the M film. Figure 1 is a flow chart of the plan for the biological conversion method of canrenone or a Conreno derivative into a relative 1 1 α-hydroxy compound. Figure 2 is the -hydroxy group of a Conreno or Conreno derivative. Figure 3 is a flow chart of the best method for biological conversion of chemical conversion; Figure 3 is a flow chart of the best method for biological conversion of 1 1 _ α-light-based light conversion of Conrad or Conreno derivatives; The specific size distribution of Conorno prepared by the method of 2; and FIG. 5 shows the specific size distribution of Conorno sterilized in the conversion fermenter according to the method of FIG. 3. Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. The corresponding reference characteristics indicate the corresponding parts in the entire picture. Description of the preferred embodiments According to the present invention, in order to prepare epoxy mexanol and other compounds conforming to the formula, various novel method plans have been devised: -35- This paper size applies Chinese National Standard (CNS) Α4 Specifications (210 × 297 mm) called 05 A7 B7 Five 'invention description (33

其中: •A-A-代表基團 _CHR4-CHR5-或-CR4=CR5- R、R4和R5分別選自包括氫、鹵素、藉基、低碳數垸基、 低碳數燒氧基、羥烷基、烷氧烷基、羥羰基、氰基、芳 氧基, R1代表α -方位之低碳數烷氧羰基或羥烷基基團, 代表基團_CHr6-cHR7-或從或/? _方位之基團; CH- I -CH- CH- -in.Where: • AA- represents the group _CHR4-CHR5- or -CR4 = CR5- R, R4 and R5 are respectively selected from the group consisting of hydrogen, halogen, borrowed group, low carbon number fluorenyl group, low carbon number alkoxy group, hydroxyalkane Group, alkoxyalkyl group, hydroxycarbonyl group, cyano group, aryloxy group, R1 represents α-azimuth low-carbon alkoxycarbonyl or hydroxyalkyl group, and represents the group _CHr6-cHR7- or from or /? _ Azimuth group; CH- I -CH- CH- -in.

工工I 經濟部中央標準局員工消費合作社印^ 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基、醯 基、經燒基、烷氧烷基、羥羰基、烷基、烷氧羰基、醯 氧貌基、氰基、芳氧基,且 R8和R9分別選自包括氫、_素、低碳數烷氧基、醯基、 喪燒基、燒氧燒基、經窥基、燒基、烷氧羰基、醯氧燒 基、氰基、芳氧基,或是R8*R9 一起包含一碳環或雜環 之結構’或是R8或R9與R64R7 一起包含一碳環或雜環結 構’融合成五環之D環。 除非另行說明,在本揭示内容中,以”低碳數,,指定的有 -36- 本紙張尺度適用中_家標準(CNS ) A4規格(21GX297公釐 (請先閱讀背面之注意事項再填寫本頁)Industrial and Industrial I, Consumer Standards Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs, where R6 and R7 are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, triphenyl, alkoxyalkyl, hydroxycarbonyl, alkyl, Alkoxycarbonyl, fluorenyl, cyano, aryloxy, and R8 and R9 are selected from the group consisting of hydrogen, hydrogen, low-carbon alkoxy, fluorenyl, benzyl, oxyalkyl, and Group, alkyl, alkoxycarbonyl, alkoxycarbonyl, cyano, aryloxy, or R8 * R9 together contains a carbocyclic or heterocyclic structure 'or R8 or R9 together with R64R7 contains a carbocyclic or The heterocyclic structure is fused into a five-ring D ring. Unless otherwise stated, in this disclosure, "low carbon number" is specified as -36- This paper size is applicable _ house standard (CNS) A4 specification (21GX297 mm (please read the precautions on the back before filling in (This page)

593305 A7 B7 五、發明説明(34 機基團最多含有7個,較佳是從1到4個碳原子。 低碳數fe氧羰基較好是衍生自具有從1到4個碳原子的貌 基’像疋甲基、乙基、丙基、異丙基、丁基、異丁基、第 一-丁基和第二-丁基者;特佳的是甲氧羰基、乙氧黢基和異 丙氧羰基。低碳數燒氧基較好是衍生自上文提及的c 1 _ c 4燒 基者,特別是衍生自初級的烷基;特佳的是甲氧基。 低碳數鏈燒醯基較好是衍生自具有1至7個碳原子的直鏈烷 基;最佳的是甲醯基和乙醯基。 在1 5,1 6 -位置之間的亞甲基橋,最好是0 -方位的。 根據本發明之方法,產製出較佳種類的化合物,是在美 國專利第4,559,332號中描述的20-螺氧烷化合物,也就是符 合式IA的那些: (請先閱讀背面之注意事項再填寫本頁} _t·, -訂593305 A7 B7 V. Description of the invention (34 The organic group contains a maximum of 7, preferably from 1 to 4 carbon atoms. The low-carbon-fe oxycarbonyl group is preferably derived from a morpho group having 1 to 4 carbon atoms. 'Like methyl, ethyl, propyl, isopropyl, butyl, isobutyl, first-butyl and second-butyl; particularly preferred are methoxycarbonyl, ethoxyfluorenyl and isopropyl Propoxycarbonyl. The low carbon number alkoxy group is preferably derived from the c 1-c 4 alkyl group mentioned above, especially derived from the primary alkyl group; particularly preferred is methoxy group. Low carbon number chain Carbofluorenyl is preferably derived from a linear alkyl group having from 1 to 7 carbon atoms; most preferred are methylfluorenyl and ethylfluorenyl. Methylene bridges between the 15, 16, 6-positions, most It is 0-azimuth. According to the method of the present invention, the preferred compounds are the 20-spiroxane compounds described in U.S. Patent No. 4,559,332, which are those that conform to formula IA: (please first Read the notes on the back and fill out this page} _t ·, -Order

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

•c—X ΙΑ 其中: -Α_Α-代表基團 _CH2-Ch2kh=ch_, 表基團_CH2_CH2-或式ΠΙΑ的或々-方位之基團 ' Η一- C Η- —CH- R1代表^ -方位之低碳數烷氧羰基或羥羰基, χ代表兩個氫原子、氧代或=s, -37 _ 本紙張尺度適用中關家標準(CNS ) M規格(mu97公酱) 工工ΙΑ 經濟部中央標準局員工消費合作社印f• c—X ΙΑ where:-Α_Α- represents the group _CH2-Ch2kh = ch_, the table group _CH2_CH2- or the group of the formula IIIA or the 々-position group 'Η 一-C Η- —CH- R1 represents ^ -Position of low-carbon alkoxycarbonyl or hydroxycarbonyl groups, χ represents two hydrogen atoms, oxo or = s, -37 _ This paper size is applicable to Zhongguanjia Standard (CNS) M specification (mu97 公 酱) 工 工 ΙΑ Staff Consumer Cooperatives, Central Bureau of Standards, Ministry of Economic Affairs

593305 A7 --- —__ B7 五、發明説明(35 ) Y1和γ2 一起代表氧橋_〇_,或 γ 1代表#1基,且 Υ2代表羥基、低碳數烷氧基,或是如果χ代表η2,也可 以是低碳數鏈燒疏氧基。 由本發明之新穎方法產製的20-螺氧燒化合物,最好是那 些其中Υ1和Υ2—起代表氧橋_〇_的式J。 特佳的式I化合物是其中X代表氧代的那些。 口在其中X代表氧代的式IAi2〇·螺氧燒化合物中,最佳的 疋其中Y1和Y2—起代表氧橋_〇_的那些。 、如同已經提及的,17y5_羥基_21_羧酸也可以其鹽類的形 式存在。特別加以考慮的是金屬和銨鹽,像是驗金屬和驗 土金屬鹽類,例如鋼、_、錢和較佳的奸鹽類,以及衍生 自氨或適當地、較佳的,在生理學上可容忍之有機含-氮鹼 =銨鹽口類。因爲㈣考慮的不只是胺類,例如低碳數燒基 胺(像是三乙胺)、羥基_低碳數烷基胺[像是2_羥基乙胺、二 乙基)胺或三-(2-藉乙基)胺]、環燒基胺類(像是二 %己胺)或爷胺(像是爷胺和N,N、二爷基乙二胺),還有含_ 氮的雜環化合物,例如具有芳香族特徵的那些(像是峨録 或奎林基),或疋具有至少邵份飽和之雜環的那些(像是N _ 乙基π虱吡哫、嗎啉、六氫吡畊或N,N,-二甲基六氫吡畊)。 在較佳的化合物中亦包括鹼金屬鹽類,特別是其中R 1代 表垸氧羰基,X代表氧代且γ&gt;γ2分別代表祕之式⑷匕 合物的卸鹽。 特佳的式I和IΑ化合物,是例如下列的: -38- 本紙張尺度適用中關家標準(CNS ) A4規格(2】Gx297公 (請先閲讀背面之注意事項再填寫本頁)593305 A7 --- —__ B7 V. Description of the invention (35) Y1 and γ2 together represent the oxygen bridge _〇_, or γ 1 represents the # 1 group, and Υ2 represents a hydroxyl group, a low-carbon alkoxy group, or if χ On behalf of η2, it may also be a low-carbon-chain alkoxy group. The 20-spirooxo compounds produced by the novel method of the present invention are preferably those of formula J in which Υ1 and Υ2 together represent the oxygen bridge _〇_. Particularly preferred compounds of formula I are those in which X represents oxo. Among the compounds of the formula IAi20.spiro oxycarbons in which X represents oxo, the most preferred are those in which Y1 and Y2 together represent the oxygen bridge _〇_. As already mentioned, 17y5_hydroxy_21_carboxylic acid can also exist in its salt form. Special consideration is given to metals and ammonium salts, such as metal and soil metal salts, such as steel, iron, copper and better treacherous salts, as well as derivatives derived from ammonia or suitably, preferably, physiologically Tolerable organic-nitrogen-base = ammonium salts. Because amidine is not only considered amines, such as low carbon number alkylamines (such as triethylamine), hydroxy_low carbon number alkylamines [such as 2-hydroxyethylamine, diethyl) amine or tri- ( 2-Byethyl) amine], cycloalkanylamines (such as di% hexylamine) or amines (such as amine and N, N, dimethylethylenediamine), and _ nitrogen-containing Cyclic compounds, such as those with aromatic characteristics (such as elu or quilinyl), or those with at least one saturated heterocyclic ring (such as N_ethylπ, pyridine, morpholine, hexahydro Pycnogenol or N, N, -dimethylhexahydropyridine). Alkali metal salts are also included in the preferred compounds, in particular where R 1 represents fluorenyloxycarbonyl, X represents oxo and γ &gt; 2 represents the unsalting salt of the hydrazone compound of Mystery formula. Particularly preferred compounds of formula I and IAA are, for example, the following: -38- This paper size applies to the Zhongguanjia Standard (CNS) A4 specification (2) Gx297 (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印製 593305 Μ —__Β7 五、發明説明(36 ) 9(^,11(^-環氧_7&lt;^-甲氧幾基-20-螺氧_4_晞_3,21-二酮, 9α,11從環氧-7從-乙氧羰基-20-螺氧-4-烯-3,21-二酮, 9α,11 環氧異丙氧羰基_2(μ螺氧_4•烯-3,21_二酮, 和化合物每個的1,2 -脱氫類似物, 9α,11汉-環氧-6汉,7汉-亞甲基-20-螺氧-4·烯-3,21_二酮, 9α,11從-環氧-6yg亞甲基-2〇-螺氧_4_晞_3,21_二酮, 9 α,11 α -環氧_6卢,7卢;15/?,16卢-雙亞甲基_2〇_螺氧_4•晞_ 3,21 -二自同,和 這些化合物每個的1,2 -脱氫類似物, 9σ,11 α·環氧- 7α -甲氧羰基-17冷-¾基-3 -氧代-孕留· 4 _烯_ 2 1 -羧酸, 9“,11“-環氧-7“-乙氧羰基_17/?-羥基-3-氧代-孕甾_ 4_烯-21-羧酸, ,11 “ -環氧-7α·異丙氧羰基-17卢·羥基-3 -氧代-孕 甾-4-晞- 21-叛酸, 9α,11 α -環氧_17冷-輕基-6&lt;^,7從-亞甲基-3-氧代-孕 甾·4_晞-21_幾酸, 9“,η α -環氧]7冷-羥基-6冷,7/?_亞甲基-3·氧代-孕 甾-4-綿· _21-幾酸, 9 以,11 “一環氧-17;5-#呈基-6/?,7^ ;15/?,16y5 -雙亞甲基-3 -氧代-孕甾-4 ·烯-2丨_羧酸,及鹼金屬鹽類,特別是這些 酸每個的卸鹽或銨,還有提及之羧酸每個的相對應1,2 -脱 氫類似物,或其鹽類。 9α,11 α -環氧- i5y5,Uy5_ 亞甲基·3,2ΐ_ 二氧代- 20 -螺 •39- 本紙張尺度適用中國國) Μ規格(2丨〇&gt;&lt;297公襲) ~ &quot; (請先閱讀背面之注意事項再填寫本頁}Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 593305 Μ —__ Β7 V. Description of the Invention (36) 9 (^, 11 (^-epoxy_7 &lt; ^-methoxyisopropyl-20-spiroxy_4_ 晞 _ 3,21-dione, 9α, 11 from epoxy-7 from -ethoxycarbonyl-20-spiro-4-ene-3,21-dione, 9α, 11 epoxy isopropoxycarbonyl_2 (μ Spiro-4-en-3,21-dione, and 1,2-dehydro analogues of each of the compounds, 9α, 11 Han-epoxy-6 Han, 7 Han-methylene-20-spiro -4 · ene-3,21_diketone, 9α, 11 from -epoxy-6yg methylene-2O-spiro-4_ 晞 _3,21_diketone, 9 α, 11 α -epoxy _6 Lu, 7 Lu; 15 / ?, 16 Lu-bismethylene_2〇_spiro_4 • 晞 _ 3,21 -diisomorphic, similar to the 1,2-dehydrogenation of each of these compounds Compound, 9σ, 11 α · epoxy-7α-methoxycarbonyl-17col-¾yl-3 -oxo-pregnant · 4-ene-2 1-carboxylic acid, 9 ", 11" -epoxy-7 "-Ethoxycarbonyl_17 /?-Hydroxy-3-oxo-progesterone_ 4-ene-21-carboxylic acid, 11" -epoxy-7α · isopropoxycarbonyl-17 lu · hydroxy-3- Oxo-progesterone-4-pyrene- 21-retedic acid, 9α, 11 α-epoxy_17cold-light-based-6 &lt; ^, 7 from-methylene-3-oxo-progesterone · 4_晞 -21_ a few acids, 9 ", η α-epoxy] 7 cold-hydroxy-6 cold, 7 /? _ Methylene-3 · oxo-progesterone-4- cotton · _21-chinic acid, 9 with, 11" mono epoxy -17; 5- # presents the group -6 / ?, 7 ^; 15 / ?, 16y5 -bismethylene-3 -oxo-pregn-4-4ene-2carboxylic acid, and alkali metal salts , Especially the desalted or ammonium of each of these acids, and the corresponding 1,2-dehydrogenated analogs of each of the carboxylic acids mentioned, or their salts. 9α, 11 α -epoxy-i5y5, Uy5_ Methylene · 3,2ΐ_ Dioxo-20-Spiral • 39- This paper size applies to China) Μ size (2 丨 〇 &gt; &lt; 297 public attack) ~ &quot; (Please read the precautions on the back first Fill out this page}

經濟部中央標準局員工消費合作社印製 593305 A7 -------- 」7 五、發明説明(37 ) 氧晞-7“-羧酸甲酯、乙酯和異丙酯, —9q,11o^環氧-15/?,16々_ 亞甲基 _3,21_ 二氧代·2〇_螺 氧-1,4 -二烯-7 π -羧酸甲酯、乙酯和異丙酯, 碾有9“,11“-環氧-3_氧代_2〇-螺氧-4-烯-7“_羧酸甲 酉旨、乙酯和異丙酯, 9 α,1 1 “ _環氧-6冷,6 /? _亞甲基_2〇·螺氧_4晞-3_酮, 9〇^,11以-環氧-6卢,7卢;15々,16;3-雙亞甲基-20-螺氧-4-烯_3-酮, 還有9α,11α_環氧羥基_17沈_(3·羥基·丙基卜3_ 氧代_雄甾-4-烯-7從羧酸甲酯、乙酯和異丙酯, 9 “,1 1 α _環氧-17 •羥基_17 α _(3_羥丙基)_6 以,7 “ _ 亞甲基-雄甾-4 -晞-3 -酮, 9從,11 α _環氧_17々_羥基-17 α _(3_羥丙基)·6冷, 亞甲基-雄甾-4 _晞-3 -酮, 9從,11 α-J衣氧·17々_羥基-17“_(3_羥丙基)_6々,70 ;15点,16々·雙亞甲基·雄留_4_烯-3_酮, 包括提及&lt;雄甾烷化合物的17α-(3_乙醯氧基丙基)和17以 -(3 -甲酿氧基丙基)類似物, 還有全部提及之雄留_ 4 _晞-3 ·酮和2 〇 _螺氧_ 4 _烯_ 3 _酮系 列之化合物的1,2 -脱氫類似物。 式I和ΙΑ&lt;化合物,及具有相同特徵性結構類型的類似化 合物的化學名稱,係根據目前的命名法,以下列方式衍生: 關於,、中Υ與Υ 一起代表_ 〇 _,係衍生自2 〇 _螺氧烷(例如 其中X代表氧代,且γι與起代表办之式㈣合物, 本紙張尺度適用中國國冬標準(CNS ) A4規袼(2H) X 297公餐) (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 593305 A7 -------- "5. Description of the Invention (37) Oxypene-7"-methyl carboxylate, ethyl ester and isopropyl ester, -9q, 11o ^ epoxy-15 / ?, 16々_ methylene_3,21_ dioxo · 20_spiro-1,4-diene-7 π-carboxylic acid methyl ester, ethyl ester and isopropyl ester , 9 ", 11" -epoxy-3_oxo_2〇-spiro-4-ene-7 "_formic acid carboxylic acid, ethyl and isopropyl ester, 9 α, 1 1" _ Epoxy-6 cold, 6 /? _ Methylene_2.spiro-4_-3_one, 90%, 11-epoxy-6 Lu, 7 Lu; 15々, 16; 3- Bismethylene-20-spiro-4-ene_3-one, and 9α, 11α_epoxyhydroxy_17_ (3.hydroxy.propyl 3_oxo_androst-4-ene- 7 from methyl carboxylate, ethyl ester, and isopropyl ester, 9 ", 1 1 α _epoxy-17 • hydroxy_17 α _ (3_hydroxypropyl) _6 to 7" _ methylene-androster -4 -fluorene-3 -one, 9 from, 11 α _epoxide_17fluorene_hydroxy-17 α _ (3_hydroxypropyl) · 6 cold, methylene-androster-4 _fluorene-3- Ketone, 9 from, 11 α-J oxo · 17々_hydroxy-17 "_ (3_hydroxypropyl) _6々, 70; 15 points, 16々 · bismethylene · androst_4_ene- 3_ ketone, including extract &lt; 17α- (3-ethoxypropyl) and 17- (3-methyloxypropyl) analogs of androstane compounds, and all of the androstene mentioned 4_ 4-3 · Ketones and 1,2-dehydro analogues of compounds of the 〇_spirooxy_ 4 _ene_ 3 _ ketone series. Chemical names of compounds of the formulae I and IA &lt; and similar compounds having the same characteristic structural type, are According to the current nomenclature, it is derived in the following way: About, Zhongzhong and Υ together represent _〇_, which is derived from 20-spiroxane (for example, where X represents oxo, and γι and the representative formula) This paper size applies the Chinese National Winter Standard (CNS) A4 Regulation (2H) X 297 Meal) (Please read the precautions on the back before filling this page)

593305 A7 B7 五、發明説明(38 螺氧燒_21,);關於其中γ1和γ2分別代表經 : I代的那些’則衍生自17/?-羥基-17從_孕留 晞 2 1-羧酸;而關於並由i ^ ^ 、/、中Y和Y分別代表羥基,且X代表 兩個虱:子的那些,則衍生自17/?,基_17^(3_輕丙基 )、准田&amp;所除非特別另行提及,在式I的終產物和類似結構 物貝與中間物中,在每個案例所有—起被提及的形 在上下又中瞭解到因爲環狀和開鏈的形式,也就是 所明的内酉曰和17/? ’基_21邊酸及其鹽類,分別是如此地 彼此密切相關,以致於僅可將後者視爲前者的水合形式。 根據本發明,爲了以高產量和合理的成本來製備式I化合 物,已經設計出數個不同的進行計劃。每個合成計劃均經 由連串中間物的製備來進行。這些中間物中有許多是新 頭的化合物,且製備這些中間物的方法也是新穎的方法。 3L劃1 (從康雷諾查匆質開始、 :種製備幻化合物的較佳進行計劃,有利地從康雷諾或 付合式X111之相關的起始物質開始 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 其中593305 A7 B7 V. Description of the invention (38 spiro-oxygenated _21,); about which γ1 and γ2 respectively represent the following: those of generation I are derived from 17 /?-Hydroxy-17 from _pregnant 晞 2 1-carboxyl Acid; and with respect to and by i ^^, /, in which Y and Y respectively represent a hydroxyl group, and X represents two lice: those that are derived from 17 / ?, the group _17 ^ (3_light propyl), Junda &amp; So unless specifically mentioned otherwise, in the final product of Formula I and similar structures, shells and intermediates, in each case, the shapes mentioned above and below are understood because of the ring and opening The form of the chain, that is, the intrinsic intrinsic and 17 /? 'Yl_21 side acids and their salts, are so closely related to each other that the latter can only be regarded as the former hydrated form. According to the present invention, to prepare the compound of formula I at high yields and reasonable costs, several different schemes have been devised. Each synthesis plan is carried out through the preparation of a series of intermediates. Many of these intermediates are novel compounds, and the methods for preparing these intermediates are also novel methods. 3L scoring 1 (starting from Conranox, a better plan for the preparation of phantom compounds, and advantageously starting from Conranox or Phenol X111 related starting materials (please read the precautions on the back before filling in this Page) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

XII工 -A-A-代表基團-CHR4-CHR5KH4=CH5_ R3、R4和R5分別選自包括氫、鹵素、羥基、低碳數烷基 低碳數说氧基、每燒基、貌氧燒基、超羧基、氰基、 芳XII-AA-representing group -CHR4-CHR5KH4 = CH5_ R3, R4 and R5 are respectively selected from the group consisting of hydrogen, halogen, hydroxyl, low-carbon alkyl and low-carbon oxygen, per-alkyl, oxy-alkyl, Super carboxyl, cyano, aromatic

4 -41- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公慶) 593305 A7 B7 五、發明説明(39 氧基, _b-b_代表基團- CHR6_CHR7_或心或方位之基團: 、?Η· -CH —CHa4 -41- This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 public holidays) 593305 A7 B7 V. Description of the invention (39 oxygen, _b-b_ represents the group-CHR6_CHR7_ or the base of the heart or orientation Mission:,? Η · -CH —CHa

-CH I -CH-CH I -CH

IU 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基、醯基 、輕燒基、燒氧烷基、羥羰基、烷基、烷氧羰基、醯氧 烷基、氰基、芳氧基,且 R8和R9分別選自包括氫、鹵素、低碳數烷氧基、醯基、 羥烷基、烷氧烷基、羥羰基、烷基、烷氧羰基、醯氧烷 基、氰基、芳氧基,或是R8和R9 一起包含一碳環或雜i 之結構,或是R8或R9與R6或R7 —起包含一碳環或雜環、= 構,融合成五環之D環。 。 利用在圖1和2中解釋之類型的生物轉變方法,將α ·方^ 的11-羥基導入式XIII化合物中,藉此而獲得式…^: 合物:IU wherein R6 and R7 are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, alkynyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, alkoxyalkyl, cyano, Aryloxy, and R8 and R9 are selected from the group consisting of hydrogen, halogen, lower alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, alkoxyalkyl, Cyano, aryloxy, or R8 and R9 together contain a carbocyclic or hetero i structure, or R8 or R9 and R6 or R7 together contain a carbocyclic or heterocyclic ring, = structure, fused into a pentacyclic ring D ring. . Using a biological transformation method of the type explained in FIGS. 1 and 2, the 11-hydroxy group of α · square ^ is introduced into a compound of formula XIII, thereby obtaining a compound of formula: ^:

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

VIII 其中_A-A-、-B-B-、R3、R8和R9如同上文之定 式XIII化合物具有結構: Y2 H C 丫1 I ⑶—rWH厂VIII where _A-A-, -B-B-, R3, R8, and R9 are as defined above. The compound of formula XIII has a structure: Y2 H C γ 1 I ⑶—rWH factory

義。較佳的是,Righteousness. Preferably,

XXXA (請先閱讀背面之注意事項再填寫本頁jXXXA (Please read the notes on the back before filling in this page j

-42- 593305 A7 B7 五、發明説明(4〇 且1 1 α -羥基的產物具有結構: H.r Y1-42- 593305 A7 B7 V. Description of the invention (40 and the product of 1 1 α-hydroxyl has structure: H.r Y1

X VII ΙΑ 其中每個 ·Α_Α代表基團·ί!ΙΗ2_(ΙΉ2·或, -Β·Β·代表基團-CH^CH2·,或是^或々.方位之基團: -CH— CHP—CH—-X VII ΙΑ where each Α_Α represents a group ί! ΙΗ2_ (ΙΉ2 · or, -Β · Β · represents a group -CH ^ CH2 ·, or ^ or 々. Orientation group: -CH— CHP— CH—-

IIIA X代表兩個氫原子、氧代或, Y1和Y2—起代表氧橋-0_,或 Y1代表羥基,且 Y代表每基、低碳數烷氧基,或如果X代表h2,也可代^ 低碳數烷醯氧基, 以及其中X代表氧代,且Y2代表羥基之化合物的鹽類,」 在該反應中產生的式VIII化合物,符合式Viha (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 h〇丫斗YccH2〕「c:=:xIIIA X represents two hydrogen atoms, oxo or, Y1 and Y2-together represents an oxygen bridge-0_, or Y1 represents a hydroxyl group, and Y represents per group, a low carbon number alkoxy group, or if X represents h2, it can also be substituted ^ Low-carbon alkanoyloxy, and salts of compounds in which X represents oxo and Y2 represents hydroxyl, "The compound of formula VIII produced in this reaction conforms to formula Viha (please read the notes on the back before filling in (This page) Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 〇〇 斗斗 YccH2] "c: =: x

VII ΙΑ -43- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210'乂297公釐)VII ΙΑ -43- This paper size applies to China National Standard (CNS) Α4 specification (210 '乂 297 mm)

經濟部中央標準局員工消費合作社印製 593305 A7 B7 五、發明説明(41 ) 其中-A-A-、-B-B-、Y1、Y2和X如同在式XXXA中之定義。 更佳的是R8和R9 —起形成2 0 -螺氧烷結構:Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 B7 V. Description of the Invention (41) Among them -A-A-, -B-B-, Y1, Y2, and X are as defined in the formula XXXA. More preferably, R8 and R9 together form a 2 0 -spiroxane structure:

XXXIII -A-A-和-B-B-分別爲-CH2-CH2-,且R3 爲氫。 在該羥基化作用步驟中,可使用的較佳生物包括褐黃麴 菌(A spergillus ochraceus) NRRL405、褐黃麴菌(Aspergillus ochraceus)ATCC 18500、黑麴菌(Aspergillus niger) ATCC 16888 和 ATCC 26693 、小巢狀麴菌(Aspergillus ni du 1 ans ) ATCC 1 1 267、酒麴菌(Rhizopus orvzae) ATCC 11145、匍枝酒麴菌(Rhizopus stolonifer、ATCC 6227b、弗氏鏈黴菌(Streptomyces fradiae) ATCC 10745、巨 桿菌(Bacillus megaterium) ATCC 14945、苦西法假單孢菌 (Pseudomonas cruciviae) ATCC 13262,和粉紅單端孢 (Trichothecium roseum) ATCC 12543。其他較佳的生物包括 塞皮種尖鐮孢(Fusarium oxysporum f. sp. cepae、ATCC 11171 和少根酒麴菌(Rhizopus arrhizus) ATCC 11145 ° 已經顯示出對該反應之活性的其他生物,包括藍色犁頭 黴(Absidia coerula) ATCC 6647、灰綠犁頭黴(Absidia glauce) ATCC 22752、雅致放射毛黴(Actinomucor elegans) ATCC 6476、黃麴菌(Aspergillus flavipes) ATCC 1030、薰 煙色麴菌(Aspergillus fumigatus) ATCC 26934、蠶黴菌 (Beauveria bas— ATCC 7159和ATCC 13 144、葡萄座腔 -44- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)XXXIII -A-A- and -B-B- are -CH2-CH2-, and R3 is hydrogen. Preferred organisms that can be used in this hydroxylation step include Aspergillus ochraceus NRRL405, Aspergillus ochraceus ATCC 18500, Aspergillus niger ATCC 16888 and ATCC 26693, Aspergillus ni du 1 ans ATCC 1 1 267, Rhizopus orvzae ATCC 11145, Rhizopus stolonifer, ATCC 6227b, Streptomyces fradiae ATCC 10745, Bacillus megaterium ATCC 14945, Pseudomonas cruciviae ATCC 13262, and Trichothecium roseum ATCC 12543. Other preferred organisms include Fusarium oxysporum f sp. cepae, ATCC 11171, and Rhizopus arrhizus ATCC 11145 ° Other organisms that have shown activity against this reaction, including Absidia coerula ATCC 6647, P. gray-green (Absidia glauce) ATCC 22752, Actinomucor elegans ATCC 6476, Aspergillus flavipes ATCC 1030, fumigant Aspergillus fumigatus ATCC 26934, Beauveria bas—ATCC 7159 and ATCC 13 144, Grape Cavity-44- This paper applies Chinese National Standard (CNS) A4 (210X297 mm) (Please read the back (Please fill in this page again)

經濟部中央榡準局員Η消費合作社印製 593305 A7 B7 五、發明説明(42 ) 菌(Botrvosphaeria obtusa) IMI 03 8560、麗赤殼(Caloneotria decora) ATCC 14767、螺卷毛殼(Chaetomium cochliodes) ATCC 10195、山爲豆生棒孢(Corynespora cassiicola) ATCC 16718、短刺小克銀漢黴(Cunninghamella blakesleeana) ATCC 8688a、刺孢小克銀漢黴(Cunninghamella echinulate) ATCC 3655、雅致小克銀漢黴(Cunninghamella elegans) ATCC 9245、克拉斐特彎、孢(Curvularia clavata) ATCC 22921、魯那特彎孢(Curvularia lunata) ACTT 12071、雷迪 西可拉柱孢(Cylindrocarpon radicicola) ATCC 1011、荷米可 拉附球菌(Epicoccum humicola) ATCC 12722、卵形孢球托 黴(Gongronella butleri、ATCC 22822、金孢菌寄生 (Hvpomyces chrvsospermus)、深黃被孢黴(Mor_tierella isabellina) ATCC 42613、大白黴(Mucor mucedo) ATCC 4065、灰藍白黴(Mucor griseo_cyanus) ATCC 1207A、虎孢 漆斑菌(Myrothecium verrucaria) ATCC 9095、珊瑚 土壤絲 菌(Nocardia corallina)、卡納斯擴:青機:(P aecilomvces carneus) ATCC 46579、展青黴菌(Penicillum patulum) ATCC 24550、阿索·歐里維克髓黴(Pithomvces atro-olivaceus、IFO 6651、犬齒骨遗黴(Pithomyces cvnodontis) ATCC 26150、密孔菌屬(Pycnosporium sp·) ATCC 12231、 紅色糖多孢菌(Saccharopolyspora erythrae、ATCC 1 1635、 黃瘤孢(Sepedonium chrysospermum、ATCC 13378、兩色司 塔開里菌(Stachvlidium bicolor) ATCC 12672、吸水鏈黴菌 (Streptomyces hygroscopicus) ATCC 2743 8、淺绛紅鏈黴菌 -45- 本紙張尺度適用中國國家標準(CNS ) A4規格(21 〇X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 593305 A7 B7 _ 五、發明説明(43 ) (Streptomyces purpurascens) ATCC 25489、總狀共頭黴 (Syncephalastrum racemosum) ATCC 18192、梨狀薩摩斯泰 樂菌(Thamnostylum piriforme) ATCC 8992、梭孢殼 (Thielavia terricola、ATCC 13 807 ,和可可輪枝孢 (Verticillium theobromae) ATCC 12474 o 經濟部中央榡準局員Η消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 可預期對11 π -羥基化作用顯示出活性的額外生物包括jg_ 菲迪可拉頭孢徽(Cephalosporium aphidicola) (Phytochemistry (1996),42 (2),411-415)、路那塔旋孢腔菌(Cochliobolus lunatasKJ. Biotechnol. (1995),42 (2),145--150)、歐曲迪 斯泰格耐拉菌(Tieghemella orchidis、(Khim. -Farm. Zh. 9(186),20(7),871-876)、海洛史普拉泰格耐拉菌 (Tieghemella hvalospora) (Khim. Farm. Zh. (1986),20(7), 871-876)、歐里維可單孢黴(Monosporium olivaceum) (Acta Microbiol. Pol.,Ser. B. (1973),5(2),103-110)、焦麴 菌(Aspergillus ustus、(Acta Microbiol· Pol·,Ser_ B. (1973), 5(2),103-110)、稻鐮孢(Fu_sarium graminearum) (Acta Microbiol· P〇l·,Ser. B. (1973),5(2),103-110)、灰綠輪枝 孢(Verticillium glaucum) (Acta Microbiol. Pol·,Ser. B. (1973),5(2),103-110),和黑化酒麴菌(Rhizopusnigricans) (J· Steroid Biochem. (1987),28(2),197-201) 〇 爲了康雷諾或其他式XIII物質的羥基化作用,準備產製 規模的發酵作用,在包括種子發酵器,或一連_二或多個 種子發酵器的種子發酵系統中製備細胞的接種物。將工作 原料孢子懸浮液與提供細胞生長之營養溶液一起導入第一 -46- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305Printed by the Central Bureau of Associate of the Ministry of Economic Affairs and the Consumer Cooperative 593305 A7 B7 V. Description of the invention (42) Botrvosphaeria obtusa IMI 03 8560, Caloneotria decora ATCC 14767, Chaetomium cochliodes ATCC 10195 Corynespora cassiicola ATCC 16718, Cunninghamella blakesleeana ATCC 8688a, Cunninghamella echinulate ATCC 3655, Cunninghamella elegans ATCC 9245, Curvularia clavata ATCC 22921, Curvularia lunata ACTT 12071, Cylindrocarpon radicicola ATCC 1011, Epicoccum humicola ) ATCC 12722, Gongronella butleri, ATCC 22822, Hvpomyces chrvsospermus, Mor_tierella isabellina ATCC 42613, Mucor mucedo ATCC 4065, gray blue and white Mold (Mucor griseo_cyanus) ATCC 1207A, Myrothecium verrucaria ATCC 909 5. Coral soil mycelia (Nocardia corallina), Kanas expansion: Green machine: (P aecilomvces carneus) ATCC 46579, Penicillum patulum (ATCC 24550), Pithomvces atro- olivaceus, IFO 6651, Pithomyces cvnodontis ATCC 26150, Pycnosporium sp · ATCC 12231, Saccharopolyspora erythrae, ATCC 1 1635, Seputeonium chrysospermum, ATCC 13 2. Two-color Stachvlidium bicolor ATCC 12672, Streptomyces hygroscopicus ATCC 2743 8. Streptomyces hygroscopicus-45- This paper is in accordance with China National Standard (CNS) A4 (21 〇X297) Mm) (Please read the notes on the back before filling this page) Order 593305 A7 B7 _ V. Description of the Invention (43) (Streptomyces purpurascens) ATCC 25489, Syncephalastrum racemosum ATCC 18192, Pear-shaped Satsuma Thamnostylum piriforme ATCC 8992, Thielavia terricola, ATCC 13 807, and Vertici llium theobromae) ATCC 12474 o Printed by the Central Bureau of Commerce of the Ministry of Economic Affairs and the Consumer Cooperative (please read the notes on the back before filling out this page) Additional organisms that can be expected to show activity on 11 π-hydroxylation include jg_ 菲迪 可Cephalosporium aphidicola (Phytochemistry (1996), 42 (2), 411-415), Cochliobolus lunatas KJ. Biotechnol. (1995), 42 (2), 145--150) , Tieghemella orchidis, (Khim.-Farm. Zh. 9 (186), 20 (7), 871-876), Tieghemella hvalospora ) (Khim. Farm. Zh. (1986), 20 (7), 871-876), Monosporium olivaceum (Acta Microbiol. Pol., Ser. B. (1973), 5 ( 2), 103-110), Aspergillus ustus, (Acta Microbiol · Pol ·, Ser_B. (1973), 5 (2), 103-110), Fu_sarium graminearum (Acta Microbiol · Pol, · Ser. B. (1973), 5 (2), 103-110), Verticillium glaucum (Acta Microbiol. Pol., Ser. B. (1973), 5 (2 ), 103-110), and Rhizopusnigricans (J. Steroid Biochem. (1987), 28 (2), 197-201) 〇 For the hydroxylation of Conreno or other substances of formula XIII, preparation of production-scale fermentation, including A seed fermentor, or a cell fermentation system of one or two or more seed fermenters, prepares an inoculum of cells. Introduce the working material spore suspension together with the nutrient solution for cell growth into the first -46- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 593305

、發明説明(44 經濟部中央標準局員工消費合作社印繁 個種予發酵器中。如果產製所想要或需要 ;超過在第-個種子發酵器中產生的體積,則可藉』:: t種:Γ行列中其餘發酵器的進行,逐步地並 y式來擴大接種物的體積。最好是在種子發酵系統 生的接種物,具有足以在產製發酵 、、’ 表貧醉态中使反應迅速開始、 達到相對上較短的產製分批猶環, 髀於A ^ 盾衣和问產製發酵器活性的 積和可存活細胞。播論在—連串種子發酵器中容器的數 目有多少,第二個和後續的種子發酵器最好達到某種 的大小,以便使在該行列每個步驟中的稀釋程度,大 是相同的。在每個種子發酵器中,接種物的最初稀釋,大 約像在產製發酵器中的稀釋度一樣。將康雷諾或其他式 XIII之物質,連同接種物和營養溶液一起裝入產製發酵器 中,並從這裡經營羥基化作用的反應。 裝入種子發酵系統中的孢子懸浮液,是得自從組成工作 原料細胞銀行中之多數小瓶中取得的工作原料孢子懸浮液 小开瓦,其在使用前儲存在低溫條件下。工作原料細胞銀行 係以下列之方式,相繼衍生自主要原料細胞銀行。從適當 之來源獲得最初懸浮於液態培養基,像是例如生理鹽水溶 液、營養溶液或表面活性劑溶液(例如非離子性之表面活性 劑,如大約0.001重量%之濃度的吐溫20)中的孢子樣本,例 如ATCC,並將該懸浮液分布在培養盤中,每個培養盤裝有 固態的營養混合物,通常是以諸如瓊脂之類不可消化的多 醣爲基礎,使孢子在該處繁殖。該固態營養混合物最好是 含有在大約0.5重量%到大約5重量%之間的葡萄糖,在大約 -47- 度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)、 Explanation of the invention (44 Employees' cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs print a variety of seeds into the fermenter. If the production system wants or needs; more than the volume produced in the first seed fermenter, you can borrow ":: T species: the progress of the remaining fermenters in the Γ series, gradually increasing the volume of the inoculum with the y formula. It is best to inoculate the seed fermentation system, which is sufficient to produce fermentation, The reaction started quickly and reached a relatively short production batch cycle, which was dependent on the active product and viable cells of the A ^ shield and the production fermenter. Sowing on the number of containers in a series of seed fermenters How much, the second and subsequent seed fermenters are preferably of a certain size, so that the degree of dilution in each step of the row is substantially the same. In each seed fermenter, the initial inoculum The dilution is about the same as that in the production fermenter. Conrano or other substances of formula XIII are charged into the production fermenter together with the inoculum and nutrient solution, and the hydroxylation reaction is operated from there.The spore suspension introduced into the seed fermentation system is a small raw tile of working material spore suspension obtained from most vials constituting the working material cell bank, which is stored under low temperature conditions before use. The working material cell bank is below The method is listed below, successively derived from the main raw material cell bank. Obtain from an appropriate source initially suspended in liquid culture medium, such as, for example, a physiological saline solution, a nutrient solution, or a surfactant solution (eg, a nonionic surfactant, such as about 0.001 20% by weight of spore samples in Tween 20), such as ATCC, and distribute the suspension in culture plates, each plate containing a solid nutrient mixture, usually a non-digestible polysaccharide such as agar Based on this, the spores are allowed to multiply there. The solid nutrient mixture preferably contains between about 0.5% and about 5% by weight of glucose, and the Chinese National Standard (CNS) A4 specification (210X297) is applied at about -47-degree. Mm) (Please read the notes on the back before filling in this page)

593305 A7 B7 五、發明説明(45 經濟部中央標準局員工消費合作社印掣 0 · 0 5重量%到大約5重量%之間的氮來源,例如腺,在大約 0.05重量%到大約〇·5重量%之間的磷來源,例如磷酸銨或 鹼金屬磷酸鹽,像是磷酸氫二鉀,在大約〇 25重量%到大 約2 · 5重量%之間的酵母溶胞產物或萃取物(或其他胺基酸來 源,像是肉萃取物或腦心浸液),在大約1重量%到大約2重 量%之間的瓊脂或其他不可消化之多醣。可視需要包括固態 營養混合物,及/或含有在大約〇 ·丨重量%到大約5重量。/〇之 間的麥芽萃取物。固態營養混合物的p H値,最好是在大約 5 · 0到大約7 · 0之間,按需要藉著鹼金屬氫氧化物或正磷酸 來調整。可使用之固態生長培養基如下:1·固®培養基# 1 ·· 1 %葡萄糖,0.2 5 %酵母萃取物,〇 . 3 % K2HP04和 2% 瓊脂(Bacto);以 20%NaOH將 pH値調整到6.5。 2% 腺(Bacto),1% 酵母萃取物(Bacto), 2%葡萄糖和2%瓊脂(Bacto);以 10%H3PO4將pH値調整到5。 0.1% 腺(Bacto),2% 麥芽萃取物(Bacto) ,2%葡萄糖和2%瓊脂(Bacto);pH値調整 到 5 · 3。 5 %赤糖糊,0 · 5 %玉米漿,〇 · 2 5 %葡萄 糖,0.25%NaCl和 〇.5%KH2P〇4,pH値 調整到5.8。 ,Difco興菌學的瓊脂(低pH値)。 爲了主要原料將來的需要,可選擇在展開主要原料細胞 2 ·固態培養基# 2 •固悲培養基# 3 : 4 ·液態培養基 48- 本紙張尺度適用中國國家標準(CNs ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(46 ) 銀行時所使用之瓊脂培養盤的數量,但是通常是製備大約 15到大約30個培養盤。在適當的生長期間之後,例如了至 10天,在含水媒劑的存在下刮擦培養盤,通常是生理鹽水 或緩衝溶液,以便收獲孢子,並將所得的主要原料懸=液 分成數個小瓶,例如,在多個每個15亳升的小瓶中各1毫 升。欲製備在研究或產製發酵操作中使用的工作原料孢子 懸浮液,可將一或多個這些第二代的主要原料小瓶中的内 容物,以上述製備主要原料孢子懸浮液的方式,分布在瓊 脂培養盤上並培養之。在完成例行的製造操作時,可使用 1 0 0到4 0 0個培養盤這樣多的來產生第二代的工作原料。將 每個培養盤分別刮擦到不同的工作原料小瓶中,每個小瓶 通常含有1毫升所產生的接種物。爲了永久保存,主要原料 懸浮液和第二代產生的接種物可有利地儲存在含有液態 或其他低溫液體之低溫儲藏容器的蒸氣域中。 在圖1所圖示的方法中,製備液態生長培養基,其包括諸 如腺之類的氮來源、酵母衍生物或相等物、葡萄糖,和諸 如磷酸鹽之類的磷來源。在種子發酵系統中的該培養基中 培養微生物的孢子。較佳的微生物是^^nrrl 4()5 (ATCC 1 8500)。然後將如此產生的種子原料連同式XI11之 受酶質一起導入產製發酵器中。攪動發酵肉湯,並充氣一 段足以使該反應進行至想要之完成程度的時間。 種子發酵器的培養基’取好由液態混合物組成,其本有. 在大約0 · 5重量%到大約5重量%之間的葡萄糖,在大約 0·05重量%到大約5重量%之間的氮來源,例如腺,在大約 -49- 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨OXM7公釐) (請先閱讀背面之注意事項再填寫本頁) 、11 I I - - I- I - . 593305 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(47 ) 0 · 0 5重量%到大約0 · 5重量%之間的磷來源,例如磷酸銨或 鹼金屬磷酸鹽,像是一價磷酸銨或磷酸氫二鉀,在大約 0 · 2 5重量%到大約2.5重量%之間的酵母溶胞產物或萃取物 (或其他胺基酸來源,像是酒槽),在大約1重量%到大約2 重量%之間的瓊脂或其他不可消化之多醣。特佳的種子生長 培養基含有在大約0.0 5重量%到大約5重量%之間的氮來源 ,例如腺,在大約0 _ 2 5重量%到大約2 · 5重量%之間的自溶 酵母或酵母萃取物’在大約〇 _ 5重量%到大約5重量%之間的 葡萄糖’以及在大約0 · 0 5重量%到大約〇 · 5重量%之間的磷 來源,像是一價磷酸銨。藉著使用其他較佳的種子培養基 ,獲得特別經濟的操作方法,其包含在大約〇 · 5重量到大約 5重量%之間的玉米漿,在大約〇 · 2 5重量%到大約2.5重量 %之間的自溶酵母或酵母萃取物,在大約〇 · 5重量%到大約5 重量%之間的葡萄糖,和在大約〇 · 〇 5重量。/()到大約〇 · 5重量 %之間的一價磷酸銨。玉米漿是特別經濟的蛋白質、肽類、 碳水化合物、有機酸、維生素、金屬離子、微量物質和磷 酸鹽的來源。也可以使用得自其他穀物的漿液來代替玉米 漿,或加在其中。最好將該培養基的pH値調整到在大約 5 _ 0到大約7 · 0的範圍内,例如,藉著加入鹼金屬氫氧化物 或正磷酸。在提供玉米漿作爲氮和碳來源之處,最好將卩只 値凋整到在大約6.2到大約6 · 8的範圍内。包括腺和葡萄糖 的培養基,最好將pH値調整到在大約5·4到大約6·2之間。 可使用在種子發酵作用中的生長培養基包括: 1·培養基#1:2%腺,2%自溶酵母(或酵母萃取物)和2%葡萄 (讀先閱讀背面之注意事項再填寫本頁)593305 A7 B7 V. Description of the invention (45 Employees' cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs of the People's Republic of China printed a nitrogen source, such as a gland, between about 0.05% and about 0.5% by weight. % Of phosphorus sources, such as ammonium phosphate or alkali metal phosphate, such as dipotassium hydrogen phosphate, yeast lysates or extracts (or other amines) between about 025% and about 2.5% by weight Source of acid, such as meat extract or brain heart infusion), agar or other non-digestible polysaccharides between about 1% and about 2% by weight. A solid nutrient mixture may be included as needed, and / or contained in about 〇 · 丨% by weight to about 5 wt./malt extract between / 〇. The pH of the solid nutrient mixture is preferably between about 5.0 · about 7 · 0, by alkali metal as needed It can be adjusted by hydroxide or orthophosphoric acid. The solid growth medium that can be used is as follows: 1 · Sol® Medium # 1 ·· 1% glucose, 0.25% yeast extract, 0.3% K2HP04 and 2% agar (Bacto); Adjust pH to 6.5% with 20% NaOH 2% (Bacto), 1% yeast extract (Bacto), 2% glucose and 2% agar (Bacto); adjust pH to 5 with 10% H3PO4. 0.1% gland (Bacto), 2% malt extract (Bacto ), 2% glucose and 2% agar (Bacto); pH 値 adjusted to 5. 3.5% brown sugar paste, 0.5% corn pulp, 0.25% glucose, 0.25% NaCl and 0.5% KH2P 〇4, pH 値 adjusted to 5.8. Difco agar agar (low pH 値). For the future needs of the main raw materials, you can choose to expand the main raw material cells 2 · Solid medium # 2 • solid sad medium # 3: 4 · Liquid medium 48- This paper size is in accordance with Chinese National Standards (CNs) A4 (210X 297 mm) (Please read the precautions on the back before filling this page) 593305 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 5 Description of the invention (46) The number of agar culture plates used in the bank, but usually about 15 to about 30 culture plates are prepared. After a suitable growth period, for example, to 10 days, in the presence of an aqueous vehicle Scrap the culture dish, usually saline or buffer solution, to harvest the spores The obtained main raw material suspension is divided into several vials, for example, 1 ml each in a plurality of 15 liter vials. To prepare a spore suspension of working raw materials used in research or production fermentation operations, The contents of one or more of these second-generation vials of the main raw materials were distributed on an agar culture plate and cultured in the manner described above for preparing the spore suspension of the main raw materials. When routine manufacturing operations are completed, as many as 100 to 400 plates can be used to produce second-generation working materials. Scrape each culture dish into different working material vials, each vial usually containing 1 ml of the inoculum produced. For permanent preservation, the main raw material suspension and the second-generation inoculum can be advantageously stored in the vapour area of a cryogenic storage container containing a liquid or other cryogenic liquid. In the method illustrated in Fig. 1, a liquid growth medium is prepared, which includes a nitrogen source such as a gland, a yeast derivative or equivalent, glucose, and a phosphorus source such as a phosphate. In this medium in a seed fermentation system, spores of microorganisms are cultured. The preferred microorganism is ^ nrrl 4 () 5 (ATCC 1 8500). The seed material thus produced is then introduced into a production fermenter together with the enzyme of formula XI11. The fermentation broth is agitated and aerated for a time sufficient to allow the reaction to proceed to the desired degree of completion. The culture medium of the seed fermenter's is made up of a liquid mixture, which is inherently there. Glucose between about 0.5% to about 5% by weight, nitrogen between about 0.05% to about 5% by weight Sources, such as glands, are approximately -49- This paper size applies Chinese National Standard (CNS) A4 specifications (2 丨 OXM7 mm) (Please read the precautions on the back before filling this page), 11 II--I- I -. 593305 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the invention (47) 0 · 0 5 wt% to about 0.5 wt% phosphorus sources, such as ammonium phosphate or alkali metal phosphate, Like a monovalent ammonium phosphate or dipotassium hydrogen phosphate, a yeast lysate or extract (or other amino acid source, such as a wine tank) between about 0.25% to about 2.5% by weight. Agar or other non-digestible polysaccharides between about 1% and about 2% by weight. Particularly preferred seed growth media contain nitrogen sources between about 0.05% to about 5% by weight, such as glands, autolysed yeasts or yeasts between about 0-25% by weight and about 2.5% by weight The extract 'glucose' between about 0.05 to about 5% by weight and a source of phosphorus between about 0.05 to about 0.5% by weight, like ammonium monovalent phosphate. By using other preferred seed media, a particularly economical method of operation is obtained, which comprises between about 0.5 and about 5% by weight corn syrup, and between about 0.5 and about 2.5% by weight Between autolyzed yeast or yeast extract, glucose between about 0.5% and about 5% by weight, and between about 0.5% by weight. / () To about 0.5% by weight of monovalent ammonium phosphate. Corn pulp is a particularly economical source of proteins, peptides, carbohydrates, organic acids, vitamins, metal ions, trace substances and phosphates. Instead of or in addition to corn syrup, syrup derived from other grains can also be used. The pH of the medium is preferably adjusted to a range of about 5-0 to about 7.0, for example, by adding an alkali metal hydroxide or orthophosphoric acid. Where corn slurry is provided as a source of nitrogen and carbon, it is best to trim maggots to a range of about 6.2 to about 6.8. For a medium including glands and glucose, it is preferable to adjust the pH to between about 5.4 and about 6.2. The growth media that can be used in seed fermentation include: 1. Medium # 1: 2% gland, 2% autolyzed yeast (or yeast extract), and 2% grapes (read the precautions on the back before filling this page)

-50- 經濟部中央標準局員工消費合作社印製 593305 A7 -----— _ B7 五、發明説明(48 ) 糖;以20%NaOH將pH値調整到5.8。 2 ·杧養基# 2 : 3 %玉米漿,1 · 5 %酵母萃取物,〇 · 3 % 一價嶙酸 銨和3%葡萄糖;以20%NaOH將pH値調整到 6.5 ° 將得自通常每亳升懸浮液中含有大約1 〇 9個孢子之小瓶的 微生物抱子導入該培養基中。當在種子培養開始時利用生 長培養基來稀釋’並不會使孢子族群之密度降至大約每毫 升107以下時,獲得種子繁殖的最佳生產力。較佳的是,在 種子發酵系統中的培養孢子,直到填充菌絲體的體積 (Ρ Μ V)至少爲大約2 〇 %爲止,較佳的是3 5 0/〇到4 5 %。因爲 在種子發酵容器(或任何複數的、構成種子發酵行列的容器) 中的循環,依賴在容器中最初的濃度,所以可能想要準備 一或二個種子發酵階段,以便使整個過程加速。然而,最 好避免連續使用二個以上的種子發酵器,因爲如果經由過 量的階段來完成種子發酵作用,將可能使活性打折扣。種 子培養發酵作用,係在大約2 3 到大約3 7的溫度範圍内 ,攪動的條件下來經營,較佳的是在大約24〇c到大約28χ: 之間的範圍。 將得自種子發酵系統的培養物,連同產製生長培養基一 起導入產製發酵器中。在本發明的一個具體實施例中,以 播菌的康雷諾或其他SXIIIi受酶質作爲該反應之受酶質 。較佳的是,該受酶質以在生長培養基中丨〇重量%到3 〇重 量%之形式加至該產製發酵器中。欲增加丨丨羥基化作用 反應可利用的表面積,藉著在將式χπι之受酶質導入發酵 -51- 本紙張尺度適用中國國家標準(CNS )^4規格(2ι〇&gt;&lt;297公策) (讀先閱讀背面之注意事項再填寫本頁)-50- Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 593305 A7 ------ _ B7 V. Description of the invention (48) Sugar; adjust pH 値 to 5.8 with 20% NaOH. 2 · 杧 养 基 # 2: 3% corn slurry, 1.5% yeast extract, 0.3% ammonium monovalent gallate and 3% glucose; adjust pH to 6.5 ° with 20% NaOH will be obtained from the usual Microbial spores in vials containing approximately 109 spores per liter of suspension were introduced into the medium. Optimal productivity for seed reproduction is obtained when dilution with growth medium at the beginning of seed culture does not reduce the density of the spore population to below 107 per milliliter. Preferably, the spores are cultured in a seed fermentation system until the volume of filled mycelia (PMV) is at least about 20%, and more preferably from 350/45 to 45%. Because the circulation in a seed fermentation container (or any number of containers that make up the seed fermentation rank) depends on the initial concentration in the container, you may want to prepare one or two seed fermentation stages to speed up the entire process. However, it is best to avoid the use of more than two seed fermenters in a row, because if the seed fermentation is done through an excessive amount of stages, the activity may be compromised. Seed culture fermentation is performed in a temperature range of about 2 3 to about 37 under agitated conditions, preferably in a range of about 24 ° C to about 28χ :. The culture obtained from the seed fermentation system is introduced into the production fermenter together with the production growth medium. In a specific embodiment of the present invention, Conreno sowed or other SXIIIi enzymes are used as the enzymes of the reaction. Preferably, the enzyme-receiving substance is added to the production fermenter in a form of 0% to 30% by weight in a growth medium. To increase the surface area available for the hydroxylation reaction, by introducing the enzymatic substance of formula χπι into the fermentation -51- This paper size applies the Chinese National Standard (CNS) ^ 4 specifications (2ι〇 &gt; &lt; 297) Policy) (Read the precautions on the back before filling in this page)

經濟部中央標準局員工消費合作社印製 593305 ______ B7 五、發明説明(49 ) ' 器之前,先使其通過線外式粉碎機,來減少該受酶質的罘每 粒大小。亦分別導入含有葡萄糖的無菌營養飼料原料,以 及第二種含有酵母衍生物,像是自溶酵母(或是相等的胺基 酸配方,以另一種來源爲基礎,像是酒槽)的無菌營養溶液 。培養基由含有下列成份的含水混合物組成:在大約〇 . 5重 量%到大約5重量%之間的葡萄糖,在大約〇 · 〇 5重量%到大 約5重量%之間的氮來源,例如腺,在大約〇 · 〇 5重量%到大 約0 · 5重量%之間的磷來源,例如嶙酸按或驗金屬嶙酸鹽, 像是嶙酸氫二_,在大約0 · 2 5重量%到大約2 · 5重量%之間 的酵母溶胞產物或萃取物(或其他胺基酸來源,像是酒槽), 在大約1重量%到大約2重量%之間的瓊脂或其他不可消化的 多醣。特佳的產製生長培養基,含有在大約〇 · 〇 5重量%到 大約5重量%之間的氮來源,像是腺,在大約〇 · 2 5重量%到 大約2 · 5重量%之間的自溶酵母或酵母萃取物,在大約〇 . 5 重量%到大約5重量%之間的葡萄糖,以及在大約〇 . 〇 5重量 %到大約0 · 5重量%之間的磷來源,像是一價磷酸銨。其他 較佳的產製培養基含有在大約0.5重量%到大約5重量%之間 的玉米漿,在大約0 · 2 5重量%到大約2.5重量%之間的自溶 酵母或酵母萃取物,在大約0 · 5重量%到大約5重量%之間皀 葡萄糖,以及在大約0 · 0 5重量%到大約〇 . 5重量%之間的一 價磷酸銨。最好分別以上述關於具有以腺/葡萄糖爲基礎之 培養基和以玉米衆爲基礎之培養基的相同較佳p Η値範圍之 種子發酵培養基的方法,來調整產製發酵培養基之pH値。 可利用之生物轉化生長培養基,陳列在下文中: •52- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) &quot; (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 593305 ______ B7 V. Description of the invention (49) Before passing the device through an external grinder to reduce the size of the enzymatic radon. Sterile nutritional feed ingredients containing glucose were also introduced, and a second type of sterile nutrition containing yeast derivatives, such as autolyzed yeast (or equivalent amino acid formula, based on another source, such as a wine tank) Solution. The culture medium consists of an aqueous mixture containing the following ingredients: glucose between about 0.5% to about 5% by weight, nitrogen sources between about 0.05% to about 5% by weight, such as glands, at Sources of phosphorus between about 0.05% to about 0.5% by weight, such as acetic acid or metalloate, such as hydrogen diacetate, at about 0.25% to about 2% · Yeast lysates or extracts (or other amino acid sources such as wine tanks) between 5% by weight, agar or other non-digestible polysaccharides between about 1% and about 2% by weight. Extraordinarily good production growth medium containing a nitrogen source between about 0.05% by weight and about 5% by weight, such as a gland, between about 0.25% by weight and about 2.5% by weight Autolyzed yeast or yeast extract, glucose between about 0.5% to about 5% by weight, and a source of phosphorus between about 0.05% to about 0.5% by weight, like one Valent ammonium phosphate. Other preferred production media contain corn syrup between about 0.5% and about 5% by weight, autolyzed yeast or yeast extract between about 0.25% and about 2.5% by weight, and about 0.5 to about 5% by weight ammonium glucose, and monovalent ammonium phosphate between about 0.5 to about 0.5% by weight. It is preferable to adjust the pH of the fermentation medium to be adjusted by the above-mentioned methods for the seed fermentation medium having the same preferable pp range as the gland / glucose-based medium and the corn-based medium, respectively. Available biotransformation growth media are listed below: • 52- This paper size applies to China National Standard (CNS) A4 (210X297 mm) &quot; (Please read the precautions on the back before filling this page)

593305 經濟部中央標準局員工消費合作社印f A7 B7 五、發明説明(5〇 ) 1.培養基#1:2%腺、2%自溶酵母(或酵母萃取物)和2%葡萄 糖;以20%NaOH將pH値調整到5.8。 2 ·培養基# 2 : 1 %腺、1 %自溶酵母(或酵母萃取物)和2 %葡萄 糖;以20%NaOH將pH値調整到5.8。 3 ·培養基# 3 : 0 · 5 %腺、0 · 5 %自溶酵母(或酵母萃取物)和 0.5%葡萄糖;以20%NaOH將pH値調整到5.8。 4 ·培養基# 4 : 3 %玉米漿、1 . 5 %酵母萃取物、〇 · 3 % —價磷酸 銨和3%葡萄糖;以20%NaOH將pH値調整到 6.5。 5 ·培養基# 5 : 2 · 5 5 %玉米漿、1 · 2 7 5 %酵母萃取物、〇 · 2 5 5 % 一價磷酸銨和3%葡萄糖;以20%NaOH將pH 値調整到6.5。 6 ·培養基# 6 : 2 · 1 %玉米漿、1 · 〇 5 %酵母萃取物、〇 . 2 1 % — 價磷酸銨和3%葡萄糖;以20%NaOH將pH値 調整到6.5。 非-無菌的康雷語和無菌的營養溶液,以五比二十,較佳 的是十比十五,最好是大體上相等的比例,在產製分批循 環内分別供給至產製發酵器中。有利的是,在利用種子發 酵肉湯接種之前,一開始先以足以建立在大約0 · 1重量%到 大約3重量%之間的濃度,較佳的是在大約0.5重量%到大約 2重量%之間之濃度的含量導入受酶質,然後定期添加,方 便地是每8到2 4小時,至在大約1重量%到大約8重量%之間 的累積比例。在以每8小時一班加入額外的受酶質之處,總 加入量稍低於僅以每日爲基礎加入受酶質之案例,例如 -53- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)593305 Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the Invention (50) 1. Medium # 1: 2% gland, 2% autolyzed yeast (or yeast extract), and 2% glucose; 20% NaOH adjusted the pH to 5.8. 2 • Medium # 2: 1% gland, 1% autolyzed yeast (or yeast extract) and 2% glucose; adjust pH to 5.8 with 20% NaOH. 3 Medium # 3: 0.5% gland, 0.5% autolyzed yeast (or yeast extract) and 0.5% glucose; adjust pH to 5.8 with 20% NaOH. 4 · Medium # 4: 3% corn slurry, 1.5% yeast extract, 0.3% ammonium phosphate and 3% glucose; pH% was adjusted to 6.5 with 20% NaOH. 5 · Medium # 5: 2 · 55% corn slurry, 1 · 2 75% yeast extract, 0 · 2 55% monovalent ammonium phosphate and 3% glucose; pH pH was adjusted to 6.5 with 20% NaOH. 6 · Medium # 6: 2.1% corn slurry, 1.05% yeast extract, 0.21% ammonium phosphate and 3% glucose; pH 値 was adjusted to 6.5 with 20% NaOH. Non-sterile Conley and sterile nutrient solutions are supplied to the production fermentation in a five-to-20, preferably ten to fifteen, and preferably approximately equal ratio in a production batch cycle Device. Advantageously, prior to inoculation with the seed fermentation broth, initially a concentration sufficient to establish between about 0.1% to about 3% by weight, preferably about 0.5% to about 2% by weight The content of the concentration is introduced into the substrate, and then added periodically, conveniently every 8 to 24 hours, to a cumulative ratio between about 1% by weight and about 8% by weight. Where additional enzymes are added every 8 hours, the total amount added is slightly lower than the case of adding enzymes only on a daily basis, such as -53- This paper size applies Chinese National Standard (CNS) A4 Specifications (210X297 mm) (Please read the notes on the back before filling this page)

593305 經濟部中央標準局員工消費合作社印掣 Α7 Β7 五、發明説明(51 ) 0 · 2 5重量%到2 · 5重量%。在後者的例子中,可能需要的累 積康雷諾加入量,是在2重量%到大約8重量%的範圍内。在 發酵反應期間供應的補充營養混合物最好是濃縮物,例如 含有在大約4 0重量%到大約6 〇重量%之間的無菌葡萄糖, 以及在大約1 6重量%到大約3 2重量%之間的無菌酵母萃取 物或其他無菌來源之酵母衍生物(或其他胺基酸來源)的混合 物。因爲供應圖1之產製發酵器的受酶質是非-無菌的,所 以足期在發酵肉湯中加入抗生素以控制不想要之生物的生 長 了加入潘如康彳放素、四環素和頭抱菌素(cefalexin)之類 的抗生素’對生長和生物轉化作用沒有不利的影響。較佳 的是’例如以肉湯總含量爲基礎,在大約〇 · 〇 〇 〇 4重量%到 大約0 · 0 0 2重量%之間的濃度,將這些抗生素導入發酵肉湯 中’包括例如再度以肉湯總含量爲基礎,在大約〇〇〇〇2重 f %到大約0 · 〇 〇 〇 6重量%之間的硫酸康黴素,在大約 0 · 0 0 0 2重量%到大約〇 〇 〇 〇 6重量%之間的四環素H c ^,及/ 或在大約0.001重量%到大約〇〇〇 3重量%之間的頭孢菌素。 通常,產製發酵分批循環是按照約略8〇_16〇小時。因此 ,通常每2到1〇小時加入式χιπ受酶質和營養溶液各一份, 較佳的是每4到6小時。有利的是,亦將防沫劑合併至種子 發酵系統中,而合併至產製發酵器中。 在圖1之方法中,裝填於產製發酵器中的接種物,以在該 發酵器中之總混合物的體積爲基礎,較佳的是大約0.5到大 約7 /〇,更佳的是大約1到大約2 %,且葡萄糖的濃度最好是 維持在大約0.01重量%到大約1〇重量%之間,較佳的是 (請先閱讀背面之注意事項再填寫本頁}593305 Stamp printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Α7 Β7 V. Description of the invention (51) 0 · 25 5 to 2 · 5 wt%. In the latter case, the cumulative Conranow addition amount that may be required is in the range of 2% to about 8% by weight. The supplemental nutritional mixture supplied during the fermentation reaction is preferably a concentrate, for example, containing sterile glucose between about 40% to about 60% by weight, and between about 16% to about 32% by weight A mixture of sterile yeast extracts or yeast derivatives (or other amino acid sources) of other sterile origin. Because the enzymes supplied to the fermenter produced in Figure 1 are non-sterile, antibiotics are added to the fermentation broth to control the growth of undesired organisms. Antibiotics such as cefalexin) have no adverse effects on growth and biotransformation. It is preferred to 'introduce these antibiotics into the fermentation broth at a concentration between about 0.004 wt% to about 0.02 wt% based on the total content of the broth', including, for example, re- Based on the total broth content, between about 20000% by weight f% to about 0. 006% by weight of Conomycin sulfate, between about 0.002% by weight and about 0.00%. Tetracycline H c ^ between 6% by weight, and / or cephalosporin between about 0.001% by weight and about 3,000% by weight. Usually, the batch fermentation cycle is about 80-60 hours. Therefore, one serving of the enzyme enzyme and the nutrient solution of formula X is generally added every 2 to 10 hours, preferably every 4 to 6 hours. Advantageously, the antifoaming agent is also incorporated into the seed fermentation system and into the production fermenter. In the method of FIG. 1, the inoculum filled in the production fermenter is based on the volume of the total mixture in the fermenter, preferably about 0.5 to about 7/0, and more preferably about 1 To about 2%, and the glucose concentration is preferably maintained between about 0.01% by weight and about 10% by weight, preferably (please read the precautions on the back before filling in this page)

-54- 593305 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(52 ) 大約0 · 0 2 5重量%到大約0 · 5重量%之間,更佳的是在大約 0 · 0 5重量%到大約〇 · 2 5重量%之間,關於定期添加,則最 好是以分批裝填總量爲基礎,一份爲大約〇 · 〇 5重量%到大 約0 · 2 5重量%。便利地將發酵溫度控制在大約2 〇 t到大約 3 7 °C的範圍内,較佳的是大約24。(:到大約28ι,但是在反 應期間内降低溫度也可能是想要的,例如以2 Ό增加,以維 持填充菌絲體之體積(PMV)低於大約60%,較佳的是低於 大約5 0 % ’並藉此避免發酵肉湯的黏度,妨礙了令人滿意 的混合。如果生物團塊生長延伸至液體表面之上,保留在 該生物團塊中的受酶質可完成反應帶,並成爲不可供羥基 化反應利用的。爲了生產力,想要在發酵反應的前2 4小時 内達到在3 0到50%的PMV,較佳的是3 5%到45%,但最好 設法使隨後的條件控制在上述的限制内進一步生長。在反 應期間,控制發酵培養基的ρΗ値在大約5 · 〇到大約6.5之間 ,較佳的是在大約5 · 2到大約5 · 8之間,並以在大約4 0 0到 大約800 rpm之間的速度來攪動發酵器。藉著以大約ο」到 大約1 · 0 vv m分批充氣,達到至少大約1 0 %飽和度的溶氧 量,並在發酵器的液面上空間維持壓力在大約大氣壓到大 約1 · 0巴之間,最好是大約〇 . 7巴。亦可按需要增加攪拌速 率’以維持最少的溶氧量。有利的是,將溶氧量維持在 1 0 %以上,事實上像5 〇 %這樣高,可促進受酶質的轉變。 將p Η値維持在5 . 5 ± 〇 · 2的範圍内,對於生物轉化也是最適 立的。按照需要藉著加入一般的防沫劑來控制起泡。在加 入全部的受酶質之後,最好繼續反應直到式VIII產物對殘 -55- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁}-54- 593305 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 Β7 V. Description of the Invention (52) About 0 · 0 2 5 wt% to about 0 · 5 wt%, more preferably about 0 · 0 Between 5% by weight and about 0.25% by weight, and for periodic addition, it is preferably based on the total loading in batches, with a portion of between about 0.05% by weight and about 0.25% by weight. It is convenient to control the fermentation temperature in the range of about 20 t to about 37 ° C, preferably about 24. (: To about 28m, but lowering the temperature during the reaction period may also be desirable, for example, to increase by 2 ° F to maintain the filled mycelium volume (PMV) below about 60%, preferably below about 50% 'and thereby avoid the viscosity of the fermentation broth, which prevents satisfactory mixing. If the biocluster grows and extends above the liquid surface, the enzymatic substance retained in the biocluster can complete the reaction zone, And become unavailable for the hydroxylation reaction. For productivity, it is desirable to reach 30 to 50% PMV within the first 24 hours of the fermentation reaction, preferably 35% to 45%, but it is best to try to make Subsequent conditions control further growth within the above-mentioned limits. During the reaction, the pH of the fermentation medium is controlled to be between about 5.0 to about 6.5, preferably between about 5.2 to about 5.8, And agitating the fermenter at a speed between about 400 to about 800 rpm. By inflating in batches at about ο "to about 1.0 vv m, a dissolved oxygen amount of at least about 10% saturation is achieved, And maintain the pressure in the headspace of the fermenter at about atmospheric pressure Between about 1.0 bar, preferably about 0.7 bar. The stirring rate can also be increased as needed to maintain a minimum dissolved oxygen amount. Advantageously, the dissolved oxygen amount is maintained above 10%, in fact As high as 50%, it can promote the conversion of the enzyme. Maintaining p Η 値 within the range of 5.5 ± 0.2 is also most suitable for biotransformation. By adding general antifoam as needed To control the foaming. After adding all the enzymes, it is best to continue the reaction until the product of formula VIII on the residue -55- This paper size applies the Chinese National Standard (CNS) A4 size (210X 297 mm) (please read the back first) Note before filling out this page}

593305 五 經濟部中央標準局員工消費合作社印製 A7 B7 、發明説明(53 餘未反應之式XI11受酶質的莫耳比例爲至少大約9比1爲止 。這樣的轉變可在8 〇 - 1 6 〇小時之上文指定的分批循環中達 成。 己經發現與低於最初填充量之最初營養消耗量有關的高 轉化,藉著控制充氣速率和攪動速率,避免受酶質濺出液 態肉湯之外。在圖丨的方法中,營養含量被消耗,然後維持 在不超過大約6 0 %的最初填充量,較佳的是大約5 〇 % ;而 在圖2和3的方法中,營養含量降低至並維持在不超過大約 8 0%的最初填充量,較佳的是大約7〇%。充氣速率較好是 不超過1 vvm,更佳的是在大約〇_5 vvm的範圍内;而攪 動速率最好是不超過6〇〇 rprn。 在圖2中以圖解説明製備式VIII化合物的特佳方法。較佳 的微生物還是405 (ATCC 18500)。在該 方法中,生長培養基最好包括在大約〇 . 5重量%到大約5重 量/〇之間的玉米漿,在大約0 · 5重量%到大約5重量%之間的 葡萄糖,在大約〇·1重量%到大約3重量%之間的酵母萃取物 ,以及在大約0.05重量%到大約0·5重量%之間的磷酸銨。 然而,也可以使用在本文中描述的其他產製生長培養基。 種子培養物基本上是以圖丨描述的方法來製備,使用在本文 中描述的任何種子發酵培養基。在混合器中,以無菌方式 製備在生長培養基中之未-微粒化之康雷諾或其他式χπι受 酶質的懸浮液,最好是以在大約丨〇重量%到大約3 〇重量% 受酶質之間的相對上較高濃度。較佳的是,無菌的製品可 包括在混合後將懸浮液滅菌或利用巴氏殺菌法。將產製一 -56- 本紙張尺度適用中國國家標準(CNS ) A4規格(2I0X297公釐) (請先閱讀背面之注意事項再填寫本頁}593305 The A7 B7 printed by the Consumer Cooperative of the Central Standards Bureau of the Five Ministry of Economic Affairs, the invention description (more than 53 unreacted formula XI11, the molar ratio of the enzyme is at least about 9 to 1. Such a change can be between 80 and 16 〇The above specified batch cycle was achieved. It has been found that the high conversion related to the initial nutrient consumption lower than the initial filling amount, by controlling the aeration rate and agitation rate, to avoid splashing liquid broth by enzymes In the method of Figure 丨, the nutrient content is consumed and then maintained at an initial filling amount of not more than about 60%, preferably about 50%; and in the method of Figures 2 and 3, the nutrient content Reduced to and maintained at no more than about 80% of the initial fill, preferably about 70%. The inflation rate is preferably no more than 1 vvm, more preferably in the range of about 0-5 vvm; and The agitation rate is preferably not more than 600 rprn. A particularly preferred method for preparing a compound of formula VIII is illustrated in Figure 2. The preferred microorganism is still 405 (ATCC 18500). In this method, the growth medium is preferably included in About 0.5% by weight Corn syrup between about 5 wt.%, Glucose between about 0.5 wt.% And about 5 wt.%, Yeast extract between about 0.1 wt.% And about 3 wt.%, And about 0.05% to about 0.5% by weight of ammonium phosphate. However, other growth-producing media described herein can also be used. Seed cultures are basically prepared in the manner described in Figure 丨 and used herein Any seed fermentation medium described in. In a mixer, prepare a suspension of non-micronized Conorno or other enzymes of the formula X in the growth medium in a sterile manner, preferably at about 0% by weight. To a relatively high concentration of about 30% by weight of the enzyme. Preferably, the sterile product may include sterilizing the suspension after mixing or using pasteurization. Paper size applies Chinese National Standard (CNS) A4 specification (2I0X297 mm) (Please read the precautions on the back before filling this page}

593305 A7 B7 五、發明説明(54 ) 批所需的無菌受酶質懸浮液總量, 藉著定期的連鎖供應將其導入產製發開=在= 之運送於漿至產t發酵器的剪切m、冑著在、、泉上 受酶質的顆粒大小,因此避免’的濕氏研磨’降低 與其藉著滅菌法不如以巴氏#菌外粉碎機的需要。 σ &amp; ^巴氏杈菌法來達成無菌的條件,凝 ^^, 一了牝心要使用男切幫浦,以 kU、,大小的陽性對照組。基本上以如同上述的類似方 式,將操菌的生長培氧基和葡萄糖溶液導入產製發酵哭中 。所有供應產製發酵器的成㈣在導人之前先將其滅菌&quot;, 所以不需要抗生素。 經濟部中央標準局員工消費合作社印製 較佳的是,在操作圖2的方法0寺,以S大約〇 5%到大約 7%之間的比例,將接種物導入產製發酵器中,發酵溫度在 大約20 C到大約37°C之間,較佳的是在大約24T:到大約28 C之間,並藉著例如導入氨氣、氫氧化銨水溶液、鹼金屬 氫氧化物水溶液或正磷酸,將pH値控制在大約4·4到大約 6 · 5之間,較佳的是在大約5 · 3到大約5 · 5之間。就像在圖i 的方法中’最好調整溫度以控制生物團塊的生長,使得 PMV不超過5 5 -60%。最初裝填的葡萄糖較佳的是在大約! 重量%到大約4重量%之間,最好是在大約2.5重量%到3 . 5 重量%之間,但是在發酵期間亦容許逐漸降至大约1 . 〇重量 %以下。定期供應一份在大約〇 . 2重量❶/g到大約1 〇重量%之 間的補充葡萄糖,依據整批裝填量而定,以便將發酵區中 的葡萄糖濃度維持在大約〇 . 1重量%到大約1 . 5重量%的範圍 内,更佳的是在大約0.2 5重量%到大約0.5重量%之間。可 57- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(55 視需要連同葡萄糖一起補充氮和磷來源。然而,因爲康雷 諾總裝填量在該批循環一開始時就已經決定好,亦可在此 時導入帶有營養的氮和嶙必需品,容許在反應期間僅使用 葡萄糖溶液來補充之。揽動的速率和性質顯然是可變的。 適度活潑地攪動,促進團塊在固體受酶質和液相之間的轉 移。然而,應該使用低剪力的攪摔機,防止微生物之骨髓 磷質的降解。最適宜的攪動速度在200至800 rpm的範圍内 改變,依據培養肉湯的黏度、氧濃度,以及受到容器、檔 板和攪:摔機構型影響的混合條件。通常較佳的授動速率在 350-600 rpm的範圍内。最好是攪動攪拌機提供軸向下的 抽出功能,以便協助發酵之生物團塊的良好混合。每一批 取好以在大約〇 · 3到大約1 · 0 v v m之間的速率充氣,更佳的 是0.4到0.8 vvm,且在發酵器之液面上空間的壓力,最好 是在大約0 · 5到大約1 · 0巴之間。最好控制溫度、攪動、充 氣和反壓,以便在生物轉化期間將溶氧量維持在至少大約 1 〇體積%的範圍内。總分批循環通常在大約1 〇 〇到大約丨4 〇 小時之間。 雖然圖2之方法的操作原則是以早期導入大體上全部的康 雷諾裝填量爲基礎,但將會明瞭發酵肉湯的生長可能在裝 入大部份康雷諾之前完成。亦可視需要將一部份康雷諾在 該批循環的後期加入。然而,通常應該將至少大約7 5 %的 無菌康雷諾裝填量,在開始發酵後4 8小時内導入轉化發酵 器中。此外,亦希望在開始發酵時,或至少在前2 4小時内 ’導入至少大約2 5重量%的康雷諾,以便促進生物轉化酵 58- 本紙張尺度適用中國國家標準(CNs ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) —· Γ 593305 A7 B7 五、發明説明(56 ) 素(群)的產生。 在如圖3所圖示的更佳方法中,在導入接種物之前,先在 產製發酵容器中將整批裝填物和營養溶液減菌。可以使用 的營養溶液,以及其中較優異的,基本上是與在圖2方法中 的相同。在本發明的具體實施例中,攪拌機的剪切作用是 破壞在滅菌時易於形成的受酶質凝集物。已經發現如果康 雷諾的平均顆粒大小小於大約2 〇 〇微米,且至少7 5重量%之 顆粒小於2 4 0微米,便能滿意地進行該反應。已經發現使用 適當的攪拌機,例如圓盤狀的汽輪攪摔機,以2〇〇到8〇〇 rpm範圍的適當速度,利用至少大約400公分/秒的周緣速 度’提供了足以維持這類顆粒大小特性的剪切速率,不管 在產製發酵器内之滅菌作用時,易於發生的凝集作用。圖3 之方法的其餘操作,基本上與圖2的方法相同。圖2和圖3的 方法,提供了數個勝過圖丨方法的不同優點。特殊的優點是 願意使用低成本的營養基底,像是玉米漿。但明瞭更多的 優點是減少了抗生素的需要,簡化了供應程序,並容許康 雷諾或其他式XIII受酶質的分批滅菌。其他特殊的優點是 能夠使用簡單的葡萄糖溶液,而不必在反應循環期間補充 複雜的營養溶液。 在圖1到3描述的方法中,圖viii之產物是一結晶狀固體 ,可藉著過濾或低速離心,從反應肉湯中將其與生物團塊 一起分離出來。另外也可從整個反應肉湯中利用有機溶劑 來萃取產物。藉著溶劑萃取來回收式v 111之產物,爲了最 大限度的回收,利用萃取溶劑來處理液相濾液和生物團塊 -59· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 丁 經濟部中央標準局員工消費合作社印製 593305 經濟部中央標準局員工消費合作社印製 A7 —- —___B7 五、發明説明(57 ) ~ 濾紙或離心餅,但是通常-95%的產物與生物團塊在一起 。通常可利用碳氫化合物、酯、氣化之碳氫化合物和酮溶 劑來進行萃取作用。較佳的溶劑是醋酸乙酯。其他代表性 的適當溶劑包括甲苯和甲基異丙基酮。爲了從液相中萃取 ,可便利地使用一份體積大約相當於它所遭遇之一份體積 反應溶液的溶劑。欲從生物團塊中回收產物,將該生物團 塊54浮於;春劑中,取好是在相對於最初受酶質裝填量過量 許多的溶劑中,例如每克最初的康雷諾裝填量5〇到1〇〇毫 升&lt;溶劑,且最好使所得的懸浮液迴流2〇分鐘至數小時之 期間,以便確保產物從生物團塊的深處和細孔中移至溶劑 相。隨後,藉著過濾或離心移除生物團塊,並最好利用新 鮮的落劑和去離子水兩者沖洗濾餅。然後混合水溶液和溶 劑,並容許各相分離。藉著從該溶液中形成結晶來回收式 VIII之產物。欲使產量達到最大,使菌絲體與新鮮的溶劑 接觸兩次。在沉澱之後容許液相完全分離,從溶劑相中回 收產物。最好是在眞空下移除溶劑,直到開始結晶爲止, 然後將濃縮的萃取物冷卻至〇OS2(rc,較佳的是1〇1到 15 c ’持續一段足以始結晶沉澱和生長的時間,通常是8至 1 2小時。 圖2之方法,尤其是圖3之方法是特佳的。這些方法以低 速操作,並負起緊密控制進行參數之責任,像是、溫 度和么氧量。此外,容易地保持無菌的條件,而不需憑藉 抗生素。 生物轉化過程是放熱的,以致於應該利用套層發酵器或 本紙張尺度適财_家縣(CNS)赠格(2iQx 297公麓) (請先閱讀背面之注意事項再填寫本頁) 衣·593305 A7 B7 V. Description of the invention (54) The total amount of aseptic enzyme-containing suspension required for the batch, which will be introduced into the production system through regular chain supply. The size of the particles is cut and held on the spring, so avoiding the "wet grinding" reduces the need for a pasteurizer outside the pasteurizer instead of sterilizing. σ & ^ Pasteurella method to achieve aseptic conditions, coagulation ^^, I want to use the male cutting pump, a positive control group of kU, size. Basically, in a similar manner as described above, the bacterial growth-promoting oxygen and glucose solution are introduced into the production fermentation cry. All products supplied to the production fermenter are sterilized before introduction, so antibiotics are not required. It is better to print from the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. In the method 0 of Figure 2, the inoculum is introduced into the production fermenter at a ratio of about 5% to about 7%. The temperature is between about 20 C and about 37 ° C, preferably between about 24 T: and about 28 C, and by, for example, introducing ammonia, an aqueous ammonium hydroxide solution, an aqueous alkali metal hydroxide solution, or orthophosphoric acid The pH is controlled to be between about 4.4 and about 5.5, and preferably between about 5.3 and about 5.5. As in the method of Figure i, it is best to adjust the temperature to control the growth of the bioclum so that the PMV does not exceed 5 5 -60%. The initial filling of glucose is preferably at about! It is preferably between about 2.5% and about 4% by weight, preferably between about 2.5% and 3.5% by weight, but it is also allowed to gradually fall below about 1.0% by weight during fermentation. 1 重量 % 至 To a regular supply of supplemental glucose between about 0.2% by weight / g to about 10% by weight, depending on the batch loading, in order to maintain the glucose concentration in the fermentation zone at about 0.1% by weight to Within the range of about 1.5% by weight, more preferably between about 0.25% by weight and about 0.5% by weight. May 57- This paper size applies to Chinese National Standards (CNS) A4 (210X 297 mm) 593305 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (55 Supplement nitrogen and phosphorus sources together with glucose as needed However, because the total filling capacity of Connor is determined at the beginning of the batch cycle, it is also possible to introduce nutrient-containing nitrogen and tritium necessities at this time, allowing only glucose solution to be used to supplement it during the reaction. The rate and nature of the change are clearly variable. Moderately agitated to promote the transfer of the mass between the solid substrate and the liquid phase. However, a low-shear beater should be used to prevent the microbial bone marrow phosphorous. Degradation. The optimum agitation speed varies within the range of 200 to 800 rpm, depending on the viscosity of the broth, the oxygen concentration, and the mixing conditions affected by the container, baffle, and agitation mechanism. Usually a better agitation The speed is in the range of 350-600 rpm. It is best to stir the stirrer to provide the axial down extraction function in order to assist the good mixing of the fermented biological mass. Each batch It is good to inflate at a rate of about 0.3 to about 1.0 vvm, more preferably 0.4 to 0.8 vvm, and the pressure of the space on the liquid surface of the fermenter is preferably about 0.5 to about 0.5 Between 1.0 bar. Temperature, agitation, aeration and back pressure are preferably controlled in order to maintain the amount of dissolved oxygen in the range of at least about 10% by volume during the biotransformation. The total batch cycle is usually around 100 To about 40 hours. Although the principle of operation of the method of Figure 2 is based on the introduction of substantially the entire Conranow loading at an early stage, it will be clear that the growth of fermented broth may be loaded in most Conranos Completed previously. A portion of Conranox can also be added later in the batch if necessary. However, at least approximately 75% of the sterile Conranault loading should normally be introduced into the conversion fermentor within 48 hours of starting fermentation In addition, it is also hoped that at the beginning of fermentation, or at least within the first 24 hours, at least about 25% by weight of Conreno will be 'introduced' in order to promote biotransformation enzymes. 210X297 mm) (Please read the precautions on the back before filling out this page) — · Γ 593305 A7 B7 V. Description of the invention (56) The production of primes (groups). In the better method shown in Figure 3, Before introducing the inoculum, the entire batch of filling and nutrient solution is sterilized in the production fermentation container. The nutrient solution that can be used, and the better among them, are basically the same as those in the method of Figure 2. In a specific embodiment of the invention, the shearing action of the blender is to destroy the enzymatic agglomerates that are liable to form during sterilization. It has been found that if the average particle size of Conorno is less than about 200 microns and at least 75% by weight of the particles Below 240 micrometers, the reaction can proceed satisfactorily. It has been found that the use of a suitable blender, such as a disc-shaped steam turbine beater, at a suitable speed in the range of 2000 to 800 rpm, using a peripheral speed of at least about 400 cm / s, provides sufficient to maintain such particle size. The characteristic shear rate is prone to agglomeration regardless of the sterilization effect in the production fermenter. The remaining operations of the method of FIG. 3 are basically the same as those of the method of FIG. 2. The methods of Figures 2 and 3 provide several different advantages over the method of Figures 丨. A special advantage is the willingness to use low-cost nutrient substrates, such as corn slurry. However, it is clear that more advantages are the reduction of the need for antibiotics, the simplification of the supply process, and the batch sterilization of enzymes of Conorno or other type XIII. Other special advantages are the ability to use simple glucose solutions without having to replenish complex nutrient solutions during the reaction cycle. In the methods described in Figures 1 to 3, the product of Figure viii is a crystalline solid that can be separated from the reaction broth together with the biological mass by filtration or low-speed centrifugation. Alternatively, organic solvents can be used to extract products from the entire reaction broth. The product of formula v 111 is recovered by solvent extraction. In order to maximize the recovery, the extraction solvent is used to treat the liquid filtrate and the biological mass. -59 · This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) Ding printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 593305 printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 —- —___ B7 V. Description of the invention (57) ~ Filter paper or Centrifuge the cake, but usually -95% of the product stays with the biomass. Extraction is usually carried out using hydrocarbons, esters, vaporized hydrocarbons and ketone solvents. The preferred solvent is ethyl acetate. Other representative suitable solvents include toluene and methyl isopropyl ketone. For extraction from the liquid phase, it is convenient to use a solvent in a volume approximately equal to the volume of the reaction solution it encounters. To recover the product from the biomass, float the biomass 54; the aphrodisiac is taken in a large excess of solvent relative to the initial enzymatic loading, such as 5 grams per gram of initial Conorno 0 to 100 ml of &lt; solvent, and preferably the resulting suspension is refluxed for a period of 20 minutes to several hours, to ensure that the product moves from the depth of the biomass and the pores to the solvent phase. Subsequently, the biological mass is removed by filtration or centrifugation, and preferably the filter cake is rinsed with both fresh drops and deionized water. The aqueous solution and solvent are then mixed and the phases are allowed to separate. The product of formula VIII is recovered by forming crystals from this solution. For maximum yield, contact the mycelium with fresh solvent twice. After precipitation, the liquid phase was allowed to separate completely and the product was recovered from the solvent phase. It is best to remove the solvent under vacuum until crystallization begins, and then the concentrated extract is cooled to 0OS2 (rc, preferably 101 to 15 c 'for a period of time sufficient to begin crystallization and growth, Usually 8 to 12 hours. The method of Figure 2 and especially the method of Figure 3 are particularly good. These methods operate at low speed and bear the responsibility of tightly controlling the parameters such as temperature, oxygen and oxygen. In addition It is easy to maintain sterile conditions without relying on antibiotics. The biotransformation process is exothermic, so that a jacketed fermenter or this paper should be used. (Please read the precautions on the back before filling out this page)

、1T 593305 A7 B7 經濟部中央標準局員工消費合作社印t 五、發明説明(58 ) 是在產物發酵器中之冷卻旋管來移除熱。另外,也可以使 反應肉湯經由外部的熱交換器循環。藉著反應在肉湯中之 氧電位的測量値,調節將空氣導入反應器的速率,使溶氧 量維持在至少大約5體積%的含量,較佳的是至少大約丨〇體 積%,足以提供反應所需之能量,並確保葡萄糖轉化成(:〇2 和H2〇。最好將pH値控制在大約4.5到大約6.5之間。 在每種不同的式XIII之受酶質之11-輕基化作用方法中, 生產力受到團塊從固悲受酶質轉移到液相,或是明瞭反應 在遠處發生之相界面的限制。如同上文所示,只要將受酶 質顆粒的平均顆粒大小減少至低於大約3 0 〇微米,且至少有 75重量%顆粒小於24〇微米,則生產力便不會受到團塊轉移 速率的明顯限制。然而,可在某些具體實施例中更促進了 這些方法的生產力,其提供實際上將在有機溶劑中之康雷 諾或其他式XIII之受酶質裝塡至產製發酵器中。根據其中 一種選擇,將受酶質溶解於不與水混溶的溶劑中,並與含 水的生長培養基接種物和表面活性劑混合。可使用之不與 水混溶的溶劑包括例如DmF、DMSO、(:6-(:12脂肪酸、 正·烷類、植物油、脱水山梨糖醇和表面活性劑水溶 液。授動該裝填物產生-乳劑反應系統,具有延伸的界面 區#可供T酶質《團塊從有機液相轉移至反應位置。 第種選擇&amp; @始將受酶質溶解於可與水混溶的溶劑 中’像是以大體上勒讲甘丄 ^ ^ ^ 知過其在水中之溶解度之濃度的丙酮、 供曰、一 乙%或甘油。藉著在昇高的溫度下製 備取初的受酶皙:女、、念 ^ t ^合履,增加溶解度,藉此更增加了將溶液 本紙張尺度剌悄財縣 ---------— (請先閱讀背面之注意事項再填寫本頁) 訂· -j i m -61- 經濟部中央標準局員工消費合作社印製 593305 A7 ______________B7 五、發明説明(59 ) ~ 形式之受酶質導入反應器中的量,且最後促進了反應器的 負载。將溫的受酶質溶液連同相對上較冷、包括生長培養 基和接種物的含水裝填物,一起裝入產製發酵反應器中。 ©父酶、丨谷液與含水培養基混合時,出現受酶質的沉殿。 然而’在大體上超飽和並適度活潑地攪動的條件下,晶核 开;^成作用勝過結晶生長’並形成高表面積之非常細微的顆 粒。這樣的高表面積助長了團塊在液相和固態受酶質之間 的轉移。此外,與水混溶之溶劑的存在,亦促進了受酶質 在含水液相中的平衡濃度。因此提高了生產力。 雖然微生物未必能容忍在液相中的高濃度溶劑,但是可 有效地使用例如範圍在大約3重量%到大約5重量%内的乙醇 濃度。 第二個選擇是使受酶質溶解於環糊精水溶液中。可作爲 實例的環糊精包括羥丙基-々·環糊精和甲基-環糊精。受 酶質··環糊精之莫耳比例可以是大約丨:丨到大約丨:丨· 5的受酶 質:環糊精。然後可以無菌之方式將受酶質:環糊精之混合物 加至生物轉化的反應器中。 1 1從_每基康雷語及其他1 1 α _經基化作用之產物(式V j j工 和VIIIΑ)是新穎的化合物,可藉著過濾反應培養基,並從 在過濾培養基上收集之生物團塊中萃取產物來分離之,可 使用傳統的有機溶劑來進行萃取,例如醋酸乙酯、丙酮、 甲苯、氣化的碳氫化合物和甲基異丁基酮。然後可使式 VIII之產物從相同類型的有機溶劑中再結晶。式νπι之化 合物具有作爲製備式;[化合物,尤其是式[八化合物之中間物 -62- 本紙張尺度適用中國國( CNS ) Α4規格(210χΥ97公釐) --- (請先閱讀背面之注意事項再填寫本頁j 訂 593305 A7 -_______ B7 五、發明説明(6〇 ) 的實際價値。 較佳的式VIII化合物,符合其中-A-A-和·Β-Β_爲-CH2- CHy,R3爲氫、低碳數烷基或低碳數烷氧基,且r8和r9 一 起組成20-螺氧烷環:1T 593305 A7 B7 Consumer Cooperative Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the Invention (58) is a cooling coil in the product fermenter to remove heat. Alternatively, the reaction broth may be circulated through an external heat exchanger. By measuring the oxygen potential of the reaction in the broth, the rate of introducing air into the reactor is adjusted so that the amount of dissolved oxygen is maintained at a level of at least about 5 vol%, preferably at least about 0 vol%, which is sufficient to provide The energy required for the reaction, and to ensure that glucose is converted to (: 0 2 and H 2 0. It is best to control the pH to be between about 4.5 and about 6.5. In each of the different enzymes of formula XIII, the 11-light group In the chemical reaction method, the productivity is limited by the mass transfer from the solid substrate to the liquid phase, or the phase interface of the reaction occurring at a distance. As shown above, as long as the average particle size of the substrate Reduced below about 300 microns, and at least 75% by weight of the particles are less than 24 microns, productivity is not significantly limited by the mass transfer rate. However, these may be further promoted in certain embodiments. The productivity of the method, which provides the fact that Conreno or other enzymes of formula XIII are loaded into a production fermenter in an organic solvent. According to one option, the enzymes are dissolved in an immiscible water In solvent It is mixed with an aqueous growth medium inoculum and a surfactant. Immiscible solvents that can be used include, for example, DmF, DMSO, (: 6-(: 12 fatty acids, n-alkanes, vegetable oils, sorbitan, and Aqueous surfactant solution. The filling-emulsion reaction system is instigated, with an extended interface area # for T-enzyme to transfer the mass from the organic liquid phase to the reaction site. The first choice &amp; @ 始 将 受 酶 质Dissolved in water-miscible solvents' like acetone, acetone, ethyl acetate, or glycerin, which has a known concentration in water. ^ ^ ^ Preparation of the first enzyme at the temperature: female ,, and ^ ^ t ^ combined shoes, increase solubility, thereby increasing the size of the paper on the solution. Read the notes on the back and fill in this page) Order -jim -61- Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 ______________B7 V. Description of the invention (59) ~ The amount of the enzyme into the reactor in the form, And finally promote the load on the reactor. The enzymatic solution is loaded into the production fermentation reactor together with the relatively cold aqueous filling material, which includes the growth medium and the inoculum.殿. However, 'under the conditions of generally supersaturated and moderately active agitation, the nucleus opens; the formation effect is better than crystal growth' and forms very fine particles with high surface area. Such high surface area promotes the clumps in the liquid Transfer between the phase and the solid substrate. In addition, the presence of a water-miscible solvent also promotes the equilibrium concentration of the substrate in the aqueous liquid phase. As a result, productivity is increased. Although microorganisms may not be tolerant in the liquid phase High concentration solvents, but for example, ethanol concentrations ranging from about 3% to about 5% by weight can be effectively used. The second option is to dissolve the enzyme in the aqueous cyclodextrin solution. Cyclodextrins which may be exemplified include hydroxypropyl-fluorene · cyclodextrin and methyl-cyclodextrin. The molar ratio of the enzymatic substance to be cyclodextrin can be about 丨: 丨 to about 丨: 丨 · 5. The enzymatic substance to be digested: cyclodextrin. The enzymatic: cyclodextrin mixture can then be added to the biotransformation reactor in a sterile manner. 1 1 per 每 Conrad and other 1 1 α _ the products of the abasification (formula V jjg and VIIIA) are novel compounds, which can be filtered by the reaction medium, and from the organisms collected on the filter medium The product is separated from the pellet by extraction using conventional organic solvents such as ethyl acetate, acetone, toluene, vaporized hydrocarbons, and methyl isobutyl ketone. The product of formula VIII can then be recrystallized from an organic solvent of the same type. The compound of formula νπι has as a preparation formula; [compounds, especially intermediates of eight compounds of formula-62- This paper size applies to China (CNS) A4 specifications (210xΥ97 mm) --- (Please read the note on the back first Please fill in this page again. Bookmark 593305 A7 -_______ B7 V. Actual price of invention description (6〇) A better compound of formula VIII, in which -AA- and · Β-Β_ is -CH2- CHy, R3 is Hydrogen, low-carbon alkyl or low-carbon alkoxy, and r8 and r9 together form a 20-spiroxane ring:

之式VIIIA化合物。 最好是根據計劃1之方法,使式V111化合物在鹼性條件下 與氰化物離子來源反應,產生式VII之烯胺化合物 (請先閱讀背面之注意事項再填寫本頁)A compound of formula VIIIA. It is best to react the compound of formula V111 with a cyanide ion source under alkaline conditions to produce an enamine compound of formula VII according to the method of plan 1. (Please read the precautions on the back before filling this page)

R3 .βR3 .β

Order

VII 在此 其中- A-A-、R3、-B-B-、R8和R9如同上文之定義 處受酶質相當於式VIIIA,式VIIA之產物 經濟部中央標準局員工消費合作社印製VII here where-A-A-, R3, -B-B-, R8 and R9 are as defined above. The enzyme is equivalent to formula VIIIA, the product of formula VIIA. Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs.

63- VII a 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(61 其中-A - A -、_ B _ B定義。63- VII a This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) 593305 A7 B7 V. Description of the invention (61 where -A-A-, _ B _ B are defined.

R Y1、γ2和X如同在式XIII中之 經濟部中央標準局員工消費合作社印製 式VIII之11α-羥基受酶質的氰化作用,可藉著使其與氰 化物離子來源,像是_氰醇,最佳的是丙酮合氰化氮,在 鹼和鹼金屬鹽的存在下反應來完成,最佳的是Li⑴。另外 ,也可藉著在酸的存在下使用鹼金屬氰化物,不需氰醇而 完成氰化作用。 在酮氰醇法中,在溶液中經營該反應,最好是使用非質 子之極性落劑,像是二甲基甲醯胺或二甲亞砜。形成晞胺 每莫耳文酶質需要至少兩莫耳氰化物離子來源,且最好是 使用稍微過量的氰化物來源。鹼最好是含氮的鹼,像是二 燒基胺、三貌基胺、烷醇胺、吡啶或其類似物。然而,也 可以使用無機鹼,像是鹼金屬碳酸鹽或鹼金屬氫氧化物。 較佳的是,式VII][之受酶質一開始便以在大約20重量%到 大約5 0重量%之比例存在,且該鹼以每當量受酶質在〇 · 5到 二當量之間的比例存在。反應溫度並未嚴格限制,但是藉 著在昇高的溫度下操作可促進生產力。因此,例如使用三 乙胺作爲驗,在大約8 〇 到大約9 〇 的範圍内有利地經營 該反應。在這樣的溫度下,反應在大約5到2 〇小時中進行至 完成。當使用二異丙基乙胺作爲鹼,並在105 下經營該反 應時’該反應在8小時時完成。在反應結束的期間,在眞 下移除溶劑,並將殘餘的油溶解於水中,以稀酸將其中 空 和 (請先閱讀背面之注意事項再填寫本頁) 衣· 訂 64- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇χ297公釐) 593305 A7 -- ·~-_____ Β7五、發明説明(62 ) 經濟部中央標準局員工消費合作社印製 至P Η 7,較佳的是氫氯酸。產物從該溶液中沉澱出來、且 隨後以蒸館水沖Α,並風乾之。可利用隋性氣體將釋放出 的He/汽提,並在鹼性溶液使其中止。將脱水的沉澱物溶 解於氣仿或其他適當的溶劑中,然後以濃縮的酸,例如6N HC1萃取之。藉著加入無機鹼將萃取物中和至7,較佳 的是驗金屬氫氧化物,並冷卻至代的溫度範圍。沖洗所得 的沉澱物並脱水之,然後使其從適當的溶劑中再結晶,例 如丙酮,產生適用於該方法下一個步驟中的式νπ之產物。 另外,該反應也可在包括可與水混溶之有機溶劑,像是 甲醇的含水溶劑系統中,或是在包括水與諸如醋酸乙酯之 類有機溶劑的兩相系統中經營。在這種選擇中,可藉著以 水來稀釋反應溶液,隨後使用有機溶劑,像是二氯甲烷或 氯仿來萃取產物,然後再利用濃縮的無機酸,例如2反hci ,從有機萃取物中反萃取,來回收產物,參見美國專利第 3,200,113 號。 根據更多種的選擇,該反應也可在諸如二甲基甲醯胺、 二甲基乙醯胺、N_甲基吡咯烷酮或二甲亞砜之類可與水混 溶的溶劑中經營,以水稀釋反應產物溶液,並例如藉著加 入驗金屬奴鹽使其成爲驗性之後,然後冷卻至〇。。到1 〇 t ,藉此引起產物沉澱。最好是利用鹼金屬次_酸鹽或其他 可有效預防氰化物放出之試劑使該系統中止。在過濾之後 以水沖洗,沉澱出的產物適合在本方法的下一個步驟中使 用0 根據更多種的選擇,可藉著在質子來源的存在下,使式 (請先閱讀背面之注意事項再填寫本頁) 衣 ' 訂 -65- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公 593305 經濟部中央標準局員工消費合作社印製 A7 __ B7 五、發明説明(63 ) VIII之受酶質與過量的鹼金屬氰化物,較佳的是NaCN, 在包括諸如二甲基甲醯胺或二甲基乙醯胺之類的非質子、 可與水混溶之極性溶劑的含水溶劑中反應,來產製式V丨J之 晞胺產物。該質子來源最好是無機酸或c i至C 5之複酸,特 佳的是硫酸。例外的是,當氰化作用之試劑爲在D M F中的 商用LiCN時,不需要加入個別的質子來源。 氰化物離子最好是以在每當量受酶質大約2 · 〇 5到大約5莫 耳當量之間的比例裝入反應器中。咸相信無機酸或其他的 質子來源,有助於H CN越過4,5和6,7雙鍵的加成作用,且 最好是以每莫耳當量受酶質至少一莫耳當量的比例存在; 但是反應系統應藉著維持超過存在之酸的過量驗金屬氰化 物’而將其維持爲驗性的。反應最好是在至少大約7 5 °c的 溫度下完成,通常是60°c到100Ό,持續大約!至大約8小 時’較佳的是大約1 · 5到大約3小時。在反應結束時,冷卻 該反應混合物,最好是至大約室溫;並藉著將該反應混合 物酸化並與冷水混合,較佳的是在大約冰浴之溫度下,使 產物晞胺沉澱出來。咸相信酸化作用關閉了 1 7 _内醋,其易 於在氰化作用中佔優勢的鹼性條件下打開。利用與在反應 期間出現的相同的酸,便利地將反應混合物酸化,較佳的 是硫酸。最好是以在每莫耳產物大約1〇到大約5 〇莫耳當量 之間的比例加入水。 式VII化合物是新穎的化合物,並具有作爲製備式〗化合 物,尤其是式IA化合物之中間物的實際價値。較 化合物,符合其中·Α一一H2_CH2_“=^^ -66- 本紙張尺度適用中國國豕標率(CNS ) Α4規格(21 〇χ 297公釐) (請先閱讀背面之注意事項再填寫本頁)R Y1, γ2, and X are the same as in Formula XIII. The 11α-hydroxy group of Formula VIII printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs is subjected to enzymatic cyanation, which can be sourced with cyanide ions, such as The cyanohydrin, most preferably acetone nitrogen cyanide, is completed by reaction in the presence of a base and an alkali metal salt, and most preferably Li (R). In addition, cyanation can also be accomplished by using an alkali metal cyanide in the presence of an acid without the need for a cyanohydrin. In the ketocyanohydrin method, the reaction is run in solution, preferably using an aprotic polar agent such as dimethylformamide or dimethylsulfoxide. Forming amidine requires at least two sources of cyanide ion per mole of enzymatic substance, and it is best to use a slight excess of the source of cyanide. The base is preferably a nitrogen-containing base such as dialkyl, trisamine, alkanolamine, pyridine or the like. However, it is also possible to use inorganic bases, such as alkali metal carbonates or alkali metal hydroxides. Preferably, the enzymatic substance of formula VII] [is present at a ratio of about 20% to about 50% by weight from the beginning, and the base is between 0.5 and two equivalents per equivalent of the enzyme. The proportion exists. The reaction temperature is not strictly limited, but productivity can be promoted by operating at an elevated temperature. Therefore, for example, using triethylamine as a test, the reaction is advantageously operated in a range of about 80 to about 90. At such temperatures, the reaction proceeds to completion in about 5 to 20 hours. When diisopropylethylamine is used as the base and the reaction is run at 105 'the reaction is completed at 8 hours. During the end of the reaction, remove the solvent under the water, dissolve the remaining oil in water, and dilute the hollow with dilute acid (please read the precautions on the back before filling this page). Applicable to Chinese National Standard (CNS) A4 specification (21 × 297 mm) 593305 A7-· ~ -_____ Β7 V. Description of invention (62) Printed to P Η 7 by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, better It is hydrochloric acid. The product was precipitated from the solution, and then A was washed with steam and air-dried. The released He / can be stripped with inert gas and stopped in alkaline solution. The dehydrated precipitate is dissolved in aerobic or other suitable solvents, and then extracted with a concentrated acid such as 6N HC1. The extract is neutralized to 7 by adding an inorganic base, preferably a metal hydroxide, and cooled to a temperature range of generation. The resulting precipitate is washed and dehydrated and then recrystallized from a suitable solvent, such as acetone, to produce a product of formula νπ suitable for use in the next step of the method. Alternatively, the reaction can be operated in an aqueous solvent system including a water-miscible organic solvent such as methanol, or in a two-phase system including water and an organic solvent such as ethyl acetate. In this option, the reaction solution can be diluted by water, followed by extraction of the product with an organic solvent such as dichloromethane or chloroform, and then the use of a concentrated inorganic acid, such as 2 reverse hci, from the organic extract Back extraction to recover product, see US Patent No. 3,200,113. Depending on the choice, the reaction can also be run in a water-miscible solvent such as dimethylformamide, dimethylacetamide, N-methylpyrrolidone, or dimethylsulfoxide to After diluting the reaction product solution with water and making it qualitative, for example by adding a metal test salt, it is then cooled to zero. . To 10 t, which caused the product to precipitate. It is best to stop the system with an alkali metal hypochlorite or other agent that is effective in preventing cyanide evolution. After filtration, washing with water, the precipitated product is suitable for use in the next step of the method. According to more choices, the formula can be used in the presence of a proton source (please read the precautions on the back before (Fill in this page) Yi'-65- This paper size is applicable to Chinese National Standard (CNS) A4 specifications (210X297, 593305, printed by the Consumers' Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs, printed by A7 __ B7 V. Description of invention (63) VIII enzyme React with an excess of an alkali metal cyanide, preferably NaCN, in an aqueous solvent including an aprotic, water-miscible polar solvent such as dimethylformamide or dimethylacetamide To produce the amidine product of formula V 丨 J. The source of the proton is preferably an inorganic acid or a complex acid of ci to C5, particularly sulfuric acid. The exception is when the reagent for cyanation is in DMF For commercial LiCN, it is not necessary to add a separate source of protons. Cyanide ions are preferably charged into the reactor at a ratio of about 2.05 to about 5 mole equivalents per equivalent of enzymatic substance. Acids or other proton sources, Helps H CN to cross the 4, 5 and 6, 7 double bond addition, and preferably exists in a ratio of at least one mole equivalent per enzyme equivalent; however, the reaction system should be maintained by exceeding The excess of acid is tested for metal cyanide 'to maintain it as a test. The reaction is preferably completed at a temperature of at least about 7 5 ° c, usually 60 ° c to 100 ° C, for about! To about 8 hours' It is preferably about 1.5 to about 3 hours. At the end of the reaction, the reaction mixture is cooled, preferably to about room temperature; and by acidifying the reaction mixture and mixing with cold water, it is preferably about ice At the temperature of the bath, the product amidine was precipitated. Salty believed that acidification turned off 17 _ lactone, which was easily opened under alkaline conditions where cyanidation prevailed. The same acid was used as it appeared during the reaction It is convenient to acidify the reaction mixture, preferably sulfuric acid. It is best to add water in a ratio between about 10 to about 50 mole equivalents per mole of product. The compound of formula VII is a novel compound and has As a compound of formula In particular, the actual valence of the intermediate of the compound of the formula IA. Compared with the compound, it is in line with · Α 一一 H2_CH2 _ "= ^^ -66- This paper size applies the Chinese National Standard (CNS) A4 specification (21 〇χ 297 mm ) (Please read the notes on the back before filling this page)

、1T 593305 A7 B7, 1T 593305 A7 B7

發明説明(64 、低碳數烷基或低碳數烷氧基,且R8和R9 一起構成2〇-螺 氧烷環: 。 XXXI工工 足式IIA化合物。最佳的式^〗化合物是5,R(5, π ),7,々-20 -胺基十,、氲經基}〇丨二甲基_3,,5丨_二 氧代螺[呋喃_2(3Η),17’ “(5’11)-[7,4]亞甲幷[411]環戍 U]菲]腈。 在計劃1合成作用的下一個步驟中,水解式νπ之烯胺, 產生式VI之二酮化合物 (請先閱讀背面之注意事項再填寫本頁jDescription of the invention (64, low-carbon alkyl or low-carbon alkoxy, and R8 and R9 together form a 20-spiroxane ring:. XXXI industrial foot compound IIA. The best compound ^〗 is 5 , R (5, π), 7, 々-20 -amino ten, hydrazone} 〇 丨 dimethyl_3,, 5 丨 _dioxospiro [furan_2 (3Η), 17 '" (5'11)-[7,4] methylenefluorene [411] cyclofluorene U] phenanthrene] nitrile. In the next step of the synthesis of Scheme 1, the enamine of formula νπ is hydrolyzed to produce a dione compound of formula VI (Please read the notes on the back before filling in this page j

VI -訂 經濟部中央標準局員工消費合作社印掣 其中-A-A-、R3、、R8和R9如同在式¥111中之定義 三水解作用可使用任何含水的有機酸或無機酸。較佳的是 ^氣酸。欲促進生產力,最好是使用可與水混溶的有機溶 州,像疋低碳數烷醇,作爲共溶劑。酸應該以每當量式νπ 又酶負至少一當量的比例存在。在含水的系統中,在大約 8〇 C下,晞胺受酶質νπ大體上可在大約$小時中轉變爲式 VII之二g同。在昇高的溫度下操作可增加生產力,但是溫度 67-VI-Ordered by the Central Bureau of Standards of the Ministry of Economic Affairs, Consumer Cooperatives, where -A-A-, R3, R8 and R9 are as defined in the formula ¥ 111. Trihydrolysis can use any water-containing organic or inorganic acid. Preferred is argon acid. To promote productivity, it is best to use organic solvents that are miscible with water, such as low carbon alkanols, as co-solvents. The acid should be present in a ratio of νπ and at least one equivalent of the enzyme. In an aqueous system, at approximately 80 ° C, the amidoamine enzymatic substance νπ can be converted to formula VII g in approximately $ hours. Operating at elevated temperatures increases productivity, but temperatures 67-

593305 A7 B7 叫Y^YCCH2〕7593305 A7 B7 is called Y ^ YCCH2] 7

五、發明説明(65 不疋具有決定性的。以溶劑系統和酸的揮發性爲基礎來決 定適當的溫度。V. Description of the invention (65 is not decisive. Determine the appropriate temperature based on the solvent system and acid volatility.

較佳的式VII之烯胺受酶質,符合式vIIA •czrxThe preferred enamines of formula VII are enzymatically compatible with formula vIIA • czrx

VIIAVIIA

且二酮產物符合式VIA (請先閱讀背面之注意事項再填寫本頁) H0/v^Pt、CCH2〕“=xAnd the diketone product conforms to the formula VIA (please read the precautions on the back before filling this page) H0 / v ^ Pt, CCH2] "= x

、1T VIA X均如同在式VIIIA中之 經濟部中央標準局員工消費合作社印製 其中母個 _ Α·Α_、_B-B-、Y1、γ2和 定義。 在反應期間結束時,將溶液冷卻至〇。〇和25^,以便使產 物:晶。產物的結晶可從諸如異丙醇或甲醇之類的適當溶 剑再总明,以便產生適合在本方法下一個步驟中使用的 ^產物,但疋通常不需要再結晶作用。式VI化合物是新 采、、5物其具有作爲製備式I化合物,尤其是式I化合物 -68- 本紙張尺度適用巾關家榡準(CNS ) Α4規格(21Qx 297公瘦 593305 A7 B7 五、發明説明(66 ) 〈中間物的實際價値。較佳的式VI化合物,符合其中士 α^-β_βκΗ2.2_,以氫、低碳數㈣或低碳數 烷氧基,且R8和R9。一起構成20_螺氧烷環:, 1T VIA X are printed in the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs in the formula VIIIA, where the parent _ Α · Α_, _B-B-, Y1, γ2 and the definitions. At the end of the reaction period, the solution was cooled to zero. 〇 and 25 ^, so that the product: crystal. The crystallization of the product can be reconfirmed from a suitable solvent such as isopropanol or methanol in order to produce a product suitable for use in the next step of the process, but recrystallization is generally not required. The compound of formula VI is a novel compound, and it has the compound of formula I, especially the compound of formula I-68- This paper size is suitable for household standard (CNS) A4 specification (21Qx 297 male thin 593305 A7 B7 V. Description of the invention (66) <the actual valence of the intermediate. The preferred compound of formula VI conforms to the formula α ^ -β_βκΗ2.2_, with hydrogen, low carbon number ㈣ or low carbon number alkoxy group, and R8 and R9 together. Form 20_spiroxane ring:

經濟部中央標準局員工消費合作社印t XXXIII 的式VIA。最佳的式VI化合物是4,s(4,a),7,α_十六氫-11沈·羥基-l〇f々-13丨/?_二甲基_3丨,5,20,_三氧代螺[呋喃2(3H),17 0 - [4,7]甲基并[17H]環戊[a]菲]-5,万(2!11)&quot;·赌。 在本發明特佳的具體實施例中,以上文描述的方法由式 V111化合物來產製式VII之產物晞胺,並就地將其轉變爲式 VI之二酮。在本發明該具體實施例中,如同上文描述,使 式VIII受酶質與過量之鹼金屬氰化物,在含有質子來源的 含水溶劑中反應,或可視需要在鹼及^以的存在不,與過 量的酮氰醇反應。然而,代替冷卻反應混合物,酸化並按 計算好之比例加入水,以便,引起烯胺的沉澱,最好避免反 應混合物的實際冷卻作用。在氰化作用反應結束時,確實 將水和酸,最好是諸如硫酸之類的無機酸,加至該混合物 中,且加入之酸的比例足以中和過量的鹼金屬氰化物,通 常每莫耳式VIII之受酶質需要導入至少一莫耳當量的酸, 較佳的是每當量受酶質在大約2到大約5莫耳當量之間。然 而,必需維持足以避免實際的沉澱,以及在液相中容許進 行之烯胺至二酮之水解作用的高溫和較高的稀釋度。因此 ,以最小的干擾和高生產力來進行該方法。水解作用最好 (請先閱讀背面之注意事項再填寫本頁) 衣· 訂 -69· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(67 ) 是在至少8 0 °C的溫度下經營,更佳的是在大約9 〇 I到大約 1 0 0 C下’通常進行大約1到大約丨〇小時,較佳的是大約2 到大約5小時。然後冷卻該反應混合物,較佳的是在大約〇 °C到大約1 5 °C之間的溫度,有利地是在冰浴中,冷卻至大 約5 C到大約1 〇 °C,以便使式v I之產物二酮沉澱。可藉著 過濾回收固態產物,並藉著以水沖洗移除不純物。 在計劃1合成作用的下一個步驟中,使式VI之二酮化合物 與金屬醇鹽反應,打開在4和7位置之間的酮橋,切開在羰 基和4 _碳之間的鍵結’形成在7 _位置處的從·方位的燒醯氧 基羰基取代物,並排除5 -碳上的氰化物。該反應之產物是 符合式V的獲基酯化合物 (請先閱讀背面之注意事項再填寫本頁)The Central Consumers Bureau of the Ministry of Economic Affairs's Consumer Cooperatives printed XXXIII-style VIA. The most preferred compound of formula VI is 4, s (4, a), 7, α-hexadecane-11-hydroxyl-10f 羟基 -13 丨 /? _ Dimethyl_3 丨, 5,20, _Trioxospiro [furan 2 (3H), 17 0-[4,7] methyl [17H] cyclopenta [a] phenanthrene] -5, 10,000 (2! 11) &quot; In a particularly preferred embodiment of the present invention, the method described above produces a sulfonamide of formula VII from a compound of formula V111 and converts it to a diketone of formula VI in situ. In this specific embodiment of the present invention, as described above, the enzyme of formula VIII is reacted with an excess of an alkali metal cyanide in an aqueous solvent containing a proton source, or in the presence of a base and an alkali if necessary, Reacts with excess ketocyanohydrin. However, instead of cooling the reaction mixture, acidify and add water in a calculated proportion so as to cause precipitation of the enamine, and it is best to avoid actual cooling of the reaction mixture. At the end of the cyanation reaction, water and an acid, preferably an inorganic acid such as sulfuric acid, are indeed added to the mixture, and the proportion of the acid added is sufficient to neutralize the excess alkali metal cyanide, usually per mole. Ear-type VIII enzymes require the introduction of at least one mole equivalent of acid, preferably between about 2 and about 5 moles of enzyme per equivalent. However, it is necessary to maintain a high temperature and a high degree of dilution sufficient to avoid actual precipitation and to allow enamine to diketone hydrolysis in the liquid phase. Therefore, the method is performed with minimal interference and high productivity. The best hydrolysis effect (please read the precautions on the back before filling this page) Clothing · Order-69 · This paper size is applicable to China National Standard (CNS) A4 specification (210X 297 mm) 593305 A7 B7 V. Description of the invention (67 ) Is operated at a temperature of at least 80 ° C, more preferably at about 90 ° to about 100 ° C, usually for about 1 to about 丨 0 hours, preferably about 2 to about 5 hours . The reaction mixture is then cooled, preferably at a temperature between about 0 ° C and about 15 ° C, advantageously in an ice bath, to about 5 ° C to about 10 ° C, so that the formula v The diketone product of I precipitates. Solid products can be recovered by filtration, and impurities can be removed by rinsing with water. In the next step of the synthesis of plan 1, the diketone compound of formula VI is reacted with a metal alkoxide, the ketone bridge between the 4 and 7 positions is opened, and the bond between the carbonyl group and the 4-carbon is cut to form Substituted oxycarbonyl substituent at the 7-position and excludes cyanide on the 5-carbon. The product of this reaction is an acyl ester compound conforming to formula V (please read the precautions on the back before filling this page)

-·&quot; 經濟部中央標準局員工消費合作社印製 其中-A-A-、R3、-B-B-、R8和R9如同在式viii中之定義,且 R1爲低碳數燒氧羧基或經羰基。在該反應中使用的金屬醇 鹽,符合式R1GOM,其中Μ爲鹼金屬,且rig相當於Ri之 烷氧取代基。當金屬醇鹽爲甲醇鉀或鈉時,最能滿足該反 應的生產量,但也可使用其他的低碳數醇鹽。奸之醇鹽是 特佳的。也可以使用酚鹽、其他的芳基氧化物,以及芳基 硫化物。該反應可便利地在符合式R1G〇H之醇的存在下完 成,其中R1 G如同上文之定義。可使用其他傳統的溶劑。最 好是式VI之受酶質以在大約2重量%到大約1 2重量%之間的 -70- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(68 比例存在,更佳的是至少大約6重量%,且R丨〇 〇 M以每莫耳 受酶負在大約0 · 5到大約4莫耳的比例存在。溫度未嚴格限 制,但是昇高的溫度可促進生產力。反應時間通常在大約4 到大約24小時之間,較佳的是大約4到16小時。依據所使 用之溶劑,該反應可便利地在大氣壓的迴流溫度下完成。 在式VI之二酮轉變爲式VI之羥基酯的作用中,副產物氰 化物之離子可能與產物反應,而形成5_氰基酯。因爲在低 濃度處較有利於該平衡,所以最好是以高稀釋度來進行反 應,例如爲了與甲醇鈉的反應,以4〇:1這樣高的稀釋度。 已經發現使用甲醇鉀而不用甲醇鈉,可獲得明顯較高的生 產力,因爲當甲醇鉀爲試劑時,在大約2〇:1範圍内的稀釋 度通常便足以將反向之氰化作用的程度減到最少。 根據本發明,已經更進-步揭示了可藉著採用適當的化 學或物理測量,從反應區中移除副產物氰化物離子,來抑 制逆向之氰化作用反應。因此,在本發明更進一步的且俨 實施例中,二酮與㈣屬醇鹽之反應可在使氰化物離子= 澱之試劑的存在下完成,像是例如包括形成不可溶之氰化 物化合物之陽離子的鹽。這樣的鹽類,例如可包括誠化鋅 、硫酸鐵,或鹼土金屬或過渡金屬本質上比相對應之氰化 物,易溶的任何_化物、硫酸鹽或其他鹽類。如果破化辞 以每當量二酮受酶質大約一當量的比例存在,盥在缺乏鹼 金屬齒化物下經營該方法相比較,已經觀察到該反應之生 產力有實質上的增加。 &quot; 即使使用沉澱劑來移除氰化物離子,最好依然以相當高 (請先閲讀背面之注意事項再填寫本頁)-· & Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economics where -A-A-, R3, -B-B-, R8 and R9 are as defined in formula viii, and R1 is a low-carbon oxycarbyl or carbonyl group. The metal alkoxide used in this reaction conforms to the formula R1GOM, where M is an alkali metal and rig is equivalent to the alkoxy substituent of Ri. When the metal alkoxide is potassium methoxide or sodium, the production capacity of the reaction is best satisfied, but other low carbon number alkoxides may be used. The alkoxide is particularly good. Phenates, other aryl oxides, and aryl sulfides can also be used. This reaction is conveniently carried out in the presence of an alcohol conforming to the formula R1GOH, where R1G is as defined above. Other traditional solvents can be used. Preferably, the enzymatic substance of formula VI is between about 2% by weight and about 12% by weight. -70- This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 593305 Central Standard of the Ministry of Economic Affairs A7 B7 printed by the Bureau ’s Consumer Cooperatives V. Description of the invention (68 ratios exist, more preferably at least about 6% by weight, and R 丨 〇M is negatively affected by about 0.5 to about 4 moles per mole The proportion exists. The temperature is not strictly limited, but the elevated temperature can promote productivity. The reaction time is usually between about 4 to about 24 hours, preferably about 4 to 16 hours. Depending on the solvent used, the reaction can be Conveniently, it is done at the reflux temperature of atmospheric pressure. In the conversion of the diketone of formula VI to the hydroxy ester of formula VI, the ion of the byproduct cyanide may react with the product to form 5-cyanoester. Because at low concentrations It is better for this equilibrium, so it is best to carry out the reaction at a high dilution, for example, for the reaction with sodium methoxide, a high dilution of 40: 1. It has been found that using potassium methoxide instead of sodium methoxide can obtain Markedly Because potassium methoxide is the reagent, a dilution in the range of about 20: 1 is usually sufficient to minimize the degree of reverse cyanation. According to the present invention, it has been further disclosed that By using appropriate chemical or physical measurements, the by-product cyanide ion is removed from the reaction zone to suppress the reverse cyanation reaction. Therefore, in a further and further embodiment of the present invention, the dione and the genus The alkoxide reaction can be performed in the presence of a reagent that causes cyanide ions to form, such as, for example, salts including cations that form insoluble cyanide compounds. Such salts may include, for example, zinc zinc, iron sulfate, Or alkaline earth metals or transition metals are substantially more soluble than the corresponding cyanides, any salts, sulfates or other salts. If the decomposed words are present in a ratio of about one equivalent of the enzymatic substance per equivalent of the diketone, Compared to operating this method in the absence of alkali metal dentate, a substantial increase in the productivity of this reaction has been observed. &Quot; Even if a precipitant is used to remove cyanide ions, it is best to Quite high (please read the notes on the back before filling this page)

-71- 593305 A7 B7 五、發明説明(69 )-71- 593305 A7 B7 V. Description of the invention (69)

的稀釋度來進行’但經由沉澱劑的使用,溶劑對二酮受_ 質的莫耳比例’可以比缺乏這類試劑的反應顯著地減少。 可根據下文描述的萃取或非-萃取程序,來完成式V之羥基 酉旨的回收。 較佳的式v I之二酮受酶質,符合式V丨AThe 'mole ratio of solvent to diketone substrate' can be significantly reduced by the use of a precipitant, compared to the reaction lacking such a reagent. Recovery of the hydroxyl group of formula V can be accomplished according to the extraction or non-extraction procedures described below. The preferred dione of formula v I is enzymatically compatible with formula V 丨 A

且經基酯產物符合式VAAnd the ester product conforms to formula VA

VIAVIA

(請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

經濟部中央標準局員工消費合作社印繁 ,且R1如同在式V中之定義 式V之產物是新穎的化合物,其具有作爲製備式I化合物 ,尤其是式IA中之間物的實際價値。較佳的式v化合物, 符合其中和·Β-Β-爲_CH2-CH2-,R3爲氫、低碳數烷基 或低碳數烷氧基,且R8和R9 —起構成2〇_螺氧烷環: XXXI工工 -72- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 593305 A7 B7 五、發明説明(70 ) 之式VA化合物。最好是式V之化合物爲n從,17“_二經基 -3 -氧代孕甾-4-晞- 7α,21_二叛酸氫甲酯,r-内醋。 可藉著使用例如濃H C 1,將反應溶液酸化,冷卻至周圍溫 度,並以諸如二氯甲烷或醋酸乙酯之類的有機溶劑萃取產 物,來分離式V化合物。以含水的鹼性沖洗溶液來沖洗萃取 物,脱水並過濾,隨後移除溶劑。另外,也可利用濃縮的 酸使含有式V之產物的反應溶液中止。濃縮該產物溶液,冷 卻至0 °C到2 5 °C ’並藉著過滤分離產物固體。 根據回收式V之產物的較佳模式,在反應結束期間後藉著 蒸餚移除甲醇和HCN,並在蒸餾之前或期間内加入水和酸 在蒸館之如加入水可將操作簡化,但是在蒸餘期間逐漸 加入’客终在蒸館鋼中的體積實際上維持固定不變。在蒸 餾過程中,式V之產物從蒸餾鍋底部形成結晶。這種回收的 模式提供了不需要萃取操作的高品質結晶狀產物。 根據另一種選擇’在藉著蒸鶴移除溶劑之後,可利用無 機酸,例如4N HC1,使含有式V產物之反應溶液中止。溶 劑的移除對於從反應產物中移除殘餘的H c N也可能是有效 的。已經發現對於純化式V之化合物而言,多重溶劑萃取作 用是不需要的,式V化合物係在製備環氧美克斯雷諾的過程 中擔任中間物之職責,如同在本文中描述的。事實上,這 類萃取作用通常是完全排除的。爲了產物的純化而使用溶 劑萃取作用,想要補充帶有鹽水的溶劑沖洗和鹼洗。但是 在排除溶劑萃取之處,也排除了鹽水和鹼洗。排除萃取作 用和沖洗,明顯地增加了該方法的生產力,不會產量 -- (請先閱讀背面之注意事項再填寫本頁) 、1Τ -73 593305 經濟部中央標準局員工消費合作社印製 五、發明説明(71 A7 B7 或產物之品質,亦排哈T #丄、λ使沖洗過之溶液脱水的需要:::諸如硫酸納之類乾燥劑將&quot;羥基〜_烷醯氧 ::法的下-個步驟, 中,其將η-經基在u位置處粗t物再度溶解於溶劑 生式既化合物: 處轉^艮好的釋離基,藉此產Employees of the Central Standards Bureau of the Ministry of Economic Affairs, Consumer Cooperatives, and R1 are as defined in Formula V. The product of Formula V is a novel compound that has the actual price of preparing a compound of Formula I, especially an intermediate in Formula IA. A preferred compound of formula V is in which B-B- is _CH2-CH2-, R3 is hydrogen, low-carbon alkyl or low-carbon alkoxy, and R8 and R9 together form 2_spiro Oxane ring: XXXI Engineering-72- This paper size is applicable to Chinese National Standard (CNS) A4 (210X 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 B7 V. Description of the invention (70) VA compound. It is preferred that the compound of formula V is n-, 17 "-diazonyl-3 -oxoprogestin-4-fluorene-7α, 21-dimethanoate, r-lactone. By using, for example, concentrated HC 1, acidify the reaction solution, cool to ambient temperature, and extract the product with an organic solvent such as dichloromethane or ethyl acetate to isolate the compound of formula V. rinse the extract with an aqueous alkaline rinse solution, and dehydrate And filtered, followed by removal of the solvent. Alternatively, the reaction solution containing the product of formula V can also be stopped with concentrated acid. The product solution is concentrated, cooled to 0 ° C to 25 ° C 'and the product solids are isolated by filtration According to a better mode for recovering the product of formula V, after the reaction period, methanol and HCN are removed by steaming, and water and acid are added before or during the distillation. The operation can be simplified if water is added in the steam room. However, during the steaming period, the volume of the guest in the steel of the steaming hall is actually kept constant. During the distillation process, the product of formula V forms crystals from the bottom of the distillation pot. This recovery mode provides no extraction required Handled high quality crystalline product. According to another option, after removing the solvent by steaming the crane, the reaction solution containing the product of formula V can be stopped using an inorganic acid, such as 4N HC1. The removal of the solvent is for removing the residual H c N from the reaction product. It may also be effective. It has been found that multiple solvent extraction is not necessary for the purification of compounds of formula V. The compounds of formula V act as intermediates in the preparation of epoxy mexenos, as in this article. In fact, this type of extraction is usually completely excluded. Solvent extraction is used for the purification of the product, and solvent washing and alkaline washing with brine are wanted. However, where solvent extraction is excluded, it is also excluded. Salt water and alkaline washing. Excluding extraction and washing significantly increased the productivity of this method, and will not yield-(Please read the notes on the back before filling this page), 1Τ -73 593305 Staff of the Central Standards Bureau of the Ministry of Economic Affairs Printed by the consumer cooperative V. Description of the invention (71 A7 B7 or the quality of the product, it also excludes the need for T # 丄, λ to dehydrate the washed solution: :: such as sulfuric acid Desiccants such as hydroxy ~~ alkaneoxy :: next step in the method, which will re-dissolve the crude t at the u position in the solvent formula compound: Good release

. IV ,、中-A-A_、R、-B_B_、R8和R9如同在式ΧΙπ中之定義 ,R如同在式V中之疋義,且R2爲低碳數芳基績酿氧基、 燒基續醯氧基、酿氧基或自化物。較佳的是,藉著將低碳 數烷基磺醯基_化物、醯基由化物或酸酐,加至含有式V之 中間產物的溶液中,與其反應而將11〇^羥基酯化。較佳的 是低碳數烷基磺醯基_化物,尤其是甲烷磺醯氣。另外, 藉著與適當的試劑反應,像,是亞硫醯溴、亞硫醯氯、磺醯 氯或草醯氣’可將1 1 α _經基轉變爲卣化物。其他可形成1 1 從-磺酸酯的試劑包括甲苯磺醯氯、苯磺醯氣和三氟甲烷磺 酸酐。反應在含有諸如三乙胺或吡啶之類的自化氫清除劑 的溶劑中經營。亦可使用諸如碳酸_或鈉之類的無機驗。 式V之輕基酯的起始濃度最好是在大約5重量%到大約5 0重 量%之間。酯化作用之試劑最好是稍微過量。二氯甲烷是特 別適合該反應的試劑,但也可使用其他的溶劑,像是二氣 乙烷、吡啶、氯仿、曱基乙基酮、二甲氧乙烷、甲基異丁 -74· 用中國國家標準(CNS ) Α4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 衣· 593305 A7 B7 五、發明説明(72 ) ^- 基酮、丙酮、其他酮類、醚類、乙腈、甲苯和四氫呋喃。 主要由溶劑的揮發性來決定反應溫度。在二氯甲燒中,反 應溫度最好是在大約-1 0 °C到大約1 〇 °c之間。 較佳的式V之輕基酯受酶質,符合式va rwJ ηIV,, -A-A_, R, -B_B_, R8 and R9 are as defined in formula X1π, R is as synonymous in formula V, and R2 is a low carbon number aryl group. The radicals are fluorenyl, alkoxy, or autogenous. Preferably, the 11-hydroxyl group is esterified by adding a low-carbon alkylsulfonyl sulfonate, fluorenyl radical or acid anhydride to a solution containing an intermediate product of formula V and reacting therewith. Low-carbon alkylsulfonyl sulfonates are preferred, especially methanesulfonyl sulfonium. In addition, by reacting with an appropriate reagent, such as thionyl bromide, thionyl chloride, sulfonyl chloride, or grass gas', the 1 1 α _ radical can be converted into a halide. Other reagents capable of forming 1 1 slave-sulfonate include tosylsulfonium chloride, benzenesulfonium sulfonium gas, and trifluoromethanesulfonic anhydride. The reaction is run in a solvent containing a hydrogen scavenger such as triethylamine or pyridine. Inorganic tests such as carbonate or sodium can also be used. The starting concentration of the light ester of formula V is preferably between about 5 wt% and about 50 wt%. The esterification agent is preferably in a slight excess. Dichloromethane is a particularly suitable reagent for this reaction, but other solvents can also be used, such as digas ethane, pyridine, chloroform, fluorenyl ethyl ketone, dimethoxyethane, methyl isobutyl-74. China National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) Clothing · 593305 A7 B7 V. Description of the invention (72) ^-Ketones, acetone, other ketones, ethers Class, acetonitrile, toluene and tetrahydrofuran. The reaction temperature is mainly determined by the volatility of the solvent. In dichloromethane, the reaction temperature is preferably between about -10 ° C and about 10 ° C. The preferred light-based ester of formula V is enzymatically compatible with the formula va rwJ η

C二 XC two X

VAVA

且產物符合式IVAAnd the product conforms to formula IVA

〔ch2〕·^~~G—X (請先閱讀背面之注意事項再填寫本頁)〔Ch2〕 · ^ ~~ G—X (Please read the precautions on the back before filling in this page)

IVA 其中_A_A_、_B_B_、γΐ、,Y2和x分別如同在式XIII中之 定義,R1爲低碳數烷醯氧基羰基或羥基羰基,且R2如同在 式IV中之定義。 經濟部中央榡準局員工消費合作社印製 式V之產物是新穎的化合物,其具有作爲製備式I化合物 ’尤其是式IA之中間物的實際價値。較佳的式iv化合物, 符合其中-A_A-和-Β_Β·爲-CH2-CH2-,R3爲氫、低碳數烷基 或低碳數烷氧基,且R8和R9 —起構成20-螺氧烷環:IVA wherein _A_A_, _B_B_, γΐ, Y2 and x are as defined in Formula XIII, R1 is a lower alkoxycarbonyl or hydroxycarbonyl group, and R2 is as defined in Formula IV. The product of Formula V printed by the Employees 'Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs is a novel compound which has a practical value as an intermediate for the preparation of a compound of Formula I', especially of Formula IA. Preferred compounds of formula iv, in which -A_A- and -B_B · are -CH2-CH2-, R3 is hydrogen, lower alkyl or lower alkoxy, and R8 and R9 together form 20-spiro Oxane ring:

XXXIII -75- 尽、、,氏張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐 593305 經濟部中央標準局員工消費合作社印m Α7 Β7 五、發明説明(73 ) 之式IVA化合物。最好是式IV之化合物爲17“_羥基_η π -(甲崎醯基)氧基-3-氧代孕甾_4_烯-7 α,2ΐ_二I酸氫甲酯 ,r -内酯。 如果想要,可藉著移除溶劑來分離式〗V化合物。較佳的 是,先以含水的驗性沖洗溶液,例如〇·5-2Ν Na〇H,來沖 洗反應溶液,接著再以酸性沖洗液,例如〇_5 ·2Ν He丨,來 冲洗之。在移除反應溶劑之後,例如藉著使產物溶解於二 氟甲:k中,然後加入其他諸如乙_之類的溶劑,降低式工ν 之產物的溶解度,引起該產物以結晶形式沉澱,而使其再 結晶。 在式IV之產物的回收中,或是在反應溶液的製備中,如 同下文描述的’爲了將式IV中間物轉變爲式π中間物,如 果以離子交換樹脂代替來處理該溶液,以便移除酸性和鹼 性的不純物,則可以免除所有的萃取及/或沖洗步驟。先以 陰離子交換樹脂處理該溶液,然後再以陽離子交換樹脂處 理之。另外’可以先利用無機的吸附劑處理反應溶液,如 鹼式氧化鋁或鹼式二氧化矽,隨後再以稀酸沖洗。鹼式二 氧化矽或鹼式氧化鋁,通常以每公斤產物在大約5到大約50 克之間的比例,與反應溶液混合,較佳的是每公斤產物在 大約15到大約20克之間。無論是否使用離子交換樹脂或無 機的吸附劑’均可藉著使樹脂或無機吸附劑與反應溶液一 起,在周圍溫度下攪拌而簡單地形成淤漿,然後藉著過滤 移除樹脂或無機吸附劑來完成該處理。 在本發明另一種較佳的具體實施例中,藉著移除一部份 -76- 本紙張尺度適用巾國國家標準(CNS ) A4規格(21〇Χ 297公釐) '—~~. (請先閱讀背面之注意事項再填寫本頁) 訂 593305 A7 ------ _B7 __五、發明説明(74 ) 的落劑,以粗製之形式回收濃縮溶液狀的產物式IV之化合 物。直接在本方法的下一個步驟中使用該濃縮溶液,從式 IV化合物中移除n“-釋離基,藉此產生式π之晞酯:XXXIII -75- Exact, and, scales are applicable to Chinese National Standards (CNS) A4 specifications (210X 297 mm 593305) Consumers Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs m Α7 Β7 V. Compounds of formula (IVA) of the invention description (73). Preferably, the compound of formula IV is 17 "_hydroxy_η π-(methazinyl) oxy-3-oxoprogesterone_4_ene-7 α, 2ΐ_diI hydrogen acid methyl ester, r -lactone If desired, the compound of formula V can be separated by removing the solvent. Preferably, the reaction solution is first rinsed with an aqueous rinsing solution, such as 0.5-2N NaOH, and then with Acidic rinsing solution, such as 0-5 · 2N He 丨. After removing the reaction solvent, for example, by dissolving the product in difluoromethane: k, and then adding other solvents such as ethyl The solubility of the product of formula ν causes the product to precipitate in crystalline form and cause it to recrystallize. In the recovery of the product of formula IV or in the preparation of the reaction solution, as described below, 'in order to intermediate formula IV Compounds are converted to intermediates of formula π, if the ion-exchange resin is used instead to treat the solvent In order to remove acidic and alkaline impurities, all extraction and / or rinsing steps can be eliminated. The solution is first treated with an anion exchange resin and then treated with a cation exchange resin. In addition, an inorganic adsorbent can be used first Treatment of a reaction solution, such as basic alumina or basic silica, followed by rinsing with dilute acid. Basic silicon dioxide or basic alumina, usually at a ratio of between about 5 and about 50 grams per kilogram of product, It is mixed with the reaction solution, preferably between about 15 and about 20 grams per kilogram of product. Regardless of whether an ion exchange resin or an inorganic adsorbent is used, the resin or the inorganic adsorbent can be used to surround the reaction solution together with the reaction solution. The slurry is simply formed by stirring at temperature, and then the resin or inorganic adsorbent is removed by filtration to complete the treatment. In another preferred embodiment of the present invention, a portion is removed by removing The paper size is applicable to the national standard (CNS) A4 specification of the towel (21〇 × 297 mm) '— ~~. (Please read the precautions on the back before filling this page) Order 593305 A7 ---- -_B7 __Fifth, the formulation of the invention (74), the concentrated solution of the compound of the formula IV is recovered in a crude form. The concentrated solution is used directly in the next step of the method, from the compound of the formula IV Removal of the n "-releasing group, thereby generating a phosphonium ester of the formula π:

(請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 其中·Α-Α_、R3、_Β_Β_、$8和化9如同在式¥111中之定義 ,且R如同在式V中之定義。爲了該反應之目的,式1乂化 合物之R2取代基可以是任何將其提取時可有效地在9_和1卜 碳 &lt; 間產生雙鍵的釋離基。較佳的是該釋離基爲低碳數烷 基磺醯氧基或醯氧基取代基,藉著與酸和鹼金屬鹽類反應 而將其移除。可使用無機酸,但較佳的是低碳數鏈烷酸。 有利的疋,與该反應有關的試劑更包括所使用之鏈燒酸之 鹼金屬鹽類。特佳的是,該釋離基包括甲磺醯氧基,且與 反應有關之試劑包括甲酸或乙酸,以及這兩種酸其中一種 或其他低碳數鏈烷酸的鹼金屬鹽類。當釋離基爲甲磺醯氧 基且移除試劑爲甲酸和甲酸鉀時,觀察到較高比例的9,i i 至11,12-鏈烯。如果在移除釋離基期間,有自由水份的存 在,則易於形成不溶物,特別是7,9-内酯 -77- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)(Please read the precautions on the back before filling out this page) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. Α-Α_, R3, _Β_Β_, $ 8 and Hua 9 are as defined in the formula ¥ 111, and R is as in Definition in Formula V. For the purpose of this reaction, the R2 substituent of the compound of Formula 1 may be any releasing group which is effective to generate a double bond between 9 and 1 carbon &lt; when extracted. It is preferred that the releasing group is a low-carbon alkylsulfonyloxy or fluorenyl substituent, which is removed by reaction with an acid and an alkali metal salt. Inorganic acids can be used, but low carbon number alkanoic acids are preferred. Advantageously, the reagents related to the reaction further include alkali metal salts of the chain burning acid used. Particularly preferably, the releasing group includes methanesulfonyloxy, and the reagents related to the reaction include formic acid or acetic acid, and alkali metal salts of one of these two acids or other low-carbon alkanoic acids. When the releasing group is methanesulfonyloxy group and the removal reagents are formic acid and potassium formate, a higher proportion of 9, i i to 11,12-alkene is observed. If free water is present during the removal of the free radicals, it is easy to form insoluble materials, especially 7,9-lactone -77- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm)

、1T 593305 Α7 Β7 五、發明説明(75 )1T 593305 Α7 Β7 V. Description of the invention (75)

其不易從終產物中移除。因此,使用乙酸酐或其他的乾 燥劑來移除在甲酸中出現的水。藉著Karl Fischer對水的分 析來測量,在反應之前以總反應溶液爲基礎,反應混合物 中的自由水份含量應維持在低於大約〇 . 5重量%的程度,較 佳的是低於大約0.1重量%。雖然該反應混合物最好是保持 在已經獲得實用的、令人滿意之結果的〇 . 3重量%水的乾燥 程度。較佳的是,反應裝填混合物含有在大約4重量%到大 約50重量%的在鏈烷酸中的式Iv受酶質。最好包含在大約4 重量%到大約20重量%的該酸之鹼金屬鹽。當使用乙酸酐作 爲乾燥劑時,最好是以每莫耳鏈烷酸在大約〇 . 〇 5莫耳到大 約0 · 2莫耳之間的比例存在。 已經發現副產物7,9 -内酯和1 1,1 2 -鏈烯在反應混合物中 的比例,在排除包含三氟乙酸、三氟乙酸酐和乙酸鉀之組 合的試劑之處相當的低,該試劑係作爲排除釋離基,並形 成烯酯(9,1 1 ·鏈晞)的試劑。三氟乙酸酐係作爲乾燥劑,且 以三氟乙酸排除試劑爲基礎,應該以至少大約3重量%之比 例存在,更佳的是至少大約1 5重量%,最佳的是大約2 〇重 量%。 另外,也可從式IV化合物中排除11 釋離基,藉著加熱 -78- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、\呑 丁 經濟部中央標準局員工消費合作社印製 593305 A7 B7 五、發明説明(76 ) 在諸如DM SO、DMF或DMA之類有機溶劑中的式 ,產生式11之晞酉旨。 更進一步根據本發明,一開始使式IV化合物與諸如乙酸 異丙烯酯之類的鏈烷酸烯酯,在諸如甲苯磺酸之類的酸, 或諸如硯酸之類的無水無機酸的存在下反應,形成式〗V化 合物的3 -烯醇酯:It is not easily removed from the end product. Therefore, acetic anhydride or other drying agents are used to remove the water present in the formic acid. Measured by Karl Fischer's analysis of water, based on the total reaction solution before the reaction, the free moisture content in the reaction mixture should be maintained below about 0.5% by weight, and preferably below about 0.1% by weight. Although the reaction mixture is preferably maintained at a dryness of 0.3% by weight of water, where practical and satisfactory results have been obtained. Preferably, the reaction charge mixture contains from about 4% to about 50% by weight of an enzyme of formula Iv in an alkanoic acid. Preferably the alkali metal salt of the acid is included at about 4% to about 20% by weight. When acetic anhydride is used as the desiccant, it is preferably present at a ratio of from about 0.05 mole to about 0.2 mole per mole of alkanoic acid. It has been found that the proportion of by-products 7,9-lactone and 1 1,1 2-alkene in the reaction mixture is quite low in excluding reagents containing a combination of trifluoroacetic acid, trifluoroacetic anhydride and potassium acetate, This reagent is used as a reagent which excludes the release group and forms an ene ester (9,1 1 · chain fluorene). Trifluoroacetic anhydride is used as a desiccant, and based on the trifluoroacetic acid exclusion agent, it should be present in a proportion of at least about 3% by weight, more preferably at least about 15% by weight, and most preferably about 20% by weight . In addition, 11 free radicals can also be excluded from the compound of formula IV. By heating -78- This paper size applies Chinese National Standard (CNS) A4 specification (210X 297 mm) (Please read the precautions on the back before filling in this Page), printed by the Consumers' Cooperative of the Central Standards Bureau, Ministry of Economic Affairs, 593305 A7 B7 5. Description of the invention (76) The formula in an organic solvent such as DM SO, DMF, or DMA produces the purpose of formula 11. Still further according to the present invention, a compound of formula IV is initially made with an alkanoate such as isopropenyl acetate in the presence of an acid such as toluenesulfonic acid, or an anhydrous inorganic acid such as osmic acid React to form a 3-enol ester of a compound of formula V:

(請先閱讀背面之注意事項再填寫本頁) 工 v(z) 另外,也可以藉著利用酸酐和鹼來處理,像是醋酸和乙 酸鈉,形成3 -烯醇酯。另外更可以包括利用烯酮,在酸的 存在下處理,產生IV(Z)。隨後在甲酸或乙酸的存在下,以 鹼金屬甲酸鹽或乙酸鹽來處理中間物式IV(Z),產生式 IV ( Y)的△ - 9,1 1晞醇乙酸酯: 經濟部中央標準局負工消費合作社印f(Please read the precautions on the back before filling in this page.) V (z) In addition, you can also use acid anhydride and alkali to treat, such as acetic acid and sodium acetate, to form 3-enol ester. In addition, it may include treatment with ketene in the presence of an acid to generate IV (Z). The intermediate is then treated with an alkali metal formate or acetate in the presence of formic acid or acetic acid, formula IV (Z), to yield Δ-9,1 1 1-alcohol acetate of formula IV (Y): Central Ministry of Economic Affairs Standards Bureau, Consumer Cooperatives, India

IV(Y) 然後可在有機溶劑中,最好是諸如甲醇之類的醇,藉著烯 醇乙故酉曰之熱分解作用’或是其與驗金屬醇鹽的反應,將 其轉變爲式11之晞酯。排除反應對於式I丨之晞酯有高度的選 -79- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五、發明説明(77 )IV (Y) can then be converted into the formula in an organic solvent, preferably an alcohol such as methanol, through the thermal decomposition of enol ethyl, or its reaction with a metal alkoxide. 11 esters. The exclusion reaction is highly selective for the esters of formula I 丨 -79- This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) 593305 A7 B7 V. Description of the invention (77)

擇性’最優先的是丨丨,i 2 _鏈烯和7 : 酯轉變成晞酮中可保存該選擇性。 較佳的式IV受酶質,符合式! v A -内酯,且在晞醇乙酸The selectivity is most preferred, and this selectivity can be preserved in the conversion of i 2 _ olefins and 7: esters to fluorenone. The better formula IV is subject to enzymes, which matches the formula! v A -lactone, and ethanol

IVA (請先閲讀背面之注意事項再填寫本頁jIVA (Please read the notes on the back before filling in this page j

CZZX 經濟部中央標準局員工消費合作社印製CZZX Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

且晞目旨產物符合式11 AAnd the objective product meets formula 11 A

IIA 其中-Α_Α_、-Β_Β_、γΐ、Y2和X分別如同在式χιπ中之 定義,且R1如同在式V中之定義。 如果想要,可藉著移除溶劑,將固體產物溶解於冷水中 ,並以有機溶劑,像是醋酸乙酯萃取來分離式〗〗化合物。在 適當的沖洗和脱水步驟之後,藉著移除萃取溶劑來回收產 物。然後將晞酯溶解於適用於轉變式I之產物的溶劑中。另 外’也可以藉著在濃縮的產物溶液中加入水,並過滤固體 產物來分離晞酯,藉此優先移除7,9 -内酯。將式11之受酶 -80- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 593305 A7 B7 五 發明説明(78 經濟部中央標準局員工消費合作社印製 質轉變爲式IA之產物,可以在美國專利第4,559,332號中插 述的方法來經營,特別將其合併於此以作爲參考,或更= 的是藉著新穎的反應,利用卣化乙醯胺啓動者,按照下文 的描述來經營之。 在本發明其他的具體實施例中,可將式羥基酯轉變爲 式II之晞酯,不需式1¥化合物之中間物的分離。在該方法 中,將羥基酯溶解於有機溶劑中,像是二氯甲烷;然後在 該溶液中加入醯化劑,例如甲烷磺醯氯,或是南化試劑, 例如磺醯氣。攪動該混合物,如果涉及齒化試劑,則L入 諸如咪唑I類的HC1清除劑。鹼與該溶液的混合是高度放巷 的,並因此應該在經過控制之速率下經營,並充份冷卻: 。在鹼的加成作用後,將所得的混合物回溫至適當的溫度 ,例如0 C至罜溫,或稍微超過,並持續反應一段時間,通 常是1至4小時。在反應完成後汽提溶劑,較佳的是在_丨 到+ 15°C的高度眞空(例如24”至228,,汞柱)條件下,更佳 是大約0 °C到大約5 °C,以便濃縮溶液並移除過量的鹼。 後將受酶質再溶解於有機溶劑中,最好是諸如二氯甲烷 類的鹵化溶劑,以便轉變爲烯醋。 釋離基排除試劑,最好是藉著在無水的反應器中混合有 機酸、有機酸鹽和乾燥劑來製備之,較佳的分別是甲酸、 鹼金屬甲酸鹽和乙酸酐。乙酸酐的加成作用是放熱的,並 導致釋放出CO,所以必須控制加成作用的速率。欲促進水 的移除,該反應之溫度較好是維持在⑽^到…^的範圍内 ’最好是大約65°C到大約75°c。然後將該試劑加至式^化 的 之 (請先閱讀背面之注意事項再填寫本頁) 訂 81- 經濟部中央標準局員工消費合作社印製 593305 A7 ________B7 五、發明説明(79 ) 合t的產物溶液中,以便完成排除反應。在拉8小時後,最 好是將反應混合物加熱至至少大約8 5 r的溫度,但是不能 超過大約95 °C,直到已經移除所有的揮發性餾出物爲止, 然後持續額外的時間以便完成反應,通常是丨至4小時。冷 卻該反應混合物,隨後藉著標準萃取技術回收,可按照想 要的藉著蒸發溶劑來回收晞g旨。 更發現可藉著另一種在排除反應後不需萃取步驟之程序 ,從反應,谷液中回收式〗j之烯酯,藉此提供了成本的節省、 產量的改善及/或生產力的改善。在本方法中,藉著在移除 甲酸之後以水稀釋反應混合物,使烯酯產物沉澱。然後藉 著過濾、分離產物。不需要萃取作用。 根據另一種選擇,將式v之羥基酯轉變爲式π之婦酯,不 需分離式IV之化合物,以氫來代替式V之羥基酯的i i “ -羥 基基團,然後藉著熱力脱氫_化作用就地形成式;^之烯酯。 以氫來代替幾基的取代作用,藉著與磺醯化自,較佳的是 續醯氯’在冷的,在諸如咪唑之類的_化氫清除劑的存在 下反應來完成之。將羥基酯溶解於如四氫呋喃之類的溶劑 中’並冷卻至0 °C至_ 7 0 °C。加入磺醯化自,並將反應混合 物回溫至適當的溫度,例如室溫,持續足以完成排除反應 的時間’通常是1到4小時。該具體實施例的方法並不只是 將兩個步驟混合成一個,還排除了下列物質的使用:_化反 應溶劑;酸(像是乙酸);以及乾燥劑(乙酸酐或硫酸鈉)。此 外,該反應不需要迴流條件,並避免了使用乙酸作爲乾燥 劑時產生之副產物C Ο的產生。 -82- 本紙張尺度適用中國國家標準(CNS ) A4規格(21 〇x 297公釐) -- (請先閱讀背面之注意事項再填寫本頁) 訂 ^1. 經濟部中央標準局員工消費合作社印繁 593305 五、發明説明(8〇 ) 根據本發明特佳的具體實施例,可將式1¥之二酮化合物 轉變爲環氧美克斯雷諾或其他的式〗化合物,不需要分離任 何純形式的中間物。根據該較佳方法,利用強酸溶液使含 有羥基酯之反應溶液中止,冷卻至周圍溫度,然後以適當 的萃取溶劑萃取之。有利的是,在萃取作用之前,先在反 應混合物中加入無機鹽的水溶液,例如丨〇重量%的生理鹽 水溶液。沖洗萃取物,並藉著共沸蒸餾作用脱水,以便移 除酮切開反應中殘留的甲醇溶劑。 然後使用含有在大約5重量%到大約50重量%之式v化合 物的所得的濃縮溶液,在寒冷的狀況下與醯化劑或烷基續 化試劑接觸,形成磺酸酯或二羧酸酯。在完成烷基磺化作 用或羧化反應之後,使反應溶液通過覆有酸性然後是鹼性 之叉換樹脂的管柱,以便移除鹼性和酸性的雜質。在分別 通過之後,以適當的溶劑沖洗管柱,例如二氯甲烷,以便 從其中回收殘餘的磺酸或二羧酸酯。將混合的洗脱液和沖 洗液溶離份混合,並最好在眞空下還原,產生含有式IV之 %故Sg或一幾&amp; S旨的濃縮溶液。然後使該濃縮溶液與包括 引起1 1 α -酯釋離基之移除,並從9,u _雙鍵中除去氫之試 劑的乾燥劑接觸。移除釋離基之試劑最好包括上述之甲酸/ 驗金屬甲酸鹽/乙酸酐之乾燥劑溶液。在反應完成後,冷卻 該反應混合物,並在眞空下移除甲酸及/或其他揮發性成份 。將殘餘物冷卻周圍溫度,接受適當的沖洗步驟,然後脱 水得到含有式Π晞酯之濃縮溶液。然後可利用在本文中,或 在美國專利第4,559,332號中描述的方法,將該烯酯轉變爲 -83- 本紙乐尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 、11 -I «^1— —^1 經濟部中央標準局員工消費合作社印製 593305 A7 一----------B7____ 五、發明説明(S1 ) 環氧美克斯雷諾或其他式I之化合物。 在本發明特佳的具體實施例中,在眞空下從反應溶液中 移除溶劑,並使式IV之產物分布在水和適當的有機溶劑之 間’例如醋酸乙酯。然後利用有機溶劑及萃取液層,並以 驗性溶液沖洗反萃取物,最好是含有鹼金屬齒化物的鹼金 屬氫氧化物之溶液。濃縮有機相,最好是在眞空下,產生 式II之烯酯產物。然後可將式η之產物溶解於有機溶劑中, 例如二氣甲烷,並進一步以在,3 3 2號專利中描述的方法進 行反應,產生式I之產物。 在環氧化作用中使用三_乙腈時,已經發現溶劑的選擇 是很重要的,卣化的溶劑是較喜愛的,而二氯甲燒是特佳 的。諸如二氯乙燒和氣苯之類的溶劑,得到相當令人滿意 的產量,但是在二氯甲烷反應介質中通常有更好的產量。 諸如乙腈和醋酸乙醋之類的溶劑通常得到較差的產量,而 在諸如甲醇或水/四氫呋喃之類溶劑中的反應,則得到想要 產量的一小部份。 更進一步根據本發明,已經揭示藉著關於環氧化反應使 用二乙醯胺而不是二_乙腈作爲過氧化物活化劑,可在 環氧美克斯雷諾的合成中獲得許多改善。根據特=的方法 ,藉著使式ΠΑ之受酶質與過氧化氫,在三氯乙醯胺和適當 緩衝溶液的存在下反應’來完成環氧化作用。較佳的是, 該反應在大約3到大約7之pH値範圍下經營 工呂’取佳的是在大 約5到大約7之間。然而,不顧這些因素,在較佳的pH値範 圍之外亦已經獲得成功的反應。 -84- 本紙張尺度適用中國國家標準(CNS ) A4規格(210x297公釐) —- (請先閱讀背面之注意事項再填寫本頁}IIA where -Α_Α_, -Β_Β_, γΐ, Y2, and X are respectively defined as in the formula χιπ, and R1 is defined as in the formula V. If desired, the compound can be isolated by removing the solvent, dissolving the solid product in cold water, and extracting it with an organic solvent, such as ethyl acetate. After proper rinsing and dehydration steps, the product is recovered by removing the extraction solvent. The fluorenyl ester is then dissolved in a solvent suitable for converting the product of formula I. Alternatively, it is also possible to preferentially remove the 7,9-lactone by adding water to the concentrated product solution and filtering the solid product to isolate the ethyl ester. The enzyme-80 of formula 11 is adapted to the Chinese national standard (CNS) A4 size (210X 297 mm) 593305 A7 B7 Five invention descriptions (78 The printed matter of the staff consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs is transformed into formula IA The product can be operated by the method interpolated in U.S. Patent No. 4,559,332, which is hereby incorporated by reference in particular, or, more specifically, by a novel reaction, using an amidated acetamide starter, as follows In other specific embodiments of the present invention, a hydroxy ester of formula can be converted to a phosphonium ester of formula II without the need to separate the intermediate of the compound of formula 1 ¥. In this method, the hydroxy ester is dissolved In an organic solvent, such as dichloromethane; then add a hydrating agent, such as methanesulfonyl chloride, or a sulfonating agent, such as sulfonium gas, to the solution. Stir the mixture, and if a dentifying agent is involved, then L HC1 scavengers such as imidazole I. Mixing of the base with the solution is highly latent and should therefore be operated at a controlled rate and cooled sufficiently: After the addition of the base, the resulting Mix The material is allowed to warm to an appropriate temperature, for example, 0 C to 罜, or slightly exceeded, and the reaction is continued for a period of time, usually 1 to 4 hours. After the reaction is completed, the solvent is stripped, preferably _ 丨 to + 15 At a high altitude (eg, 24 "to 228, Hg), it is more preferably about 0 ° C to about 5 ° C in order to concentrate the solution and remove excess alkali. The enzyme is then redissolved in Among organic solvents, halogenated solvents such as dichloromethane are preferred for conversion to vinyl acetate. The ion-exclusion reagent is preferably prepared by mixing organic acids, organic acid salts, and desiccants in an anhydrous reactor. For the preparation, the preferred ones are formic acid, alkali metal formate and acetic anhydride. The addition of acetic anhydride is exothermic and results in the release of CO, so the rate of addition must be controlled. To promote the removal of water The temperature of the reaction is preferably maintained in the range of ⑽ ^ to ... ^ ', preferably about 65 ° C to about 75 ° c. Then add this reagent to the formula (Please read the note on the back first (Please fill in this page again for details) Order 81- Staff Consumption of Central Bureau of Standards, Ministry of Economic Affairs Printed by Suzakusha 593305 A7 ________B7 V. Description of the invention (79) In the product solution of t to complete the elimination reaction. After 8 hours of drawing, it is best to heat the reaction mixture to a temperature of at least about 8 5 r, but not Over approximately 95 ° C until all volatile distillates have been removed, and then continue for an additional period of time to complete the reaction, typically 1-4 hours. The reaction mixture is cooled and subsequently recovered by standard extraction techniques. I want to recover 晞 g by evaporating the solvent. I also found that by using another procedure that does not require an extraction step after the reaction is eliminated, the enyl ester of formula j can be recovered from the reaction and valley liquid, thereby providing a cost Savings, yield improvements and / or productivity improvements. In this method, the ene ester product is precipitated by diluting the reaction mixture with water after removing formic acid. The product was then isolated by filtration. No extraction is required. According to another option, the hydroxy ester of formula v is converted to the ester of formula π, without isolating the compound of formula IV, replacing the ii "-hydroxy group of the hydroxy ester of formula V with hydrogen, and then dehydrogenating by heat _Chemical formation is in situ; the enyl ester of ^. Substitute the substitution of several groups with hydrogen, and by sulfonation with, it is better to continue hydrazine 'in the cold, such as in imidazole. The reaction is completed in the presence of a hydrogenation scavenger. The hydroxyester is dissolved in a solvent such as tetrahydrofuran and cooled to 0 ° C to -7 ° C. Sulfonation is added and the reaction mixture is warmed. To an appropriate temperature, such as room temperature, for a period of time sufficient to complete the elimination reaction 'is usually 1 to 4 hours. The method of this specific example does not merely mix two steps into one, but also excludes the use of the following substances: Solvents (such as acetic acid); and desiccants (acetic anhydride or sodium sulfate). In addition, the reaction does not require reflux conditions, and avoids the production of by-products C 0 when using acetic acid as a desiccant.- 82- This paper size applies to China Standard (CNS) A4 (21 0x297 mm)-(Please read the notes on the back before filling out this page) Order ^ 1. Staff Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs, India Fan 5933305 5. Description of Invention (8 〇) According to a particularly preferred embodiment of the present invention, the dione compound of the formula 1 ¥ can be converted to epoxy mexanol or other compounds of the formula, without the need to isolate any intermediates in pure form. According to this preferred The method uses a strong acid solution to stop the reaction solution containing the hydroxyester, cools to the surrounding temperature, and then extracts it with an appropriate extraction solvent. Advantageously, before the extraction, an aqueous solution of an inorganic salt is added to the reaction mixture, for example, 0% by weight of a physiological saline solution. The extract is rinsed and dehydrated by azeotropic distillation to remove the methanol solvent remaining in the ketone cleaving reaction. Then use a compound of formula v at about 5% to about 50% by weight The resulting concentrated solution is contacted with a sulfonating agent or an alkylating agent under cold conditions to form a sulfonic acid ester or a dicarboxylic acid ester. After the alkyl sulfonation is completed, After the carboxylation reaction, the reaction solution is passed through a column covered with an acidic and then a basic fork-changing resin in order to remove basic and acidic impurities. After passing through each column separately, rinse the column with a suitable solvent, such as two Chloromethane in order to recover the residual sulfonic acid or dicarboxylic acid esters from it. The mixed eluate and rinse fractions are mixed and preferably reduced under vacuum to produce Sg or a few &amp; S concentrated solution. The concentrated solution is then contacted with a desiccant including a reagent that causes removal of the 1 1 α-ester release group and removes hydrogen from the 9, u _ double bond. The release group is removed The reagent preferably includes the formic acid / metal formate / acetic anhydride desiccant solution described above. After the reaction is completed, the reaction mixture is cooled and the formic acid and / or other volatile components are removed under air. The residue is cooled to ambient temperature, subjected to a suitable rinsing step, and then dehydrated to obtain a concentrated solution containing a formula II ester. The olefinic ester can then be converted to -83 using the method described in this article or in US Patent No. 4,559,332. This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm) (Please read first Note on the back, please fill in this page again), 11 -I «^ 1— — ^ 1 Printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 I ---------- B7____ V. Description of the Invention (S1 ) Epoxy Mexanol or other compounds of formula I. In a particularly preferred embodiment of the present invention, the solvent is removed from the reaction solution under airspace and the product of formula IV is distributed between water and a suitable organic solvent 'such as ethyl acetate. The back extract is then washed with an organic solvent and an extract layer, and the solution is preferably an alkali metal hydroxide solution containing an alkali metal dentate. The organic phase is concentrated, preferably under argon, to produce the enyl product of formula II. The product of formula η can then be dissolved in an organic solvent, such as digas methane, and further reacted in the manner described in the Patent No. 332 to produce the product of formula I. When tri-acetonitrile is used in epoxidation, it has been found that the choice of solvent is important. The tritiated solvent is preferred, and dichloromethane is particularly preferred. Solvents such as dichloroethane and gaseous benzene yield fairly satisfactory yields, but generally yield better yields in dichloromethane reaction media. Solvents such as acetonitrile and ethyl acetate usually result in poor yields, while reactions in solvents such as methanol or water / tetrahydrofuran give a fraction of the desired yield. Still further according to the present invention, it has been revealed that by using diethylamidamine instead of di-acetonitrile as a peroxide activator with respect to the epoxidation reaction, many improvements can be obtained in the synthesis of epoxy mexanol. According to the special method, the epoxidation is completed by reacting the enzyme of formula IIA with hydrogen peroxide in the presence of trichloroacetamide and a suitable buffer solution. Preferably, the reaction is carried out at a pH range of about 3 to about 7; preferably, about 5 to about 7. Regardless of these factors, however, successful reactions have been achieved outside the preferred pH range. -84- This paper size applies to China National Standard (CNS) A4 (210x297 mm) —- (Please read the precautions on the back before filling this page}

經濟部中央標準局員工消費合作社印製 593305 Μ —____ Β7 五、發明説明(82 ) 利用由磷酸氫二鉀構成之緩衝溶液,及/或以在大約1:4 到大約2 : 1之間的相對比例,最好是在大約2 : 3之範圍内, 由嶙酸氫二鉀和嶙酸二氫鉀所構成的緩衝溶液,獲得特別 有利的結果。也可以使用硼酸緩衝溶液,但是通常得到比 磷酸二鉀或ΚΑΡΟ4或Κ:2ΗΡ〇4/ΚΗ2Ρ04混合物更慢的轉 換。無論緩衝溶液的組成爲何,均應提供上文指示之pH値 範圍。撇開緩衝溶液的整體組成或其可能給予的實際pH値 不談,已經觀察到如果至少一部份的緩衝溶液是由二元的 磷酸氫鹽離子所構成。則反應將會更有效率得多。咸相信 孩離子可能在形成包括啓動者和氫過氧化物離子的加成化 合物或複合物時,本質上分擔了作爲均相催化劑之職務, 它們的交替產生可能對整個環氧化作用的反應機制而言是 必要的。因此,對於二元磷酸氫鹽(較好是來自k2hP〇4)的 定量需求可能僅是少量的催化濃度。一般而言,最好是 HPO4以每當量受酶質至少大約〇 _ i當量的比例存在,例如 在大約0 · 1到大約〇 · 3當量之間。 在適當的溶劑,較佳的是二氣甲烷中完成該反應,但另 外也可以使用其他的_化溶劑,像是氯苯或二氯乙烷。亦 發現甲苯和甲苯與乙腈的混合物也是令人滿意的。不需承 話特足的理論,假設反應在兩相系統中進行得最有效率, 在其中形成氫過氧化物中間物,並分布至低水含量的有機 相中,再與在有機相中的受酶質反應。因此,較佳的溶劑 是水溶性較低的那些。可藉著包含諸如乙腈之類的其他= 劑,促進從甲苯中更有效率的回收。 吟 ----------- (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 M —____ B7 V. Description of the Invention (82) Use a buffer solution composed of dipotassium hydrogen phosphate, and / or use a solution between approximately 1: 4 and approximately 2: 1 The relative ratio, preferably in the range of about 2: 3, is particularly favorable with a buffer solution composed of dipotassium hydrogen acetate and potassium dihydrogen acetate. Boric acid buffer solutions can also be used, but usually result in slower conversions than dipotassium phosphate or KAPO4 or K: 2QPO4 / KQ2P04 mixtures. Regardless of the composition of the buffer solution, the pH range indicated above should be provided. Regardless of the overall composition of the buffer solution or the actual pH it may give, it has been observed that if at least a portion of the buffer solution is composed of a binary hydrogen phosphate ion. The response will be much more efficient. Xian believes that in the formation of addition compounds or complexes that include initiators and hydroperoxide ions, they essentially share the role of homogeneous catalysts, and their alternating production may react to the entire epoxidation reaction mechanism. Words are necessary. Therefore, the quantitative requirement for the dibasic hydrogen phosphate (preferably from k2hP04) may be only a small amount of catalytic concentration. In general, it is preferred that HPO4 is present in a ratio of at least about 0_i equivalents per equivalent of enzyme, such as between about 0.1 to about 0.3 equivalents. The reaction is carried out in a suitable solvent, preferably digas methane, but other solvents such as chlorobenzene or dichloroethane can also be used. It was also found that toluene and mixtures of toluene and acetonitrile were also satisfactory. Needless to say that the theory is sufficient, it is assumed that the reaction proceeds most efficiently in a two-phase system, in which a hydroperoxide intermediate is formed and distributed to the organic phase with low water content, and then reacts with the organic phase in the organic phase. Subject to enzymatic reactions. Therefore, preferred solvents are those with lower water solubility. By including other agents such as acetonitrile, more efficient recovery from toluene can be facilitated. Yin ----------- (Please read the notes on the back before filling this page)

,1T, 1T

593305 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(83 在將式11受酶質轉變爲式I產物之中,甲苯提供了有利的 過程,因爲受酶質自由地溶解於甲苯中,而產物則否。因 此’在反應期間内當轉變達到4 〇 - 5 0 %範圍時,產物沉澱出 來’產生三相的混合物,從其中可便利地藉著過濾來分離 產物。在本方法的轉變步驟中,甲醇、醋酸乙酯、單獨的 乙腈、THF和THF/水,不能提供像鹵化溶劑或甲苯這樣有 效的結果。 二氣乙驢胺是最喜愛的試劑,也可以使用其他的三鹵化 乙醯胺,像是二氟乙醯胺。也可以使用三卣化甲基苯甲醯 胺,以及其他在吸電子之三自化甲基基團和醯胺之羰基之 間,具有亞芳基邵份的化合物。也可以使用3,3,3 _三鹵化 丙醯胺,但是具有較不佳的結果。通常過氧化物活化劑可 符合下式: R°C(〇)NH2 其中R°爲具有至少像單氯甲基基團一樣高之吸電子強度(藉 著sigma常數來測定)的基團。更佳的是,過氧化物活化劑可 符合下式: f 〇 X —C一Rp-c!— 其中X、χ和χ3分別選自卣素、氫、燒基、齒坑基和氯基 及氰烷基,且rp選自亞芳基和_(cx4x5)n_,其中 X X X X和X其中至少有—個是鹵素或全鹵烷 基。當X1、X2、X3、X4或X5中任何_個不是_素時,它 較好是自燒基,最好是全线基。特佳的活化劑包括其中n (請先閱讀背面之注意事項再填寫本頁)593305 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (83 In converting the enzyme of formula 11 to the product of formula I, toluene provides an advantageous process because the enzyme is freely dissolved in toluene And the product is not. So 'the product precipitates out when the transformation reaches the range of 40-50% during the reaction' produces a three-phase mixture from which the product can be conveniently separated by filtration. In this method In the conversion step, methanol, ethyl acetate, acetonitrile alone, THF, and THF / water cannot provide such effective results as halogenated solvents or toluene. Digas is the favorite reagent, but other three Halogenated acetamide, such as difluoroacetamide. Trimethylated methylbenzamide can also be used, as well as other aryl groups between the electron-withdrawing tri-automated methyl group and the carbonyl group of fluorenamide. Compounds based on phenols. 3,3,3_trihalogenopropylammonium amine can also be used, but with poorer results. Generally peroxide activators can fit the formula: R ° C (〇) NH2 where R ° For having at least something like monochloride Group with the same high electron-withdrawing strength (measured by the sigma constant). More preferably, the peroxide activator can meet the following formula: f 〇X —C—Rp-c! — Where X, χ and χ3 are selected from halogen, hydrogen, alkynyl, dentyl, chloro and cyanoalkyl, and rp is selected from arylene and _ (cx4x5) n_, where at least one of XXXX and X is halogen Or perhaloalkyl. When any one of X1, X2, X3, X4, or X5 is not a prime, it is preferably a self-fired group, most preferably a full-line group. Particularly preferred activators include n (please (Read the notes on the back and fill out this page)

-86 經濟部中央標準局員工消費合作社印製 593305 A7 ____B7 五、發明説明(84 ) 爲0,且X1、X2和X3中至少兩個是鹵素;或其中X1、Χ2、 X3、X4和X5全那都是鹵素或全鹵燒基的那些。較佳的是, χΐ、X2、χ3、χ4和χ5分別是C1或F,最好是C1,雖然混 合的自化物也是適合的,像是全氯烷基或全溴烷基及其混 合物。 較佳的是,過氧化物活化劑以每當量最初存在之受酶質 至少大約1當量的比例存在,更佳的是在大約丨· 5到大約2當 量之間。反應應該負載至少稍微過量的過氧化氫,或是隨 著環乳化作用之進行逐漸地添加。雖然在反應中每莫耳受 酶質僅消耗一到二當量的過氧化氫,但是過氧化氫最好以 實際超過受酶質和活化劑最初存在的量來裝載之。不以特 定的理論來限制本發明,咸相信反應機制涉及活化劑與 Ο Ο Η之加成化合物的形成,該反應的形成是可逆的,且平 衡有利於逆反應,因此爲了使反應向前方進行,需要最初 實際上過量的過氧化氫。反應的溫度並未嚴格限制,且在〇 °c到100°c的範圍内可有效地完成。最適當的溫度係依據所 選擇的溶劑。通常較佳的溫度是在大約2 0 I到3 0之間, 但在某些溶劑中,例如甲苯,反應可有利地在6〇O_7(rc的 範圍内經營。在2 5 °C下,反應通常需要不到丨〇小時,通常 是3到6小時。如果需要額外的活化劑和過氧化氫,可在反 應循環結束時加入,以便達到受酶質的完全轉變。 在反應循環結束時,移除液相,最好沖洗有機的反應溶 液’以便移除可溶於水的雜質,隨後可藉著移除溶劑來回 收產物。在移除溶劑之前,應該沖洗反應溶液,最少利用 (請先閱讀背面之注意事項再填寫本頁)-86 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 ____B7 V. The description of the invention (84) is 0, and at least two of X1, X2, and X3 are halogen; or where X1, X2, X3, X4, and X5 are all Those are all halogen or perhalogenated. Preferably, χΐ, X2, χ3, χ4, and χ5 are C1 or F, respectively, and most preferably C1, although mixed compounds are also suitable, such as perchloroalkyl or perbromoalkyl and mixtures thereof. Preferably, the peroxide activator is present at a ratio of at least about 1 equivalent per enzyme equivalent of the enzymatic substance initially present, and more preferably between about 5 and about 2 equivalents. The reaction should be loaded with at least a slight excess of hydrogen peroxide or gradually added as the ring emulsification proceeds. Although only one to two equivalents of hydrogen peroxide are consumed per mole of the enzyme in the reaction, it is preferred that the hydrogen peroxide be loaded in an amount that actually exceeds the amount of enzyme and activator originally present. Without limiting the present invention by a specific theory, I believe that the reaction mechanism involves the formation of an addition compound of activator and 〇 ,, the formation of the reaction is reversible, and the equilibrium is favorable for the reverse reaction, so in order to make the reaction proceed forward, Requires an initial practical excess of hydrogen peroxide. The temperature of the reaction is not strictly limited, and it can be efficiently completed in the range of 0 ° C to 100 ° C. The most appropriate temperature depends on the solvent selected. Generally the preferred temperature is between about 20 and 30, but in some solvents, such as toluene, the reaction can advantageously operate in the range of 600-7 (rc.) At 25 ° C, the reaction It usually takes less than 0 hours, usually 3 to 6 hours. If additional activators and hydrogen peroxide are needed, they can be added at the end of the reaction cycle in order to achieve the complete conversion of the enzyme. At the end of the reaction cycle, remove In addition to the liquid phase, it is best to rinse the organic reaction solution 'in order to remove water-soluble impurities, and then the product can be recovered by removing the solvent. Before removing the solvent, the reaction solution should be rinsed and used at least (please read first (Notes on the back then fill out this page)

、1T -87- 593305 經濟部中央標準局員工消費合作社印製1T -87- 593305 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs

A7 B7 五、發明説明(85 ) Μ和到適度的驗性沖洗液,例如碳酸鈉。最好是以下列溶 液連續沖洗反應混合物:溫和的還原溶液,像是弱的(例如3 重量%)亞硫酸鈉水溶液;鹼性溶液,例如Na〇H或Κ〇Η( 較佳的是大約0·5Ν);酸性溶液,像是HC1(較佳的是大約 1 N);以及最後的中性沖洗液,包括水或鹽水,較佳的是飽 和的鹽水’以便減少產物的喪失。在移除反應溶劑之前, 可有利地加入其他的溶劑,像是有機溶劑,較佳的是乙醇 ’以便在蒸餾移除更多揮發性反應溶劑之後,可藉著結晶 作用來回收產物。 應瞭解到使用二氯乙醯胺或其他新穎之過氧化物活化劑 的新穎環氧化方法,具有遠超過製備環氧美克斯雷諾之各 種計劃的應用,且事實上可越過各種在液相中接受反應之 受酶質的鏈烯雙鍵,使用在環氧化物的形成上。該反應對 於其中烯碳爲四取代和三取代的不飽和化合物特別有效, 也就是RaRbC = CRcRd和RaRbc = CRCRH,其中^到…代 表氫以外的取代基。當受酶質爲帶有三取代雙鍵之環狀化 合物,或是帶有四取代雙鍵之環狀或非環狀化合物時,反 應進行的最迅速和完全。該反應之代表性受酶質包括△ _ 9,1 1 -康雷諾,以及A7 B7 5. Description of the invention (85) M and a moderately sensible rinsing solution, such as sodium carbonate. The reaction mixture is preferably continuously rinsed with a mild reducing solution, such as a weak (eg, 3% by weight) aqueous sodium sulfite solution; an alkaline solution, such as NaOH or KOH (preferably about 0.5N ); An acidic solution, such as HC1 (preferably about 1 N); and a final neutral rinse, including water or saline, preferably saturated saline 'in order to reduce product loss. Prior to the removal of the reaction solvent, other solvents, such as organic solvents, preferably ethanol 'can be advantageously added so that after more volatile reaction solvents are removed by distillation, the product can be recovered by crystallization. It should be understood that novel epoxidation methods using dichloroacetamide or other novel peroxide activators have applications that far exceed the various plans for the preparation of epoxy mexanol, and in fact can be used in a variety of ways in the liquid phase. The olefinic double bond of the enzymatic substance undergoing the reaction is used for the formation of epoxide. This reaction is particularly effective for unsaturated compounds in which the olefinic carbon is tetra- and tri-substituted, that is, RaRbC = CRcRd and RaRbc = CRCRH, where ^ to ... represent substituents other than hydrogen. When the substrate is a cyclic compound with a triple-substituted double bond, or a cyclic or acyclic compound with a tetra-substituted double bond, the reaction proceeds most rapidly and completely. Representative enzymes of this reaction include △ _9,1 1 -Conoreno, and

-88 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 593305 A7 B7-88-This paper size is applicable to China National Standard (CNS) A4 (210X 297mm) (Please read the precautions on the back before filling this page) Order 593305 A7 B7

Ο 因爲具有三取代和四取代之雙键時,反應進行得較迅速 和完全,所以在可能包含其他雙键,其中鏈烯碳是單取代 或甚至是雙取代的化合物中,跨越這類雙鍵的選擇性環氧 化作用是特別地有效。 更應該瞭解到在單取代或甚至是雙取代之雙鍵的環氧化 作用中,可有利地使用該反應,像是在各種類固醇受酶質 中的11,12-鏈烯。然而,因爲優先環氧化較高取代的雙鍵 ,例如9,1 1 -鏈晞,而具有高選擇性,所以本發明之方法對 於在本文中別處描述的各種反應計劃之環氧化步锻,達成 高產量和生產力是特別有效的。 已經顯示經過改良的方法,對於藉著下列物皙夕堪落儿 作用:〇 Because the reaction proceeds more quickly and completely with double bonds with tri- and tetra-substitutions, in compounds that may contain other double bonds where the alkenyl carbon is mono- or even di-substituted, spanning such double bonds The selective epoxidation is particularly effective. It should be further understood that this reaction can be advantageously used in the epoxidation of mono- or even disubstituted double bonds, such as 11,12-alkenes in various steroid receptors. However, because the highly substituted double bonds, such as 9,1 1 -strands, are preferentially epoxidized and have high selectivity, the method of the present invention achieves the epoxidation step for various reaction schemes described elsewhere herein. High yields and productivity are particularly effective. Improved methods have been shown to work well with the following:

本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) (請先閱讀背面之注意事項再填寫本頁)This paper size applies to Chinese National Standard (CNS) A4 specification (210 × 297 mm) (Please read the precautions on the back before filling this page)

〇 經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 593305 A7 --------B7 五、發明説明(87 )〇 Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economics Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economics 593305 A7 -------- B7 V. Description of Invention (87)

是特別有利的應用。 對於本發明之方法已經證實了多重的優點,其中使用三 氣乙醯胺來代替三氣乙腈在環氧化反應中作爲移轉氧的試 劑。忒二軋乙醯胺之試劑系統對於跨越三取代雙鍵的環氧 化作用,利用在相同分子結構中的雙取代和“0 _酮鏈烯類 ’提供了嚴格的區域控制。因此,實際上增加了反應產量 、產物輪廓和終純度。更進一步揭示三氣乙醯胺並未體驗 到使用三_化乙腈所觀察到實際上過量的氧產生,給予環 氧化作用經過改良的安全性。與三氣乙腈促進反應相反, 一亂乙醯胺的反應顯示最少的放熱效應,因此有利於控制 該反應的熱力輪廓。觀察攪動的影響是最少的y且反應器 效率是更一致的,還有更多勝過三氣乙腈法的優點。該反 應比二氯乙腈促進之反應,更能夠負貴按比例擴大。產物 的分離和純化很簡單,並沒有體驗到像例如使用間-氯過氧 苯甲酸或其他過氧酸時遇到的羰基官能之顯著拜耳-維利格 -90- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁}It is a particularly advantageous application. Multiple advantages have been demonstrated for the method of the present invention, in which trigas acetamide is used instead of trigas acetonitrile as a reagent for transferring oxygen in the epoxidation reaction. For the epoxidation of acetamide, the reagent system for epoxidation across tri-substituted double bonds, using the double substitution in the same molecular structure and "0_ketoalkenes" provides strict regional control. Therefore, it actually increases The reaction yield, product profile, and final purity were further revealed. It was further revealed that triacetam did not experience the actual excess oxygen production observed with tris-acetonitrile, giving improved safety to epoxidation. And Sangas In contrast, acetonitrile promotes the reaction. The reaction of acetamide shows the least exothermic effect, so it is beneficial to control the thermal profile of the reaction. Observe that the effect of agitation is minimal and the reactor efficiency is more consistent, and there are more wins. Advantages of the three-gas acetonitrile method. This reaction is more expensive than the reaction promoted by dichloroacetonitrile and can be scaled up. The isolation and purification of the product is simple, and I have not experienced anything like using m-chloroperoxybenzoic acid or other Significant carbonyl function encountered in peroxyacid Bayer-Willieg-90- This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) (Please read first Note the surface to fill out this page}

593305 A7 B7 五、發明説明(88 ) (Bayer-Villager)氧化作用(過氧化物促進酮轉變爲醋之作用) ,且試劑便宜、容易取得並容易操作。 本發明之新穎的環氧化作用法,在計劃1合成的推論步驟 中是非常有用的。在特佳的具體實施例中,計劃1過程的完 整方法如下: 。593305 A7 B7 V. Description of the invention (88) (Bayer-Villager) oxidation (peroxide promotes the conversion of ketones to vinegar), and the reagent is cheap, easy to obtain and easy to operate. The novel epoxidation method of the present invention is very useful in the inference step of the synthesis of plan 1. In a particularly preferred embodiment, the complete method of the Plan 1 process is as follows:.

(請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

-91--91-

本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7· 五This paper size applies to China National Standard (CNS) A4 (210X 297 mm) 593305 A7 B7 · 5

、發明説明(89 本發明第二個新穎的反應計劃(計劃2 ),從康雷諾或其他 符合式XIII的受酶質開始2. Description of the invention (89 The second novel reaction plan (Plan 2) of the present invention, starting from Conorno or other enzymes conforming to formula XIII)

XIII 。在本方法的第一個步驟中,利用大體上與上述將式VIII 受酶質轉變爲式VII中間物相同的氰化反應計割,將式ΧΙΠ 之受酶質轉變爲式XII之產物 (請先閱讀背面之注意事項再填寫本頁)XIII. In the first step of the method, the enzymatic substance of formula XII is converted to the product of formula XII using a cyanation reaction scheme substantially the same as that described above for converting the enzyme of formula VIII to an intermediate of formula VII (Read the notes on the back before filling out this page)

訂 經濟部中央標準局員工消費合作社印製Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs

XIIXII

較佳的是式XIII之受酶質符合式XI〗J A 丫 2 c=z:x 且烯胺產物符合式ΧΙΙΑ -92- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)It is preferred that the enzymatic substance of formula XIII conforms to formula XI J A y 2 c = z: x and the enamine product conforms to formula XΙΙΑ-92- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm)

XIIIA 593305 A7 B7 五、發明説明(90XIIIA 593305 A7 B7 V. Description of the invention (90

XIIA 其中- A-A-、-B-B-、Y1、Y2和X分別如同在式XIII中之 定義。 在計劃2的第二個步驟中,利用大體上與上述將式VI11受 酶質轉變爲式VII中間物相同的反應計劃,將式XII之烯胺 水解成式XI之中間物二酮產物 vXIIA where-A-A-, -B-B-, Y1, Y2, and X are as defined in Formula XIII, respectively. In the second step of Scheme 2, the enamine of formula XII is hydrolyzed to the intermediate diketone product of formula XI using a reaction scheme substantially the same as that described above for converting the enzyme of formula VI11 to the intermediate of formula VII.

(請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

XI 經濟部中央標準局員工消費合作社印製XI Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

其中- A-A-、R3、-B_B-、R8和R9如同在式VIII中之定義 較佳的是,式XII之受酶質符合式XIIA -93- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(91Among them,-AA-, R3, -B_B-, R8, and R9 are as defined in formula VIII. It is better that the enzymatic substance of formula XII complies with formula XIIA-93- This paper standard applies to China National Standard (CNS) A4 (210X 297 mm) 593305 A7 B7 V. Description of the invention (91

Q—XQ—X

且二酮產物符合式XIAAnd the diketone product conforms to formula XIA

XIIAXIIA

丫 2 I c=x ΧΙΑ 其中-Α-Α-、-Β-Β、Υ1、Υ2和X分別如同在式VIIIA中之定義。 進一步根據計劃2,使式XI之二酮與鹼金屬醇鹽反應,形 成美克斯雷諾或其他符合式X之產物Γ 2 I c = x χΙΑ where -A-A-, -B-B, Υ1, Υ2, and X are as defined in Formula VIIIA, respectively. Further according to plan 2, the dione of formula XI is reacted with an alkali metal alkoxide to form Mexileau or other products conforming to formula X

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

X 其中-A-A-、R3、-B-B·、R8和R9分別如同在式VIII中之定義 。R1如同在式V中之定義。該方法利用大體上與上述將式 -94- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 593305 A7 五X wherein -A-A-, R3, -B-B ·, R8 and R9 are as defined in formula VIII, respectively. R1 is as defined in Formula V. This method uses roughly the same formula as above. -94- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 A7 5

、發明説明(92 ), Description of the invention (92)

V1化合物轉變爲式v那些相同的反應計劃來完成。較佳的 是,式XI之受酶質符合式XIAThe conversion of the V1 compound to those of the formula V is accomplished by the same reaction plan. Preferably, the enzyme of formula XI conforms to formula XIA

-c—X ΧΙΑ 且中間產物符合式ΧΑ (請先閱讀背面之注意事項再填寫本頁)-c—X ΧΙΑ and the intermediate product conforms to the formula ⅩΑ (Please read the precautions on the back before filling this page)

CCH2D1 -c=x ΧΑ 經濟部中央標準局員工消費合作社印製 其中- Α_Α_、_Β_Β_、γΐ、γ2和χ分別如同在式ΧΙΙΙ中之 定義。R1如同在式V中之定義。 接下來藉著新穎的生物轉化方法,將康雷諾及其他式χ化 合物羥基化,產生式IX之產物 , -95- 本紙張尺度適财目®㈣辟(CNS ) A4規格(210X;97公釐 593305 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(93 )CCH2D1 -c = x ΧΑ Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economics where-Α_Α_, _Β_Β_, γΐ, γ2, and χ are as defined in the formula XIII. R1 is as defined in Formula V. Next, by a novel biotransformation method, Conreno and other compounds of formula χ are hydroxylated to produce the product of formula IX. -95- This paper is suitable for paper size ® CNS A4 (210X; 97mm) 593305 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 5. Description of the Invention (93)

其中- A-A-、R3、-B-B-、R8和R9如同在式VIII中之定義,且 R1如同在式V中之定義,在該羥基化作用步驟中可以使用 的生物爲犬土 壤絲菌(Nocardia conicruria) ATCC 3 1548、橙 色土壤絲菌(Nocardia aurentia) ATCC 12674、山為豆生棒孢 (Corynespora cassiicola) ATCC 16718 、吸水鏈黴菌 (Streptomyces hydroscopicus) ATCC 27438、深黃被孢黴 (Mortierella isablellina) ATCC 42613 &gt; 蠶黴菌(Beauvria bassiana) ATCC 7519 、產紫青黴菌(Penicillum purpurogenum) ATCC 46581、金孢菌寄生(Hypomyces chrysospermus) IMI 109891 、 梨狀薩摩斯泰樂菌 (Thamnostylum piriforme) ATCC 8992、短刺小克銀漢黴 (Cunnignhamella blakesleeana) ATCC 8688a、刺孢小克銀漢 黴(Cunningnhamella echinulate) ATCC 3655、雅致小克銀漢 黴(Cunninghamella elegans) ATCC 9245、粉紅單端孢 (Trichothecium roseum) ATCC 12543、荷米可拉附球菌 (Epicoccum humicola) ATCC 12722 、紅色糖多孢菌 (Saccharopolyspora eythrae) ATCC 1 1635、蠶黴菌(Beauvria bassiana) ATCC 13144、簡單節桿菌(Arthrobacter simplex) 、環氧桿菌(Bacterium cyclooxydans) ATCC 12673、雷迪西 -96- 本紙張尺度適用中國國家標準(CNS ) A4規格(21 〇X 297公釐) (請先閲讀背面之注意事項再填寫本頁) 、?τ 593305 A7 B7 五、發明説明(94 ) 可拉柱孢(Cylindrocarpon radicicola) ATCC 11011、橙色土 壤絲菌(Nocardia aurentia) ATCC 12674、犬土 壤絲菌 (Nocardia canicruria)、瑞斯崔克特土壤絲菌(Norcardia restrictus) ATCC 14887、睪固酉同假單抱菌(pseud〇monas testosteroni) ATCC 1 1996、馬赤球菌(Rhodococcus equi) ATCC 21329、偶發分枝桿菌(Mycobacterium fortuitum) ATCC-6842 和玫瑰色赤球菌(Rhodococcus rhodochrous) ATCC 19150。該反應大體上係以上述有關於圖1和2之方法 來完成,圖1之方法是特佳的。 在該生物轉化中所使用的生長培養基,最好含有在大約 0 · 0 5重量%到大約重量5 %之間的可利用氮;在大約〇 . 5重 量%到大約重量5 %之間的葡萄糖;在大約〇 . 2 5重量%到大 約重量2 · 5 %之間的酵母衍生物;以及在大約〇 . 〇 5重量%到 大約重量〇 · 5 %之間的可利用磷。特佳的生長培養基包括下 列: 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 大豆粗粉:在大約0 · 5重量%到大約3重量%之間的葡萄糖; 在大約0.1重量%到大約1重量%之間的大豆粗粉;在大約 0 · 0 5重量%到大約0 · 5重量%之間的驗金屬鹵化物;在大約 0 · 0 5重量%到大約5 6 0 · 5重量%之間的酵母衍生物,像是自 溶酵母或酵母萃取物;在大約0.0 5重量%到大約〇 . 5重量% 之間的磷酸鹽,像是K2HP〇4 ; pH = 7 ; 腺-酵母萃取物-葡萄糖:在大約0 · 2重量%到大約2重量%之 間的腺;在大約0 · 0 5重量%到大約0 · 5重量%之間的酵母萃 取物;以及在大約2重量%到大約5重量%之間的葡萄糖; -97- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) &quot; 593305 A7 B7 五、發明説明(95 謬勒喜頓(Mueller-Hinton);在大約1〇重量%到大約40重量 %之間的牛輸液;在大約〇 · 3 5重量%到大約8.7 5重量°/〇之 間的酪蛋白胺基酸;在大約〇 ·丨5重量%到大約〇 · 7重量%之 間的殿粉。 眞菌可在大豆粗粉或腺營養物中生長,同時放線菌屬和 眞細菌可在大豆粗粉(爲了生物轉化作用,加上〇 · 5重量%到 1重量%的羧酸鹽,如甲酸鈉)或膠勒_喜頓肉湯中生長。 在實例1 9中討論藉著發酵作用從美克斯雷諾中產生的J j 卢-羥基美克斯雷諾。 式IX之產物是新穎的化合物,可藉著過濾將其分離,以 適當的有機溶劑沖洗,例如醋酸乙酯,並從相同或類似的 溶劑中使其再結晶。它們具有作爲製備式I化合物,尤其是 式IA化合物之中間物的實際價値。較佳的式〗X化合物符合 其中-Α_Α·和-B-B-爲_CH2_CH2·,R3爲氫、低碳數烷基或低 碳數烷氧基,且R8和R9 —起構成2〇_螺氧烷環:Wherein-AA-, R3, -BB-, R8 and R9 are as defined in Formula VIII, and R1 is as defined in Formula V. The organism that can be used in this hydroxylation step is soil mycelia (Nocardia conicruria) ATCC 3 1548, Nocardia aurentia ATCC 12674, Corynespora cassiicola ATCC 16718, Streptomyces hydroscopicus ATCC 27438, Mortierella isablellina ATCC 42613 &gt; Beauvria bassiana ATCC 7519, Penicillum purpurogenum ATCC 46581, Hypomyces chrysospermus IMI 109891, Tamnostylum piriforme ATCC 9899, short spines Cunnignhamella blakesleeana ATCC 8688a, Cunningnhamella echinulate ATCC 3655, Cunninghamella elegans ATCC 9245, Trichothecium roseum ATCC 12543, Hermicilla Epicoccum humicola ATCC 12722, Saccharopolyspora eythr ae) ATCC 1 1635, Beauvria bassiana ATCC 13144, Arthrobacter simplex, Bacterium cyclooxydans ATCC 12673, Radisi-96- This paper is in accordance with China National Standard (CNS) A4 Specifications (21 0X 297 mm) (Please read the notes on the back before filling out this page),? Τ 593305 A7 B7 V. Description of the invention (94) Cylindrocarpon radicicola ATCC 11011, Orange soil mycelia (Nocardia aurentia) ATCC 12674, Nocardia canicruria, Norcardia restrictus ATCC 14887, pseudomonas testosteroni ATCC 1 1996, horse Rhodococcus equi ATCC 21329, Mycobacterium fortuitum ATCC-6842 and Rhodococcus rhodochrous ATCC 19150. This reaction is generally carried out by the method described above with regard to Figs. 1 and 2, which is particularly preferred. The growth medium used in the biotransformation preferably contains available nitrogen between about 0.5% to about 5% by weight; glucose between about 0.5% to about 5% by weight ; Yeast derivatives between about 0.25% to about 2.5% by weight; and available phosphorus between about 0.05% to about 0.5% by weight. The best growth media include the following: Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) Soy meal: between about 0.5% to about 3% by weight Glucose; soy meal between about 0.1% and about 1% by weight; metal halide between about 0.5% and about 0.5% by weight; between about 0.5% and 0.5% by weight Yeast derivatives between about 56.5% by weight, like autolyzed yeast or yeast extract; phosphates, between about 0.05% by weight and about 0.5% by weight, like K2HP〇4 pH = 7; glandular-yeast extract-glucose: glands between about 0.2% and about 2% by weight; yeast extraction between about 0.5% and about 0.5% by weight And glucose between about 2% by weight and about 5% by weight; -97- This paper size applies to China National Standard (CNS) A4 (210X297 mm) &quot; 593305 A7 B7 V. Description of the invention (95 Leellerton (Mueller-Hinton); at about 10% by weight Bovine infusion between about 40% by weight; casein amino acid between about 0.35% by weight and about 8.75% by weight ° / 〇; between about 0.5% by weight and about 0.7% by weight It can be grown in soybean meal or glandular nutrients, while Actinomyces and tadpole bacteria can be grown in soybean meal (for biotransformation, add 0.5% to 1% by weight Carboxylate, such as sodium formate) or Geller_Hydron broth. J j Lu-Hydroxy mexanol produced from Mex Renault by fermentation is discussed in Example 19. Product of Formula IX Are novel compounds that can be isolated by filtration, washed with a suitable organic solvent, such as ethyl acetate, and recrystallized from the same or similar solvents. They have the ability to prepare compounds of formula I, especially formula IA The actual valence of the intermediate of the compound is 较佳. Preferred compounds of formula X are in which -Α_Α · and -BB- are _CH2_CH2 ·, R3 is hydrogen, a low-carbon alkyl group or a low-carbon alkoxy group, and R8 and R9 —To form a 20-spiroxane ring:

XXXIII (請先閲讀背面之注意事項再填寫本頁} 訂 經濟部中央標準局員工消費合作社印繁 在合成計劃2的下一個步驟中,使式IX之產物與脱氫試劑 反應,產生式11化合物XXXIII (Please read the notes on the back before filling out this page} Order In the next step of Synthesis Plan 2, the product of formula IX is reacted with a dehydrogenation reagent to produce a compound of formula 11

II -98- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X 297公釐) 五、發明説明(96 A7 B7 其中-A-A-、R3、β R 1 , n /- -V λ/ …R和汉9如同在式VIII中之定義,且 R如同在式V中之佘# , 義° ^受酶質符合式IXA時,II -98- This paper size is in accordance with Chinese National Standard (CNS) A4 specification (21〇X 297mm) 5. Description of the invention (96 A7 B7 of which -AA-, R3, β R 1, n /--V λ / … R and Han 9 are as defined in Formula VIII, and R is as 佘 # in Formula V, meaning ^ When the subject enzyme conforms to Formula IXA,

產物爲式IIAThe product is of formula IIA

IXA C#先聞讀背面,注意事項真填寫本頁)IXA C # first read and read the back, the notes really fill in this page)

C〇H2^—c—xC〇H2 ^ -c-x

IIA 經濟部中央標準局員工消費合作社印製 其中-A-A-、-B-B-、V1,且R1如同在式V中1定義和X分別如同在式XUI中之定義 在該合成計劃的最終步驟中,藉著根據在美國專利第 4,559,332唬中描述的方法;或較好是藉著在前文中描述的 本發明之新穎環氧化作用方法,藉著環氧化作用將如之產 物轉變爲式I化合物。 在特佳的具體實施例中,計劃2過程的完整方法如下: -99- 本紙張尺度適财關緖準(CNS ) &amp;見格(210X297公¢7 593305 A7 B7 五、發明説明(97IIA The Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs printed -AA-, -BB-, V1, and R1 is defined as 1 in formula V and X is defined as in formula XUI, respectively. The product such as the compound of formula I is converted by epoxidation by the method described in US Patent No. 4,559,332; or preferably by the novel epoxidation method of the present invention described in the foregoing. In a particularly preferred embodiment, the complete method of the Plan 2 process is as follows: -99- This paper size is suitable for financial and related standards (CNS) &amp; See the grid (210X297 public ¢ 7 593305 A7 B7 V. Description of the invention (97

康雷諾Conreno

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

(請先閱讀背面之注意事項再填寫本頁) -100-本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 Α7 Β7 五、發明説明(98 ) jtjj 3 在该案例中的合成,始於符合式χχ之受酶質(Please read the precautions on the back before filling this page) -100- This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm) 593305 Α7 Β7 V. Description of the invention (98) jtjj 3 In this case Synthesis begins with the enzyme

其中- Α-Α-和R3如同在式vm中之定義,·β_β_μ同在式 VIII中的足義’除了 R6和R7都不是在μ,〗7位置處與〇環 融合之環的一部份,且R26爲低碳數烷基,較佳的是甲基。 式XX之父酶貝與銳内鏘鹽(sulfonium ylide)的反應,產生 符合式XIX之環氧中間物Where-Α-Α- and R3 are the same as defined in formula vm, and β_β_μ is the same as in formula VIII, except that R6 and R7 are not in μ, and part of the ring fused with ring 0 at position 7 And R26 is a low carbon number alkyl group, preferably a methyl group. Reaction of the parent enzyme of formula XX with sulfonium ylide to produce an epoxy intermediate conforming to formula XIX

(請先閱讀背面之注意事項再填寫本頁) 、11 經濟部中央標準局員工消費合作社印製 XIX 其中、R3、_B_B_*R26如同在式χχ中之定義。 在合成計劃3的下一個步驟中,將式χιχ之中間物轉變爲 另一種式XVIII之中間物 -101- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公瘦) 593305 經濟部中央標準局員工消費合作社印t 五、發明説明(99 A7 B7(Please read the precautions on the back before filling out this page), 11 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs XIX Among them, R3, _B_B_ * R26 are as defined in the formula χχ. In the next step of Synthesis Plan 3, the intermediate of formula χιχ is transformed into another intermediate of formula XVIII-101- This paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 male thin) 593305 Central Ministry of Economic Affairs Printed by the Bureau of Standards Consumer Cooperatives V. Invention Description (99 A7 B7

CO.Et XV工工工 其中-A-A-、R3和4 n 4 — B-如同在式xx中之定義。在該步驟中 ,精耆與NaCH(C〇〇Pt、 丄 丄 、 以)2,在鹼的存在下,在溶劑中反應, 將式χΐχ之受酶質轉變爲式xvm之中間物。式χν⑴化合 物+路在’、’、水和驗金屬南化物中,產生符合式mi之脱竣 基中間化合物 ΟCO.Et XV workers where -A-A-, R3 and 4 n 4 — B- are as defined in formula xx. In this step, spermidine reacts with NaCH (CoPt, 丄,), 2 in the presence of a base in a solvent, and converts the enzyme of formula χΐχ into an intermediate of formula xvm. A compound of formula χν⑴ + in ’,’, water, and a metal-detecting compound, yields an unbroken intermediate compound conforming to formula mi Ο

XV工工 其中- Α·Α·、R3和如同在式χχ中之定義。將式χχ化合 物轉變爲式XVII化合物的方法,基本上相當於在美國專利 第3,897,417號、3,413,288號和3,330,489號中描述的那些, 特別將其合併於此以作爲參考。雖然受酶質不同,但是導 入17-螺内酯部份之試劑、機制和條件基本上是相同的。 式XVII之中間物與脱氫試劑的反應,產生更進一步的式 XVI之中間物 102- 本紙張尺度適用中國國家標準(CNS ) Α4規格(2】0Χ 297公釐) (請先閱讀背面之注意事項再填寫本頁)XV 工 工 where-Α · Α ·, R3 and as defined in the formula χχ. The method of converting a compound of formula χχ to a compound of formula XVII is basically equivalent to those described in U.S. Patent Nos. 3,897,417, 3,413,288, and 3,330,489, which are specifically incorporated herein by reference. Although the enzymes are different, the reagents, mechanisms and conditions for introducing 17-spirolactone are basically the same. The reaction between the intermediate of formula XVII and the dehydrogenation reagent produces a further intermediate of formula XVI. 102- This paper size applies the Chinese National Standard (CNS) A4 specification (2) 0 × 297 mm. (Please read the note on the back first (Fill in this page again)

、1T 593305 A7 B7 五、發明説明(100 ) Ο1T 593305 A7 B7 V. Description of the invention (100) 〇

XVI 其中- A-A-、R3和-B-B-如同上文之定義。 代表性有用的脱氫試劑包括二氯二氰基苯醌(DDq)和氯 酉昆(2,3,5,6 -四氯-對-苯醌)。另外,也可藉著在碳_6處之_ 化作用,接著脱去_化氫,來完成脱氫作用。 接下來將式XVI之中間物轉變爲式XV之晞胺 C請先閱讀背面之注意事項再填寫本頁j 〇XVI where-A-A-, R3 and -B-B- are as defined above. Representative useful dehydrogenation reagents include dichlorodicyanobenzoquinone (DDq) and chloroquine (2,3,5,6-tetrachloro-p-benzoquinone). In addition, the dehydrogenation can also be accomplished by the _ation at carbon_6, followed by the dehydrogenation. Next, the intermediate of formula XVI is converted to amidine of formula XV. Please read the precautions on the back before filling in this page.

νηλ -訂 經濟部中央標準局員工消費合作社印製νηλ-Order printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs

XV 其中·Α-Α-、R3和·Β_Β·如同在式XX中之定義。轉化作用 係藉著氰化作用,基本上利用上述將式VIII之11α-羥基化 合物轉變爲式νπ之晞胺的方法。通常氰化物離子來源可以 是驗金屬氰化物。鹼最好是吡啶及/或四甲基胍。可使用甲 醇溶劑。 -103- I紙張尺度適準(CNS ) Α4規格(21〇、χ 297公釐丁 &quot; ~ 593305 A7 B7 五、發明説明(101) 式X v之產物是新减的化合物’可藉著層析法分離之。這 些及其他式AXV之新穎化合物,具有作爲製備式I,尤其是 式IA化合物之中間物的實際價値。式AXV之化合物符合下 列結構XV in which Α-Α-, R3, and Β_Β are as defined in Formula XX. The conversion is basically a method for converting the 11α-hydroxy compound of the formula VIII to the amidine of the formula νπ by cyanation. Usually the source of cyanide ions can be metal cyanide. The base is preferably pyridine and / or tetramethylguanidine. Methanol solvents can be used. -103- I Paper Size Appropriate (CNS) A4 Specification (21〇, χ 297 mm D &quot; ~ 593305 A7 B7 V. Description of the Invention (101) The product of formula X v is a newly reduced compound 'can be obtained by layer These and other novel compounds of formula AXV have practical valence as intermediates for the preparation of compounds of formula I, especially of formula IA. Compounds of formula AXV conform to the following structure

B kB k

AXV 其中- A- A-、-B-B-、R3、R8和R9如同上文之定義。在最 佳的式X V化合物中’ -和- 爲- CH2-CH2-。 根據上述產製式VI之二酮化合物的水解作用,可將式χν 之烯胺轉變爲式XIV之二酮. (請先閱讀背面之注意事項再填寫本頁)AXV where-A- A-, -B-B-, R3, R8 and R9 are as defined above. In the most preferred compound of formula X V, '-and-are -CH2-CH2-. According to the hydrolysis of the diketone compound of formula VI above, the enamine of formula χν can be converted to the diketone of formula XIV. (Please read the precautions on the back before filling this page)

、1T 經濟部中央標準局員工消費合作社印製 〇、 1T Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 〇

XIV 其中- A-A-、R3和- B-B-如同在式XX中之定義。關於環氧 -104- 本紙張尺度適用中國國家標準(CNS ) Α4规格(21〇Χ 297公釐) 593305 A7 B7XIV where -A-A-, R3 and -B-B- are as defined in formula XX. About Epoxy -104- This paper size applies to Chinese National Standard (CNS) A4 specification (21〇 × 297mm) 593305 A7 B7

五、發明説明(102 美克斯雷諾的合成,特佳的是也落在式VIA範圍内的那些 式XIV化合物。 ‘ 式XIV之產物是新穎的化合物,可藉著沉澱作用分離之 。這些及其他式AXIV之新穎化合物具有作爲製備式I化合 物’尤其是式IA化合物之中間物的實際價値。式AXIV化 合物符合下列結構V. Description of the invention (102 For the synthesis of Max Reynolds, the compounds of formula XIV that also fall within the scope of formula VIA are particularly preferred. The products of formula XIV are novel compounds that can be separated by precipitation. These and Other novel compounds of the formula AXIV have practical valences as intermediates for the preparation of compounds of the formula I, especially of the compounds of the formula IA. The compounds of the formula AXIV conform to the following structure

AXIV 其中- A_A_、_B_B_、R3、R8*R9如同上文之定義。在最 佳的式AXIV和XIV化合物中,·Α-Α&gt;_Β-Β-爲-CH2_CH2-。 基本上利用上述將式VI之二酮轉變爲式V之羥基酯的方 法’將式XIV之化合物進一步轉變爲式XXXI之化合物。在 該案例中’必須在進一步轉變爲式χχχΠ的產物之前 (請先閱讀背面之注意事項再填寫本頁)AXIV where-A_A_, _B_B_, R3, R8 * R9 are as defined above. In the most preferred compounds of the formulae AXIV and XIV, · A-A &gt; _Β-Β- is -CH2_CH2-. The compound of formula XIV is further converted to a compound of formula XXXI basically using the method of converting a diketone of formula VI to a hydroxy ester of formula V described above. In this case, ‘must be converted to the product of formula χχχΠ (please read the notes on the back before filling this page)

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

先分離中間物式XXXIFirst isolate the intermediate formula XXXI

XXXI -105- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210'乂297公釐)XXXI -105- This paper size applies to Chinese National Standard (CNS) Α4 specification (210 '乂 297 mm)

加熱 593305 Α7 Β7 五、發明説明(103) XXX工工 其中- A-A·和_B-B -如同在式XX中之定義。較佳的式 XXXI化合物是在式IIA範圍内的那些。利用上文描述之方 法,或是在美國專利第4,559,332號中的方法,將式XXXI化 合物轉變爲式XXXII化合物。在特佳的具體實施例中,計 劃3過程的完整方法如下: (請先閱讀背面之注意事項再填寫本頁)Heating 593305 Α7 Β7 V. Description of the invention (103) XXX workers-where A-A · and _B-B-are as defined in formula XX. Preferred compounds of formula XXXI are those within the scope of formula IIA. The compound of formula XXXI is converted to a compound of formula XXXII using the method described above or the method in U.S. Patent No. 4,559,332. In a particularly good embodiment, the complete method of the plan 3 process is as follows: (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

HCI, CH#OH, ΗλΟHCI, CH # OH, ΗλΟ

本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 五、發明説明(l〇4 A7 B7 itill 之門1ΓΓ驟與㈣3的㈣,也就是崎合式χχ 义化合物開始’來製備式xvn之中間物。 1¾►後將式X V11之φ ρη %卢答a 4 559川… 例如使用$國專利第 ,9,332號中的万法,,產生式XXIV之化合物 〇This paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm). 5. Description of the invention (104 A7 B7 itill gate 1ΓΓ 骤 and ㈣3㈣, which is the formula of the compound χχ starting from the meaning of the compound. The intermediate of xvn. 1¾►Then φρη% of the formula X V11 Luta a 4 559 Chuan ... For example, using the method of National Patent No. 9,332, to produce a compound of formula XXIV.

(請先閱讀背面之注意事項再填寫本頁) . 經濟部中央標準局員工消費合作社印製 XXIV 2_a-a-、R^_B_B•如同在式xxt之定義。然而,在 發明特佳的具體實施例中,根據上文在計m中描述,將 式轉變爲3U之產物的方法,利用包括賴型過氧 化物活化劑之氧化劑,最佳的是三氯乙醯胺,跨越9,&quot;·雙 鍵將式χνπ受酶質環氧化。該反應之條件及試劑比例,大 體上如同將式II# g旨轉變爲環氧美克斯雷諾中的描述。 已經發現亦可利用過氧酸,像是例如間_氯過氧苯甲酸, 以非,良好之產量完成式XVII受酶質的環氧化作用。然而 ,三氣乙醯胺試劑對於減少拜耳·維利格(Bayer_Villager)氧 化作用副產物的形成,提供了優異的結果。離然可移除後者的 副產物,但是這需要從諸如醋酸乙酯之類的溶劑中研製, 接著使其從諸如二氯甲烷之類的其他溶劑中形成結晶。將 式XXIV之裱氧化合物脱氫,藉著與諸如DDQ或氯醌之類 的脱氫(氧化)劑反應,或使用溴化作用/脱溴化氫作用(或其 -107- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐)(Please read the notes on the back before filling out this page). Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs XXIV 2_a-a-, R ^ _B_B • As defined in the formula xtt. However, in a particularly preferred embodiment of the invention, according to the method described in the above paragraph, the method of converting the formula to a product of 3U, using an oxidant including a lye peroxide activator, the most preferred is trichloroethyl Ammonium amine, spanning 9, &quot; · Double bond epoxidizes the formula χνπ by the enzyme. The conditions and reagent ratios of this reaction are roughly the same as those described in the formula II # g to epoxy Mexileau. It has been found that peroxyacids, such as, for example, m-chloroperoxybenzoic acid, can be used to complete the enzymatic epoxidation of formula XVII in good yields. However, trigas acetamidine reagents provide excellent results in reducing the formation of Bayer-Villager oxidation by-products. The latter by-product can be removed, but this requires trituration from a solvent such as ethyl acetate, which is then crystallized from other solvents such as dichloromethane. Dehydrogenate the oxygenated compound of formula XXIV by reacting with a dehydrogenating (oxidizing) agent such as DDQ or chloroquinone, or by using bromination / dehydrobromide (or -107- this paper standard applies) China National Standard (CNS) Α4 specification (210X297 mm)

、1T I —1 . 593305 A7 B7 五、發明説明(1〇5) 他鹵化作用/脱鹵化氫作用)之程序,在6 -和7 -碳之間產生 雙鍵,而產生其他的式XXIII之新穎中間物1T I -1. 593305 A7 B7 V. Description of the invention (105) The procedure of other halogenation / dehydrohalogenation) produces a double bond between 6- and 7-carbons, and produces other compounds of formula XXIII. Novel intermediate

XXIII 經濟部中央標準局員工消費合作衽印製 其中-A-A-和-B-B-如同在式XX中之定義。特佳的式 XXIII化合物是其中- A-A·和- B-B如同在式XIΠ中之定義 的那些。 雖然直接的氧化作用對於形成式XXIII之產物是有效的, 但是產量通常很低。因此,最好是以兩個步驟來完成氧化 作用,首先在C-6位置將式XXIV受酶質鹵化,然後脱卣化 氫成爲6,7 -鏈晞。鹵化作用最好是利用n _鹵素有機試劑來 元成,像是例如N _溴琥珀醯亞胺。在適當的溶劑中,像是 例如乙腈,在諸如過氧化苯甲醯之類的_化作用啓動者的 存在下芫成溴化作用。該反應可有效率地在大約5 〇 t到大 約100°C的溫度範圍中進行,便利地在大氣壓之迴流溫度下 ,在諸如四氣化碳、乙腈或其混合物之類溶劑中進行。然 而,爲了完成該反應,通常需要進行4至1〇小時的反應。將 反應溶劑汽提掉,並將殘餘物溶解於不與水混溶的溶劑中 ,例如醋酸乙酯。以溫和的鹼性溶液(像是鹼金屬碳酸氫鹽) 和水連續沖洗所得的溶液,或較佳的是飽和鹽水,以便減 少產物得喪失,隨後汽提溶劑,並將殘餘物溶解於其他適 (請先閱讀背面之注意事項再填寫本頁) 、11 -108- 經濟部中央標準局員工消費合作社印製 593305 A7 _____ B7 五、發明説明(106 ) 用於脱_化氫反應的溶劑(像是二甲基甲醯胺)中。 將適當的脱鹵化氫試劑,例如丨,4 -二氮二雜環[2,2,2 ]辛 燒(DABCO),單獨或與諸如LiBr之類的鹼金屬鹵化物一起 加至為/春液中’將遠溶液加熱至適當的反應溫度,例如6 〇 °C到8 0 °C,並持續該反應數小時,通常是4至丨5小時,以 便芫成脱溴化氫之作用。如果需要,可在反應循環中加入 額外的脱溴化氫試劑,以便使反應完成。然後可藉著例如 加入水使產物沉澱,然後藉著過濾將其分離,其回收式 XXIII之產物,最好是以額外的水沖洗之。最好是使產物從 例如二甲基甲醯胺中再結晶。 式XXIII之產物,像是9,1 1 -環氧康雷諾,是新穎的化合 物,可藉著萃取/結晶作用分離之。它們具有作爲製備式j化 合物,尤其是式IA化合物之中間物的實際價値。例如,可 利用它們作爲製備式X X11之化合物的受酶質。在最佳的式 XXIII化合物中,-A-A-和-Β·Β·爲-CH2-CH2-。 大fa上利用上述製備式VII化合物的方法,使式X X111化 合物與氰化物離子反應,產生符合式XXIIi新穎的環氧烯 胺化合物XXIII Printed by the Consumer Standards Cooperative Bureau of the Central Bureau of Standards of the Ministry of Economic Affairs where -A-A- and -B-B- are as defined in formula XX. Particularly preferred compounds of formula XXIII are those in which -A-A · and -B-B are as defined in formula XIII. Although direct oxidation is effective for forming the product of formula XXIII, the yield is usually low. Therefore, it is best to complete the oxidation in two steps. First, the formula XXIV is halogenated by the enzymatic substance at the C-6 position, and then dehydrogenated to 6,7-chain pyrene. The halogenation is preferably carried out using an n-halogen organic reagent such as, for example, N-bromosuccinimide. In a suitable solvent, such as, for example, acetonitrile, it is brominated in the presence of a initiator of a chemical reaction such as benzamidine peroxide. The reaction can be efficiently performed in a temperature range of about 50 to about 100 ° C, conveniently at a reflux temperature of atmospheric pressure, in a solvent such as tetragasified carbon, acetonitrile, or a mixture thereof. However, in order to complete the reaction, it is usually necessary to carry out the reaction for 4 to 10 hours. The reaction solvent is stripped off and the residue is dissolved in a water-immiscible solvent such as ethyl acetate. The resulting solution is continuously rinsed with a mild alkaline solution (such as an alkali metal bicarbonate) and water, or preferably saturated brine, to reduce product loss. The solvent is then stripped and the residue is dissolved in other suitable solvents. (Please read the notes on the back before filling this page), 11 -108- Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 _____ B7 V. Description of the invention (106) Solvents for dehydrogenation reactions (like Dimethylformamide). Add appropriate dehydrohalogenating reagents, such as 丨, 4-diazabicyclo [2,2,2] octane (DABCO), alone or with an alkali metal halide such as LiBr Medium 'heats the remote solution to an appropriate reaction temperature, such as 60 ° C to 80 ° C, and continues the reaction for several hours, usually 4 to 5 hours, in order to effect dehydrobromide. If necessary, additional dehydrobromide reagents can be added to the reaction cycle to complete the reaction. The product can then be precipitated by, for example, adding water, and then separated by filtration. The product of formula XXIII is recovered, preferably washed with additional water. Preferably, the product is recrystallized from, for example, dimethylformamide. Products of formula XXIII, such as 9,1 1-epoxy Conreno, are novel compounds that can be separated by extraction / crystallization. They have practical valences as intermediates for the preparation of compounds of formula j, especially compounds of formula IA. For example, they can be used as enzyme substrates for preparing compounds of formula X X11. In the most preferred compound of formula XXIII, -A-A- and -B · B · are -CH2-CH2-. Using the above method for preparing a compound of formula VII on large fa, the compound of formula X X111 is reacted with a cyanide ion to produce a novel epoxyenamine compound in accordance with formula XXIIi

本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page)

593305 A7 五、發明説明(107 ) 經濟部中央標準局員工消費合作社印製 其中- A-A-、R3和·Β-Β -如同在式XX中之定義。特佳的式 XXII化合物是其中-Α-Α-和-Β-Β-如同在式XIII中之定義 的那些。 式XXII之產物是新穎的化合物,可藉著沉澱和過濾作用 分離之。它們具有作爲製備式I化合物,尤其是式ΙΑ化合物 之中間物的實際價値。在最佳的式XXII化合物中,-Α-Α-和 -Β-Β-爲-CH2-CH2-。 大體上利用上述製備式VI化合物的方法,將式X X11之環 氧烯胺化合物轉變爲式XXI之新穎的環氧二酮化合物。 式XXI之產物是新穎的化合物,可藉著沉澱和過濾作用 分離之。它們具有作爲製備式丨化合物,尤其是式IA化合物 之中間物的實際價値。特佳的式XXI化合物是其中_八_八_和 如同在式XIII中之定義的那些。在最佳的式χχι化 合物中,-Α-Α-和-B-B^_CH2_eH2_。 利用上文描述的環氧化作用,或是美國專利第4,559,332 號中的方A %式XX!之化合物轉變爲式之化合物 。在特佳的具體實施例中,計劃4過程的完整方法如下: -110- 本紙張尺度適用中國國家標準( (請先閱讀背面之注意事項再填寫本頁} 丨«. 訂 -^1. 593305 A7 B7 五、發明説明(108 )593305 A7 V. Description of the invention (107) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs where-A-A-, R3 and · Β-Β-as defined in Formula XX. Particularly preferred compounds of formula XXII are those in which -A-A- and -B-B- are as defined in formula XIII. The product of formula XXII is a novel compound which can be separated by precipitation and filtration. They have practical valences as intermediates for the preparation of compounds of formula I, especially compounds of formula IA. In the most preferred compound of formula XXII, -A-A- and -B-B- are -CH2-CH2-. In general, the method for preparing the compound of formula VI is used to convert the epoxy enamine compound of formula X X11 into a novel epoxy diketone compound of formula XXI. The product of formula XXI is a novel compound which can be separated by precipitation and filtration. They have practical valences as intermediates for the preparation of compounds of formula 丨 and especially compounds of formula IA. Particularly preferred compounds of formula XXI are those in which eight and eight are as defined in formula XIII. Among the best compounds of formula χχι, -Α-Α- and -B-B ^ _CH2_eH2_. Using the epoxidation described above, or a compound of formula XX! Into a compound of formula in US Patent No. 4,559,332. In the specific embodiment of the best, the complete method of the plan 4 process is as follows: -110- This paper size is applicable to Chinese national standards ((Please read the precautions on the back before filling this page) 丨 «. Order-^ 1. 593305 A7 B7 V. Description of the invention (108)

(請先閱讀背面之注意事項再填寫本頁)(Please read the notes on the back before filling this page)

、1T 經濟部中央標準局員工消費合作社印製Printed by 1T Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs

-111- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 593305 A7 B7 五、發明説明(109 計劃 計劃5之方法始於符合式X XI X之受酶質 Λ 〇-111- This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210 × 297 mm) 593305 A7 B7 V. Description of the invention (109 plan Plan 5 The method of the plan starts with the enzymes conforming to the formula X XI X Λ 〇

XXIX 其中_Α_Α_和·Β-Β_如同在式XX中之定義。藉著與原甲酸 三甲酯反應將該受酶質轉變爲式XXVIII之產物 〇XXIX where _Α_Α_ and · Β-Β_ are as defined in Formula XX. The enzyme is converted into a product of formula XXVIII by reaction with trimethyl orthoformate.

XXVIII 。其中- Α-Α-、R3和- Β-Β-如同在式XX中之定義。在形成 式XXVIII之後,利用上述將式XX之受酶質轉變爲式χνΐι 的方法,將式XXIX之化合物轉變爲式XXVII之化合物。 式XXVII之化合物具有下列結構: (請先閱讀背面之注意事項再填寫本頁j 經濟部中央標準局員工消費合作社印製 〇XXVIII. Where-Α-Α-, R3 and -Β-Β- are as defined in formula XX. After the formula XXVIII is formed, a compound of the formula XXIX is converted to a compound of the formula XXVII by the above-mentioned method for converting an enzymatic substance of the formula XX to a formula χνιι. The compound of formula XXVII has the following structure: (Please read the notes on the back before filling out this page. J Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs.

XXVII 其中-A-A-和-B-B-如同在式XX中之定義,且Rx爲任何共 同的羥基保護基團。 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)XXVII where -A-A- and -B-B- are as defined in formula XX, and Rx is any common hydroxy protecting group. This paper size applies to China National Standard (CNS) A4 (210X297 mm)

-112- 593305 A7 B7-112- 593305 A7 B7

五、發明説明(110 利用上述製備式XVI化合物的方法,將sXXvn化合物 氧化,產生符合式XXVI之新穎化合物V. Description of the invention

XXVI 其中-A-A-和-B-B-如同在式XX中之定義。特佳的式χχιχ、 XXVIII、χχνπ和XXVI之化合物,是其中_A_A-和_b_b_ 如同在式XIII中之定義的那些。 式XXVI之產物是新穎的化合物,可藉著沉澱/過濾作用 分離之。它們具有作爲製備式〗化合物,尤其是式丨A化合物 之中間物的實際價値。特佳的式XXVI化合物是其中_A_A_ 和-B-B-如同在式XIII中之定義的那些。在最佳的式χχνι 化合物中,- A_A-和。 利用上述有關式VIII化合物之氰化作用的方法,將新穎 的式XXVI中間物轉變爲新穎的式χχν之、羥基晞胺中間物 (請先閱讀背面之注意事項再填寫本頁) 、11 經濟部中央標隼局員工消費合作社印製 〇XXVI where -A-A- and -B-B- are as defined in formula XX. Particularly preferred compounds of the formula χχιχ, XXVIII, χχνπ and XXVI are those in which _A_A- and _b_b_ are as defined in formula XIII. The product of formula XXVI is a novel compound which can be separated by precipitation / filtration. They have practical valences as intermediates for the preparation of compounds of formula 尤其, especially compounds of formula AA. Particularly preferred compounds of formula XXVI are those in which _A_A_ and -B-B- are as defined in formula XIII. In the best compound of formula χχνι, -A_A- and. Using the above method for cyanation of compounds of formula VIII, the novel intermediate of formula XXVI is transformed into a novel intermediate of hydroxyxamine of formula χχν (please read the precautions on the back before filling this page), 11 Ministry of Economy Printed by the Central Bureau of Standards Consumer Cooperatives

XXV -113- 本紙張尺度適用中國國家標準(CNS )八4規^771^ 297 麓了 593305 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(ill) 其中-A-A-、R3*_B_B_如同在式XX中之定義。 式XXV之產物是新穎的化合物,可藉著沉澱/過濾作用分 離之。它們具有作爲製備式I化合物,尤其是式IA化合物之 中間物的實際價値。特佳的式XXV化合物是其中_A-A_和 B-如同在式XIII中之定義的那些。在最佳的式χχν化合物 中,-A-A-和-B-B-爲-CH2-CH2-。 基本上利用上述有關製備式VI之二酮化合物的條件,將 式XXV之9-羥基烯胺中間物轉變爲式XIV之二酮化合物。 在此案例中,注意到該反應可有效率地同時水解烯胺結構 ,並在9,1 1位置處脱水,以便導入9,丨丨雙鍵。然後利用與 在上述計劃3中的相同步驟,將式XI v化合物轉變爲式 XXXI化合物,並由其轉變爲式χΠΙ化合物。 在特佳的具體實施例中,計劃5過程的完整方法如下:XXV -113- This paper size applies Chinese National Standards (CNS) Rule 8 ^ 771 ^ 297 305 593305 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Α7 Β7 V. Invention Note (ill) Among them -AA-, R3 * _B_B_ is as defined in Equation XX. The product of formula XXV is a novel compound which can be separated by precipitation / filtration. They have practical valences as intermediates for the preparation of compounds of formula I, especially compounds of formula IA. Particularly preferred compounds of formula XXV are those in which _A-A_ and B- are as defined in formula XIII. Among the best compounds of formula χχν, -A-A- and -B-B- are -CH2-CH2-. Basically the conditions described above for the preparation of diketone compounds of formula VI were used to convert the 9-hydroxyenamine intermediate of formula XXV to the diketone compound of formula XIV. In this case, it is noted that this reaction can efficiently hydrolyze the enamine structure simultaneously and dehydrate at the position of 9, 1 1 in order to introduce a 9, 丨 丨 double bond. The compound of formula XI v is then converted to a compound of formula XXXI using the same procedure as in Scheme 3 above, and from it to a compound of formula χIII. In a particularly preferred embodiment, the complete method of the Plan 5 process is as follows:

環氧美克斯雷諾 -114- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 593305 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(112 ) 計劃6 十d 6 k t、製備環氧美克斯雷諾及其他符合式I之化合物 的有利方法,係從雄留埽二酮或其他符合式χχχν之化合 物的1 1 α -羥基化作用開始Epoxy Mex Renault-114- This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) 593305 A7 B7 Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the Invention (112) Plan 6 Ten d 6 kt, an advantageous method for the preparation of epoxy mexanolol and other compounds according to formula I, starts with 1 1 α-hydroxylation of androstenedione or other compounds according to formula χχχν

XXXV 其中·Α·Α-、R3和-Β-Β_如同在之定義,產生符合j X X X VI的中間物XXXV where · Α · Α-, R3, and -Β-Β_, as defined above, produce intermediates conforming to j X X X VI

XXXVI 其中_A_A_、r3*_B-B-如同在式χΠΙ*之定義。除了受 酶質的選擇之外,經營1 1 α -羥基化作用的方法,基本上如 同上文在計劃1中的描述。下列的微生物能夠完成雄留烯二 酮或其他式XXXV之化合物的1 1 α -羥基化作用: 愚黃麴菌(Aspergillus ochraceus) NRRL 405 (ATCC 18500); 麗麴菌(Aspergillus tiiger、ATCC 1 1394; 小巢狀麴菌(AspergHlus nidulans) ATCC 1 1267; -115 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) {請先閱讀背面之注意事項再填寫本百cXXXVI where _A_A_, r3 * _B-B- are as defined in the formula χΠΙ *. Except for the choice of enzymes, the method of operating 1 1 α-hydroxylation is basically the same as described in Plan 1 above. The following microorganisms can perform 1 1 α-hydroxylation of androstenedione or other compounds of the formula XXXV: Aspergillus ochraceus NRRL 405 (ATCC 18500); Aspergillus tiiger, ATCC 1 1394 ; AspergHlus nidulans ATCC 1 1267; -115 This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) {Please read the precautions on the back before filling this hundred

A7 ____ B7 五、發明説明(ll3 ) 2S-M 菌(Rhizopus orvzae、ATCC 11145; 复技酒麴菌(Rhizopus stolonifer、ATCC 6227b;A7 ____ B7 V. Description of the invention (ll3) 2S-M bacteria (Rhizopus orvzae, ATCC 11145; Rhizopus stolonifer, ATCC 6227b;

孢端(Ijichothecium roseurrn ATCC 12519 和 ATCC 8685 〇 接下來藉著使1 1 a -羥基雄甾-4 -晞-3,1 7 -二酮或其他式 XXXVI之化合物,與諸如原甲酸三烷基酯之類的醚化試劑 ,在酸催化劑的存在下反應,將其轉變爲式(丨〇丨)之丨丨“ _ 羥基-3,4-晞醇醚: 3Spore end (Ijichothecium roseurrn ATCC 12519 and ATCC 8685). Next, by using 1 1 a -hydroxyandrosta-4 -fluorene-3,17 -dione or other compounds of formula XXXVI, such as trialkyl orthoformate Etherification reagents such as these are reacted in the presence of an acid catalyst to transform them into 丨 丨 "of formula (丨 〇 丨) _ hydroxy-3,4-fluorenol ether: 3

(請先閱讀背面之注意事項再填寫本頁) 101 其中-A-A-、-R3和-Β-Β-如同在式XIII中之定義,且R11爲 經濟部中央標準局員工消費合作社印製 甲基或其他的低碳數烷基(Ci至C4)。欲完成該轉化作用, 藉著使1 1 α -羥基受酶質與酸混合而將其酸化,像是例如苯 ~ 水合物或甲苯續酸水合物,並溶解於低碳數醇溶劑中 ’最好是乙醇。在5到4 0分鐘的期間内,逐漸地導入原甲酸 三燒基酯,較佳的是原甲酸三乙酯,同時將該混合物維持 在寒冷中’較佳的是在大約到大約15χ:。然後使該混合 物回溫,並在2 〇 °C到大約6 0 °C之間的溫度下完成反應。最 好是在3 0到5 0 °C下1至3小時來完成反應,然後加熱至迴流 一段額外的時間,通常是2到6小時,以便完成反應。冷卻 反應混合物,較佳的是0到1 5 °C,最好是大約5 °C,並在眞 S下移除溶劑。 -116- 本紙張尺度適用中國國^^( CNS ) A4規格(210X297公釐)一 &quot; ' W3305 經濟部中央標準局員工消費合作社印製 、發明説明(114) 利用與上述在計劃3中相同的反應計劃,將式XX化合物 轉變爲式XVII化合物,將式χχχπι之17_螺内醋的部份導 入式10 1化合物中。例如,可使式101受酶質與锍内鑕鹽在 如驗金屬氯氧化物之類鹼的存在下,在諸如DM s〇之類的 適當落劑中反應,產生符合式i 0 2之中間物:(Please read the notes on the back before filling this page) 101 where -AA-, -R3, and -Β-Β- are the same as defined in formula XIII, and R11 is a methyl group printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Or other low carbon number alkyl (Ci to C4). To complete the conversion, acidify the 1 1 α-hydroxyl enzyme by mixing it with an acid, such as benzene ~ hydrate or toluic acid hydrate, and dissolve it in a low-carbon alcohol solvent. Good is ethanol. Over a period of 5 to 40 minutes, the tri- orthoformate, preferably triethyl orthoformate, is gradually introduced, while maintaining the mixture in the cold ', preferably at about 15 to about 15x :. The mixture was then allowed to warm and the reaction was completed at a temperature between 20 ° C and about 60 ° C. It is best to complete the reaction at 30 to 50 ° C for 1 to 3 hours and then heat to reflux for an additional time, usually 2 to 6 hours, to complete the reaction. The reaction mixture is cooled, preferably 0 to 15 ° C, and most preferably about 5 ° C, and the solvent is removed at 眞 S. -116- This paper size is applicable to China ^^ (CNS) A4 specification (210X297 mm)-"W3305 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, and the description of the invention (114) Use the same as above in Plan 3 The reaction plan is to convert a compound of formula XX into a compound of formula XVII, and introduce a part of 17-spirolactone of formula χχχπι into the compound of formula 101. For example, formula 101 can be reacted with an enantiomeric salt in the presence of a base such as metal chloride, in a suitable solvent such as DM s0, to produce an intermediate conforming to formula i 0 2 Things:

其中_A-A-、R3、Rl1和如同在式101中之定義。然 後使式102&lt;中間物與丙二酸二酯在鹼金屬醇鹽的存在下反 應,形成五員的螺内醋環,並產生式103之中間物 〇Where _A-A-, R3, Rl1, and are as defined in Formula 101. Then, the intermediate of Formula 102 &lt; and the malonic diester are reacted in the presence of an alkali metal alkoxide to form a five-membered spironolactone ring, and an intermediate of Formula 103 is produced

其中-n、R3、RU、R12和_b_b-如同在式χιπ中之定義 。最後,使式1 〇 3化合物在適當的溶劑中,像是二甲基甲醯 胺,在鹼金屬齒化物的存在下接受加熱,使烷氧羰基部份 裂開’而產生了式1 〇 4之中間物· -117- 本紙張尺度適用中國國家標準(CNS ) A4規格(77^^^釐) (請先閱讀背面之注意事項再填寫本頁)Where -n, R3, RU, R12, and _b_b- are as defined in the formula χιπ. Finally, the compound of formula 103 is subjected to heating in an appropriate solvent, such as dimethylformamide, in the presence of an alkali metal dentate, so that the alkoxycarbonyl group is partially cleaved, to give formula 104 Intermediate · -117- This paper size applies Chinese National Standard (CNS) A4 specification (77 ^^^) (Please read the precautions on the back before filling this page)

593305 A7 B7 五、發明説明(出 〇593305 A7 B7 V. Description of the Invention (Export 〇

104 其中-A-A-、R3、R&quot;和-B-B·再度如同在式χπι中之定義。 接下來將3,4-晞醇醚化合物! 〇4轉變爲式χχπι之化合物 ,也就是其中R8和R9—起形成式χχχιπ部份的式…^化 合物。該氧化作用步驟基本上以與在計劃4之合成中,將式 XXIV化合物轉變爲式ΧΧΙΙΙ中間物之氧化作用相同的方法 來完成、。可使用諸如2,3_二氣_5,6_二氰基·丨,4-苯醌 (DDQ)或四氯苯醌(氯醌)之類的試劑來完成直接氧化作用 ,或較佳的是藉著首先利用諸如Ν•溴琥珀醯亞胺或丨,3_二 溴·5,5-二甲基内醯脲(DBDMH)之類的Ν__素溴化劑將其 溴化,然後利用鹼將其脱溴化氳,例如sLiBr和熱的存在 下利用DABCO,‘來完成兩個步驟的氧化作用。在使用nb s 進行溴化作用之處,也必須使用酸將3_烯醇醚轉變爲烯酮 \DBDMH,一種離子性而非自由基團之溴化劑,本身對於 溴化作用就是有效的,並將晞醇醚轉變爲烯酮。 經濟部中央標準局員工消費合作社印製 :ft藉著上文在計劃1中描述的㈣,將^VI11化合物轉 變爲環氧美克斯雷諾,或其他的式〗化合物。 母個式10 1、102、103和104之中間物都是新穎的化合 物,具有作爲環氧美克斯雷諾或其他式IA和I化合物之中間 物的實際價値。每個式101、1〇2、1〇3和1〇4之化合物中 ,-A-A-和_Β·Β_較好是-cuHr,且R3爲氫、低碳數 表紙張尺度適财關家辟(CNS ) M規格(2]()&gt;&lt;297公襲 -118- 593305 A7 B7 五、發明説明(116) 烷基或低碳數烷氧基。最好是式101之化合物爲3 -乙氧基-1 1 α -羥基雄甾_ 3,5 -二烯-1 7 -酮,式1 0 2之化合物爲3 _乙 氧基螺[雄甾-3,5 -二烯-1 7 /?,2 ’ -環氧乙烯]_ 1 1 π -醇,式 103之化合物爲3 -乙氧基-11 α,17α -二氫孕甾-3,5_二烯_ 21,21-二羧酸氫乙酯,r-内酯,且式104之化合物爲3 -乙 乳基-11 泛,17 α --—鼠孕 ® - 3,5 -—婦-2 1 - :¾ ’ τ&quot;-内酉旨0 在特佳的具體實施例中,計劃6過程的完整方法如下:104 where -A-A-, R3, R &quot; and -B-B · are again as defined in the formula χπι. Next, the 3,4-fluorenol ether compound! 〇4 is transformed into a compound of the formula χχπι, that is, a compound in which R8 and R9 together form a part of the formula χχχιπ. This oxidation step is basically performed in the same way as in the synthesis of Scheme 4, the oxidation of a compound of formula XXIV into an intermediate of formula XXIII. Direct oxidation can be accomplished using reagents such as 2,3_digas_5,6_dicyano-, 4-benzoquinone (DDQ) or tetrachlorobenzoquinone (chloroquinone), or better It is brominated by first using a bromine agent such as N • bromosuccinimide or N-, 3-dibromo-5,5-dimethylendourea (DBDMH), and then using The base will debromize it, such as sLiBr and heat in the presence of DABCO, 'to complete the two-step oxidation. Where nb s is used for bromination, acid must also be used to convert 3-enol ether to ketene \ DBDMH, an ionic rather than free radical bromination agent, which is effective for bromination in itself, And convert the methyl alcohol ether to ketene. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs: ft Use the ^ described in Plan 1 above to convert ^ VI11 compounds to epoxy mexrenol, or other compounds of formula. The intermediates of formulae 1, 1, 102, 103, and 104 are all novel compounds with actual valences as epoxy intermediates of Mexrenault or other compounds of formulae IA and I. In each of the compounds of formula 101, 102, 103, and 104, -AA- and _Β · Β_ are preferably -cuHr, and R3 is hydrogen. (CNS) M specification (2) () &lt; 297 public attack -118-593305 A7 B7 5. Description of the invention (116) Alkyl or low carbon number alkoxy group, preferably the compound of formula 101 is 3 -Ethoxy-1 1 α -hydroxyandrosta-3,5-diene-1 7-one, the compound of formula 102 is 3 _ethoxyspiro [androsta-3,5-diene-1 7 / ?, 2 '-ethylene oxide] _ 1 1 π -alcohol, the compound of formula 103 is 3 -ethoxy-11 α, 17α -dihydroprogestin-3,5_diene_ 21,21- Ethyl hydrogen dicarboxylate, r-lactone, and the compound of formula 104 is 3-ethylethoxy-11 ubiquitin, 17 α --- Mouse®-3, 5--Women-2 1-: ¾ 'τ &quot;-内 酉 定 0 In a particularly preferred embodiment, the complete method of the plan 6 process is as follows:

雄甾烯二酮 CAP)(Androstenedione CAP)

加熱 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製Heating (Please read the notes on the back before filling out this page)

N«CI, DMFN «CI, DMF

-119- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(in) _丨丨___j ----- 計劃7 计劃7提供環氧美克斯雷諾及其他式〗化合物的合成,使 用包括θ-谷^醇、膽固醇、豆留醇或其他式之化 合物的起始受酶質-119- This paper size is in accordance with Chinese National Standard (CNS) A4 (210X 297 mm) 593305 A7 B7 V. Description of the invention (in) _ 丨 丨 ___j ----- Program 7 Program 7 provides epoxy beauty Synthol and other compounds of the formula are synthesized using starting enzymes including θ-glutanol, cholesterol, stigmasterol or other compounds of the formula

R1 經濟部中央標準局員工消費合作社印製 XXXV工工 -中-A-A·、R和_b_b_如同在式χπι中之定義,DD爲CH2_ CH2-或-CH = CH-,且每個Rl3、rh、Rl5和Rl6分別選自 氫或C i至c 4烷基。 在合成的第一個步驟中,藉著式χχχνπ之生物轉化作 用來製備1 1 α -羥基雄留烯二酮或其他式χχχν之化合物。 大體上根據上述有關康雷諾(或其他式XIII受酶質)之11沈_ 羥基化作用的方法,來完成該生物轉化過程。 在合成1 1 α _羥基雄留烯二酮中,一開始藉著式χχχνπ 之化合物的生物轉化來製備4_雄留婦7•二酮。最初生 物轉化作用’可藉著在美國專利第3,759,791號中描述的方 法來完成,特別將其合併於此以作爲參考。隨後,大體上 根據上述有關康雷諾(或其他式ΧΙΠ之受酶質)之丨丨α -羥基 化作用的方法,將4 -雄甾晞_ 3,i 7 _二酮轉變爲丨丨α _羥基雄 甾缔二酉同。 计劃7的其餘部份與計劃6相同。在特佳的具體實施例中 (請先閱讀背面之注意事項再填寫本頁)R1 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. rh, R15, and R16 are each selected from hydrogen or Ci to c4 alkyl. In the first step of the synthesis, 1 1 α-hydroxyandrostenedione or other compounds of the formula χχχν is prepared by biotransformation of the formula χχχνπ. In general, the biotransformation process is completed according to the above-mentioned method of 11_ hydroxylation of Conreno (or other enzymes of formula XIII). In the synthesis of 1 1 α-hydroxyandrostenedione, 4_androstil 7 • dione was initially prepared by the biological transformation of a compound of the formula χχχνπ. The initial biotransformation 'can be accomplished by the method described in U.S. Patent No. 3,759,791, which is specifically incorporated herein by reference. Subsequently, according to the above-mentioned method of α-hydroxylation of Conreno (or other enzymatic substance of formula XIII), 4-androstidine _ 3, i 7 _ dione was converted to 丨 α _ Hydroxyandrogens are associated with dioxins. The rest of Program 7 is the same as Program 6. In the special embodiment (please read the notes on the back before filling this page)

-120- 593305 A7 B7 五、發明説明(118) ’計劃7過程的完整方法如下:-120- 593305 A7 B7 V. Description of the Invention (118) The complete method of the plan 7 process is as follows:

(請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 合成艾皮樂雷諾及相關化合物的重大併發症,是需要在 7 -碳處以立體選擇性之方式導入α ·烷氧羰基取代基,而在 甾族結構的其他位置沒有不想要的修改。根據本發明,已 經揭示導入7 α -烷氧羰基的有效合成路徑,涉及一開始在 7 -碳處的氰化作用,接著形成5,7 -二内酯,以及二内酯與 烷基化試劑的鹼打開反應,產生想要的7 α -烷氧羰基取代 基。 -121 - 本纸張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 593305 A7 B7 五、發明説明(l2〇) 其鹽類之形式移除7酸。 折爲了形成二内醋,可利用已知的方法來製備7_氰基受酶 〃 可使在7 _碳處未被取代的受酶質與稍微過量的 亂化物離子,較佳的是每當量受酶質大W.G5至大約κ25 當量,在含有水/DMS〇溶劑混合物的弱酸性溶液中反應。 較佳的是,該反應混合物含有羧酸,例如每當量受酶質大 約一當量的乙酸。形成7a_*70_CN異構物,而以7泛-異 構物爲主要的異構物。可利用傳統方法回收7從_氰基類固 醇。該附屬品的製備,可使用此項技藝中已知的其他方法。 通常根據計劃8,可由在1 7-位置處以銅、R8或R9取代, 其中R8和R9如同上述,並在C-9和C-11處具有脂肪族、鏈 烯、環氧或羥基取代之構型的7 -氰基中間物,形成5,7 -二 内酯,也就是 (請先閲讀背面之注意事項再填寫本頁j 訂(Please read the precautions on the back before filling out this page) The major complication of the synthesis of Epileur Reynolds and related compounds printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs requires the stereoselective introduction of α at 7-carbon -Alkoxycarbonyl substituents without unwanted modification elsewhere in the steroid structure. According to the present invention, an effective synthetic route for the introduction of a 7 α-alkoxycarbonyl group has been disclosed, which involves cyanation at 7-carbon at first, followed by the formation of 5,7-dilactone, and the dilactone and alkylating agent The base opens the reaction to give the desired 7α-alkoxycarbonyl substituent. -121-This paper size is in accordance with Chinese National Standard (CNS) A4 specification (210 × 297 mm) 593305 A7 B7 5. Description of the invention (l20) 7 acid is removed in its salt form. In order to form dilactone, known methods can be used to prepare the 7-cyanoenzyme. The unsubstituted enzyme at the 7-carbon and a slight excess of chaotic ion can be used, preferably per equivalent. The substrate is reacted in a weakly acidic solution containing a water / DMSO solvent mixture, with a large W.G5 to about κ25 equivalents. Preferably, the reaction mixture contains a carboxylic acid, such as about one equivalent of acetic acid per equivalent of the enzyme. 7a_ * 70_CN isomers are formed, with 7 pan-isomers as the main isomers. 7-cyanosteroids can be recovered using conventional methods. The accessory can be prepared using other methods known in the art. Usually according to plan 8, can be substituted with copper, R8 or R9 at the 17-position, where R8 and R9 are as described above, and have aliphatic, alkenyl, epoxy or hydroxyl substituted configurations at C-9 and C-11 Type 7-cyano intermediates to form 5,7-dilactones, that is, (please read the precautions on the back before filling in this page)

XL 一&gt;XL one &gt;

經濟部中央標準局員工消費合作社印製Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

%90 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 Μ Β7五、發明説明(121 )其中-A-A-、-B-B-和R3如同上文之定義,R80和R90與R8 和R9相同,或R8G和R9G—起構成酮,且R18如同下文關於 計劃9之描述,而_ E - E -係選自% 90 This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 Μ B7 V. Description of the invention (121) Among which -AA-, -BB- and R3 are as defined above, R80 and R90 and R8 Same as R9, or R8G and R9G together form a ketone, and R18 is as described below for plan 9, and _ E-E-is selected from

例如 例如 例如 VCH- CH, XL工工工 &quot;C - CH- OH 'CH- CH-For example For example VCH- CH, XL workers &quot; C-CH- OH 'CH- CH-

XLIVXLIV

XLV (請先閱讀背面之注意事項再填寫本頁) «·XLV (Please read the notes on the back before filling this page) «·

、1T on24 \I c—- 例如 ;c—ch2., 1T on24 \ I c—- For example; c—ch2.

XLVI 〇”一·通常是 &gt;1η·XLVI 〇 ”一 · Usually &gt; 1η ·

XLVII 然後將式XLII之化合物轉變成7 a ·烷氧基_羰基: 經濟部中央標準局員工消費合作社印製XLVII then converts the compound of formula XLII to 7 a · alkoxy_carbonyl: printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

XL·工工 -124- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(I22) R β·〇XL · Gonggong -124- This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) 593305 A7 B7 V. Description of the invention (I22) R β · 〇

XLVI工工 在每個XL、XLI、XLII和XLVIII中,R80和R90較好是 起構成酮或 \ / ί 7) IIIMI ( CHg) 4XLVI workers In each of XL, XLI, XLII and XLVIII, R80 and R90 preferably form a ketone or / / ί 7) IIIMI (CHg) 4

XXXIV 其中Υ1、Υ2、X和C(17)如同上文之定義,最好是XXXIV where Υ1, Υ2, X and C (17) are as defined above, preferably

(讀先閱讀背面之注意事項再填寫本頁)(Read the notes on the back before filling in this page)

、1T 經濟部中央標準局員工消費合作社印製 XXXIII R3最好是Η,R1最好是甲氧羰基,且-A-A-和-B-B_最好各 爲-CH2-CH2-。將明瞭該反應亦可利用經保護之3 -酮基團 完成,藉著將其轉變並在整個反應序列中維持每個醚或縮 酮之形式。另一種計劃8之方法,包括如同前文提及的,使 用各種在式XLI和XLII之範圍内的中間物。 注意到經由計劃8,從3 -酮-A · 4,7 -羧基形成5,7 -二内酯 之試劑爲原甲酸三燒基g旨,在計劃6中將1 1 α -經基雄甾晞 二酮轉變爲3 -晞醇醚-△ -1 1々·羥基中間物i 1亦使用相同 之試劑’咸相信計劃8反應之路徑係依賴在c - 7處的取代作 用。在H+存在下與原甲酸酯之反應,形成中間物碳鑌離子 •125 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 _________ B7 五、發明説明(123 ) ,其在C-7處具有羧基,且其正電荷在c_3和c_5之間平衡 。當質子喪失時’ C-3碳鑕離子產生式1〇1之化合物,而c_ 5碳錄離子產生二内酯。在C-7處有氫,咸相信偏愛3,5_二 烯-3-烷氧基(烯醇醚),因爲具有雙鍵共軛作用。在cj處 具有7a-C〇2取代基c_5碳鏘離子被羧基捕捉,並形成、' 内醋。在此時3 _酮I基團優先被轉變爲縮酮,藉此驅使該反 應%成。 在以下的計劃9和1 〇中,描述計劃8的較佳具體實施例。 計劃9 4劃9始於與計劃4相同的受酶質,也就是式X X化合物。 首先將該受酶質氧化成式B化合物: (請先閱讀背面之注意事項再填寫本頁) R3 ηPrinted by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs of the 1T. XXXIII R3 is preferably Η, R1 is preferably methoxycarbonyl, and -A-A- and -B-B_ are each preferably -CH2-CH2-. It will be understood that the reaction can also be accomplished using a protected 3-keto group by converting it and maintaining the form of each ether or ketal throughout the reaction sequence. Another method of plan 8 involves, as mentioned earlier, the use of various intermediates in the range of formulas XLI and XLII. It is noted that via Scheme 8, the reagent for forming 5,7-dilactone from 3-keto-A · 4,7-carboxyl group is trisorcinyl orthoformate. In Plan 6, the 1 1 α-transylandrostidine The conversion of the diketone to 3-alcohol ether-Δ-1 1々 · hydroxy intermediate i 1 also uses the same reagents. It is believed that the route of the reaction of plan 8 depends on the substitution at c-7. Reacts with orthoformate in the presence of H + to form an intermediate carbohydrate ion. 125 This paper is sized to the Chinese National Standard (CNS) A4 (210X297 mm) 593305 A7 _________ B7 5. Description of the invention (123) It has a carboxyl group at C-7, and its positive charge is balanced between c_3 and c_5. When the proton is lost, the C-3 carbohydrate ion produces a compound of formula 101, and the c-5 carbohydrate ion generates a dilactone. There is hydrogen at C-7, and it is believed that 3,5-diene-3-alkoxy (enol ether) is preferred because of its double bond conjugation. Carbion ions with a 7a-C02 substituent c_5 at cj are captured by the carboxyl group and formed into lactone. At this time, the 3-keto I group is preferentially converted to a ketal, thereby driving the reaction to completion. In the following plans 9 and 10, preferred specific embodiments of plan 8 are described. Plan 9 4 Plan 9 begins with the same enzymes as Plan 4, namely compounds of formula X X. First oxidize the enzyme to a compound of formula B: (Please read the precautions on the back before filling this page) R3 η

經濟部中央標準局員工消費合作社印黎 其中-A_A-、R3和-Β-Β-如同在式XIII中之定義。根據在計劃 4的合成中,任何上述與將式χχι v化合物轉變爲式χχιπ 中間物有關的反應計劃,來經營該氧化反應。利用在計劃8 中描述的方法,將式Β化合物轉變爲式c之7-氰基中間物: R3The Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, Yin Li, where -A_A-, R3 and -B-B- are as defined in Formula XIII. The oxidation reaction is operated according to any of the above reaction schemes related to the conversion of a compound of formula χχι v to an intermediate of formula χχιπ in the synthesis of Scheme 4. Using the method described in Scheme 8, convert the compound of formula B to the 7-cyano intermediate of formula c: R3

本紙浪尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 593305 A7 --·-____ . B7 ^ 一 &quot;一 —— 一 _ 五、發明説明(124) 其中·Α-Α-、&amp;3和_B-B-如同在式XIII中之定義。接著利 用先前在計劃6中使用之原甲酸三烷基酯試劑,將式c化合 物轉變爲式D之5,7-内酯: R3The scale of this paper applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 593305 A7-· -____. B7 ^ 一 &quot; 一 —— 一 _ 5. Description of the invention (124) of which Α-Α-, &amp; 3 and _BB- as defined in Formula XIII. The compound of formula c is then converted to a 5,7-lactone of formula D using the trialkyl orthoformate reagent previously used in Scheme 6: R3

(請先閱讀背面之注意事項再填寫本頁j 經濟部中央標準局員工消費合作社印繁 其中_A_A_、R3和_B_B_如同在sXIn*之定義,且r17爲 C 1 - C 4纟元基。★亥式D之5,7 _二内@旨,例如藉著經由碳酸氫鹽 沖洗而移除酸,可從未反應的7 -冷-c 〇 〇 η中輕易地分離出 來’藉此建立想要的C-7立體化學,並在後續的、在鹼性條 件下經營的反應中,妨礙表異構化作用。如同在計劃8中的 描述,經由與烷基_之反應將該内酯酯化,產生式〗j之晞醋 中間物。 繼續計劃9的合成,將式D化合物轉變爲式11化合物。已 經將帶有3-酮基團保護者轉變爲縮酮,根據上述計劃3和6 的反應計劃,在前,將式XXXIII之20-螺氧烷基團選擇性 地導入1 7 -位置,藉此產生式Ε化合物 ,(Please read the notes on the back before filling in this page. _A_A_, R3, and _B_B_ are defined in sXIn *, and r17 is C 1-C 4 yuan basis. ★★ Hei-style D of 5,7 _ two internal @purpose, for example, by removing the acid by bicarbonate washing, it can be easily separated from the unreacted 7-cold-c 〇η ′, thereby establishing Desired C-7 stereochemistry and hinder epimerization in subsequent reactions operating under alkaline conditions. As described in Plan 8, the lactone is reacted via reaction with an alkyl group Esterification yields a vinegar intermediate of formula j. Continue the synthesis of plan 9 to convert a compound of formula D to a compound of formula 11. The protector with a 3-keto group has been converted to a ketal, according to plan 3 and above The reaction plan of 6 is that the 20-spiroxyalkyl group of formula XXXIII is selectively introduced to the 1 7-position, thereby generating a compound of formula E,

本紙張尺度適用中國國家標準(CNS ) A4規格(21〇x 297公釐) 、可 593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(125) 因爲3 -酮受到保護,可以選擇最適合攻擊C - 1 7 _,並與 通過在3 -位置處之反應而形成副產物無關的水解條件。在 式E之3 -縮酮化合物水解成式F的3 -酮基團結構之後,This paper size is in accordance with Chinese National Standard (CNS) A4 specification (21 × 297 mm), but can be printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, A7, B7. 5. Description of the invention (125) Because 3-ketones are protected, they can Choose hydrolysis conditions that are best suited to attack C-1 7 _ and have nothing to do with the formation of by-products by reaction at the 3-position. After the 3-ketal compound of formula E is hydrolyzed to a 3-keto group structure of formula F,

使後者中間物與烷基碘,在鹼的存在下反應,經由計劃8的 轉化作用,產生式II之中間物烯酯。最後,利用任何在上述 計劃1中的方法,將後者中間物轉變爲環氧美克斯雷諾或其 他的式I化合物。 計劃9不僅得益於控制由5,7_内酯中間物供給的立體化學 ’更獲得容許廣泛水解條件的優點,而不妨礙17_螺内醋。 像本發明其他合成計劃的反應一樣,計劃9之反應亦可使 用方;與上文特別描述的那些不同的受酶質之轉化作用。因 此,例如,亦可在17_碳處被如同上文定義之汉8和R9取代 的化合物上,或更特定地被下式之取代基: ,The latter intermediate is reacted with an alkyl iodide in the presence of a base, via the conversion of Scheme 8, to produce an intermediate ene ester of formula II. Finally, using any of the methods in Scheme 1 above, the latter intermediate is converted to epoxy mexrenol or other compounds of formula I. Plan 9 not only benefits from controlling the stereochemistry supplied by the 5,7-lactone intermediate, but also gains the advantage of allowing a wide range of hydrolysis conditions without hindering 17-spirolactone. Like the reactions of the other synthetic schemes of the present invention, the reactions of Scheme 9 can also be used; different enzyme-converting effects than those specifically described above. Thus, for example, a compound substituted at the 17-carbon with Han 8 and R9 as defined above, or more specifically a substituent of the formula:

八 IEight I

C( 1 7) IIUK CH2) 2 . Q - X ^ , ' χχχιχ /、中、γ1和Y2如同上文之定義,且c(17)表示17_碳,在 17_碳處取代之化合物上,完成3_酮·或3_縮酮氰基類固 _ -128- 本紙張尺度適财關家標準(CNS ) M規格(2lQxw公 (請先閱讀背面之注意事項再填寫本頁)C (1 7) IIUK CH2) 2. Q-X ^, 'χχχιχ /, medium, γ1 and Y2 are as defined above, and c (17) represents 17_ carbon, on the compound substituted at 17_ carbon, Complete 3_keto · or 3_ketal cyano-solids_ -128- This paper is suitable for financial standards (CNS) M specifications (2lQxw)

593305 A7 B7 、發明説明(I26 醇至3-酮-或3_縮酮_5,7_二内酯之轉化,或是3·酮-或3-縮 _d,7-二内酯至7從-烷氧羰基之轉化。然而,藉著利用 1 7 -酮受酶質之專一反應程序的使用,以及隨後上述有關將 1 7 -螺内酯和7沈-燒氧窥基導入3 _酮-△_ 9,1 1類固醇的專一 性反應計劃,而獲得重大的利益,特別是在過程的經濟性 上。 Γ 式D、Ε和F之内g旨是新穎的化合物,根據計劃9之合成, 其可用來製備環氧美克斯雷諾及其他式I和IA之化合物。在 這些化合物中,-A-A-和_B-B_最好是·〇Η2·〇Η2_,且r3 爲氫、低碳數烷基或低碳數烷氧基。最佳的式D化合物是其 中R17爲甲氧基者。 八 在特佳的具體實施例中,計劃9過程的完整方法如下· (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 -129- 本紙張尺度適用中國國家榡準(CNS ) A4規格(210X297公釐) 593305 B7 五、發明説明(127 ) Ο Ο593305 A7 B7, description of the invention (I26 alcohol to 3-keto- or 3-ketal_5,7_ dilactone conversion, or 3 · keto- or 3-ketal, 7-dilactone to 7 Conversion from -alkoxycarbonyl. However, by using a 17-ketone-specific enzymatic reaction procedure, and the subsequent introduction of the above-mentioned 17-spirolactone and 7-s-oxyalkoxy groups into 3_keto- △ _ 9, 1 1 specific response plan for steroids, and gain significant benefits, especially in the economics of the process. Γ Formulas D, E, and F are novel compounds that are synthesized according to plan 9, which It can be used to prepare epoxy mexanol and other compounds of formula I and IA. Among these compounds, -AA- and _B-B_ are preferably · 〇Η2 · 〇Η2_, and r3 is hydrogen and low carbon number Alkyl or low-carbon alkoxy. The best compounds of formula D are those in which R17 is methoxy. Eight In a particularly preferred embodiment, the complete method for the process of plan 9 is as follows. (Please read the note on the back first Please fill in this page again) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -129- This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) 593 305 B7 V. Description of the invention (127) Ο Ο

(請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 -130- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 593305(Please read the notes on the back before filling out this page) Order Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -130- This paper size applies to China National Standard (CNS) Α4 size (210 × 297 mm) 593305

發明説明(l28 it 劃 1 ο 計劃10到的形式C之7_氰基中間物爲止均與計劃9相同。 在計劃10的下一個步驟中,使7_氰基類固醇與原甲酸三烷 基酯在烷醇溶劑中反應,較佳的是在甲醇中與原甲酸三甲 酯反應,同時藉著將3_酮轉變爲晞醇並將17_酮轉變爲縮酮 來保護這兩個基團。隨後例如藉著與氫化二烷基鋁反應, 較佳的是氫化二異丁基鋁,將7_氰基還原爲7_甲醯基,藉 此產生式2 0 3之化合物: 203 其中- A-A-、R3和_B_B_如同在式χΠΙ中之定義,且Ri8爲 CpC:4烷基。在保護酮基團之前,如同上述,藉著氫化二烷 基錯防止其還原。接著使式2 〇 3之中間物,在過量醇 (R19OH)的存在下,與稀释之含水的酸反應,以便選擇性 地水解1 7 縮酮,產生式2 〇 4之中間物: (請先閱讀背面之注意事項再填寫本頁) 訂 經濟部中央標準局員工消費合作社印製 O'9DESCRIPTION OF THE INVENTION (l28 it, Division 1 ο 7 to cyano intermediates in Form C to Form 10 are the same as in Plan 9. In the next step of Plan 10, 7-cyanosteroids and trialkyl orthoformate The reaction is carried out in an alkanol solvent, preferably in methanol with trimethyl orthoformate, while protecting these two groups by converting 3-ketone to methyl alcohol and 17-ketone to ketal. Subsequently, for example, by reacting with a dialkylaluminum hydride, preferably diisobutylaluminum hydride, the 7-cyano group is reduced to a 7-formamidine group, thereby producing a compound of formula 203: 203 of which-AA -, R3 and _B_B_ are as defined in the formula χΠI, and Ri8 is CpC: 4 alkyl. Before protecting the keto group, as described above, its reduction is prevented by hydrogenated dialkyl group. Then formula 2 is used. The intermediate of 3, in the presence of excess alcohol (R19OH), reacts with the diluted aqueous acid to selectively hydrolyze the 17 ketal to produce the intermediate of formula 2.04: (Please read the precautions on the back first (Fill in this page again) Order O'9 printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs

[204] 其中R19係選自低碳數烷基(較好是CiSC4),或R19基團在 -131- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210x 297公釐) 593305[204] where R19 is selected from low carbon number alkyl (preferably CiSC4), or R19 group is in -131- This paper size is applicable to Chinese National Standard (CNS) A4 specification (210x 297 mm) 593305

經濟部中央標準局員工消費合作社印^ 〇Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ^ 〇

CO^R A7 B7 五、發明説明(Π9) 3 -位置處形成在3 -碳處的環狀0,〇 -氧代伸烷氧基取代基。 更進一步藉著在不·含水之酸的存在下,以烷醇(R19〇H)處 理來保護半縮酮[204],產生式205之中間物: [205] 其中- A- A_、-B-B-、R3和R19如同上文之定義·,且R20爲 C 至C 4燒基。然後根據上述計劃3和6之反應步驟,將1 7 _ 螺内酯導入,因此經由下文略述之程序進行:CO ^ R A7 B7 V. Description of the invention (Π9) A cyclic 0,0-oxoalkoxy substituent at the 3-carbon position at the 3-position. Furthermore, the hemiketal was protected by treatment with alkanol (R19〇H) in the presence of a non-aqueous acid [204] to produce an intermediate of formula 205: [205] where-A- A_, -BB -, R3 and R19 are as defined above, and R20 is a C to C 4 alkyl group. Then according to the above reaction steps of plans 3 and 6, 1 7 _ spironolactone is introduced, so proceed through the procedure outlined below:

2S2S

[207] 4 -132- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁}[207] 4 -132- This paper size applies to Chinese National Standard (CNS) A4 (210X297mm) (Please read the precautions on the back before filling in this page}

593305 A7 B7 五、發明説明(130 ) Ο593305 A7 B7 V. Description of the invention (130) Ο

其中-A-A-、-B_B_、R3、Rl^R2〇如同上文之定義, R25爲(^至^烷基。 義,且 物 隨後藉著傳統的水解作用將3 _位置脱保護,並再度導入 -酮基團和5,7-半縮醛,產生更進一步,符合式2〇9的中間 ΌAmong them, -AA-, -B_B_, R3, and R1 ^ R2〇 are as defined above, R25 is (^ to ^ alkyl.), And the 3_ position is subsequently deprotected by traditional hydrolysis and introduced again -Keto group and 5,7-hemiacetal, yielding a further intermediate hydrazone according to formula 209

[209] 經濟部中央標準局員工消費合作社印製 其中- A-A·、-B-B_*R3如同上文之定義。接下來根據上 述有關將式II化合物轉變爲式I化合物的任何方法,導入 9,11之環氧部份。在環氧化反應的氧化條件下,將半縮酿 部份轉化成5,7-二内酯,藉此產生更進一步,符合式2 n之 中間物: -133- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五、發明説明( ο[209] Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economics where-A-A ·, -B-B_ * R3 are as defined above. The epoxy portion of 9,11 is then introduced according to any method described above for converting a compound of formula II to a compound of formula I. Under the oxidizing conditions of the epoxidation reaction, the hemicondensation part is converted into 5,7-dilactone, thereby generating a further intermediate that meets the formula 2 n: CNS) A4 specification (210X297 mm) 593305 A7 B7 V. Description of the invention (ο

[211] 同上文之定義。任何殘餘 其中·Α-Α-、-Β-Β -和 r3 如 2 10之9,11-環氧-5,7_半縮趁中間物反應產物 的式 Ο[211] As defined above. Any residues in which Α-Α-, -Β-Β-, and r3 are as follows:

(請先閱讀背面之注意事項再填寫本頁j •訂· 經濟部中央標準局員工消費合作社印製 [210] ^中·Α_Α·、_B_B^R3如同上文之定 傳统万法氧化成式2ir化合物。最後,利用在計劃8中描 迷有關將5,7.二内轉變爲7α_燒氧羰基化合物的方法, 將式2U之中間物轉變爲環氧美克斯雷諾或其他的幻化合 物。因此,完整的計劃1 〇之過程如下,並瞭解至少下列的 步%可尤地冗成,不需回收中間物。計劃i 0之合成的完整 方法如下: -134- -^1 不、為取人度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(l32)(Please read the precautions on the back before filling in this page. J • Order · Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs [210] ^ 中 · Α_Α ·, _B_B ^ R3 As stated above, the traditional Wanfa oxidation method is 2ir Finally, the method described in Scheme 8 was used to convert 5,7. 2 to 7α-oxooxycarbonyl compounds, the intermediate of formula 2U was converted to epoxy mexrenol or other magic compounds. Therefore, the process of the complete plan 10 is as follows, and it is understood that at least the following steps can be particularly redundant without the need to recover intermediates. The complete method for the synthesis of plan i 0 is as follows: -134--^ 1 No, take Manpower applies Chinese National Standard (CNS) A4 specification (210X 297 mm) 593305 A7 B7 V. Description of invention (l32)

OR' V///CHO 丨203】OR 'V /// CHO 丨 203】

氧化 經濟部中央標準局員工消費合作社印製Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

211J 0 艾皮樂雷諾 -135- (請先閱讀背面之注意事項再填寫本頁)211J 0 Epile Leno -135- (Please read the notes on the back before filling this page)

本紙張尺度適用中國國家標準(CNS ) A4規格(2I0X297公釐)This paper size applies to China National Standard (CNS) A4 (2I0X297 mm)

XXXIX 經濟部中央標準局員工消費合作社印製 593305 發明説明(l33 就像在計劃9的案例ψ ,,,〗中’上述有關計劃1 〇的反應提供了重 疒、特別疋關於過程的經濟性;但是計劃1 0之新穎 :亦對與特別描述的那些不同的受酶質,具有較普通 …Μ用例如,將7 -甲醯基導入3 _烯醇醚類固醇,保護所 侍的7 -甲醯基_ △ s 。j 〇,6_3,4-烯醇醚,水解5,7-半縮醛,以 及後績的脱保護作用仏 * 更作用,均可在17-位置處被如上定義之R8和 R取代之類固醇,或承杜+ 口吁4更特疋地在17-位置,被其中Χ'γ1、 Υ和C(17)如上定義之取代基: 7) ΠΙΜ( CHfc) 2 . c 取代的類固醇上經營。 十畫】1 0的另一種方法,包括使用在上文中分別從式A 2 〇 3 J A2 1 〇之範圍内的各種中間物。每個從式〇 3到A2 i i的 中間物均是新穎的化合物,並可根據計劃1 0的合成方法, 用來製備%氧美克斯雷諾或其他的式*ia化合物。 在特佳的具體實施例中,計劃1 0過程的完整方法如下: -136· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐 (請先閱讀背面之注意事項再填寫本頁)XXXIX Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 593305 Invention Description (l33 As in the case of Plan 9 ψ ,,, 〖'the above-mentioned response to Plan 10 provides important, especially economic, processes; But Plan 10 is novel: it also has more common enzymes that are different from those specifically described. For example, 7-methylamido is introduced into 3-enol ether steroids to protect the 7-formamidine. _ △ s .j 〇, 6_3,4-enol ether, hydrolyzed 5,7-hemiacetal, and deprotection effect of subsequent performance 仏 * more effective, can be defined at the 17-position as R8 and R-substituted steroids, or Cheng Du + Kou 4 more specifically at the 17-position, are substituted by X′γ1, γ and C (17) as defined above: 7) ΠΙΜ (CHfc) 2. C Operating on steroids. Ten paintings] Another method of 10, including the use of various intermediates in the above range from the formula A 2 0 3 J A 2 1 0, respectively. Each intermediate from formula 03 to A2i i is a novel compound and can be used to prepare% oxmex Reynolds or other compounds of formula * ia according to the synthetic method of plan 10. In a specific embodiment, the complete method of planning the 10 process is as follows: -136 · This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm (please read the precautions on the back before filling this page)

593305 A7 B7五、發明説明(I34)593305 A7 B7 V. Description of the Invention (I34)

經濟部中央標準局員工消費合作社印製 -137· (請先閱讀背面之注意事項再填寫本頁)Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs -137 · (Please read the precautions on the back before filling this page)

本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) «上又解釋的數個計劃中 γ — 一甲 侍知本發明方法中所選用的 反應步驟,在製造環氧美$ j 衣乳吴克斯雷諾及相關化合物時,提供 2際的柔減。關鍵性特徵特別包括:⑷諸如康雷諾、雄 田’希一酮或谷留醇之類受酶質轉變爲&quot;…戈9 衍生物的生物轉化作用(同0每欣〇 工土 _ (门寺將冷_谷甾醇轉變爲1 7 -酮結榍 );(1&gt;)藉著將含有11(^-或9^/、&gt;-|、/丨人11 a y α -嫂基 &lt; 化合物脱水,導Λ 9,1 1雙鍵’接著經由9 1〗靜齡ΑΑ &quot; , ,!1雙鍵的氧化作用,導入環氧基團 ;(C)藉著形成軸,料胺水解成H使該二酮與齡 金屬醇鹽反應,附接上^燒氧幾基;((1)在17位置處形成 20-螺歧心(e)形成5,7_二内醋,並將該二内酯酉旨化成 7-燒氧羰基;⑴藉著在其他位置的各種轉化期間内,轉變 成3-缔醇醚或3'縮酮來保護3_酮(包括在”位置處形成2〇. 螺氧燒環)。有少許的限制,這四個構成過程要素(b)至⑷ ’可以差不多的任何順序來經營。過程要素⑷和(f)提供可 相匹敵的柔韌性。它們提供了形成環氧美克斯雷諾和其他 式1化合物的路徑’比起美國專利第4,559,332號的方法簡單 -午夕。此外’ E們在生產力和產量上提供了重大的優點。 在如同上述的反應計劃説明中,反應產物的回收、分離 經濟部中央標準局員工消費合作社印f 和純,通常可藉著熟諳此藝者已熟知的方法來完成。除非 另仃龙明’條件、溶劑和試劑均是傳統的、沒有嚴格限制 的’或二者皆是。然而’如同上文特別料的某些特殊程 序’提供了有助於各種方法步驟和方法計劃之有利的總產 量及/或生產力,及/或中間物和最後9,〗環氧類固醇產物 之高品質的優點。 -138- 本紙張尺度適用中_家標準(cm ) “格(2H)X297公釐) 經濟部中央標準局員工消費合作社印製 593305 A7 ---— _B7 五、發' 根據本發明產製之20-螺氧烷化合物的實用性,描述於This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm). Among the several plans explained above, γ — a reactionary method used in the method of the present invention, in the manufacture of epoxy US $ j clothing Ruox Lei Renuo and related compounds, to provide two-time softening. Key features include, in particular: the biotransformation of enzymes such as Conreno, Tada's monoketone or sterol, which are converted to &quot; ... Ge 9 derivatives Temple converts cold_sitosterol to 1 7 -keto-condensation); (1 &gt;) by containing 11 (^-or 9 ^ /, &gt;-|, / 丨 human 11 ay α-fluorenyl &lt; compound Dehydration leads to Λ 9,1 1 double bond ', and then through the oxidation of the static bond ΑΑ &quot;,,! 1 double bond to introduce epoxy groups; (C) By forming a shaft, the amine is hydrolyzed to H The diketone is reacted with the aging metal alkoxide to attach ^ oxoyl; ((1) 20-spiro dislocation is formed at the 17 position; (e) 5,7_dilactone is formed, and the Lactones are converted to 7-oxooxycarbonyl groups; ⑴ protects 3-ketones (including the formation of 2.0 at the "position" by converting to 3-alcohol ether or 3 'ketal during various conversion periods at other positions. Spiro oxygen burn ring). With a few restrictions, the four constituent process elements (b) to ⑷ 'can be operated in almost any order. Process elements ⑷ and (f) provide comparable flexibility. They provide formation Epoxy Mex Renault and The route of his formula 1 compound is simpler than the method of U.S. Patent No. 4,559,332-Midnight. In addition, they provide significant advantages in productivity and yield. In the reaction plan descriptions described above, the recovery of reaction products, Separating the consumer cooperatives from the Central Bureau of Standards of the Ministry of Economic Affairs and the consumer cooperatives can usually be accomplished by methods familiar to the artist. Unless otherwise stated, "The conditions, solvents, and reagents are traditional and there are no strict restrictions." Or both. However, 'Some special procedures, as expected above', provide favorable total yields and / or productivity, and / or intermediates and finals, which contribute to the various method steps and method planning. The advantages of the high quality of epoxy steroid products. -138- This paper size is suitable for the standard _ house standard (cm) "grid (2H) X297 mm) printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 ------- _B7 V. The practicality of the 20-spiroxane compound produced according to the present invention is described in

Grob美國專利第4,559,332號中,特別將其合併於此以作爲 參考。 根據本發明產製之20-螺氧烷化合物,由於其良好的生物 特性而聞名,並因此是有價値的具有藥學活性的成份。例 如,它們具有強的醛固酮·拮抗劑之作用,因此它們降低並 使用由於醛固酮引起之過度高鈉保留和鉀排泄正常化。因 此i們具有作爲保留卸之利尿劑的重要治療用途,例如在 治療高血恩、心官能不全或肝硬化方面。 已知2 -螺氧烷衍生物具有醛固酮·拮抗劑之作用,參見例 如 Fieser和 Fieser: Steroids ;第 708 頁(Reinhold Publ· Corp·, New York,1959)和英國專利申請案第1041,534號;亦已知 類似作用的1 7 /?-羥基-2 1 -羧酸類及其鹽類,參見例如美國 專利第3,849,404號。這類化合物至今已經使用在治療上, 然而,其具有相當大的缺點,就是它們總是具有某些性·專 一性的活性,而在例行的長期治療期間或之後,有麻煩的 結果。特別不想要的是因爲已知之抗·醛固酮製品的抗-雄激 素活性所引起的麻煩影響。 在下列的實例中進一步説明本發明的方法、過程和組合 物,以及在本文中使用的條件和試劑。 實例1 利用在表1中列舉的生長培養基來製備斜面 -139- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 -^1. ^3305 A7 B7 五 λ發明説明(l37) 經濟部中央標準局員工消費合作社印製 表 1 _YPDA (斜面和平面使用的培養基) 酵母萃取物 生 糖 蒸餘水適量至 -pH 爲 6.7 :利用Η3ρ〇41〇%重量/體積調整至pH 5 分ί ' - -關於斜面:在18 Οχ 18毫米的試管中7.5毫升 -關於平面(10公分的0): 在200x20毫米的試管中25毫升 •在120°C下滅菌20分鐘 在滅菌之後的pH値:5 欲產生第一代的培養物,將褐黃麴菌的苗 中的蒸餾水(2毫升)中;並將5毫升等份的該懸浮液=管 在每個如同上述製備之斜面上。將斜面在25。〇下培養抹 之後培養物表面的外觀爲白色棉絮狀的菌絲體。背面是一 了色的,下部爲橘色,上部爲黃-橘色。 疋著 將第一代的斜面培養物懸浮於含有吐溫8 〇非離子性表面 活性劑(3重量%)的無菌溶液(4毫升)中,並利用該懸浮液的 0· 15毫升之等份來接種以在表2中列舉之生長培養基製備的 2 0克 Moo亳升 (請先閱讀背面之注意事項再填寫本頁) -訂 ^1. -140- 593305 A7 B7 、發明説明(138 ) 一 — 第二代斜面。 表2 (供第二代和例杆斜面使用) 麥芽萃取物 20克 腺 1克~' 葡萄糖 20克 瓊脂 20克 蒸餘水適量至 -pH 爲 5 · 3 分配至試管中(180x8毫米)7.5毫升 -在120°C下滅菌20分鐘 1 000毫升 (請先閱讀背面之注意事項再填寫本頁} 麵· 訂 經濟部中央標準局員工消費合作社印製 是褐橘色。 製備具有在表3中所列組成的保護培養基 表3 -保護培養基 脱脂牛奶 蒸餾水 在250毫升燒瓶中含有5〇。〇的1〇〇毫升蒸餾水 加入脱脂牛奶。在12〇°C下滅菌15分鐘。冷卻至 33 C ’並在超過一天之前使用。_ 將得自五個第代斜面的培養物懸浮於在1〇〇亳^ 保護溶液(1 5亳升)中。將懸浮液按等份(各0 · 5亳升)八配在 ΙΟΟχΙΟφ米的試管中冷涑乾燥。在_7〇°C到 卜將這些 141- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29?公釐) 593305 經濟部中央標準局員工消費合作社印製 A7 --- _— — B7__五、發明説明(139) '~ - 在丙酮/乾冰浴中職冷;東2()分鐘,然後立刻移至預先冷;東 至-4(TC到-5(TC的乾燥室。將預先冷象的等份在⑼微:录 柱之殘餘壓力和S-3(rc下冷;東乾燥。在冷來乾燥結束時, 將兩到三個具有濕度指示劑之無菌矽膠顆粒加至每個試管 中,並以火燄密封。 要獲得適合大規模發酵使用的母培養物斜面,將一等份 以上述万法製備之冷凍乾燥培養物,懸浮於蒸餾水U毫升) 中,並以0.15毫升爲一等份,利用該懸浮液來接種斜面, 其具有在表2中列舉之組成的生長培養基。在25。〇下培養母 斜面7天在培養結束時,將在斜面上發展的培養物保存在 4。(:下。 欲製備例行的斜面培養物,將得自母斜面的培養物懸浮 於含吐溫8 0(3重量%)的無菌溶液(4毫升)中,並以〇15毫 升爲一等份,將所得的懸浮液分配到已經利用在表2中描述 &lt;生長培養基塗覆的斜面上。可使用例行的斜面培養物來 接種實驗室或工業發酵用最初的種子燒瓶。 欲製備最初的種子燒瓶培養物,移出得自如同上述製備 之例行斜面的培養物,並懸浮於含有吐溫8〇(3重量%)的溶 液(10亳升)中。將所得懸浮液的一等份〇1毫升,導入含具 有在表4中所列舉之組成的生長培養基的500毫升折流燒瓶 中0 -142- 本紙張尺度適财關家縣(CNS ) A4規格(21GX297公菱)— (請先閲讀背面之注意事項再填寫本頁) 訂 593305 Α7 Β7Grob U.S. Patent No. 4,559,332 is specifically incorporated herein by reference. The 20-spiroxane compound produced according to the present invention is well-known for its good biological properties, and is therefore a valuable hafnium-containing pharmaceutically active ingredient. For example, they have a strong aldosterone antagonist effect, so they reduce and use excessively high sodium retention and potassium excretion normalization due to aldosterone. Therefore, they have important therapeutic uses as diuretics for retention, such as in the treatment of hyperglycemia, cardiac insufficiency, or liver cirrhosis. 2-spiroxane derivatives are known to have the effect of aldosterone antagonists, see for example Fieser and Fieser: Steroids; page 708 (Reinhold Publ Corp., New York, 1959) and British Patent Application No. 1041,534 ; 17 /?-Hydroxy-2 1 -carboxylic acids and salts thereof having a similar effect are also known; see, for example, US Patent No. 3,849,404. Such compounds have so far been used therapeutically, however, they have a considerable disadvantage in that they always have certain and specific activities, and have troublesome results during or after routine long-term treatment. Particularly undesirable is the troublesome effect caused by the anti-androgen activity of known anti-aldosterone products. The following examples further illustrate the methods, processes, and compositions of the present invention, as well as the conditions and reagents used herein. Example 1 Using the growth medium listed in Table 1 to prepare the slanted surface-139- This paper size applies the Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) Order-^ 1. ^ 3305 A7 B7 Five λ invention description (l37) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs Table 1 _YPDA (medium for slanted and flat surfaces) yeast extract raw sugar distilled water amount to -pH 6.7: use Ρ3ρ〇41〇% weight / volume adjustment to pH 5 minutes---About the bevel: 7.5 ml in a 18 χ 18 mm test tube-About the plane (10 cm 0): 25 ml in a 200 x 20 mm test tube Sterilize at 120 ° C for 20 minutes. PH 之后 after sterilization: 5 To produce the first-generation culture, distill the water (2 ml) in the seedlings of Scutellaria luteus; and 5 ml aliquots of the suspension = The tube is on each bevel as prepared above. Place the bevel at 25. The appearance of the surface of the culture after incubation at 0 ° was a white cotton-like mycelium. The back is tinted, the lower part is orange, and the upper part is yellow-orange. The first-generation slant culture was suspended in a sterile solution (4 ml) containing a Tween 80 nonionic surfactant (3% by weight), and an 0.15 ml aliquot of the suspension was used Come to inoculate 20 grams of Moo liters prepared with the growth media listed in Table 2 (please read the precautions on the back before filling out this page)-Order ^ 1. -140- 593305 A7 B7, Description of the Invention (138)- — Second generation bevel. Table 2 (for the second generation and the example bevel) Malt extract 20 g gland 1 g ~ 'glucose 20 g agar 20 g distilled water amount to -pH 5 · 3 Dispense into test tube (180x8 mm) 7.5 Ml-1000 ml sterilized at 120 ° C for 20 minutes (please read the precautions on the back before filling out this page) noodles · order printed by the Ministry of Economic Affairs Central Standard Bureau employee consumer cooperative is brown orange. Preparations are shown in Table 3. Protected medium with the composition listed in Table 3-Protected medium skim milk distilled water in a 250 ml flask containing 100 ml of distilled water was added to skim milk. Sterilize at 120 ° C for 15 minutes. Cool to 33 C 'and Use more than a day ago._ Suspend the cultures from the five generations of bevels in a 100 亳 ^ protective solution (15 亳 L). Divide the suspension in equal portions (each 0.5 各 L) Eight mixes are cold-dried in test tubes of ΙΟΟχΙΟ φ meters. These 141-paper sizes apply to Chinese National Standard (CNS) A4 (210X29? Mm) at _70 ° C to 593305. Consumption by employees of the Central Bureau of Standards Cooperative printed A7 --- _--- B7__V. Description of the invention (139) '~-Work cold in acetone / dry ice bath; East 2 () minutes, and then immediately move to pre-cooling; East to -4 (TC to -5 (TC drying chamber. Will Pre-cooled aliquots were at the micro: remnant pressure of the column and cooled at S-3 (rc; dry at the east. At the end of the cold-drying, add two to three sterile silicone particles with a humidity indicator to each Each test tube is sealed with a flame. To obtain a slant of the mother culture suitable for large-scale fermentation, aliquots of the freeze-dried culture prepared by the above method are suspended in distilled water (U ml), and 0.15 ml is used as In one aliquot, the suspension was used to inoculate a slant with a growth medium having the composition listed in Table 2. The mother slant was cultured at 25 ° C for 7 days. At the end of the culture, the culture developed on the slant was stored in 4. (: Bottom.) To prepare a conventional slant culture, the culture obtained from the mother slant is suspended in a sterile solution (4 ml) containing Tween 80 (3% by weight), and 0.15 ml is used as In one aliquot, distribute the resulting suspension to a coating that has been applied using the growth medium described in Table 2 Can be used to inoculate the initial seed flask for laboratory or industrial fermentation. To prepare the initial seed flask culture, remove the culture obtained from the conventional bevel preparation as described above and suspend In a solution (10 liters) containing Tween 80 (3% by weight), an aliquot of the resulting suspension, 0.01 ml, was introduced into a 500 ml fold containing a growth medium having the composition listed in Table 4. Flow flask 0 -142- The paper size is suitable for Guancai County (CNS) A4 size (21GX297 male diamond) — (Please read the precautions on the back before filling this page)

五、發明説明(14G 表4 (供最初和轉化燒瓶培養物及圓底燒瓶使用) 葡萄糖 20克 腺 20克 酵母自溶產物 20克 蒸镏水適量至 -pH 爲 5.2 -以 NaOH 20%調整到pH 5.8 -分配至500毫升折流燒瓶中100毫升 -分配至2000毫升圓底燒瓶中(3個折流板)500 毫升 -滅菌120°Cx20分鐘 -在滅菌後的pH値約爲5.7 1 000毫升 (讀先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 在28°C下,在旋轉攪拌器(200 rpm,5公分位移)上培養種 子燒瓶24小時,藉此產生具有3至4毫米直徑之類似小球的 菌絲體形式的培養物。在顯微鏡觀察時,發現種子培養物 是純的培養物,對稱地生長,有大的充份纏繞的菌絲。懸 浮液的pH値爲5.4到5.6。以離心定出PMV爲5到8%(3 000 rpm X 5 分鐘)〇 藉著利用得自種子培養物燒瓶的生物團塊(1毫升)接種在 第二個5 0 0亳升攪捽燒瓶中具有表4所列舉之組成的生長培 養基(100亳升),來製備轉化燒瓶培養物。在28°C下,在旋 轉攪:拌器(2 0 0 r p m,5公分位移)培養所得的混合物1 8小時 。檢查培養物,發現包括3 - 4毫米直徑之小球狀的菌絲體。 在顯微鏡檢查時,確定該培養物爲純培養物,具有對稱和 絲狀生長,其中頂端細胞充滿細胞質,而較老的細胞幾乎 沒有空泡化。培養物懸浮液的p Η値是5到5 · 2,由離心決定 -143· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(⑷) 的PMV是在10%到15%之間。因此,認爲該培養物適合將 康雷諾轉變爲11α -羥基康雷諾。 將康雷諾(1克)降低顆粒尺寸至大約5微米,並懸浮於無 菌的水(2 0毫升)中。在該懸浮液中加入:4 〇 % (重量/體積)無 菌的葡萄糖溶液;16%(重量/體積)無菌的自溶酵母溶液; 以及無菌的抗生素溶液;全部按照在表5中0小時反應時間 所指示的比例。藉著將硫酸康黴素(4〇毫克)、四環素 HC1(40亳克)和頭孢菌素(2〇〇毫克)溶解於水(1〇〇毫升)中 來製備抗生素溶液。將類固醇懸浮液、葡萄糖溶液和自溶 p母溶液逐漸加至在攪拌燒瓶中所含有的培養物中 表5 在攪拌燒瓶中康雷諾之生物轉化作用過程中,指定添加類固 〉谷液(添加物和抗生素) C請先閱讀背面之注意事項再填寫本頁j 丨«· 經濟部中央標準局員工消費合作社印製V. Description of the invention (14G Table 4 (for initial and transformation flask cultures and round-bottomed flasks) glucose 20 g gland 20 g yeast autolysate 20 g distilled water appropriate amount-pH 5.2-adjusted to 20% NaOH pH 5.8-Dispensed into a 500 ml baffled flask 100 ml-Dispensed into a 2000 ml round bottom flask (3 baffles) 500 ml-Sterilized 120 ° C x 20 minutes-pH sterilized after sterilization ~ 5.7 1 000 ml (Read the precautions on the back before you fill in this page.) Printed by the Consumer Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs, at 28 ° C, by cultivating seed flasks on a rotary stirrer (200 rpm, 5 cm displacement) for 24 hours. A culture in the form of a mycelium-like mycelium having a diameter of 3 to 4 mm was produced. When observed under a microscope, the seed culture was found to be a pure culture that grew symmetrically with large fully entangled mycelium. Suspension The pH of the solution was 5.4 to 5.6. The PMV was determined to be 5 to 8% (3 000 rpm x 5 minutes) by centrifugation. By inoculating the second pellet (1 ml) from the seed culture flask on the second The 5 0 0 liter stirrer flask has the items listed in Table 4. The composition of the growth medium (100 liters) was used to prepare a transformation flask culture. The resulting mixture was cultured at 28 ° C for 18 hours in a rotary stirrer (200 rpm, 5 cm displacement). Check the culture It was found to include small spherical mycelium with a diameter of 3-4 mm. Upon microscopic examination, the culture was determined to be a pure culture with symmetrical and filamentous growth, in which the apical cells were filled with cytoplasm, while the older cells were almost There is no cavitation. The p Η 値 of the culture suspension is 5 to 5 · 2, which is determined by centrifugation -143 · This paper size applies the Chinese National Standard (CNS) A4 specification (210X 297 mm) 593305 A7 B7 V. Invention Note (PM) that PMV is between 10% and 15%. Therefore, the culture is considered suitable for converting Conranow to 11α-hydroxy Conranow. Reducing Conranow (1 g) to a particle size of approximately 5 microns, And suspended in sterile water (20 ml). To this suspension were added: 40% (w / v) sterile glucose solution; 16% (w / v) sterile autolyzed yeast solution; and sterile Antibiotic solution; The ratios indicated by the 0-hour reaction time in Table 5. By dissolving conomycin sulfate (40 mg), tetracycline HC1 (40 g), and cephalosporin (200 mg) in water (100 mg). Ml) to prepare antibiotic solution. Gradually add steroid suspension, glucose solution and autolyzed p master solution to the culture contained in the stirring flask. Table 5 During the biotransformation of Conreno in the stirring flask, specify Adding solids> Valley liquid (additives and antibiotics) C Please read the notes on the back before filling in this page j 丨 «· Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

在反進行時,定期分析反應混合物以確定葡萄糖含量, 本紙張尺錢财_ 訂· 144- 593305 A7 B7 五、發明説明(142 ) 並藉著薄層層析法確定11從-羥基康雷諾的轉化。在反應期 間以經過控制的速率在發酵反應混合物中加入額外的康雷 諾受酶質和營養,以便維持葡萄糖含量在大約0.1重量%的 範圍内。類固醇懸浮液、葡萄糖溶液、自溶酵母溶液和抗 生素落液的添加計劃表列在表5中。在2 5 下在旋轉攪拌器 (2 00 rpm,5公分位移)上持續轉化反應96小時。在發酵期 間,卩11値範園在4.5到6之間。只要?]^¥昇高到6〇〇/()或以上 ,便取回1 0亳升邵份的肉湯培養物,並以丨〇 〇毫升蒸餾水 代替。在反應期間,藉著在反應循環開始後以4、7、23、 31、47、55、71、80和96小時之間隔採樣肉湯,並藉著丁^ 分析試樣,來監視康雷諾的消失和n羥基康雷諾的出現 。從表6中列舉的這些試樣決定反應的進展。 表 6 ^- 一康雷諾在擾拌燒瓶中之生物轉化作用^時間進、 時間~轉化速7 f.=〇.81 丄f 基 (請先閱讀背面之注意事項再填寫本頁) . 訂 經濟部中央標準局員工消費合作社印製During the reverse process, the reaction mixture was regularly analyzed to determine the glucose content. This paper rule Money 144-593305 A7 B7 V. Description of the invention (142) and determined by thin layer chromatography 11 Conversion. Additional Conranox enzymes and nutrients were added to the fermentation reaction mixture at a controlled rate during the reaction to maintain the glucose content in the range of about 0.1% by weight. The schedules for the addition of steroid suspensions, glucose solutions, autolyzed yeast solutions and antibiotic drops are listed in Table 5. The conversion reaction was continued on a rotary stirrer (200 rpm, 5 cm displacement) at 25 for 96 hours. During the fermentation period, 卩 11 卩 Fanyuan was between 4.5 and 6. as long as? ] ^ ¥ was raised to 600 / () or more, and 10 liters of broth culture was retrieved and replaced with 1000 ml of distilled water. During the reaction period, monitor the Conreno by sampling the broth at intervals of 4, 7, 23, 31, 47, 55, 71, 80, and 96 hours after the start of the reaction cycle, and analyze the sample by Ding ^. Disappeared and the appearance of n-Hydro Conreno. Determined from the progress of the reaction of these samples listed in Table 6. Table 6 ^-Bioconversion effect of Yicono Renuo in a stirred flask ^ time advance, time ~ conversion rate 7 f. = 0.81 基 f basis (please read the precautions on the back before filling this page). Order economy Printed by the Consumer Standards Cooperative of the Ministry of Standards

-145· 本紙張尺度適用中國國家標準(CNS ) A4規格(21 OX 297公釐) 593305 A7 B7 五、發明説明(I43) 實例2 以類似在實例1中描述的方法來製備最初的種子燒瓶培養 物。製備具有在表7中所列之組成的營養混合物。 表7 在1 0升玻璃發酵器中供轉化培養物使用 量 克/升 葡萄糖 80克 20 腺 80克 20 酵母自溶物 80克 20 防沫劑SAG 47 1 0.5克 去離子水適量至 -在130°C下將空的發酵器滅菌30分鐘 •裝入3升的去離子水,加熱至40°C -加入並攪拌培養基之成份 -揽拌15分鐘,帶有3.9升之體積 -pH値爲5.1 -利用NaOH 20%重量/體積調整成5.8 -以120°Cx20分鐘滅菌 -在滅菌後的pH値爲5.5-5.7 4升 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 將一開始裝載的營養混合物(4升)導入1 0升幾何體積的轉化 發酵器中。發酵器爲圓柱狀的離心管,具有2.58之長度對 直徑的比例。提供4 0 0 r p m渦輪攪:拌器,具有兩個2號輪盤 ,各有6個葉片。葉輪的外直徑爲80毫米,每個葉片的輻向 直徑爲25毫米,高度爲30毫米,上輪位在容器頂部之下 -146- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(I44) 280毫米,下輪在頂部之下36 5毫米,容器的折 210毫米,從容器内垂直壁向内輻射狀延伸25毫米。又馬 將種子培養物(40毫升)與裝在發酵器中的營養混人,並 藉著在,以及在0.5公斤/平方公分的壓力下〇 5^/升 分鐘的充氣速率下培養22小時,建立轉化培養物。在。小 時時,培養物的PMV爲20-25%,且pH 5至5 2。 製備在無菌之水(400毫升)中含有康雷諾(8〇克)的懸浮液 ’並將1 〇亳升的部份加至在轉化發酵器中的混合物中。同 時以在表8中在0小時反應時間所指示的比例,加入4〇%(重 I /體積)無菌的葡萄糖溶液,1 6 % (重量/體積)無菌的自溶 酵母溶液和無菌的抗生素溶液。以類似實例1中描述的方法 來製備抗生素溶液。 表8 在10升玻璃發酵器中康雷諾之生物轉化作用過程中,指定添加類 固醇和溶液(添加物和抗生素) 反應時間 小時 類固醇懸浮液 亳升約略克 葡萄糖溶液 毫升 自溶酵母溶液 亳升 抗生素溶液 毫升 0 10 4 25 12.5 40 4 25 12.5 8 10 4 25 12.5 12 25 12.5 16 10 4 25 12.5 20 25 12.5 24 10 4 25 12.5 40 -147- 本紙張尺度適财_家標準(CNS ) A4規格(2iGx297公幻 (請先閱讀背面之注意事項再填寫本頁)-145 · This paper size is in accordance with Chinese National Standard (CNS) A4 (21 OX 297 mm) 593305 A7 B7 V. Description of the Invention (I43) Example 2 The initial seed flask culture was prepared by a method similar to that described in Example 1. Thing. A nutritional mixture was prepared having the composition listed in Table 7. Table 7 Amount of transformation culture used in a 10 liter glass fermenter g / L glucose 80 g 20 gland 80 g 20 yeast autolysate 80 g 20 antifoam agent SAG 47 1 0.5 g deionized water amount to-at 130 Sterilize the empty fermenter for 30 minutes at ° C • Fill with 3 liters of deionized water and heat to 40 ° C-Add and stir the ingredients of the culture medium-Stir for 15 minutes with a volume of 3.9 liters-pH 値 is 5.1 -Use NaOH 20% weight / volume to adjust to 5.8-Sterilize at 120 ° C x 20 minutes-pH 后 after sterilization is 5.5-5.7 4 liters printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back first) (Fill in this page) The initial loading of the nutrient mixture (4 liters) into a 10 liter geometric volume conversion fermenter. The fermenter is a cylindrical centrifuge tube with a length to diameter ratio of 2.58. Provide 400 r p m turbo agitator: agitator with two No. 2 wheel discs, each with 6 blades. The outer diameter of the impeller is 80 mm, the radial diameter of each blade is 25 mm, and the height is 30 mm. The upper wheel is located below the top of the container. -146- This paper size applies to Chinese National Standard (CNS) A4 (210X 297) (Mm) 593305 A7 B7 V. Description of the invention (I44) 280 mm, the lower wheel is 36.5 mm below the top, the container is folded 210 mm, and the inner wall of the container extends 25 mm radially inward. Ma also mixed the seed culture (40 ml) with the nutrients contained in the fermenter, and cultivated it for 22 hours at a pressure rate of 0.5 kg / cm2 under a pressure of 0.5 kg / cm2, Establish transformation cultures. in. At hours, the culture had a PMV of 20-25% and a pH of 5 to 52. A suspension containing Conreno (80 g) in sterile water (400 ml) was prepared and a 10 liter portion was added to the mixture in a conversion fermenter. At the same time, in the proportion indicated in Table 8 at a reaction time of 0 hours, add 40% (weight I / vol) sterile glucose solution, 16% (weight / vol) sterile autolyzed yeast solution and sterile antibiotic solution. . An antibiotic solution was prepared in a similar manner as described in Example 1. Table 8 During the bioconversion process of Conreno in a 10 liter glass fermenter, the specified addition of steroids and solutions (additives and antibiotics) reaction time is small. The steroid suspension is lifted to about a gram of glucose solution, ml of autolyzed yeast solution, and antibiotic solution. 0 10 4 25 12.5 40 4 25 12.5 8 10 4 25 12.5 12 25 12.5 16 10 4 25 12.5 20 25 12.5 24 10 4 25 12.5 40 -147- The paper size is suitable for financial use_CNS A4 size (2iGx297 Public Fantasy (Please read the notes on the back before filling this page)

經濟部中央標準局員工消費合作社印裂 5 3 3 9 5 A7 B7 立、發明説明(145) 28 32 36 40 44 48 52 56 60 64 68 72 76 10 4 25 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 25 25 12.5 12.5 4 25 25 25 25 25 25 25 25 25 25 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 (請先閱讀背面之注意事項再填寫本頁) 40 訂 經濟部中央標準局員工消費合作社印製 80 84 88 當反應進行時,定期分析反應混合物以便決定葡萄糖含量 ,並藉著薄層層析法決定1 1沈-羥基康雷諾的轉變。以如下 述之反應肉湯試樣的TL C分析爲基礎,按照消耗的康雷諾 受酶質,將額外的康雷諾加至反應混合物中。亦監视葡萄 糖含量,並在葡萄糖濃度降至大約〇.〇5重量%或以下時, 加入補充的葡萄糖溶液,使濃度昇高至大約〇 · 2 5重量〇/〇。 亦在反應循環的不同時間加入營養和抗生素。類固醇懸浮 液、葡萄糖溶液、自溶酵母溶液和抗生素溶液的添加計劃 -148- 二紙張尺度適用中國國表標準(CNS ) A4規格(21 〇X Μ?公着) 經濟部中央標準局—工消費合作社印製 593305 A7 ____ B7 五、發明説明(I46 ) 表列在表8中。在每份體積液體每分鐘0 · 5份體積空氣 (vvm)下,在〇·3公斤/平方公分的正頂壓力下持續轉化反應 9 0小時。溫度維持在2 8 °C下直到p v Μ達到4 5 %爲止,然後 降至2 ό C並維持在該溫度下,使ρ ν μ從4 5 %成長到6 0 %, 隨後控制在24°C下。最初的攪動速率爲4〇〇 rpm,在4〇小 時後增加至7 0 0 r p m。藉著按照指示添加2 μ正嶙酸或2 Μ NaOH將pH値維持在4.7至5.3之間。當發展出泡沫時,藉 著加入數滴防沫劑SAG 47 1來控制起泡。在反應期間,以 4小時之間隔,藉著肉湯試樣的TLC分析來監視康雷諾的消 失和1 1 α -羥基康雷諾的出現。當大部份的康雷諾都從肉湯 中消失時,加入額外的增加量。 在加入所有的康雷諾之後中止反應,此時TL c分析顯示 康雷諾受酶質相對於1 1從-羥基康雷諾的濃度已降至大約 5% 〇 在反應循環結束時,通過乾酪布過濾發酵肉湯,從液體 肉两中分離菌絲體。將菌絲體部份再懸浮於醋酸乙酉旨中, 利用在反應過程中每克裝載的康雷諾大約6 5份體積(5 · 2升) 。在擾動下使在醋酸乙酯中之菌絲體懸浮液迴流1小時,冷 卻至大約2 0 C ’並在瓷漏斗(Buchner)上過濾。以醋酸乙酯( 母克康雷語裝載5份體積;0.4升)和去離子水(5〇〇毫升)連 續冲洗菌絲體餅’以便從濾餅中移走醋酸乙酯萃取物。拋 棄濾餅。將富含萃取物的溶劑洗液和水洗液收集在分離器 中,然後容許靜置2小時使相位分離。 然後拋棄液相,並在眞空下濃縮有機相,至剩餘體積35〇 -149- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 訂 -^1. 經濟部中央標準局員工消費合作社印製 593305 A7 B7 五、發明説明(I47) 毫升。將留在底部的冷卻至15°C並保持攪動大約1小時。過 濾殘餘物的懸浮液以移出結晶之產物,並利用醋酸乙酿(4 〇 晕升)沖洗滤餅。在脱水後確定產生的1 1 α -龜基康雷諾爲 6 0克。 實例3 以在實例1中描述之方法,從例行斜面製備孢子懸浮液。 在2000毫升折流圓底燒瓶(3個折流板,各5〇毫米χ30毫米) 中,將一等份(0.5毫升)的孢子懸浮液導入具有在表4中所 列之組成的營養溶液(5 0 0毫升)中。在2 5 Ό下,在另一種攪 拌器(每分鐘動程1 2 0 ;位移5 )上,在燒瓶中培養所得的混 合物2 4小時,藉此產生培養物,在顯微鏡檢查時,觀察到 顯然是純培養物,具有充份纏繞的菌絲。培養物的ρ Η値是 在大約5·3到5.5之間,且PMV(藉著在3 0 0 0 rpm下離心5 分鐘定出)爲8到1 0 %。 利用如此製備之培養物,在具有幾何體積丨6 〇升和長寬比 2.31(長=9 85毫米,直徑=425毫米)的立式圓柱狀離心管 之不鏽鋼發酵器中製備種子培養物。提供發酵器具有兩個 輪盤的圓盤渦輪式攪捽器,每個輪盤各具有六個葉片,外 直徑爲240毫米,每個葉片具有8〇毫米之輻向直徑和50毫 米之高度。上輪位在離發酵器頂部780毫米的深度,第二個 位在995毫米深。立式折流板長度爲89〇毫米,從發酵器内 垂直壁向内輻射狀延伸4〇毫米。以170 rpm操作攪拌器。 將具有在表9中所列舉之組成的營養混合物(丨〇 〇升)導入發 酵器中’接著導入一部份上述製備並具有5·7之PH値的預 -150- 本紙張尺度適用中國國家標準(CNS )六4規格(21〇χ 297公釐) — (請先閱讀背面之注意事項再填寫本頁) -訂 593305 A7 B7 五、發明説明(148) 接種物(1升)。 表9 供在160升發酵器中的植物培養使用,需要約8升的種子產製發酵器 量 克/升 葡萄糖 2公斤 20 腺 2公斤 20 酵母自溶物 2公斤 20 防沫劑SAG 471 0.010公斤 微量 去離子水適量至 -在130°C下將空的發酵器滅菌30分鐘 -裝入6升的去離子水,加熱至40°C -加入並攪拌培養基之成份 -攪拌15分鐘,具有95升之體積 -在121°C下滅菌30分鐘 -滅菌後的pH値爲5.7 -加入無菌的去離子水至100升 100升 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 以0.5升/升·分鐘之充氣速率,在0.5公斤/平方公分的液面 上壓力下培養該接種混合物2 2小時。溫度控制在2 8 °C下直 到PM V達到2 5 %爲止,然後降低至2 5 °C。pH値控制在5 _ 1 到5 .3的範圍内。貧絲體體積的生長連同種子培養反應之 p Η値和溶氧量顯示在表1 0中。 -151- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 593305Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 5 3 3 9 5 A7 B7 Legislation and Description of Inventions (145) 28 32 36 40 44 48 52 56 60 64 68 72 76 10 4 25 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 25 25 12.5 12.5 4 25 25 25 25 25 25 25 25 25 25 25 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 12.5 (please read the notes on the back before filling this page) Printed by Cooperative Society 80 84 88 As the reaction proceeds, the reaction mixture is periodically analyzed to determine the glucose content, and the conversion of 11-hydroxy-Conorno is determined by thin-layer chromatography. Based on the TLC analysis of the reaction broth samples described below, additional Conorno was added to the reaction mixture in accordance with the consumed Conorex enzyme. The glucose content was also monitored, and when the glucose concentration dropped to about 0.055% by weight or less, a supplementary glucose solution was added to raise the concentration to about 0.25% by weight / 0. Nutrition and antibiotics are also added at different times in the reaction cycle. Addition plan of steroid suspension, glucose solution, autolyzed yeast solution and antibiotic solution -148- Two paper scales are applicable to China National Standards (CNS) A4 specifications (21 × M? Publication) Central Standards Bureau of the Ministry of Economic Affairs-industrial consumption Printed by the cooperative 593305 A7 ____ B7 5. The description of the invention (I46) is shown in Table 8. The conversion reaction was continued for 90 hours under a positive top pressure of 0.3 kg / cm² at 0.5 parts by volume of air (vvm) per part of liquid per minute. The temperature was maintained at 28 ° C until pv Μ reached 45%, then decreased to 2 ° C and maintained at this temperature, so that ρ ν μ grew from 45 to 60%, and then controlled at 24 ° C under. The initial agitation rate was 400 rpm and increased to 700 r p m after 40 hours. The pH was maintained between 4.7 and 5.3 by adding 2 μ orthoacetic acid or 2 M NaOH as indicated. When foaming develops, foaming is controlled by adding a few drops of antifoam agent SAG 47 1. During the reaction, the loss of Conreno and the appearance of 1 1 α-hydroxyconreno were monitored by TLC analysis of broth samples at 4-hour intervals. When most of the Conorno disappear from the broth, add additional amounts. The reaction was stopped after all the Conranow was added. At this time, TL c analysis showed that the concentration of Conranox enzymatic substance relative to 1 1 -hydroxy Conranow had been reduced to approximately 5%. Broth, the mycelia are separated from both liquid meat. The mycelium part was resuspended in ethyl acetate, using approximately 65 parts by volume (5.2 liters) per gram of Conreno loaded during the reaction. The mycelium suspension in ethyl acetate was refluxed for 1 hour under agitation, cooled to about 20 C 'and filtered on a porcelain funnel (Buchner). The mycelium cake was continuously rinsed with ethyl acetate (five volumes; 0.4 liters in mother Concan); and deionized water (500 ml) to remove the ethyl acetate extract from the filter cake. Discard the filter cake. The extract-rich solvent wash and water wash were collected in a separator, and then allowed to stand for 2 hours to separate the phases. Then discard the liquid phase and concentrate the organic phase under empty space to the remaining volume of 35-149- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page ) Order- ^ 1. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 593305 A7 B7 V. Description of Invention (I47) ml. Allow the bottom to cool to 15 ° C and keep stirring for about 1 hour. The suspension of the residue was filtered to remove the crystallized product, and the filter cake was rinsed with ethyl acetate (40 ml). After dehydration, it was determined that the amount of 1 1 α-Turkey Conreno produced was 60 g. Example 3 A spore suspension was prepared from a routine bevel in the manner described in Example 1. In a 2000 ml baffled round bottom flask (3 baffles, 50 mm x 30 mm each), an aliquot (0.5 ml) of the spore suspension was introduced into a nutrient solution having the composition listed in Table 4 ( 500 ml). The resulting mixture was cultured in a flask for 24 hours at 25 ° F. on another stirrer (1 200 stroke per minute; displacement 5), thereby producing a culture, which was clearly observed during microscopy. It is a pure culture with fully tangled mycelium. The ρ Η 値 of the culture is between approximately 5.3 and 5.5, and the PMV (determined by centrifugation at 3,000 rpm for 5 minutes) is 8 to 10%. Using the culture thus prepared, a seed culture was prepared in a stainless steel fermenter having a vertical cylindrical centrifuge tube having a geometric volume of 600 liters and an aspect ratio of 2.31 (length = 9 85 mm, diameter = 425 mm). A disc-turbine stirrer having two discs was provided, each disc having six blades each having an outer diameter of 240 mm and each blade having a radial diameter of 80 mm and a height of 50 mm. The upper wheel is at a depth of 780 mm from the top of the fermenter, and the second wheel is at a depth of 995 mm. The vertical baffle has a length of 89 mm and extends radially inward from the vertical wall in the fermenter by 40 mm. The agitator was operated at 170 rpm. Introduce the nutrient mixture (丨 00 liters) with the composition listed in Table 9 into the fermenter 'and then introduce a part of the pre-150 prepared above with a pH of 5.7- Standard (CNS) six 4 specifications (21〇χ 297 mm)-(Please read the precautions on the back before filling out this page)-Order 593305 A7 B7 V. Description of the invention (148) Inoculum (1 liter). Table 9 For the cultivation of plants in a 160 liter fermenter, about 8 liters of seeds are needed to produce a fermenter. G / liter glucose 2 kg 20 glands 2 kg 20 yeast autolysate 2 kg 20 antifoam agent SAG 471 0.010 kg trace Deionized water is appropriate to-sterilize the empty fermenter at 130 ° C for 30 minutes-fill 6 liters of deionized water and heat to 40 ° C-add and stir the ingredients of the culture medium-stir for 15 minutes with 95 liters Volume-Sterilization at 121 ° C for 30 minutes-pH 后 after sterilization-5.7-Add sterile deionized water to 100 liters 100 liters. The cooperative prints to incubate the inoculated mixture at a 0.5 l / l · min aeration rate under a 0.5 kg / cm2 surface pressure for 22 hours. The temperature was controlled at 28 ° C until PM V reached 25%, and then decreased to 25 ° C. pH 値 is controlled in the range of 5 -1 to 5.3. The growth of the lean body volume is shown in Table 10 along with the pΗ 値 and dissolved oxygen content of the seed culture reaction. -151- This paper size applies to Chinese National Standard (CNS) Α4 size (210 × 297 mm) 593305

7 7 A B 五、發明説明(i49) 表1 0 在種子培養發酵作用中菌絲體生長的時間過程 發酵期間 小時 pH値 填充菌絲體體積(PMV)% (3000 rpm,5 分鐘) 溶氧% 0 5·7±0·1 100 4 5·7 土 0.1 100 8 5.7 土 0·1 12 土 3 85 土 5 12 5.7 土 0.1 15 土 3 72 土 5 16 5.5±0.1 25 土 5 40 土 5 20 5.4 土 0.1 30 土 5 35 土 5 22 5.3 土 0.1 33 土 5 30 土 5 24 5.2 土 0.1 35土5 25 土 5 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 利用如此製備之種子培養物,在具有直徑1.0 2公尺、高度 1 . 5公尺和1.4立方公尺之幾何體積的立式圓柱狀不鏽鋼發 酵器中,完成轉化發酵過程。提供發酵器具有兩個推進器 的渦輪攪拌器,一個位在反應器頂部之下8 6 7公分,另一個 位在頂部之下1 4 3 5公分。每個輪盤各有六個葉片,分別具 有95公分之輻向直徑和75公分之高度。垂直折流板高1440 公分,從反應器内垂直壁向内輻射狀延伸100公分。製備具 有在表1 1中列舉之組成的營養混合物。 -152- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 5933057 7 AB V. Description of the invention (i49) Table 1 0 Time course of mycelium growth during seed culture fermentation. Hour pH during fermentation. Filled mycelium volume (PMV)% (3000 rpm, 5 minutes). 0 5 · 7 ± 0 · 1 100 4 5 · 7 soil 0.1 100 8 5.7 soil 0 · 1 12 soil 3 85 soil 5 12 5.7 soil 0.1 15 soil 3 72 soil 5 16 5.5 ± 0.1 25 soil 5 40 soil 5 20 5.4 Soil 0.1 30 Soil 5 35 Soil 5 22 5.3 Soil 0.1 33 Soil 5 30 Soil 5 24 5.2 Soil 0.1 35 Soil 5 25 Soil 5 (Please read the notes on the back before filling out this page) Printed by the Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs The seed culture thus prepared was used to complete the transformation fermentation process in a vertical cylindrical stainless steel fermenter with a geometric volume of 1.0 2 meters in diameter, 1.5 meters in height, and 1.4 cubic meters in geometry. A fermenter was provided with a turbo agitator with two propellers, one 867 cm below the top of the reactor and one 4 3 5 cm below the top. Each wheel has six blades each with a radial diameter of 95 cm and a height of 75 cm. The vertical baffle is 1440 cm high and extends 100 cm radially inward from the vertical wall in the reactor. A nutritional mixture having the composition listed in Table 11 was prepared. -152- This paper size applies to China National Standard (CNS) A4 (210X297 mm) 593305

AA

7 B 五、發明説明(15〇) 表1 1 在1000升發酵器中供生物轉化作用培養物使用 量 克/升 葡萄糖 16公斤 23 腺 16公斤 23 酵母自溶物 16公斤 23 防沫劑SAG 471 0.080公斤 微量 去離子水適量至 -在130°C下將空的發酵器滅菌1小時 -裝入600升的去離子水,加熱至40°C -加入並攪掉培養基之成份 -攪拌15分鐘,具有650升之體積 -在121°C下滅菌30分鐘 -滅菌後的pH値爲5.7 -加入無菌的去離子水至700升 700升 !| J--------— (請先1讀背面之注意事項再填寫本頁 、1Τ 將最初裝載量(700升)的該營養混合物(pH = 5.7)導入發酵 器中,接著導入如上述製備的本實驗之種子接種物(7升)。 經濟部中央標準局員工消費合作社印製 以0.5升/升-分鐘之充氣速率,在0.5公斤/平方公分的液 面上壓力下,培養含有接種物的營養混合物2 4小時。將溫 度控制在28°C下,且攪拌速率爲1 10 rpm。在表12中顯示 菌絲體體積的生長,連同種子培養反應的p Η値和溶氧量。 -153- 本紙張尺度適用中國國家標準(CNS ) A4規格(210Χ297公釐) 593305 五、發明説明(151) 表12 在轉化培養之發酵器中菌絲體生長的時間過程 發酵期間 小時 pH値 填充菌絲體體積(PMV)% (3000 rpm X 5 分鐘) 溶氧% 0 5.6土0.2 100 4 5.5 土 0·2 100 8 5·5 土 0.2 12 土 3 95±5 12 15 土 3 90 土 5 16 5.4 土 0.1 20 土 5 75±5 20 5.3 土 0.1 25 土5 60 土 5 22 5.2 土 0.1 30 土 5 40 土 5 (讀先閱讀背面之注意事項再填寫本頁) 在培養結束時,獲得菌絲體的小球,但是小球通常很小, 且相當地鬆散。將散布的菌絲體懸浮於肉湯中。最後的pH 値爲5 . 1到5.3。 經濟部中央標準局員工消費合作社印製 將如此產製的轉化培養物加至在無菌之水(5升)中的康雷 諾(1.2 5公斤;微粒化成5微米)懸浮液中。按照在表1 4中反 應時間0所指定的比例,加入添加物溶液和抗生素溶液。在 表1 3中列出添加物溶液的組成。 -154- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五、發明説明(i52) 表1 3添加物溶液(供生物轉化之培養物使用) 量 右旋糖 40公斤 酵母自溶物 8公斤 防沫劑S A G 4 7 1 0 · 0 1 0公斤 去離子水適量至 -在130°C下將150升空發酵器滅菌丨小時 -裝入70升的去離子水,加熱至4〇°C -加入並授拌,’添加物溶液”之成份 -擅:摔30分鐘,具有95升之體積 -pH値爲4.9 -在120°C下滅菌20分鐘 -滅菌後的pH値爲5 100升 (請先閱讀背面之注意事項再填寫本頁} 訂 經濟部中央標準局員工消費合作社印製 利用0.5升/升-分鐘的充氣速率,並在〇·5公斤/平方公分的 液面上壓力下,大約96小時完成生物轉化作用,且ρΗ値之 範圍在4.7到5 · 3之間’按照需要藉著加入7 $ μ N a Ο Η或 4Μ ^^〇4來調整之。攪拌速率一開始爲1〇〇 rpm,在4〇 小時時增加至165 rpm,並在64小時時爲250 rpm。起始 溫度爲28Ό,當PMV達到45%時降至26°C,並當PMV昇 高到6〇%時降至24τ。需要控制起泡時,以微滴 471。以4小時之間隔監視在發酵作用中的葡萄糖含量,當 葡萄糖濃度低於1 gpl時,加入無菌添加物溶液的補充量 (1〇升)。在反應期間亦藉著HPLC來監視康雷諾的消失和 -155-7 B V. Description of the invention (15) Table 1 1 Biotransformation culture used in 1000 liter fermenter g / L glucose 16 kg 23 gland 16 kg 23 yeast autolysate 16 kg 23 antifoam agent SAG 471 0.080 kg of trace deionized water is appropriate to-sterilize the empty fermenter at 130 ° C for 1 hour-fill 600 liters of deionized water and heat to 40 ° C-add and stir off the ingredients of the culture medium-stir for 15 minutes, It has a volume of 650 liters-sterilized at 121 ° C for 30 minutes-the pH after sterilization is 5.7-add sterile deionized water to 700 liters and 700 liters! | J --------— (please first 1 Read the notes on the back and fill in this page again. 1T introduce the nutritional mixture (pH = 5.7) with the initial loading (700 liters) into the fermenter, and then introduce the seed inoculum (7 liters) of this experiment prepared as described above. The Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs prints the nutrient mixture containing the inoculum at an inflation rate of 0.5 liters / liter-minute at a surface pressure of 0.5 kg / cm2 for 24 hours. The temperature is controlled at 28 ° C, and the stirring rate is 1 10 rpm. Shown in Table 12 The growth of mycelial volume, together with the pΗ 値 and dissolved oxygen content of the seed culture reaction. -153- This paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) 593305 V. Description of the invention (151) Table 12 Time course of mycelium growth in a fermenter for transformation culture. Hours pH during fermentation. Filling of mycelium volume (PMV)% (3000 rpm X 5 minutes). Dissolved oxygen% 0 5.6 soil 0.2 100 4 5.5 soil 0 · 2 100 8 5 · 5 soil 0.2 12 soil 3 95 ± 5 12 15 soil 3 90 soil 5 16 5.4 soil 0.1 20 soil 5 75 ± 5 20 5.3 soil 0.1 25 soil 5 60 soil 5 22 5.2 soil 0.1 30 soil 5 40 soil 5 ( Read the notes on the back before filling in this page.) At the end of the culture, small pellets of mycelium are obtained, but the pellets are usually small and fairly loose. The scattered mycelium is suspended in the broth. Finally The pH 値 is 5.1 to 5.3. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, the transformation culture thus produced is added to Conreno (1.2 5 kg in sterile water (5 liters); micronized into 5 Μm) suspension. The proportions specified in Table 14 for reaction time 0 Add the additive solution and antibiotic solution. The composition of the additive solution is listed in Table 1 3. -154- This paper size is applicable to Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 A7 B7 V. Description of the invention (i52 ) Table 1 3 Additive solution (for biotransformation cultures) Amount of dextrose 40 kg yeast autolysate 8 kg antifoam agent SAG 4 7 1 0 · 0 1 0 kg Deionized water amount to-at 130 ° Sterilize 150 liters of empty fermenter under C 丨 hour-fill 70 liters of deionized water and heat to 40 ° C-add and mix, the ingredients of the "additive solution"-good: drop for 30 minutes, with 95 liters Volume-pH 値 is 4.9-Sterilize at 120 ° C for 20 minutes-pH 后 after sterilization is 5 100 liters (please read the precautions on the back before filling out this page) Order printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Using a 0.5 l / litre-minute inflation rate and a surface pressure of 0.5 kg / cm², the biotransformation is completed in about 96 hours, and the range of ρΗ 値 is between 4.7 and 5 · 3 'according to It needs to be adjusted by adding 7 $ μ N a 〇 Η or 4Μ ^^ 〇4The stirring rate was initially 100 rpm, increased to 165 rpm at 40 hours, and 250 rpm at 64 hours. The initial temperature was 28 ° F, dropped to 26 ° C when PMV reached 45%, and dropped to 24τ when PMV rose to 60%. When you need to control foaming, use Drop 471. The glucose content during the fermentation was monitored at 4-hour intervals. When the glucose concentration was below 1 gpl, a supplemental amount of sterile additive solution (10 liters) was added. The disappearance of Conorno and -155- was also monitored by HPLC during the reaction.

,I - -I -- - 593305 A7 ------------- B7 _ 五、發明説明(153 ) 1 1泛-經基康雷諾的出現。當至少9 〇 0/〇的起始康雷諾裝載量 已經轉變爲1 1沈-髮基康雷諾時,加入丨.2 5 0公斤康雷諾補 充量。當補充的康雷諾顯示有9 〇 %已經轉變時,再導入另 外1.2 5 0公斤的補充量。利用相同的標準加入更多的補充量 (各1.25 0公斤),直到已經導入總反應器裝載量(2〇公斤)爲 止。在全邵的康雷諾都已經裝入反應器之後,中止反應, 此時相對於所產生之1丨α _羥基康雷諾的量,未反應康雷諾 的濃度爲5 %。康雷諾、無菌添加物溶液和抗生素溶液的添 加計劃表,如在表1 4中所示。 在康雷諾j 物和抗生: 表14 支物轉化的過程中,在發酵器中加入類固醇和溶液(添加 *:) 反應時間 小時 康雷諸以懸浮液 公斤進行的公斤 無菌添加溶液 升 抗生素落液 升 體積 大約升 0 1.250 1.25 10 8 700 4 10 8 1.250 2.5 10 12 10 16 1.250 10 20 10 24 1.250 5 10 8 800 28 1.250 10 32 1.250 10 36 1.250 10 40 1.250 10 44 1.250 10 48 1.250 12.5 10 8 900 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) -156· 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 經濟部中央標準局員工消費合作社印製 593305 Α7 ________Β7 五、發明説明(I54) 52 1.250 10 56 1.250 10 60 1.250 10 64 1.250 10 68 1.250 10 72 1.250 20 10 8 1050 76 0 80 84 88 92 總計 當生物轉化完成時,藉著在籃式離心管中離心,從肉湯 中分離出菌絲體。藉著HPLC決定濾液中僅在收獲肉湯中含 有2 %總量的丨丨α -羥基康雷諾,因此將其排除。將菌絲體 綠浮於在2立方公尺之容量的萃取桶中的醋酸乙酯(丨〇 〇 〇升) 中。在授摔之下,並在醋酸乙酯之迴流條件下加熱該懸浮 液一小時,然後冷卻並在籃式離心管中離心。以醋酸乙酯 (2 0 0升)冲洗菌絲體餅,隨後將其拋棄。容許富含類固醇的 洛劑萃取物靜置一小時,以便分離水相。利用更多量之萨 鮫乙酯溶劑(200升)萃取水相,然後拋π〜柯贫離〜丨 合的=劑相澄清,並置於濃縮器(5〇〇升幾何體積)中,j =下濃縮至殘餘體積丨00升。在進行蒸發作用時,最初^ 濃縮器的混合萃取物和沖洗溶液爲1〇〇升,當溶劑除去Ε 藉著連續或定期加入混合溶液使體積維持固定。在完乂 發作用的步驟之後,將仍留在底部的冷卻至2〇 ,並俨 (請先閱讀背面之注意事項再填寫本頁) 、1Τ -157 -, I--I--593305 A7 ------------- B7 _ V. Description of the invention (153) 1 1 Pan-via the emergence of Gicono Reynolds. When the initial Conorno load of at least 9 0/0 has been changed to 11 Shen Fafa Conreno, add 2.5 kg of Conreno supplement. When 90% of the supplemented Reynolds showed a shift, another 1.250 kg of replenishment was introduced. Add more replenishment (1.25 kg each) using the same standards until the total reactor load (20 kg) has been introduced. After all of the Reynolds in Shao have been charged into the reactor, the reaction is stopped. At this time, the concentration of the unreacted Conreno is 5% with respect to the amount of 1-α-hydroxyconreno produced. The schedule for the addition of Conranox, sterile additive solutions, and antibiotic solutions is shown in Table 14. Conranol J and Antibiotics: Table 14 During the conversion of the branch, add steroids and solutions to the fermenter (add * :). The reaction time is small. Liter volume approx. 0 1.250 1.25 10 8 700 4 10 8 1.250 2.5 10 12 10 16 1.250 10 20 10 24 1.250 5 10 8 800 28 1.250 10 32 1.250 10 36 1.250 10 40 1.250 10 44 1.250 10 48 1.250 12.5 10 8 900 Printed by the Consumers' Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the notes on the back before filling this page) -156 · This paper size applies to China National Standards (CNS) Α4 specifications (210 × 297 mm) Printed by the cooperative 593305 Α7 ________ Β7 V. Description of the invention (I54) 52 1.250 10 56 1.250 10 60 1.250 10 64 1.250 10 68 1.250 10 72 1.250 20 10 8 1050 76 0 80 84 88 92 Total When the biotransformation is completed, Centrifuge in a basket centrifuge tube to isolate mycelia from the broth. By HPLC, it was determined that the filtrate contained only 2% of the total α-hydroxyconorno in the harvest broth, and was therefore excluded. The mycelium green was floated in ethyl acetate (1000 liters) in an extraction tank with a capacity of 2 m3. The suspension was heated under reflux and ethyl acetate under reflux for one hour, then cooled and centrifuged in a basket centrifuge tube. Rinse the mycelium cake with ethyl acetate (200 liters) and discard it. The steroid-enriched lotion extract was allowed to stand for one hour to separate the aqueous phase. The aqueous phase was extracted with a larger amount of ethyl acetate (200 liters), and then the solvent phase was clarified by throwing π ~ CO 贫 ~~, and placed in a concentrator (500 liter geometric volume), j = It was concentrated to a residual volume of 00 liters. When performing evaporation, the mixed extract and rinse solution of the concentrator was 100 liters at first. When the solvent was removed, the volume was maintained constant by adding the mixed solution continuously or periodically. After completing the action steps, cool to the bottom, which is still at the bottom, and then (please read the precautions on the back before filling this page), 1T -157-

593305 7 五、發明説明(155) - ^時,然後在瓷漏斗濾器上過濾。以醋酸乙酯(2〇升)沖洗 濃縮器的罐子,然後使用沖洗溶液去沖洗在滤器上的爐餅 。在5〇°c下在眞空下將產物脱水16小時。產生14公斤的η 以-羥基康雷諾。 實例4 將過AMANRRL 405的冷凍乾燥孢子懸浮於具有在表 15中所列舉之組成的玉米漿生長培養基(2亳井)中: ---------— 一 h /工、V L 七 ; τ : 表15 -土米漿培養基(供原始種子培養用之生長典養其 玉米漿 30克 酵母萃取物 15克 一價磚酸按 3克 葡萄糖(在滅菌後裝入) 蒸餾水適量至1000亳升 pH値爲4.6,利用20% NaOH調整,將50毫升分配到250毫升 的錐形燒瓶中,在121°C下滅菌20分鐘 30克 (請先閱讀背面之注意事項再填寫本頁) 丨«· 訂 經濟部中央標準局員工消費合作社印繁 爲了孢子的繁殖,在瓊脂培養盤上利用所得的懸浮液來接 種。製備十個瓊脂培養盤,每個均帶有在表16中所列舉之 組成的固體葡萄糖/酵母萃取物/磷酸鹽/瓊脂生長培養基: 表16-GYPA(葡萄糖/酵母萃取物/嶙酸鹽/瓊脂之培養盤) 葡萄糖(在滅菌後裝入) 10克 酵母萃取物 2.5克 k2hpo4 3克 瓊脂 20克 蒸麵水適量至1000毫升 -158- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) *-------: ', 》 〜一 #岡砂服叹贪丞Y : 表17-GYP/甘油(供原料小瓶用的葡萄糖/酵母萃取物/嶙酸鹽/甘油培春幻 葡萄糖(在滅菌後裝入) 10克 酵母萃取物 2.5克 K2HP〇4 3克 ϊΐ ~~ ' &quot; -- 蒸餾水適量至1 0 0 0毫升 20克 張 紙 ____ 本 經濟部中央標準局員工消費合作社印製 593305 A7 ----------- B7 五、發明説明(I56 ) 調整p Η値至6.5 在1 2 1 °C下滅菌3 〇分鐘 將〇 · 2毫升爲一等份的懸浮液移至每個培養盤的表面。在2 $ C下培養該培養盤十天,之後將所有培養盤中收獲的孢子 在121 C下滅菌3〇分鐘__ 將所侍的懸浮液分成十二瓶,每個小瓶移入丨毫升。這些冲 瓶組成主要細胞銀行,可將其取出產生工作細胞銀行,用 來產生康雷諾轉變爲n羥基康雷諾之接種物。將包本主 要=胞銀行的小瓶儲存在·13(rc的液態氮冰箱之蒸氣相中口。 攸開始製備工作細胞銀行,將得自一個主要細胞銀行小 瓶的孢=再懸浮於具有在表15中所列之組成的無菌生長培 養基(j亳升)中。將該懸浮液分成十個〇·2毫升的等份,並 利用每等份來接種具有在表16中所列之組成,帶有固體生 長培養基的瓊脂培養盤。在25Χ:Τ培養這些培養盤1〇天。 t培養三天後,不想要的生長培養基是棕橘色的。在培 〜束時,產生大量的金黃色孢子。藉著上述有關製備主 要細胞銀行的程序,從每個培養盤中收獲孢子。一共製備 (度適用巾S _辟(CNS)593305 7 V. Description of the invention (155)-^, then filter on a porcelain funnel filter. Rinse the pot of the concentrator with ethyl acetate (20 liters), and then use the rinse solution to rinse the cake on the filter. The product was dehydrated at 50 ° C. for 16 hours under vacuum. 14 kg of η-Hydroxy-Connor is produced. Example 4 Freeze-dried spores of AMANRRL 405 were suspended in a corn slurry growth medium (2 wells) having the composition listed in Table 15: ---------- one hour / work, VL seven Τ: Table 15-Clay slurry culture medium (for the growth of the original seed culture, its corn slurry 30 grams of yeast extract, 15 grams of monovalent brick acid, 3 grams of glucose (filled after sterilization), distilled water amount to 1000 亳The pH was increased to 4.6, adjusted with 20% NaOH, 50 ml was dispensed into a 250 ml conical flask, and sterilized at 121 ° C for 20 minutes and 30 g (please read the precautions on the back before filling this page) 丨 « · Ordered by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs for the propagation of spores, the resulting suspension was used to inoculate on agar culture plates. Ten agar culture plates were prepared, each with the composition listed in Table 16. Solid glucose / yeast extract / phosphate / agar growth medium: Table 16-GYPA (glucose / yeast extract / gallate / agar culture plate) glucose (filled after sterilization) 10 g yeast extract 2.5 g k2hpo4 3 g agar 20 The amount of steamed noodles is 1000ml -158- This paper size is applicable to Chinese National Standard (CNS) A4 (210X297mm) * -------: ',》 ~ 一 #gangsha service : Table 17-GYP / Glycerin (glucose / yeast extract for raw material vials / gallate / glycerol ecstasy glucose (filled after sterilization) 10 g yeast extract 2.5 g K2HP〇3 3 gϊΐ ~~ '&quot;-Appropriate amount of distilled water to 100 ml 20 grams of paper ____ Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 ----------- B7 V. Description of the invention (I56 ) Adjust p Η 値 to 6.5 Sterilize for 30 minutes at 121 ° C. Move 0.2 ml aliquots of suspension to the surface of each culture plate. Incubate the culture plate at 2 $ C for ten days Then, spores harvested from all culture plates were sterilized at 121 C for 30 minutes. __ The suspension was divided into twelve bottles, each vial was transferred into 丨 ml. These wash bottles constitute the main cell bank, which can be removed Generate a working cell bank to generate Conranow's inoculum for conversion to n-Hydroxy Conranow. Primarily = Cell Bank The vial was stored in the vapor phase of a liquid nitrogen refrigerator at 13 ° C. You began to prepare a working cell bank, re-suspending the spores obtained from a major cell bank vial = aseptic growth with the composition listed in Table 15. The suspension was divided into ten 0.2 ml aliquots, and each aliquot was used to inoculate an agar culture plate having the composition listed in Table 16 with a solid growth medium. These plates were cultured at 25 ×: T for 10 days. After three days of incubation, the unwanted growth medium was brown-orange. A large number of golden yellow spores are produced during cultivation. Spores were harvested from each dish using the procedures described above for preparing major cell banks. Prepared in total (degree applicable towel S _ 辟 (CNS)

-159· 593305 A7 ________B7_ 五、發明説明(I57) 1 0 0個小瓶,每個各含有1毫升懸浮液。這些小瓶構成工作 細胞銀行。亦藉著儲存在_丨3 0。(:之液態氮冰箱的蒸氣相中 來保存工作細胞銀行小瓶。 將具有在表15中所列之組成的生長培養基(5〇毫升)裝入 2 5 0毫升的錐形燒瓶中。將一等份(〇 . 5毫升)工作細胞懸浮 液導入燒瓶中,並與生長培養基混合。在2 5 °C下培養該接 種混合物2 4小時,產生具有大約4 5 %的填充菌絲體體積百 分比之原始種子培養物。目視檢查培養物時,發現包含! _ 2 毫米直徑之類似小球狀的菌絲體;並在顯微鏡觀察時,其 顯然是純的培養物。 第二代種子培養物的培養由將具有在表丨5中所列之組成 的生長培養基導入2_8升F ernbach燒瓶中開始,並以一部份 (1 〇毫升)本實驗的原始種子培養物來接種,其製備如同上 述。在25°C下,在旋轉攪拌器(200 rpm,5公分位移)培養該 接種混合物2 4小時。在培養結束時,培養物顯示出與上述 原始種子培養物相同的特性,並適合用在將康雷諾生物轉 化成1 1 ^ #呈基康雷諾的轉化發酵作用中。 在Braun Biostat發酵器中經營轉化作用,其結構如下 容量: 15升,具有圓底 經濟部中央標準局員工消費合作社印裂 (請先閱讀背面之注意事項再填寫本頁) 南度: 5 3公分 直徑: 2 0公分 H/D: 2.65 推進器:7.46公分直徑,6個槳葉,各2.2幻.4公分 推進間隔:從桶子的;|部6 5 · 5、1 4.5和2 5 . 5公分 -160- 本紙張尺度適用中國國家標準(CNS] A4規格(210X297公釐~ ---- 593305 A7 表1 8 (供在10升發酵器中之生物轉化培卷物用的斗舲4立糁物) 量 量/升 葡萄糖 160克 20克 腺 160克 20克 酵母萃取物 160克 20克 防沫劑SAG 471 4.0毫升 0.5毫升 康雷諾 去離子水適量至7.5升 在121°C下滅菌30分鐘 160克 20克 經濟部中央標準局員工消費合作社印製 ____ B7 五、發明説明(158 ) ^ 折流板:四個1 · 9 X 4 8公分 喷務器· 1 〇 · 1公分直徑’ 21孔〜1毫米直徑 溫度控制:藉著外部套管的方式提供 以2 0克/升的濃度將康雷諾懸浮於去離子水(4升)中,並加 入一邵份具有在表1 8中所列舉之組成的生長培養基,同時 以3 00 rpm攪拌在發酵器中的混合物。 (請先閱讀背面之注意事項再填寫本頁 攪拌所得的懸浮液1 5分鐘,之後利用額外的去離子水使體 積高達7·5升。在此時藉著加入2〇重量❶/。的Na〇H溶液,將 懸浮液的pH値調整成5·2到6.5,然後在Braim E發酵器中 ’加熱至1 2 1 °C滅菌3 0分鐘。在滅菌後的ρ η値爲6.3 土 〇 . 2 ,且終體積爲7.0升。以一部份(0.5升)按照上述製備之本 實例的第二種子培養物來接種無菌的懸浮液,並藉著加入 50%無菌的葡萄糖溶液使體積高達8.〇升。在28。〇的溫度下 進行發酵作用,直到PMV達到50%爲止,然後降至2 6°C, -161- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐1 一 經濟部中央標準局員工消費合作社印製 593305 A7 __________^ 五、發明説明(159) 並當PMV超過50%時再降至24Ό,以便維持低於大約6〇% 的固定PMV。經由噴霧器導入空氣,以原始液體體積爲基 礎的0.5 vvm之速率,並將在發酵器中的壓力維持在7〇〇毫 米汞柱。以600 rpm開始攪拌,並因爲需要保持溶氧量在 3 0體積%以上,逐步增加至丨〇〇〇 rpm。監視葡萄糖含量。 在取初的咼葡萄糖濃度因爲發酵反應的消耗而降至1 %之後 ,經由50重量%之無菌的葡萄糖溶液來提供補充的葡萄糖 ,以便維持在該批循環之殘餘物中有〇.〇5%到之間的濃 度。在接種前的pH値爲6.3 ±0.2。在開始發酵期,pH値降 至大約5.3之後,藉著加入氫氧化銨將循環之殘餘物的pH 値維持在5 · 5 ± 0 · 2的範圍内。藉著加入商品名爲s A G 4 7 i, 由〇SI Specialties,Inc.提供的聚乙二醇防沫劑固體來控制 起泡。 培養物的生長一開始發生在循環的前24小時期間,在此 時PMV大約40%,PH値約爲5.6,且溶氧量約爲5〇體積% 。甚至在培養物正在生長時便開始康雷諾的轉化作用。在 生物轉化期間,藉著分析每日的試樣來監視康雷諾和n “ _ 基康雷“的丨辰度。利用熱醋酸乙醋萃取試樣,並藉著 T L C和Η P L C分析所得的試樣溶液。當殘餘的康雷諾濃度爲 最初濃度的大約1 〇 %時,生物轉化作用被視爲是完成。大 約的轉化時間爲1 1 〇到i 3 〇小時。 當生物轉化完成時,藉著離心從肉湯中分離出菌絲體之 生物團塊。以等體積的醋酸乙酯萃取上清液,並拋棄液層 。將菌絲體的部份再懸浮於醋酸乙酯中,每克裝入發酵反 -162- 本紙張尺度適用中涵家標準(CNS ) &amp;見格(297公釐厂 (請先閱讀背面之注意事項再填寫本頁) 1«· 訂 593305 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(l6〇) 應器之康雷諾使用大約65份體積。在攪拌之下,迴流菌絲 體懸浮液一小時,冷卻至大約2 0 X:,並在瓷漏斗上過濾。 以每克裝入發酵器之康雷諾5份體積醋酸乙酯來沖洗菌絲體 處餅兩次’然後以去離子水(1升)沖洗,以除去殘餘的醋酸 乙醋。混合含水的萃取物、豐富的溶劑、溶劑沖洗液和水 洗液。拋棄或再度萃取殘餘用盡的菌絲體濾餅,依據其中 剩餘類固醇的分析。容許靜置混合的液相兩小時。隨後分 離並拋棄液相,並在眞空下濃縮有機相,直到體積大約5〇〇 I升爲止。然後將留在底邵的冷卻至1 5 °c,並慢慢地攪掉 大約一小時。藉著過濾回收結晶產物,以冷的醋酸乙酉旨 (1 〇 0毫升)沖洗。藉著蒸發從結晶中移除溶劑,並在5 〇 t的 眞空下將結晶產物脱水。 按照在實例4中的描述,將褐黃麴菌ΑΤΓΓ 1 85 00冷凍乾 燥的孢子懸浮於玉米漿生長培養基(2亳升)中。亦以實例4 中的方法來製備十個瓊脂培養盤。按照實例4中的描述,培 養這些培養盤並收獲之,提供主要細胞銀行。將含有主要 細胞銀行的小瓶儲存在“ 3 〇。(:的液態氮冰箱之蒸氣相中。 按照在實例4中的描述,從主要細胞銀行的小瓶來製備工 作細胞銀行,並儲存在_130。(:的氮冰箱中。 知具有在表19中所列之組成的生長培養基(3〇〇毫升)裝入 2升折流燒瓶中。將一等份(3毫升)工作細胞懸浮液導入該 燒瓶。在旋轉攪拌器(2〇〇 rpm,5公分位移)上,在28π下掉 養該接種混合物20-24小時,產生原始種子培養物,具有大 -163- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐)~&quot; -----. (請先閱讀背面之注意事項再填寫本頁} 1«. 訂 593305 A7 ______B7五、發明説明(161 ) 約4 5 %的填充菌絲體體積百分比。在目視檢查培養物時, 發現包含類似小球狀的菌絲體,具有1到2毫米直徑;並在 顯微靜檢查時,顯示其爲純培養物。 表19 供原始和第二個種子培養物使用之生長培卷某 量/升 葡萄糖(在滅菌後裝入) 20克 腺 20克 酵母萃取物 20克 蒸餾水適量至1 〇 〇 〇毫升 在1 2 1 °C下滅菌3 0分鐘 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印掣 第二個種子培養物的培養,藉著將8升具有在表丨9中所列之 組成的生長培養基導入1 4升玻璃發酵器中而開始。利用 160毫升到200亳升的本實例之原始種子培養物來接種發酵 器。其製備如同上述。 在28°C下培養該接種混合物18-2〇小時,2〇〇 rpm擾摔 ’充氣速率爲0.5 vvm,在繁殖結束時,培養物顯示出與 上述關於原始種子相同的特性。 在60升發酵器中經營轉化作用,大體上以在實例4中的描 述的方式,除了生長培養基具有在表2 〇中所列的組成,且 取初裝入的第二個種子培養物爲350亳升至7〇〇毫升。攪拌 速率一開始爲2 0 0 rp m,但因爲需要維持溶氧量在丨〇體積 %以上,增加至5 〇 〇 rp m。關於2 0克/升康雷諾的約略生物 轉化時間爲8 0到1 6 0小時。 -164- 尺度適用中國國家標準(CNS ) A4規格(210X297公釐) &quot;' --- 訂 A7 B7 五 發明説明(162 表20 用之生長培養基 i萄糖(在滅菌後裝入)腺-159 · 593305 A7 ________B7_ 5. Description of the Invention (I57) 100 vials, each containing 1 ml of suspension. These vials constitute a working cell bank. Also by storing in _ 丨 3 0. (: The working cell bank vial was stored in the vapor phase of a liquid nitrogen refrigerator. The growth medium (50 ml) with the composition listed in Table 15 was placed in a 250 ml conical flask. (0.5 ml) working cell suspension was introduced into the flask and mixed with growth medium. The inoculation mixture was incubated at 25 ° C for 24 hours, yielding an original with a mycelium volume percentage of approximately 45% Seed culture. When the culture was visually inspected, it was found to contain! _ 2 mm-diameter-like spherical mycelium; and when observed under a microscope, it was apparently a pure culture. The second-generation seed culture was cultivated by The growth medium having the composition listed in Table 5 was introduced into a 2-8 liter Fernbach flask and inoculated with a portion (10 ml) of the original seed culture of this experiment, which was prepared as described above. At 25 Incubate the inoculated mixture for 24 hours on a rotary stirrer (200 rpm, 5 cm displacement) at ° C. At the end of the cultivation, the culture showed the same characteristics as the original seed culture described above, and was suitable for use. Conranos Bio is transformed into 1 1 ^ # in the transformation fermentation of Conrad. Operating in the Braun Biostat fermenter, its structure is as follows: 15 liters, with a round bottom printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. (Please read the precautions on the back before filling in this page) South degree: 5 3 cm diameter: 20 cm H / D: 2.65 propeller: 7.46 cm diameter, 6 blades, each 2.2 magic. 4 cm advance interval : From the bucket; | Department 6 5 · 5, 1 4.5 and 2 5.5 cm -160- This paper size applies to the Chinese National Standard (CNS) A4 (210X297 mm ~ ---- 593305 A7 Table 1 8 (Fruit bucket 4 stand for biotransformation of rolls in a 10 liter fermenter) Amount / liter glucose 160 g 20 g gland 160 g 20 g yeast extract 160 g 20 g antifoam agent SAG 471 4.0 0.5ml Conrador deionized water to 7.5 liters Sterilized at 121 ° C for 30 minutes 160g 20g Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs ____ B7 V. Description of the invention (158) ^ Baffle plate: 4 1 · 9 X 4 8 cm sprayer · 1 · 1 cm diameter ' 21 holes ~ 1 mm diameter temperature control: Provided by means of an external sleeve to suspend Conreno in deionized water (4 liters) at a concentration of 20 g / l, and add one portion The growth medium of the listed composition, while stirring the mixture in the fermenter at 300 rpm. (Please read the precautions on the back before filling in the suspension on this page for 15 minutes, and then use additional deionized water to make Volume up to 7.5 liters. At this time, by adding 20 wt%. NaOH solution, the pH of the suspension was adjusted to 5.2 to 6.5, and then sterilized by heating in a Braim E fermenter to 1 2 1 ° C for 30 minutes. Ρ η 値 after sterilization was 6.3 soil 0.2, and the final volume was 7.0 liters. A portion (0.5 liter) of the second seed culture of this example prepared as described above was used to inoculate a sterile suspension, and the volume was up to 8.0 liters by adding a 50% sterile glucose solution. At 28. 〇 Fermentation is performed at a temperature of 50% until PMV reaches 50 ° C, and then drops to 26 ° C, -161- This paper size applies Chinese National Standard (CNS) A4 specifications (210X297 mm 1) Staff of the Central Bureau of Standards, Ministry of Economic Affairs Printed by the Consumer Cooperative 593305 A7 __________ ^ 5. Description of the Invention (159) and when the PMV exceeds 50%, it is reduced to 24% in order to maintain a fixed PMV of less than about 60%. Air is introduced through a sprayer based on the original liquid volume At a rate of 0.5 vvm and maintaining the pressure in the fermenter at 700 mm Hg. Start stirring at 600 rpm and gradually increase the dissolved oxygen content to 30% by volume as needed rpm. Monitor the glucose content. After the initial glucose concentration is reduced to 1% due to the consumption of the fermentation reaction, supplemental glucose is provided through a 50% by weight sterile glucose solution in order to maintain the residue in the batch cycle It has a concentration of 0.05% to between. The pH 前 before inoculation is 6.3 ± 0.2. After the pH 値 drops to about 5.3 at the beginning of the fermentation period, the residue of the cycle is added by adding ammonium hydroxide. The pH 値 was maintained in the range of 5 · 5 ± 0 · 2. Foaming was controlled by the addition of a solid polyethylene glycol antifoam provided by OSI Specialties, Inc. under the trade name s AG 4 7 i. Culture The growth of the material initially occurred during the first 24 hours of the cycle, at which time PMV was about 40%, the pH was about 5.6, and the amount of dissolved oxygen was about 50% by volume. Conreno started even when the culture was growing. During biotransformation, monitor the Conranow and n "_ Concord" by analyzing daily samples. The samples were extracted with hot ethyl acetate, and TLC and PLC were used. Analyze the resulting sample solution. When the residual Conranow concentration is approximately 10% of the original concentration, the bioconversion is considered complete. The approximate conversion time is 110 to 300 hours. When the bioconversion is complete At this time, the biological mass of the mycelium was separated from the broth by centrifugation. The supernatant was extracted with an equal volume of ethyl acetate, and the liquid layer was discarded. The portion of the mycelium was resuspended in ethyl acetate , Each gram is loaded with fermentation anti-162- This paper size applies to the Chinese standard (CNS) &amp; See Grid (297 mm factory (please read the notes on the back before filling this page) 1 «· Order 593305 Printed by the Employees' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Α7 Β7 V. Description of the invention (16) The Reynolds of the reactor uses about 65 parts by volume. Under stirring, the mycelium suspension is refluxed for one hour, cooled to about 20X :, and filtered on a porcelain funnel. The perireone of the Reynolds is filled in the fermenter Five volumes of ethyl acetate were used to rinse the mycelium cake twice 'and then rinsed with deionized water (1 liter) to remove residual ethyl acetate. Mix aqueous extracts, rich solvents, solvent rinses, and water washes. Discard or re-extract the residual depleted mycelium filter cake, based on the analysis of the remaining steroids. Allow the mixed liquid phases to stand for two hours. The liquid phase was then separated and discarded, and the organic phase was concentrated under vacuum to a volume of about 500 liters. Then leave the bottom to cool to 15 ° C and slowly stir off for about an hour. The crystalline product was recovered by filtration, and rinsed with cold ethyl acetate (100 ml). The solvent was removed from the crystals by evaporation, and the crystallized product was dehydrated under a vacuum of 50 t. As described in Example 4, freeze-dried spores of A. flavus ATTI 1 85 00 were suspended in corn slurry growth medium (2 l). Ten agar plates were also prepared in the same manner as in Example 4. These plates were grown and harvested as described in Example 4 to provide the main cell bank. The vial containing the main cell bank was stored in the vapor phase of a liquid nitrogen refrigerator. The working cell bank was prepared from the vial of the main cell bank as described in Example 4 and stored at -130. (: Nitrogen refrigerator. The growth medium (300 ml) with the composition listed in Table 19 was charged into a 2 liter deflection flask. An aliquot (3 ml) of the working cell suspension was introduced into the flask. . On a rotary stirrer (200 rpm, 5 cm displacement), the inoculation mixture was grown at 28π for 20-24 hours to produce an original seed culture with a large size of -163-. This paper size applies to Chinese national standards (CNS ) Α4 specification (210X297mm) ~ &quot; -----. (Please read the notes on the back before filling out this page} 1 «. Order 593305 A7 ______B7 V. Description of the invention (161) Approximately 45% of the filling Mycelial volume percentage. When the culture was visually inspected, it was found to contain small spheroid-like mycelia with a diameter of 1 to 2 millimeters; and during microstatic examination, it was shown to be a pure culture. Table 19 Original And a second seed culture A certain amount per liter of glucose per liter (loaded after sterilization) 20 g gland 20 g yeast extract 20 g distilled water to 1000 ml sterilized at 12 1 ° C for 30 minutes (please read the back Please fill in this page again)) The second seed culture of the staff consumer cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs shall be used for the cultivation of the second seed culture. Start the incubator with 160 ml to 200 liters of the original seed culture of this example. Inoculate the fermenter. Prepare as described above. Incubate the inoculation mixture at 28 ° C for 18-20 hours at 200 rpm. The aeration rate was 0.5 vvm, and at the end of breeding, the culture showed the same characteristics as described above for the original seeds. The transformation was operated in a 60 liter fermenter, generally in the manner described in Example 4, except for growth The culture medium has the composition listed in Table 20, and the second seed culture taken from the initial load is 350 liters to 700 ml. The stirring rate is initially 2000 rp m, but because of the need to maintain the solubility Oxygen Above vol%, it increased to 500 rp m. The approximate bioconversion time for 20 grams / liter of Conorno is 80 to 160 hours. -164- The scale is applicable to China National Standard (CNS) A4 specifications ( 210X297 mm) &quot; '--- Order A7 B7 Five invention description (162 Table 20 Growth medium i Glucose (filled after sterilization) Gland

酵母萃取物 以在無菌水中之20%淤漿之形式 jZ±jij^_35 升,在 12rcT^^IT 實例6 Γ請先閱讀背面之注意事¾再填寫本頁) 1« 使用得自根據在實例4中描述的方法製備之工作細胞銀十 的孢子懸浮液,大體上亦根據在實例4中描述的方法來製命 原始和第二個種子培養物。利用以此方式產生的第二個奉 子培養物,根據在圖i中説明之類型的修改方法,進行兩秦 生物轉化作用,並以圖2中説明的方法進行兩輪。在表2 Η 列舉出轉化生長培養基、康雷諾添加計劃表、收獲時間矛 這些過程的轉化程度。R2 Α過程使用以與實例3類似之原貝 爲基礎的康雷諾添加計劃,而R2 c過程則藉著僅添加兩;j 康雷諾,來修改實例3,一次在該批開始時,而另一次是4 24小時後。在r2b和r2d過程中,在該批開始時導入全名 的康雷諾裝载量,並以在實例4中描述的方式來完成該過身 ’除了在將康雷諾裝入發酵器之前,先在不同的容器中另 要裝入的康雷諾滅菌,並在進行時加入葡萄糖。使用章4 氏(Waring)摻合器,以便減少在滅菌時產生的厚塊。在R2 -165 本紙張尺度適用中國國家標準(CNS)八4規格(210x 297公麓) ,丁 、-=口 經濟部中央標準局員工消費合作社印製Yeast extract in the form of a 20% slurry in sterile water jZ ± jij ^ _35 liters, at 12rcT ^^ IT Example 6 Γ Please read the notes on the back first ¾ then fill out this page) 1 «Use from according to the examples A spore suspension of the working cell silver ten prepared by the method described in 4 was used to prepare the original and second seed cultures substantially also according to the method described in Example 4. Using the second Fengzi culture produced in this way, two Qin biotransformations were performed according to the type of modification method illustrated in Figure i, and two rounds were performed in the method illustrated in Figure 2. Table 2 Η lists the degree of transformation of the transforming growth medium, Conreno supplement schedule, and harvest time. The R2 Α process uses a Conreno addition plan based on the original shell similar to Example 3, while the R2 c process modifies instance 3 by adding only two; j Conreno, once at the beginning of the batch and another It's 4 after 24 hours. In the r2b and r2d process, the full name Conranow load is imported at the beginning of the batch and the pass is completed in the manner described in Example 4. Conranos is sterilized in a separate container and glucose is added during the process. Use a chapter 4 Waring blender to reduce lumps generated during sterilization. In R2 -165, this paper size applies Chinese National Standard (CNS) 8-4 specifications (210x 297 feet).

n n I 593305 A7 B7 五、發明説明(163 ) 和R2 B過程中,將在甲醇溶液中的康雷諾導入該批反應中 ,就這方面是分別與實例3和4相異的過程。 表2 1 -最初之康雷諾生物轉化作用過程的説明 過程編號 R2 A R2B R2C R2D 培養基(克/升) 玉米漿 30 與R2A過程 30 與R2C過程 酵母萃取物 15 相同 15 相同 NH4H2P〇4 3 3 葡萄糖 15 30 OSA 0.5毫升 0.5毫升 pH値 以 2.5 N NaOH 以2.5 N NaOH 調整到6.0 調整到6.5 康雷諾 10克/80毫升甲 80克/640毫 滅菌並掺合; 滅菌並捧合 醇,在0,1S, 升甲醇,在0 在0小時加入 ;在0小時 24, 30, 36, 42, 小時時一起 25克,在24小 時加入200 50, 56, 62和 68 加入 時加入200克 克 小時時加入 收獲時間 143小時 166小時 125小時 104小時 生物轉化 45.9% 95.6% 98.1% 95.1% 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 在過程R2A和R2B中,甲醇濃度在發酵啤酒中累積到大約 6.0 %,發現其抑制了培養物的生長和生物轉化作用。然而 ,以這些過程的結果爲基礎,推論是甲醇或其他可與水混 溶的溶劑,可有效地以較低濃度供應,以便增加康雷諾的 裝載,並以細粒沉澱之形式提供,提供大的界面面積,以 -166- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 __________ B7 五、發明説明(164 ) 經濟部中央標準局員工消費合作社印製 便使康雷諸暴露在反應下。 證實康雷諾在滅菌溫度(丨2 1 °C )下是穩定的,但會聚集成 厚塊。使用韋林氏摻合器,將團塊擠壓成細粒,使其順利 地轉變成產物。 ’ 實例7 使用得自根據在實例4中描述的方法產生之工作細胞銀行 的孢子懸浮液,大體上亦以在實例4中描述的方式,來製: 原始和第二個種子培養物。在表22中展示實例7之説明和結 果。利用以該方式產生的第二個種子培養物,進行一個^ 體上如同實例3描述的生物轉化作用(R3C),並進行三個根 據實例5中一般描述之方法的生物轉化作用。在後三個過程 中(R3A、R3B和R3D),在手提桶子中將康雷諾與葡萄糖以 外的生長培養基一起滅菌。從其他的桶子供應未滅菌的葡 萄糖。在接種之前或在生物轉化作用的早期,將滅菌的康 雷諾懸浮液導入發酵器中。在過程R3]B中,以465導入補 充的播菌康雷諾和生長培養基。經由韋林氏摻合器去除在 滅菌時形成的康雷諾厚塊,使因此而產生的細粒懸浮液進 入發酵器。在表22和23中列出這些過程的轉化生長培養基 康田%添加計劃、營養添加計劃、收獲時間和轉變的程 度0 (請先閱讀背面之注意事項再填寫本頁j -訂 &gt; -^1. -167- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 五、發明説明(i65) 經濟部中央標準局員工消費合作社印f 表2 2 -康雷諾生物轉化作用之過程的説明 過程編號 R3 A R3B R3C R3D 培養基(克/ 升) 與過程R3A 玉米漿 30 與過程R3A 腺:20 相同 酵母萃取物 15 相同 酵母萃取物:2〇 NH4H2P〇4 3 葡萄糖:20 葡萄糖 15 OSA3毫升 OSA 0.5毫升 以 2.5 N NaOH pH値 以 2.5 N NaOH 調整到6.5 調整到6.5 裝入康雷諾 將康雷諾滅菌並 與過程R3A相 未滅菌的康雷 與過程R3A 摻合。BL50克 同BI:50克 諾:藉著在表23 相同BL50克 16.5小時:110克 16.5小時:110克 中所列的計劃 16.5 小時:110 46.5小時:80克 裝入 克 供給 見表23 見表23 見表23 見表23 收獲時間 118.5小時 118.5小時 118.5小時 73.5小時 生物轉化 93.7% 94.7% 60.0% 68.0% (請先閱讀背面之注意事項再填寫本頁) -168-本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 五 發明説明(I66)n n I 593305 A7 B7 5. In the process of the invention (163) and R2 B, the introduction of Conreno in a methanol solution into this batch of reactions is a process different from Examples 3 and 4 in this respect. Table 2 1-Description of the original Conranox biotransformation process Process number R2 A R2B R2C R2D medium (g / l) Corn slurry 30 and R2A process 30 and R2C process yeast extract 15 same 15 same NH4H2P04 4 3 glucose 15 30 OSA 0.5ml 0.5ml pH 値 2.5N NaOH 2.5N NaOH Adjusted to 6.0 Adjusted to 6.5 Conreno 10g / 80ml A 80g / 640 milliliter sterilized and blended; sterilized and mixed with alcohol, at 0, 1S, liters of methanol, added at 0 in 0 hours; 25 grams together at 0, 24, 30, 36, 42, hours; 200 50, 56, 62 and 68 added at 24 hours; Harvest time 143 hours 166 hours 125 hours 104 hours Biotransformation 45.9% 95.6% 98.1% 95.1% Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) In the process R2A and R2B, The methanol concentration accumulated to about 6.0% in the fermented beer and was found to inhibit the growth and biotransformation of the culture. However, based on the results of these processes, it is inferred that methanol or other water-miscible solvents can be effectively supplied at lower concentrations in order to increase Conorno's loading and provide it in the form of fine-grained precipitates, providing large The interface area is -166- This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 A7 __________ B7 V. Description of the invention (164) Printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs makes Kang Lei Exposure to reaction. It was confirmed that Connor was stable at sterilization temperature (21 ° C), but converged into thick blocks. Using a Welling's blender, the agglomerates are extruded into fine granules to allow them to transform smoothly into products. Example 7 A spore suspension obtained from a working cell bank produced according to the method described in Example 4 was used, generally also in the manner described in Example 4, to produce: the original and the second seed culture. The description and results of Example 7 are shown in Table 22. Using the second seed culture produced in this way, a biotransformation (R3C) as described in Example 3 was performed in vivo, and three biotransformations according to the method generally described in Example 5 were performed. In the last three processes (R3A, R3B, and R3D), Conreno is sterilized in a hand bucket with growth media other than glucose. Supply unsterilized glucose from other buckets. The sterile Conreno suspension is introduced into the fermenter before inoculation or early in the biotransformation. In process R3] B, supplemented sowing conreno and growth medium were introduced at 465. The Conranow lumps formed during sterilization were removed via a Wehring blender, and the resulting fine-particle suspension was fed into the fermenter. The transformation growth medium Kangtian% addition plan, nutrient addition plan, harvest time, and degree of transformation of these processes are listed in Tables 22 and 23. 0 (Please read the precautions on the back before filling out this page j -Order &gt;-^ 1. -167- This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) 593305 V. Description of Invention (i65) Printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Table 2 2-Conranos Biotransformation Process description Process number R3 A R3B R3C R3D medium (g / l) and process R3A corn slurry 30 and process R3A gland: 20 same yeast extract 15 same yeast extract: 2〇NH4H2P〇4 3 glucose: 20 glucose 15 OSA3 Ml of OSA 0.5 ml with 2.5 N NaOH pH 値 adjust with 2.5 N NaOH to 6.5 adjust to 6.5 Load Conranos Sterilize Conranos and blend it with Process R3A Non-sterilized Conrad and Process R3A. BL50 g with BI: 50 Knorr: By the same BL50 grams in Table 23 16.5 hours: 110 grams 16.5 hours: 110 grams Scheduled 16.5 hours: 110 46.5 hours: 80 grams per gram supply see 23 See Table 23 See Table 23 See Table 23 Harvest time 118.5 hours 118.5 hours 118.5 hours 73.5 hours Biotransformation 93.7% 94.7% 60.0% 68.0% (Please read the notes on the back before filling this page) -168- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 A7 B7 Five invention descriptions (I66)

經濟部中央標準局員工消費合作社印製 康雷諾200克/2 葡萄糖 腺和酵母萃 抗生素20毫克康 康雷語/生 康雷諾/生 康雷諾/生 升無菌的DI水 50%溶液 取物各20克 黴素20毫克四環 長培養基參 長培養基 長培養基 克 克 在1升水中 素1〇〇毫克頭孢 見表22 參見表22 參見表22 克 菌素在50毫升巾 克/升 克/升 克/升 0 - - - - 50克/0.4升 50克/0.4升 50克/0.4升 14.5 16 100 25 50毫升 —— - 16.5 ~ - - - 110 克/1.2 升 110 克/1.2 110 克 A .2 升 升 20.5 16 140 25 - —- 一 28.5 16 140 25 - •㈣ — 34.5 16 150 25 — __ — 40.5 16 150 25 50毫升 — - 46.5 880 130 25 - 80克/0.8升 — 52.5 160 120 25 一 —— -- 58.5 160 150 25 - — — 64.5 160 180 25 50毫升 — - 70.5 160 140 25 — — - - (請先閱讀背面之注意事項再填寫本頁) 訂 -169. 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇&gt;&lt;297公釐) 593305 A7 B7 五、發明説明(I67) 經濟部中央標準局員工消費合作社印製 因馬絲狀生長,在本實例的全部四個過程中都看到高黏性 的發酵肉湯。欲克服與充氣、混合、PH値控制和溫度控制 有關,由高黏性產生的阻礙,在這些過程中需增加充氣速 率和攪拌速度。轉化作用如願地在較嚴格的條件下進行, 但是在液體肉湯表面上形成緊密的餅。藉著該餅將一些未 反應的康雷諾帶出肉湯之外。 實例8 在表24中蓋述實例8的説明和結果。進行四個發酵過程, 其中藉著康雷諾的生物轉化作用來產製n羥基康雷諾。 在這些過程其中兩個(R4A和R4D)中,以大體上類似實例6 之過程R3 Α和R3D的相同方式來經營生物轉化作用。在過 程R4C中,通常以在實例3中描述的方法將康雷諾轉變爲&quot; 沒-羥基康雷諾。在過程R4B中,該過程通常根據在實例4 中的描述來冗成,也就是正好在接種之前,在發酵器中將 康雷語和生長培養基滅菌,在該批反應開始時導入全部的 氮和磷營養,並且僅供應含有葡萄糖的補充溶液至發酵器 内,以便在該批反應進行時維持葡萄糖的含量。在較後的 過程(R4B)中,每6小時監視葡萄糖濃度,並按照指示加入 葡萄糖溶液,以便控制葡萄糖含量在0 · 5到1 %的範圍内。 這些過程的康雷諾添加計劃列在表25中。 -170· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公麓) (請先閱讀背面之注意事項再填寫本頁) -訂_ 593305 A7 B7 五 、發明説明(l68) 表24-康雷諾生物轉化作用之展開實驗的方法説明 過程編號 R4 A R4B R4C R4D 培養基(克/升) 玉米漿 30 與過程R4A 腺:20 與過程R4A 酵母萃取物 15 相同 酵母萃取物:20 相同 ΝΗ4Η2Ρ〇4 3 葡萄糖:2〇 葡萄糖 15 〇SA:3毫升 OSA 0.5毫升 以 2.5 N NaOH pH値 以 2·5 N NaOH 調整到6.5 調整到6.5 裝入康雷諾 將康雷諾滅菌並 在發酵器中將 未滅菌的康雷 將康雷諾$ 摻合。BI:40克 160克康雷諾 諾:藉著在表25 菌並摻合。 23.5小時:120克 滅菌 中所列的計劃 ΒΙ_·4〇 克 23.5 装入 小時:120克 裝入培養基 見表25 見表25 見表25 見表25 收獲時間 122小時 122小時 122小時 122小時 生物轉化 95.6% 97.6% 95.4% 96.7% (請先閱讀背面之注意事項再填寫本頁} «. 經濟部中央標準局員工消費合作社印製 -171 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐 593305Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 200g / 2 Glucose and Yeast Extracted Antibiotics 20mg Grammycin 20 mg tetracyclic long medium ginseng medium long gram g in 1 liter of water 100 mg cephalosporin see table 22 see table 22 see table 22 grammycin in 50 ml towels g / l g / l g / 0----50 g / 0.4 liter 50 g / 0.4 liter 50 g / 0.4 liter 14.5 16 100 25 50 ml--16.5 ~---110 g / 1.2 liter 110 g / 1.2 110 g A .2 liter Liter 20.5 16 140 25-—- 1 28.5 16 140 25-• ㈣ — 34.5 16 150 25 — __ — 40.5 16 150 25 50 ml —-46.5 880 130 25-80 g / 0.8 liter — 52.5 160 120 25 1 — -58.5 160 150 25-—-64.5 160 180 25 50 ml —-70.5 160 140 25 — —--(Please read the notes on the back before filling out this page) Order -169. This paper size applies to Chinese national standards ( CNS) A4 specification (21〇 &gt; &lt; 297 mm) 593305 A7 B7 Note (I67) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Due to the horse-like growth, high-viscosity fermented broth was seen in all four processes in this example. In order to overcome the obstacles caused by high viscosity caused by aeration, mixing, pH control and temperature control, it is necessary to increase the aeration rate and stirring speed in these processes. The conversion is carried out under more stringent conditions as desired, but forms a tight cake on the surface of the liquid broth. Use the cake to take some unreacted Conreno out of the broth. Example 8 The description and results of Example 8 are summarized in Table 24. Four fermentation processes were carried out, in which n-Hydroxy Conreno was produced by Conreno's biotransformation. In two of these processes (R4A and R4D), the biotransformation was operated in the same way as the processes R3 A and R3D of Example 6. In the process R4C, Conranow is generally converted to &quot; N-Hydroxy Conranow in the manner described in Example 3. In process R4B, this process is usually redundant as described in Example 4, that is, just before inoculation, the Conley and growth medium are sterilized in the fermenter, and all nitrogen and nitrogen are introduced at the beginning of the batch reaction Phosphorus is nutritional, and only a supplementary solution containing glucose is supplied to the fermenter in order to maintain the glucose content as the batch reaction proceeds. In the later process (R4B), the glucose concentration is monitored every 6 hours and the glucose solution is added as instructed to control the glucose content in the range of 0.5 to 1%. The Conrad addition schedule for these processes is listed in Table 25. -170 · This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 feet) (Please read the precautions on the back before filling this page)-Order _ 593305 A7 B7 V. Description of Invention (l68) Table 24-Kang Methodology of the development experiment of Renault Biotransformation Process number R4 A R4B R4C R4D medium (g / l) Corn slurry 30 and process R4A gland: 20 and process R4A yeast extract 15 Same yeast extract: 20 Same ΝΗ4Η2Ρ〇4 3 Glucose: 2 glucose 15 〇SA: 3 ml of OSA 0.5 ml with 2.5 N NaOH pH 値 with 2.5 N NaOH Adjust to 6.5 Adjust to Conranox Sterilize Conranox and unsterilize Kangran in a fermenter Ray Blends Connor $. BI: 40 g 160 g Conorno: By bacteria in Table 25 and blended. 23.5 hours: 120 grams of schedule listed in sterilization of 40 grams 23.5 Loading hours: 120 grams of loading medium See Table 25 See Table 25 See Table 25 See Table 25 Harvest time 122 hours 122 hours 122 hours 122 hours Biotransformation 95.6% 97.6% 95.4% 96.7% (Please read the notes on the back before filling out this page} «. Printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs -171 This paper size applies to China National Standard (CNS) A4 (210X297) Cm 593305

7 7 A B 五、發明説明(169) 經濟部中央標準局員工消費合作社印掣 表25-在展開實驗時,康雷諾、葡萄糖和生長培養基的供給計劃 添加 時間 小時 R4C R4A R4B R4D 康雷諾200克/2 葡萄糖 腺和酵母萃 抗生素20毫克康黴 生長培養基 生長培 康雷諾/生 升無菌的水 克 50%溶液 克 取物各20克 在1升水中 克 素20毫克四環素100 毫克頭孢菌素在50 毫升中(以康雷諾於 漿形式加入) 參見表24 養基參 見表24 長培養基參 見表24 克/升 14 600 135 25 50毫升 — — — 20 —— 100 -- -- — - — 23 — __ — 120 克/1.2 升 120 克/1.2 升 26 — 100 25 — — — — 32 — 135 25 — — — ~ 38 500 120 25 50毫升 —— —— — 44 — 100 25 — — — — 50 __ 100 25 — 晒幢 — — 56 — 150 25 — — —— 義一 62 500 150 25 50毫升 — —— — 68 — 200 25 — -- — — 74 — 300 25 — — — — 80 — 100 25 一- -- — — 86 — 125 25 · — 讓一 晒· 92 — 175 25 — — —— — 98 — 150 -- — -- — — 104 — 175 — ~ — — — 110 — 175 — — — —— — 116 — 200 — — — — — -172- (請先閱讀背面之注意事項再填寫本頁) 訂 P. 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 五、發明説明(no) 充酵&amp;在大4份發酵循環的期間内,都在高攪拌和 2:-Γ 酵啤酒已經在-天内或在接種後就已 經變成鬲黏性的。 實例9 在表26中列出有關進行本實例之轉化生長培養基、康雷 語添加計劃、收獲時間,和轉化的程度。 、除了如下的説明之外,大體上以在實例8之過程r4b中描 述的方法來完成四個生物轉化過程。在過程R5B中,使用 頂邪渴輪盤推進器來攪拌,在其他的過程中則以向下抽取 的海水推進器來代替之。向下抽取的作用使肉湯向軸心流 入發酵器的中心,而減少餅的形成。在過程r 5 D中,在接 種之後立刻加入甲醇(2〇〇毫升)。因爲在發酵器中的康雷諾 是無菌的,所有的營養除了葡萄糖之外均在該批反應開始 時加入,排除了連續供應氮來源、磷來源或抗生素的需要。 -173- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁}7 7 AB V. Description of the invention (169) Consumption Cooperatives of the Central Standards Bureau, Ministry of Economic Affairs, India, 25. When the experiment is started, the supply schedule of Conorno, glucose and growth medium is hours R4C R4A R4B R4D Conorno 200g / 2 Glucose gland and yeast-derived antibiotics 20 mg of Kang mold growth medium growth perconox / liter sterile water 50 g solution 20 g each in 1 liter of water 20 mg tetracycline 100 mg cephalosporin in 50 ml Medium (added in the form of Conreno in a slurry) See Table 24 Nutrients See Table 24 Long medium See Table 24 g / L 14 600 135 25 50 ml — — — 20 — 100--— — — 23 — __ — 120 g / 1.2 liters 120 g / 1.2 liters 26 — 100 25 — — — — 32 — 135 25 — — — ~ 38 500 120 25 50 ml — — — 44 — 100 25 — — — — 50 __ 100 25 — Sun building — — 56 — 150 25 — — — — Yi Yi 62 500 150 25 50 ml — — — 68 — 200 25 — — — — 74 — 300 25 — — — 80 — 100 25 — — — — —86 — 125 25 · — Let's go · 92 — 175 25 — — — — 98 — 150-—-— — 104 — 175 — ~ — — — 110 — 175 — — — — — 116 — 200 — — — — — -172- (Please read the notes on the back before filling out this page) Order P. This paper size is applicable to China National Standard (CNS) A4 (210X 297 mm) Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs System V. Description of the invention (no) Fermentation &amp; During the period of 4 large fermentation cycles, all are under high agitation and 2: -Γ fermented beer has become sticky within -days or after inoculation. Example 9 In Table 26, the transformation growth medium, Conrad addition plan, harvest time, and degree of transformation for performing this example are listed. Except for the following explanations, the four biotransformation processes were generally performed by the method described in the process r4b of Example 8. In process R5B, a thirsty roulette propeller is used for agitation. In other processes, a downwardly drawn seawater propeller is used instead. The downward pumping action causes the broth to flow axially into the center of the fermenter, reducing cake formation. In process r 5 D, methanol (200 ml) was added immediately after seeding. Because the Connor in the fermenter is sterile, all nutrients except glucose are added at the beginning of the batch, eliminating the need for a continuous supply of nitrogen, phosphorus, or antibiotics. -173- This paper size applies to China National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page}

593305 A7 B7 經濟部中央榡準局員工消費合作衽印製 五、發明説明(171 表26-在10升規模之生物轉化作用的展開實驗之過程的方法説明 過程編號 R5 A R5B R5C R5D 培養基(克/升) 玉米漿 酵母萃取物 ΝΗ4Η2Ρ〇4 葡萄糖 OSA pH値 30 15 3 15 0.5毫升 以 2·5 N NaOH 調整到6.5 與過程R5A 相同 腺:20 酵母萃取物:2〇 葡萄糖:20 〇SA:3亳升 以 2.5 N NaOH 調整到6.5 與過程R5A 相同 裝入康雷諾 在發酵器中將 160克康雷諾滅 菌 在發酵器中將 160克康雷諾 滅菌 在發酵器中將 16〇克康雷諾 滅菌 在發酵器中 將160克康雷 諾滅菌 培養基供應 供應葡萄糖 供應葡萄糖 供應葡萄糖 供應葡萄糖 收獲時間 119.5小時 119.5小時 106小時 119.5小時 生物轉化 96% 94.1% 88.5% 92.4% 爲了維持在液體表面上生長之固相的浸潤,在該批反應開 始後9 6小時,在每個發酵器中加入生長培養基(2升)。藉著 加入生長培養基或使用向下抽取的推進器(過程r 5 B ),旅 不能完全克服混合的問題,但是該過程的結果證實該方法 的可行性和優點,並顯示根據傳統習慣可提供令人滿意的 混合。 -174- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29?公釐) (請先閱讀背面之注意事項再填寫本頁)593305 A7 B7 Consumption cooperation with employees of the Central Bureau of Standards of the Ministry of Economic Affairs. Printed 5. Description of the invention (171 Table 26-Method for carrying out the experiment on the biotransformation on a scale of 10 liters. Process description R5 A R5B R5C R5D culture medium Per litre) corn pulp yeast extract ΝΗ4Η2Ρ〇4 glucose OSA pH 値 30 15 3 15 0.5 ml adjusted with 6.5 N NaOH to 6.5 Same as the process R5A gland: 20 yeast extract: 2 glucose: 20 〇SA: 3 The liter was adjusted to 2.5 with 2.5 N NaOH. It was the same as the process R5A. Loaded into Conranos. Sterilized 160 grams of Conranos in the fermenter. Sterilized 160 grams of Conranos in the fermenter. Sterilized 160 grams of Conranos in the fermentation. 160 grams of Conreno sterilization medium supply glucose supply glucose supply glucose supply glucose supply glucose harvest time 119.5 hours 119.5 hours 106 hours 119.5 hours Biotransformation 96% 94.1% 88.5% 92.4% In order to maintain the infiltration of the solid phase growing on the liquid surface 9 to 6 hours after the start of the batch, add growth medium (2 liters) to each fermenter. By adding the growth medium Using a downwardly drawn thruster (process r 5 B), the brigade cannot completely overcome the mixing problem, but the results of the process confirm the feasibility and advantages of the method and show that it can provide satisfactory mixing according to traditional practices- 174- The size of this paper applies to Chinese National Standard (CNS) A4 (210X29? Mm) (Please read the precautions on the back before filling this page)

、1T 593305 A7 B7 五、發明説明(I72) 實例1 0 大體上以在實例9中描述的方法來進行三個生物轉化的過 程。在表2 7中列出轉化培養基、康雷諾添加計劃、收獲時 間,和本實例之過程的轉化程度: 表27-10升規模之生物轉化作用的實驗方法之説明 過程編號 R6A R6B R6C 培養基(克/升) 玉米漿 30 與過程R6A 腺:20 酵母萃取物 15 相同 酵母萃取物:2〇 NH4H2P〇4 3 葡萄糖:20 葡萄糖 15 OSA:0.5 毫升 OSA 0.5毫升 以2.5 N NaOH調整到 pH値 以 2.5 N NaOH 調 整到6.5 6.5 裝入康雷語 在發酵器中將160 在發酵器中將160 在發酵器中將160克康 克康雷諸滅菌 克康雷諾滅菌 雷諾滅菌 培養基供應 供應葡萄糖:在71 供應葡萄糖;在 供應葡萄糖;不另外 小時1.3升培養基 96小時0.5升培養 添加 和0.8升無菌的水 基和0.5升無菌的 水 : 收獲時間 120小時 120小時 120小時 生物轉化 95% 96% 90% 物料平衡 59% 54% 80% 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 在過程R6A中,在7 1小時後加入生長培養基(1.3升)和無菌 的水(0.8升),以便淹沒在液體肉湯表面上生長的菌絲體餅 。爲了相同的目的,在過程R6 B中,在9 5小時後加入生長 -175- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐1 593305 五、發明説明(Π3) 培養基(0.5升)和無菌的水(G5升)。物料平衡數據顯示減 少在液面上建造出的餅,可定出較佳的物料平衡。 實例1 1 進行發酵過程以便比較康雷諾的預先滅菌以及在轉化發 酵器中將康雷諾與生長培養基一起減菌。在過程R7A中, 按照圖2中的説明,在可與過程r2C、R2D、R3 A、R3B、 R3D、R4 A和R4D相比擬的那些條件下完成該過程。過程 R7B則按照圖3的説明,在可與實例4、9和丨〇,以及過程 R4B相比擬的那些條件下完成。在表2 8中列出本實例之過 私的轉化生長培養基、康雷語添加計劃、收獲時間和轉化 程度: (請先閱讀背面之注意事項再填寫本頁) -訂 經濟部中央標準局員工消費合作社印製 176- ------ 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 五、發明説明(174 ) 表2 8 -1 0升規模之生物轉化作用的實驗方法説明 過程編號 R7A R7B 培養基(克/升) 玉米漿 30 與過程R7 A相同 酵母萃取物 15 NH4H2P〇4 3 葡萄糖 15 OSA 0.5毫升 pH値 以2.5NNaOH調整到6.5 裝入康雷諾 在發酵器外將160克康雷 在發酵器中將160克康雷 諾滅菌並摻合 諾滅菌 培養基供應 供應葡萄糖;將康雷諾與 供應葡萄糖: 1.6升生長培養基一起加 不另外添加 入 收獲時間 118.5小時 118.5小時 生物轉化 93% 89% (請先閲讀背面之注意事項再填寫本頁 經濟部中央標準局員工消費合作社印製 以得自過程R7 B之最終試樣爲基礎的物料平衡爲8 9.5 %, 顯示在生轉化作用中並無明顯的受酶質喪失或降解。確定 兩個過程的混合都是適當的。 在最初8 0小時的期間内,殘餘的葡萄糖濃度在想要的5 -1 0 gp 1控制範圍以上。過程的效率顯然不受在兩個發酵器 液面上空間堆積之鬆餅的影響。 實例1 2 -177- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 經濟部中央標準局員工消費合作社印製 五、發明説明(175) 按照在表2 9中的概述,以一系列1升萃取過程來決定萃取 效率。在每一個過程中,利用醋酸乙酯(1升/升發酵體積)從 菌絲體中萃取類固醇。每個過程進行兩次連續的萃取。以 RP-HPLC爲基礎,在第一次萃取時回收大約80%的總類固 醇;並藉著第二次萃取使回收增加至9 5 %。第三次萃取將 回收其他的3 %類固醇。剩下的2 %喪失在上清液液相中。利 用眞空將萃取抽吸至無水,但是不用任何額外的溶劑沖洗 。如果爲了方法經濟上的理由,利用溶劑追捕將改善得自 原始萃取的回收。 表29 -在1升萃取作用中11以-羥基康雷諾的回收(總和的%) 過程編號 第一次萃取 第二次萃取 第三次萃取 上清液 R5A 79% 16% 2% 2% R5A 84% 12% 2% 2% R4A 72% 20% 4% 4% R4A 79% 14% 2% 5% R4B 76% 19% 4% 1% R4B 79% 16% 3% 2% R4B 82% 15% 2% 1% 平均 79% 16% 3% 2% 以1升肉湯規模來評估甲基異丁酮(MIBK)和甲苯作爲1 1 α -羥基康雷諾之萃取/結晶作用溶劑。使用如同上述的萃取草 案,比較ΜΙΒΚ和甲苯與醋酸乙酯的萃取效率和結晶作用之 效能。 -178- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁 、1Τ - 593305 A7 B7 經濟部中央標準局員工消費合作社印製 五、發明説明(I76) 作爲評估圖2和3之方法的一部份,在每個方法的發酵猶 環開始時所提供之康雷諾受酶質上,經營顆粒大小的研究 。如同上述’在將康雷諾導入發酵器中之前,先將供應圖1 之方法的康雷諾微粒化。在該過程中,並未將康雷諾減菌 ’藉著加入抗生素來控制不想要的微生物的生長。圖2和3 的過秋則在反應之纟將康雷諾滅菌。在圖2的過程中,係在 導入發酵器之前’在掺合器中完成滅菌。在圖3的過程中, 在該批反應開始時,在發酵器中將在生長培養基中之康雷 諾的懸浮液滅菌。如同在前文中討論的,滅菌易引起康雷 諾顆粒的聚集。因爲康雷諾在含水生長培養基中有限的溶 解度,該方法的生產力視團塊從固相中的移轉而定,並因 此可期望依賴固體顆粒狀受酶質所提供的界面面積,其視 顆粒大小的分布而定。這些考量一開始就成爲圖2和3之方 法的阻礙物。 然而,發現在圖2之摻合器和圖3之發酵桶中的攪拌作用 ,與在圖2中用來移轉的剪切幫浦之作用,使顆粒大小範圍 相當接近供應圖1之方法的未滅菌和微粒化之康雷諾的附聚 作用退化。藉著在這三個過程中,每個反應循環開始時可 表3 0 ·三個;f 、同的康雷諾試樣之顆粒分布 vf ,1 严 |1»1 1 V 試樣 45-125 微米 &lt;180微米 平均大小微米 過程編號# 生物轉化作用% 康雷諾裝載量1 75% 95% — R3C:93.1%(120 小時) -179- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇χ 297公釐) (請先閲讀背面之注意事項再填寫本頁} 1« -訂· 593305 A7 B7 五、發明説明(177 ) R4C:96.3%(120 小時) 捧合的試樣 31.2% 77.2% 139.5 β3Α··94·6%(120 小時) R3B:95.2%(120 小時) 滅菌的d試樣 24.7% 65.1% 157.4 R4B:97.6%(120 小時) R5B:93.8%(120 小時) (請先閱讀背面之注意事項再填寫本頁} 從表3 0之數據得知,將注意到攪拌器和剪切幫浦可有效地 將已滅菌之康雷諾的平均顆粒大小,降低至與未滅菌受酶 質之大小等級相同,但是剩下的顯著大小差異將有利於未 滅菌的受酶質。不管這些差異,反應效率數據顯示,預先 滅菌的方法至少像圖1的方法一樣是有生產力的。在圖2的 方法中,藉著某些進一步減少和控制顆粒大小的步驟,例 如滅菌康雷#之濕式研磨,及/或藉著巴斯德滅菌而非滅菌 ,可獲得更多的利益。 實例1 4 以在實例5中描述的方法來製備種子培養物。在2〇小時後 ’在接種發酵器中的菌絲體是柔軟的,具有4 〇 % ρ μ V。其 ρ Η値爲5 · 4,且剩下未使用的1 4 · 8 gp 1葡萄糖。 經濟部中央標準局員工消費合作社印裝 製備具有表20中所示之組成的轉化生長培養基(35升)。 在供應培養基的製備中,分別將葡萄糖和酵母萃取物滅菌 ,並混合成一份,以3 0重量%之葡萄糖和丨〇重量%之酵母 萃取物的起始濃度。將該份供給物的1)11値調整到57。 利用該培養基(表2 0 ),進行兩個將康雷諾轉變爲1 1從-羥 基康雷諸的生物轉化過程。每個過程分別在備有攪拌器, 包括一個Rushton滿輪推進器和兩個Lightnin,A31q^進器的 180- 本紙張尺度適用中國國豕標率(CNS ) A4規格(21 〇 X 297公瘦) 593305 A7 _____ B7 五、發明説明(l78) 60升發酵器中經營。 一開始裝入發酵器的生長培養基爲3 5升。加入微粒化但 未滅菌的康雷諾,至0 · 5 %之起始濃度。以2 · 5 %之起始接種 比例,利用在實例5中描述之方法製備的種子培養物來接種 發酵器中的培養基。在28 °C的溫度,200至500 rpm之攪: 拌速率’ 0.5 vvm之充氣速率,和足以維持至少2〇體積% 之溶氧量的反壓力下完成發酵作用。在生產過程期間發展 的轉化培養基’疋非常小的擴圓小球的形式(大約1 _ 2毫米) 。通常以在實例1中描述的方法,將康雷諾和補充營養份連 續供應至發酵器中。每四小時以在發酵器中每升肉湯3.4克 葡萄糖和0 · 6克酵母萃取物的比例來進行營養的添加。 在表3 1中列出在本實例每個過程的期間内,在設定間隔 時主要的充氣速率、攪捽速率、溶氧量、PMV,和pH値, 以及在該批反應期間進行葡萄糖的添加。表3 2顯示康雷婼 轉皮作用的外觀。在4 6小時後中止過程r 1 1 a ;過程r 1 1 B 則持續至96小時。在較後的過程中,在81小時時達到9 3 0/〇 的轉變;在84小時時再添加一次供應物;然後中止供應物 。注思到在停止供應之時和過程結束之間,發生了明顯的 黏性變化。 (請先閲讀背面之注意事項再填寫本頁) 1«· 訂 經濟部中央標準局員工消費合作社印製 -181- 本紙張尺度適用中國國家標準(CNS ) 規格(210X^97公釐)~~ 593305 A7 B7 、發明説明(Π9) 經濟部中央標準局員工消費合作社印製 表3 1 發_ H乍用R 1 1 A 時間 空氣(1pm) rpm %DO 反壓力 PMV(%) pH値 葡萄糖(克/升) 0.1 20 200 93 0 2 6.17 5.8 7 20 200 85.1 0 5 6.03 5.5 12.4 20 300 50.2 0 5.43 21.8 20 400 25.5 0 38 6.98 0 29 20 500 17 0 35 5.22 30.2 20 500 18.8 10 5.01 31 20 500 79 10 4.81 1 35.7 20 500 100 10 45 5.57 0 46.2 20 500 23 6 45 5.8 1 總葡萄糖:27.5克/升總酵母萃取物:8.75克/升 發酵作用R11B 時間 空氣(1pm) rpm %DO 反壓力 PMV(%) pH値 葡萄糖(克/升) 0.1 20 200 92.9 0 2 5.98 5.5 7 20 200 82.3 0 5 5.9 5 12.4 20 300 49.5 0 5.48 21.8 20 400 18 0 40 7.12 0 29 20 500 36.8 0 35 5.1 3 35.7 20 500 94.5 10 4.74 0 46.2 20 500 14.5 6 45 5.32 2 55 20 500 16.7 10 5.31 0.5 58.6 20 500 19.4 15 5.32 1 61.9 20 500 13 15 40 5.36 2 71.7 20 500 13 15 42 5.37 0 81.1 20 500 22.9 15 5.42 2.5 85.6 20 500 22 15 45 5.48 1 97.5 20 500 108 15 45 6.47 0 117.7 20 500 15 7.37 0 總葡萄糖:63克/升 總酵母萃取物:14.5克/升 -182- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) (請先閲讀背面之注意事項再填寫本頁 丨«· 、1Τ 593305 五、發明説明(180) 經濟部中央標準局員工消費合作社印掣 表32 發酵過程R11A:康雷諾轉化作用 濃度(克/升〕 轉化 計算ΗΟ-康雷諾 轉化率(克/升/小時) 試樣 時間 ΟΗ-康雷諾 康雷諾 總計 (%) (克/升) 計算値 測量値 R11A-0 0.10 0.00 5.41 5.41 R11Α-7 7.00 0.18 4.89 5.07 3.58 0.18 0.03 0.03 R11A-22 21.8 2.02 2.12 4.14 48.75 2.44 0.15 0.12 R11A-29 29.00 3.67 4.14 7.81 47.03 4.48 0.28 0.23 R11A-36 35.7 6.68 1.44 8.12 82.27 7.74 0.49 0.45 R11A-46 46.20 7.09 0.41 7.51 94.48 8.59 0.08 0.04 發酵過程R1 1Β:康雷諾轉化作用 濃度(克/升〕 轉化 計算ΗΟ-康雷諾 轉化率(克/升/小時) 試樣 時間 ΟΗ-康雷諾 康雷諾 總計 (%) (克/升) 計算値 測量値 R11B-0 0.10 0.00 5.60 5.60 R11B-7 7.00 0.20 4.98 5.18 3.78 0.19 0.03 0.03 R11B-22 21.80 2.51 2.46 4.97 50.49 2.52 0.16 0.16 R11B-29 29.00 4.48 16.99 21.47 20.87 4.69 0.30 0.27 R11B-36 35.70 8.18 10.35 18.53 44.16 9.70 0.75 0.55 R11B-55 55.0 17.03 13.20 30.23 56.33 19.50 0.32 0.36 R11B-59 58.6 20.80 11.73 32.53 63.95 21.97 0.69 1.05 R11B-62 61.9 22.19 8.62 30.81 72.02 24.50 0.77 0.42 R11B-72 71.7 26.62 3.61 30.23 88.06 29.46 0.51 0.45 R11B-81 81.1 27.13 2.05 29.18 92.97 30.32 0.09 0.05 R11B-86 85.6 26.87 2.02 28.88 93.02 30.11 -0.04 -0.06 R11B-97 97.5 23.95 1.71 25.66 93.34 30.22 0.01 -0.25 R11B-118 117.7 24.10 1.68 25.79 93.47 30.26 0.00 0.01 (請先閱讀背面之注意事項再填寫本頁)1T 593305 A7 B7 V. Description of the Invention (I72) Example 1 0 Three biotransformation processes were carried out substantially in the manner described in Example 9. List the transformation medium, Conranos addition schedule, harvest time, and the degree of transformation of the process in this example in Table 27. Table 27. Description of the Experimental Methods for Biotransformation on a 10-liter Scale Process Number R6A R6B R6C Medium (g Per litre) Corn slurry 30 Same as R6A gland: 20 yeast extract 15 same yeast extract: 2〇NH4H2P〇4 3 glucose: 20 glucose 15 OSA: 0.5 ml OSA 0.5 ml with 2.5 N NaOH adjusted to pH 値 with 2.5 N NaOH adjusted to 6.5 6.5 Load Conley in the fermenter will be 160 in the fermenter will be 160 in the fermentor will be 160 grams of Concord sterilized Kronor sterilized Reynolds sterilized medium supply glucose: supply glucose at 71 ; Supply glucose; no additional hours 1.3 liters medium 96 hours 0.5 liters culture addition and 0.8 liters of sterile water-based and 0.5 liters of sterile water: harvest time 120 hours 120 hours 120 hours biotransformation 95% 96% 90% material balance 59 % 54% 80% Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) In process R6A, After 71 h addition of growth medium (1.3 L) and sterile water (0.8 l), in order to submerge mycelial cake on the surface of the liquid broth growth. For the same purpose, in the process R6 B, add growth after 175 hours -175- This paper size applies Chinese National Standard (CNS) A4 specifications (210X 297 mm 1 593305 V. Description of the invention (Π3) Medium (0.5 Liters) and sterile water (G5 liters). The material balance data show that reducing the cakes built on the liquid surface can determine a better material balance. Example 1 1 A fermentation process was performed to compare Conranow's pre-sterilization and conversion Conreno is attenuated with the growth medium in the fermenter. In process R7A, as illustrated in Figure 2, under conditions comparable to those of process r2C, R2D, R3 A, R3B, R3D, R4 A, and R4D This process is completed. Process R7B is completed under the conditions comparable to those of Examples 4, 9, and 丨, and Process R4B, as illustrated in Figure 3. The undesired transformational growth of this example is listed in Tables 28. Culture medium, Conley language addition plan, harvest time and degree of transformation: (Please read the notes on the back before filling out this page)-Ordered by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs to print 176- ------ This paper size Applicable in China Standard (CNS) A4 (210X297 mm) 593305 V. Description of the invention (174) Table 2 Experimental method description of biotransformation on a scale of 10 liters-Process number R7A R7B medium (g / L) Corn slurry 30 and Process R7 A same yeast extract 15 NH4H2P〇4 3 glucose 15 OSA 0.5 ml pH 値 adjusted to 2.5 NNaOH to 6.5 Load Conranox outside the fermenter 160 g of Conrad sterilized and blended in the fermenter Hano sterilization medium supply and supply of glucose; Conreno with supply of glucose: 1.6 liters of growth medium with or without addition to harvest time 118.5 hours 118.5 hours Biotransformation 93% 89% (Please read the precautions on the back before filling out this page The Ministry of Central Standards Bureau ’s Consumer Cooperative printed a material balance of 89.5% based on the final sample obtained from process R7 B, showing no significant loss or degradation of enzymes during biotransformation. Two processes were identified The mixing is appropriate. During the first 80 hours, the residual glucose concentration is within the desired control range of 5 to 10 gp 1 Above. The efficiency of the process is obviously not affected by the muffins stacked on the liquid surface of the two fermenters. Example 1 2 -177- This paper size applies to China National Standard (CNS) A4 (210X297 mm) 593305 Ministry of Economic Affairs Printed by the Consumer Standards Cooperative of the Central Bureau of Standards 5. Description of the Invention (175) According to the summary in Table 29, a series of 1 liter extraction processes are used to determine the extraction efficiency. In each process, ethyl acetate (1 L / L fermentation volume) was used to extract steroids from the mycelium. Each process is continuous and extracted twice. Based on RP-HPLC, approximately 80% of the total steroids were recovered during the first extraction; and the recovery was increased to 95% by the second extraction. The third extraction will recover the other 3% steroids. The remaining 2% is lost in the supernatant liquid phase. Extract with suction to dryness, but rinse without any additional solvents. If for method economic reasons, solvent hunting will improve the recovery from the original extraction. Table 29-Recovery of 11-Hydroxy Conreno in 1 liter extraction (% of total) Process number First extraction Second extraction Third extraction supernatant R5A 79% 16% 2% 2% R5A 84 % 12% 2% 2% R4A 72% 20% 4% 4% R4A 79% 14% 2% 5% R4B 76% 19% 4% 1% R4B 79% 16% 3% 2% R4B 82% 15% 2% 1% Average 79% 16% 3% 2% Methyl isobutyl ketone (MIBK) and toluene were evaluated on a 1 liter broth scale as the extraction / crystallization solvent for 1 1 α-hydroxyconoreno. Using the extraction scheme as described above, the extraction efficiency and crystallization efficiency of MIBK and toluene and ethyl acetate were compared. -178- This paper size applies to China National Standard (CNS) A4 (210X 297mm) (Please read the notes on the back before filling out this page, 1T-593305 A7 B7 Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 2. Description of the Invention (I76) As part of the method for evaluating Figures 2 and 3, the study of particle size was carried out on the Conreno enzymes provided at the beginning of the fermentation cycle of each method. Prior to introducing Conranow into the fermentor, the Conranow, which supplies the method of Figure 1, was micronized. In the process, Conranow was not 'subtracted' by adding antibiotics to control the growth of unwanted microorganisms. Figure 2 and In the process of Figure 3, Conreno was sterilized at the end of the reaction. In the process of Figure 2, the sterilization was completed in the blender before introduction into the fermenter. In the process of Figure 3, at the beginning of the batch reaction, The fermentor sterilizes the suspension of Conorno in the growth medium. As discussed earlier, sterilization can easily cause the accumulation of Conreno particles. Because of the limited solubility of Conreno in aqueous growth media, The productivity of this method depends on the transfer of clumps from the solid phase, and it can therefore be expected to depend on the interfacial area provided by the solid particulate enzymatic substance, which depends on the particle size distribution. These considerations became graphs from the beginning Obstacles to the methods 2 and 3. However, the agitation effect in the blender of Fig. 2 and the fermenter of Fig. 3 and the effect of the shear pump used for migration in Fig. 2 were found to make the particle size The range is quite close to the agglomeration degradation of the non-sterilized and micronized Conorno supplied by the method of Figure 1. By these three processes, the beginning of each reaction cycle can be shown in Table 30. Three; f, the same Particle distribution vf of Conranos sample, 1 strict | 1 »1 1 V specimen 45-125 microns &lt; 180 microns average size micron process number # biotransformation% Conranow loading 1 75% 95% — R3C: 93.1 % (120 hours) -179- This paper size applies to Chinese National Standard (CNS) A4 (21〇χ 297mm) (Please read the precautions on the back before filling out this page} 1 «-Order · 593305 A7 B7 5 Description of the invention (177) R4C: 96.3% (120 hours) % 77.2% 139.5 β3Α ·· 94 · 6% (120 hours) R3B: 95.2% (120 hours) Sterilized d sample 24.7% 65.1% 157.4 R4B: 97.6% (120 hours) R5B: 93.8% (120 hours) ( Please read the precautions on the back before filling in this page} From the data in Table 30, you will notice that the agitator and shear pump can effectively reduce the average particle size of the sterilized Conorno The size of the enzymes is the same, but the remaining significant size differences will benefit the unsterilized enzymes. Despite these differences, reaction efficiency data show that pre-sterilization methods are at least as productive as the method in Figure 1. In the method of Figure 2, further benefits can be obtained by some further reduction and control of particle size steps, such as wet milling of sterilized Conley #, and / or by pasteurization rather than sterilization. Example 14 A seed culture was prepared in the manner described in Example 5. After 20 hours, the mycelium in the inoculated fermenter was soft, with 40% ρ μV. Its ρ Η 値 is 5 · 4 and unused 1 4 · 8 gp 1 glucose is left. Printed by a Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A transforming growth medium (35 liters) having the composition shown in Table 20 was prepared. In the preparation of the supply medium, the glucose and the yeast extract were respectively sterilized and mixed into one portion at a starting concentration of 30% by weight of glucose and 10% by weight of the yeast extract. 1) 11 値 of this supply was adjusted to 57. Using this medium (Table 20), two biotransformation processes were performed to convert Conranow to 1 1 -hydroxyl Conax. Each process is equipped with a stirrer, including a Rushton full-wheel propeller and two Lightnin, A31q ^ feeders. 180- This paper size applies to China National Standard (CNS) A4 specifications (21 〇X 297 male thin ) 593305 A7 _____ B7 V. Description of the Invention (l78) Operating in a 60-liter fermenter. The growth medium initially loaded into the fermenter was 35 liters. Add micronized but non-sterile Conranow to a starting concentration of 0.5%. The seed culture prepared by the method described in Example 5 was used to inoculate the culture medium in the fermenter at an initial inoculation ratio of 2.5%. Fermentation is performed at a temperature of 28 ° C, agitation of 200 to 500 rpm: agitation rate &apos; 0.5 vvm aeration rate, and a back pressure sufficient to maintain at least 20% by volume of dissolved oxygen. The transformation medium developed during the production process is in the form of very small rounded spheres (approximately 1-2 mm). Conreno and supplementary nutrients were continuously supplied to the fermenter in the manner described in Example 1. Nutrition was added every four hours at a ratio of 3.4 grams of glucose and 0.6 grams of yeast extract per liter of broth in the fermenter. In Table 31, the main aeration rate, stirring rate, dissolved oxygen amount, PMV, and pH 値 are set during the period of each process in this example, and the glucose is added during the batch reaction. . Table 3 2 shows the appearance of Conley's transdermal effect. The process r 1 1 a was aborted after 46 hours; the process r 1 1 B continued to 96 hours. In the later process, a transition of 930/0 was reached at 81 hours; the supply was added again at 84 hours; then the supply was discontinued. Note that a noticeable change in viscosity occurred between the time the supply was stopped and the end of the process. (Please read the precautions on the back before filling this page) 1 «· Ordered by the Central Consumers Bureau of the Ministry of Economic Affairs and printed by the Consumer Cooperatives -181- This paper size applies to China National Standard (CNS) specifications (210X ^ 97 mm) ~~ 593305 A7 B7, Invention Description (Π9) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 3 1 _ H Rong R 1 1 A Time Air (1pm) rpm% DO Back Pressure PMV (%) pH 値 Glucose (g Per liter) 0.1 20 200 93 0 2 6.17 5.8 7 20 200 85.1 0 5 6.03 5.5 12.4 20 300 50.2 0 5.43 21.8 20 400 25.5 0 38 6.98 0 29 20 500 17 0 35 5.22 30.2 20 500 18.8 10 5.01 31 20 500 79 10 4.81 1 35.7 20 500 100 10 45 5.57 0 46.2 20 500 23 6 45 5.8 1 Total glucose: 27.5 g / L total yeast extract: 8.75 g / L Fermentation R11B Time Air (1pm) rpm% DO Back pressure PMV ( %) pH 値 glucose (g / l) 0.1 20 200 92.9 0 2 5.98 5.5 7 20 200 82.3 0 5 5.9 5 12.4 20 300 49.5 0 5.48 21.8 20 400 18 0 40 7.12 0 29 20 500 36.8 0 35 5.1 3 35.7 20 500 94.5 10 4.74 0 46.2 20 500 14.5 6 45 5.32 2 55 20 500 16.7 10 5.31 0.5 58.6 20 500 19.4 15 5.32 1 61.9 20 500 13 15 40 5.36 2 71.7 20 500 13 15 42 5.37 0 81.1 20 500 22.9 15 5.42 2.5 85.6 20 500 22 15 45 5.48 1 97.5 20 500 108 15 45 6.47 0 117.7 20 500 15 7.37 0 Total glucose: 63 g / L Total Yeast Extract: 14.5 g / L -182- This paper size applies Chinese National Standard (CNS) A4 specification (210 × 297 mm) (Please read the precautions on the back before filling in this Page 丨 «, 1T 593305 V. Description of the invention (180) Printed by the Consumers' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 32 Fermentation process R11A: Conranow conversion concentration (g / L) Conversion calculation Per liter / hour) Sample time 〇Η-Cono Reno Cono Reynolds (%) (g / L) Calculated 値 Measured R11A-0 0.10 0.00 5.41 5.41 R11A-7 7.00 0.18 4.89 5.07 3.58 0.18 0.03 0.03 R11A-22 21.8 2.02 2.12 4.14 48.75 2.44 0.15 0.12 R11A-29 29.00 3.67 4.14 7.81 47.03 4.48 0.28 0.23 R11A-36 35.7 6.68 1.44 8.12 82.27 7.74 0.49 0.45 R11A-46 46.20 7.09 0.41 7.51 94.48 8.59 0.08 0.04 Fermentation process R1 1B : Conreno conversion effect concentration (g / L) Conversion calculation ΗΟ-Conoreno conversion rate (g / L / hour) Sample time 〇Η-Conoreno Conreno total (%) (g / L) Calculation 値 Measurement 値 R11B- 0 0.10 0.00 5.60 5.60 R11B-7 7.00 0.20 4.98 5.18 3.78 0.19 0.03 0.03 R11B-22 21.80 2.51 2.46 4.97 50.49 2.52 0.16 0.16 R11B-29 29.00 4.48 16.99 21.47 20.87 4.69 0.30 0.27 R11B-36 35.70 8.18 10.35 18.53 44.16 9.70 0.75 0.55 R11B -55 55.0 17.03 13.20 30.23 56.33 19.50 0.32 0.36 R11B-59 58.6 20.80 11.73 32.53 63.95 21.97 0.69 1.05 R11B-62 61.9 22.19 8.62 30.81 72.02 24.50 0.77 0.42 R11B-72 71.7 26.62 3.61 30.23 88.06 29.46 0.51 0.45 R11B13-81 92.97 30.32 0.09 0.05 R11B-86 85.6 26.87 2.02 28.88 93.02 30.11 -0.04 -0.06 R11B-97 97.5 23.95 1.71 25.66 93.34 30.22 0.01 -0.25 R11B-118 117.7 24.10 1.68 25.79 93.47 30.26 0.00 0.01 (Please read the notes on the back and fill in (This page)

、1T -183-本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐) 經濟部中央標準局員工消費合作社印製 593305 A7 Γ________ Β7 五、發明説明(181) 一 iM±5_ 根據上述的一般方法,測試各種培養物將康雷諾轉變爲 11 α -康雷諾之生物轉化的效率。 以在實例5中描述的方法來製備黑麴菌(AspeH1hl, niger) ATCC 1 1394 少根酒趣菌(Rhizopus arrhizus^ATrr 11145和 (JB^hizopus stolonifer) ACTT 6227b各別的工作細 胞銀行。利用得自工作細胞銀行的孢子懸浮液(1毫升)來接 種具有在表18中所列之組成的生長培養基(5〇毫升),並置 於恆溫箱中。藉著在26 °C下發酵大約20小時,在恆溫箱中 製備種子培養物。以200 rpm之速率攪拌恆溫箱。 使用每種微生物的種子培養物各一等份(2毫升)來接種含 有表1 8之生長培養基(3 〇毫升)的轉化燒瓶。使用每種培養 物來接種兩個燒瓶,總共六個。在36t下將康雷諾(2〇〇亳 克)溶解於甲醇(4毫升)中,並將〇·5毫升一等份的該溶液導 入每個燒瓶中。通常在實例5描述的條件下完成生物轉化作 用,並每天添加50重量%的葡萄糖溶液(1毫升)。在前72小 時之後,對個別的轉化發酵燒瓶中菌絲體的發展進行下列 的觀察: ATCC 11394 -良好均衡的生長 ATCC 11145 _在前4 8小時良好的生長,但是菌絲體叢 生成球,在後2 4小時沒有明顯的生長。 ATCC 6227b -良好的生長;菌絲體團塊叢生成球。 取出肉湯的試樣,分析生物轉化的程度。在三天後,利用 ATCC 1 1 3 94之發酵作用,提供了 8〇到9〇%的! ! “ -幾基 -184- 本紙張尺度適用中國國家標準(CNS ) 格(210X 297公釐) '〜 (請先閱讀背面之注意事項再填寫本頁) 、\呑 ^1. 593305、 1T -183- This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 × 297 mm) Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 Γ ________ Β7 V. Description of the invention (181) iM ± 5_ According to the above The general method of testing the biotransformation efficiency of various cultures to convert Conranow to 11α-Conranow. Separate working cell banks of AspeH1hl, niger ATCC 1 1394 and Rhizopus arrhizus ^ ATrr 11145 and (JB ^ hizopus stolonifer) ACTT 6227b were prepared by the method described in Example 5. A spore suspension (1 ml) from a working cell bank was used to inoculate a growth medium (50 ml) having the composition listed in Table 18 and placed in an incubator. By fermentation at 26 ° C for approximately 20 hours, Prepare the seed culture in an incubator. Stir the incubator at 200 rpm. Use an aliquot (2 ml) of the seed culture of each microorganism to inoculate a transformation containing the growth medium (30 ml) of Table 18 Flasks. Use each culture to inoculate two flasks for a total of six. Dissolve Conreno (200 g) in methanol (4 ml) at 36 t, and aliquot 0.5 ml of this The solution was introduced into each flask. The biotransformation was normally completed under the conditions described in Example 5, and a 50% by weight glucose solution (1 ml) was added daily. After the first 72 hours, the bacteria in the individual transformation fermentation flasks were added. The following observations were made on the development of the body: ATCC 11394-Good and balanced growth ATCC 11145 _ Good growth in the first 48 hours, but mycelial clumps formed spheres and no significant growth in the next 24 hours. ATCC 6227b-Good Growth; Mycelium clumps form spheres. Take a sample of broth and analyze the degree of biotransformation. After three days, the fermentation of ATCC 1 1 3 94 was used to provide 80 to 90%! "-Jiji-184- This paper size applies Chinese National Standard (CNS) grid (210X 297mm) '~ (Please read the precautions on the back before filling this page), \ 呑 ^ 1. 593305

A B 五、發明説明(182) 康雷諾之轉化;ATCC 1 1 145提供了 50%的轉化;而 A T C C 6 2 2 7 b 才是供了 8 0 至 J 9 0 〇/〇 ό 勺轉 &gt;ί 匕。 實例1 6 大體上利用在實例1 5中描述的方法,測試其他微生物將 康雷諾轉化成1 1 α -羥基康雷諾的效率。受試的生物和試驗 結果陳列在表3 3中: 表33-進行將康雷諾轉化成11心輕基康雷諾之生物轉化測試的培養物 培養物 ATCC編號 培養基1 結果 约略的轉化率 酒麴菌 1145 CSL + 50% 一 匍枝酒麴菌 6227b CSL + 80-90% - 小巢狀麴菌 11267 CSL + 50% 80% 黑麴菌 11394 CSL + 80-90% 褐黃麴菌 NRRL405 CSL + 90% 褐黃麴菌 18500 CSL + 90% 枯草桿菌(Bacillus subtilis) 31028 P&amp;CSL 0% 0% 枯草桿菌 31028 CSL - 0% 0% 桿菌屬(Bacillus sp·) 31029 P&amp;CSL - 0% 0% 桿菌屬 31029 CSL 嗎 0% 氺 巨桿菌(Bacillus megaterium) 14945 P&amp;SCL + 5% 80%* 巨桿菌 14945 CSL + 5% 10%* 粉紅單端孢 12519 CSL + 80%* 90%* 粉紅單端孢 8685 CSL + 80%* 90%* 弗氏鏈徽菌 10745 CSL + &lt;5% &lt;10% 弗氏鏈黴菌 10745 TSB - 氺 * -185- 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨〇&gt;&lt;297公釐) (讀先閱讀背面之注意事項再填寫本頁) -、1Τ 經濟部中央標準局員工消費合作社印製 593305AB V. Description of the invention (182) Connor's transformation; ATCC 1 1 145 provides 50% of the transformation; ATCC 6 2 2 7 b is for 80 to J 9 0 〇 / 〇 spoon transfer &gt; ί dagger. Example 16 Using the method described in Example 15 in general, other microorganisms were tested for their efficiency in converting Conranow to 1 1 α-hydroxyconranol. The organisms tested and the test results are shown in Table 33: Table 33-Cultures subjected to bioconversion tests to convert Conranos to 11-heart light Conranos ATCC numbered medium 1 Results approximately conversion rate 1145 CSL + 50% Saccharomyces cerevisiae 6227b CSL + 80-90%-S. licheniformis 11267 CSL + 50% 80% Black fungus 11394 CSL + 80-90% Pseudomonas flavus NRRL405 CSL + 90% 18500 CSL + 90% Bacillus subtilis 31028 P &amp; CSL 0% 0% Bacillus subtilis 31028 CSL-0% 0% Bacillus sp. 31029 P &amp; CSL-0% 0% Bacillus 31029 CSL 0% Bacillus megaterium 14945 P & SCL + 5% 80% * Macrobacterium 14945 CSL + 5% 10% * Monophyllum pink 12519 CSL + 80% * 90% * Monophyllum pink 8685 CSL + 80% * 90% * Streptomyces freundii 10745 CSL + &lt; 5% &lt; 10% Streptomyces freundii 10745 TSB-氺 * -185- This paper size applies to China National Standard (CNS) A4 specifications (2丨 〇 &gt; &lt; 297 mm) (Read the precautions on the back before filling in this page)-、 1Τ Staff of the Central Standards Bureau of the Ministry of Economic Affairs Cooperatives printed 593,305

AA

7 B 五、發明説明(183) 淡紫灰鏈徽菌 13664 CSL - 0% * 淡紫灰鏈徽菌 13664 TSB - 0% 0% 簡單土壤絲菌(Nocardiodes simple) 6946 BP - 0% 0% 簡單土壤絲菌 13260 BP * * 假單孢菌屬 14696 BP - 氺 氺 假單孢菌屬 14696 CSL + &lt;5% &lt;10% 假單孢菌屬 14696 TSB - 0% * 假單孢菌屬 13261 BP + 氺 &lt;10% 苦西法假單孢菌 13262 BP # &lt;10% 普提達假單孢菌(Pseudomonas putida)*形成其他無法確認之 產物 15175 BP 0% 0% (請先閱讀背面之注意事項再填寫本頁 1培養基:C S L -玉米漿;T S B -胰蛋白酶消化之大豆肉湯 ;P&amp;CSL -腺和玉米漿;BP·牛肉萃取物和腺。 實例1 7 經濟部中央標準局員工消費合作社印掣 測試各種微生物將康雷語轉化成9 α -經基康雷諾的效率 。如同在表3 4所列的來製備進行該實例之發酵培養基: 表34 大豆粗粉: 右旋糖 20克 大豆粗粉 5克 NaCl 5克 -186- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 A7 B7 -------------—~~-——— 五、發明説明(184) 經濟部中央標準局員工消費合作社印製 酵母萃取物 5克 KH2P〇4 5克 水 至1升 pH値 7.0 腺/酵母萃取物/葡萄糖: 葡萄糖 40克 細菌腺(bactopeptone) 10克 酵母萃取物 5克 水 至1升 謬勒-喜頓(Mueller-Hinton): 牛肉浸液 3〇〇克 酪蛋白胺基酸 ”·5克 澱粉 1·5克 水 至1升 眞菌屬在大豆粗粉培養基和腺-酵母萃取物·葡萄糖中生長, 放線菌屬和眞細菌屬在大豆粗粉(爲了生物轉化作用,加 〇 · 9重量%的甲酸鈉)和謬勒 -喜頓肉湯中生長。 一開始的培養物係以冰凍的孢子母液接種(在25〇毫升錐 形燒瓶中2 0毫升大豆粗粉) 。以牛乳濾紙覆蓋燒瓶,並作爲 生物保護。利用開始培養物(24或48小時長)來接種代謝培 養物(也疋在250¾升錐形燒瓶中20毫升)-具有到15% 的叉叉體積-在加入供轉化反應使用之類固醇受酶質之前, 培養後者2 4到4 8小時。 將康雷諾溶解於/懸浮於甲醇(20毫克/毫升)中,過滤滅菌 -187- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公麓Γ 593305 經濟部中央標準局員工消費合作社印製 A7 -—_____ B7__ 五、發明説明(185 ) ~〜 ,並加至培養物中,至0·1亳克/毫升之終濃度。所有的燒 舐均在經過控制的溫室中,在2 6 π、6 〇 %溫度下,以2 5 〇 rpm振盪(2&quot;投擲)。 在加入受酶質之後5到48小時,或在24小時時收獲生物 轉化作用。藉著將醋酸乙酯(2 3毫升)或二氯甲烷加至發酵 燒瓶中開始收獲。然後振盪燒瓶兩分鐘,並將每個燒瓶的 内谷物倒入5 0毫升錐形試管中。欲分離相位,在室溫單位 下以4000 rpm離心試管20分鐘。將有機層從每個試管中移 至20毫升硼矽酸鹽玻璃小瓶中,並在變速眞空中蒸發。將 小瓶加帽並儲存在-20°C下。 欲獲得物質進行結構確定,藉著增加振盪燒瓶發酵作用 的數目至25,使生物轉化作用按比例擴大至5〇〇毫升。在 收獲的時候(在加入受酶質之後24或48小時),分別在每個 燒瓶中加入醋酸乙酯’並將燒瓶加帽,再放回振盪器中2 〇 分鐘。然後將燒瓶的内容物倒入聚丙烯瓶中,並離心來分 離相位,或倒入容許藉著重力分離相位的分液漏斗中。將 有機相脱水,產生包含在反應混合物中的粗製之類固醇萃 取物。 首先藉著薄層層析法,在矽膠(25〇微米)之背面螢光板 (254毫微米)上分析反應產物。在每個含有得自反應混合物 之脱水醋酸乙酯萃取物的小瓶中分別加入醋酸乙酯(5〇〇微 升)。藉著高效率液體層析法和質譜分析來經營進一步的分 析。在9 5 : 5體積/體積之氣仿/甲醇介質中展開層析板。 藉著高效率液體層析法和質譜分析來經營進一步的分析 -188- 本紙張尺度適用中國國家標準(CNS ) A4規格(210&gt;&lt;297公釐) (請先閱讀背面之注意事項再填寫本頁) 丨^»· -丁, 、言 -^1. I 1 II —-- 593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(186) 。使用帶有Millennium軟體、光二極管陣列的檢測器和自動 採樣器的 Waters HPLC。逆相 HPLC 則使用 Waters NovaPak C -1 8 (4微米之顆粒大小)Radi alPak 4毫米離心管。在管柱中一 開始使用的2 5分鐘直線溶劑梯度爲水:乙腈(7 5 : 2 5 ),結束 時爲水:乙腈(2 5 : 7 5 )。接著以三分鐘梯度至1 〇 〇 %乙腈,並 在開始條件中更新管柱之前,以4分鐘異古拉提克 (isocratic)沖洗。 爲了 LC/MS,在乙腈和水相中以2nM之濃度加入乙酸銨。 層析作用並不會受到明顯地影響。得自管柱之洗脱液裂成 22:1,將大部份的物質送到ρ〇Α檢測器。剩下4.5%的物質 則送至S ciex API III質譜儀之電子噴霧離子化室。以正電模 式完成質譜分析。爲了 UV和MS數據的共同分析,在HPLC 上以單一波長之層析譜,將類似的數據線從PDA檢測器傳 送至質譜儀。 質譜之裂解方式證實可用來將羥基化之受酶質加分類。 兩種預期的經基化康雷諾,11 羥基·和9α-羥基-康雷諾 ,以一致之方式但以不同的頻率喪失水份,可用來作爲診 斷劑。再者,9α -羥基康雷諾比ιΐα -羥基康雷諾更容易形 成銨加成化合物。在表35中所列的是康雷諾發酵作用之 TLC、HPLC/UV和LC/MS數據的摘要,顯示受試的微生 物在將康雷諾轉變爲9α -羥基康雷諾上是有效的。其中較 佳的微生物是山爲豆生棒孢(Corvnespora cassiicola) ATCC 16718 。 -189- 本紙張尺度適用中國國家標準(CNS ) Α4規格(2〗ΟΧ297公釐) (請先閱讀背面之注意事項再填寫本頁) 、^τ 593305 B7 五、發明説明(Μ?} 經濟部中央標準局員工消費合作社印製 表3 5 -關於康雷諾發酵作用之TLC、HPLC/UV和LC/MS數據之摘要 9以OH-康雷諾之證據 培養物 在9汉OH-AD 處的TLC墨點 在9 a OH-康雷 諾處的HPLC_ 高峰w/UV MS:357(M+H) ,339(-H20)&amp; 375(+NH4) 藍色犁頭黴ATCC6647 η y y/n 灰綠梨頭黴ATCC 22752 η 雅致放射毛黴ATCC 6476 tr y tr 黃麴菌ATCC 1030 tr 薰煙色麴菌ATCC 26934 tr y n 小巢狀麴菌ATCC 11267 tr y y 黑麴菌ATCC 16888 n y y 黑麴菌ATCC26693 n y n 褐黃麴菌ATCC 18500 n y n 環氧桿菌 iBacterium cvclo- n tr n oxvdans、 iSearle、 ATCC 12673 蠶攧:菌ATCC 7159 tr y y 蠶黴菌ATCC 13144 y y y 葡萄座腔菌IMI 038560 y tr tr 麗赤殼ATCC 14767 n tr ty 螺卷毛殼ATCC 10195 tr tr y/n 睪固酮叢毛單孢菌 tr tr n -190- (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 5933057 B V. Description of the invention (183) Streptomyces lilacinus 13664 CSL-0% * Streptomyces lilacinus 13664 TSB-0% 0% Nocardiodes simple 6946 BP-0% 0% simple Soil Mycelia 13260 BP * * Pseudomonas 14696 BP-Pseudomonas 14696 CSL + &lt; 5% &lt; 10% Pseudomonas 14696 TSB-0% * Pseudomonas 13261 BP + 10 10% Pseudomonas kusifa 13262 BP # &lt; 10% Pseudomonas putida * forms other unidentifiable products 15175 BP 0% 0% (please read the first Note: Please fill in this page again. 1 Medium: CSL-corn slurry; TSB-trypsin-digested soy broth; P & CSL-gland and corn slurry; BP · beef extract and gland. Consumption cooperatives tested various microorganisms to convert Conley to 9 α-Kyrelino. The fermentation medium for this example was prepared as listed in Table 34: Table 34 Soy meal: Dextrose 20 Grams of soybean meal, 5 grams of NaCl, 5 grams of -186- This paper size applies to Chinese national standards (CN S) A4 specification (210X297 mm) 593305 A7 B7 -------------— ~~ -——— 5. Description of the invention (184) Yeasts printed by employees' cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Extract 5 g KH2P〇4 5 g water to 1 liter pH 値 7.0 Gland / yeast extract / glucose: 40 g glucose bactopeptone 10 g yeast extract 5 g water to 1 liter Mueller-Hidden (Mueller -Hinton): 300 grams of beef infusion casein amino acid "· 5 grams of starch 1.5 grams of water to 1 liter of genus Pseudomonas grow on soybean meal meal medium and glandular-yeast extract · glucose And Genus Bacteroides are grown in soybean meal (for biotransformation, 0.9% by weight sodium formate) and Mueller-Hidden broth. Initial cultures were inoculated with frozen spore mother liquor (at 25 20 ml of soybean meal in a 0 ml Erlenmeyer flask). Cover the flask with milk filter paper as a biological protection. Inoculate the metabolic culture (also in a 250¾L Erlenmeyer flask with the starting culture (24 or 48 hours long)) 20 ml)-with a fork volume of 15%-in the plus The reaction for conversion of the steroid by the use of quality prior to the enzyme, the culture which is 24 to 48 hours. Dissolve / suspend in Reynolds in methanol (20 mg / ml), filter sterilize -187- This paper size applies to China National Standard (CNS) A4 specifications (210X297 Gonglu Γ 593305 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy A7 -—_____ B7__ 5. Description of the invention (185) ~~, and added to the culture to a final concentration of 0.1 · g / ml. All roasts are in a controlled greenhouse at 2 6 π At 60%, shake at 2500rpm (2 &quot; throwing). Biotransformation is harvested 5 to 48 hours after adding the substrate, or 24 hours. By ethyl acetate (2 3 ml ) Or dichloromethane is added to the fermentation flask to start the harvest. Then shake the flask for two minutes and pour the inner grain of each flask into a 50 ml conical test tube. To separate the phases, centrifuge at 4000 rpm at room temperature Test tube for 20 minutes. Move the organic layer from each test tube to a 20 ml borosilicate glass vial and evaporate it in the air with variable speed. Cap the vial and store at -20 ° C. To obtain a substance for structure determination By adding a shake flask The number of effects was increased to 25, and the biotransformation effect was scaled up to 500 ml. At the time of harvest (24 or 48 hours after the enzyme was added), ethyl acetate was added to each flask and the flask was Cap and return to shaker for 20 minutes. Then pour the contents of the flask into a polypropylene bottle and centrifuge to separate the phases, or into a separatory funnel that allows the phases to be separated by gravity. Place the organic phase Dehydration produces a crude steroid extract contained in the reaction mixture. The reaction products are first analyzed by thin-layer chromatography on a silica gel (25 micron) on the back fluorescent plate (254 nm). Ethyl acetate (500 μl) was added to each vial of dehydrated ethyl acetate extract of the reaction mixture. Further analysis was performed by high-efficiency liquid chromatography and mass spectrometry. At 9 5: 5 vol / Chromatographic plates are developed in a volume of gas imitation / methanol medium. Further analysis is carried out by high-efficiency liquid chromatography and mass spectrometry -188- This paper is in accordance with China National Standard (CNS) A4 specifications (2 10 &gt; &lt; 297 mm) (Please read the precautions on the back before filling this page) 丨 ^ »· -ding,,--1. I 1 II --- 593305 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs Preparation A7 B7 V. Description of the invention (186). Waters HPLC with Millennium software, photodiode array detector and automatic sampler. Reverse phase HPLC using Waters NovaPak C -1 8 (4 micron particle size) Radi alPak 4 mm centrifuge tubes. The initial 25-minute linear solvent gradient in the column was water: acetonitrile (7 5: 2 5), and at the end it was water: acetonitrile (2 5: 7 5). Then a three minute gradient to 100% acetonitrile and a 4 minute isocratic rinse before updating the column in the starting conditions. For LC / MS, ammonium acetate was added to the acetonitrile and water phases at a concentration of 2 nM. Chromatography is not significantly affected. The eluate from the column was split into 22: 1 and most of the material was sent to the ρOA detector. The remaining 4.5% was sent to the electron spray ionization chamber of the Sciex API III mass spectrometer. Mass spectrometry analysis was performed in positive mode. For common analysis of UV and MS data, a similar data line was transferred from the PDA detector to the mass spectrometer in a single wavelength chromatogram on HPLC. Mass spectrometry was used to classify hydroxylated enzymes. Two prospective acylated Conreno, 11-hydroxyl and 9α-hydroxy-Conreno, lose water in a consistent manner but at different frequencies and can be used as diagnostics. Furthermore, 9α-hydroxyconoreno is more likely to form an ammonium addition compound than ιαα-hydroxyconreno. Listed in Table 35 is a summary of TLC, HPLC / UV, and LC / MS data from Conranox fermentations, showing that the tested microorganisms were effective in converting Conranow to 9α-hydroxy Conranow. The better microorganism is Corvnespora cassiicola ATCC 16718. -189- This paper size is in accordance with China National Standard (CNS) A4 specification (2〗 〇297 × 297 mm) (Please read the precautions on the back before filling this page), ^ τ 593305 B7 V. Description of Invention (Μ?) Ministry of Economy Printed by the Central Standards Bureau Consumer Cooperatives Table 3 5-Summary of TLC, HPLC / UV, and LC / MS data on Conranox fermentation 9 Based on the evidence of OH-Conradano Cultures TLC ink at 9 Han OH-AD HPLC at 9 a OH-Conoreno_ Peak w / UV MS: 357 (M + H), 339 (-H20) &amp; 375 (+ NH4) Pleurotus candida ATCC6647 η yy / n Gray-green pear head Mold ATCC 22752 η Mucor elegans ATCC 6476 tr y tr Pseudomonas aeruginosa ATCC 1030 tr A. fumigatus ATCC 26934 tr yn Puccinia striiformis ATCC 11267 tr yy Black fungus ATCC 16888 nyy Black fungus ATCC 26693 nyn brown yellow Pseudomonas ATCC 18500 nyn Snail Curl Shell ATCC 10195 tr tr y / n Testosterone clinomonas tr tr n -190- (Please read the notes on the back before filling out this page) This paper size applies to China National Standard (CNS) A4 (210X297 mm) 593305

AA

7 B 五、發明説明(188) 經濟部中央標準局員工消費合作社印製 fComomona testosteroni) (Searle)ATCC 11996 山扁豆生棒孢ATCC 16718 y y y 短刺小克銀漢黴ATCC y y y 8688a 刺孢小克銀漢黴ATCC y y y 3655 雅致小克銀漢黴ATCC y y y 9245 克拉斐特彎孢ATCC 22921 n y y/n 魯那特彎孢ATCC 12071 y n n 雷迪西可拉柱孢(Searle) tr n n ATCC 11011 荷米可拉附球菌ATCC y y y 12722 米附球菌 HEpicoccum tr tr tr orvzae) ATCC 12724 尖鐮孢ATCC 7601 tr 塞皮種尖鐮孢ATCC 11171 n 藤倉赤黴 (Gibberella tr y y fujikuroi) ATCC 14842 融黏帚黴 (Gliocladium y tr tr deli guescens) ATCC 10097 卵形孢球托黴ATCC 22822 y yUV? y 金孢菌寄生IMI 109891 y y y 產油油脂酵母(Lipomvces n lipofer、ATCC 10792 黑孢殼 iMelanospora omata) tr n n (請先閱讀背面之注意事項再填寫本頁) -191- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 五、發明説明(189 ) 經濟部中央標準局員工消費合作社印掣 ATCC 26180 深黃被孢黴ATCC 42613 y y n 灰藍白黴ATCC 1027a η 大白黴ATCC 4605 tr y y 偶發分枝桿菌ATCC 6842 疣孢漆斑黴ATCC 9095 tr tr y 橙色土壤桿菌 (Searle) n tr n ATCC 12674 犬土壤桿菌(Searle) y y n 珊瑚土壤桿菌ATCC 19070 n 卡納斯擬音黴ATCC 46579 n y n 產黃青黴ATCC 9480 n 展青黴ATCC 24550 y y y/n 產紫青黴ATCC 46581 tr y y 阿索-歐里維克髓黴ATCC tr y tr 6651 犬齒髓黴ATCC 26150 n tr tr 布拉克鬚黴(Thvcomvces y y y/n blakesleeanus、 密孔菌屬ATCC 12231 y y y/n 鬚腹菌屬(Rhizopogonsp.) 少根酒麴菌ATCC 11145 tr y n 匍枝酒麴菌ATCC 6227b n 馬赤球菌ATCC 14887 n tr n 馬赤球菌ATCC 21329 tr tr n (請先閱讀背面之注意事項再填寫本頁) -192- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 五、發明説明(19〇) 經濟部中央標準局員工消費合作社印製 赤球菌屬 η η η 玫瑰色赤球菌ATCC 19150 η tr η 紅色糖多孢菌ATCC 11635 y y y 安普魯瘤孢iSepedonium ampullosporum) IMI 203033 η η η 黃瘤孢ATCC 13378 η 阿菲尼斯赛普托麥薩 η yUV? y/n iSeptomvxa affinis) ATCC 6737 兩色司塔開里菌ATCC 12672 y y y/n 加利福尼亞鏈黴菌ATCC 15436 η % 西内瑞可鏈黴菌 η fStreptomvces cinereocrocatus) ATCC 3443 天藍色鏈黴菌ATCC 10147 η 團片鏈徽菌ATCC 25453 弗氏鏈徽菌ATCC 10745 η 灰色鍵黴菌嗜冷亞種 η fStreptomvces griseus subsp. eriseus) ATCC 13968 灰色鏈黴菌ATCC 11984 η 海瑞根鏈黴菌 η (請先閱讀背面之注意事項再填寫本頁 . 訂 ^1. -193 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 kl B7 五、發明説明(191) fStreptomvces hvdro genans) η ATCC 19631 吸水鏈徽菌ATCC 27438 y y y 淡紫灰鏈徽菌Panlab 105 η 寡生孢鏈黴菌ATCC 25489 η 淺绛紅鏈黴菌ATCC 25489 η tr tr 玫瑰色鏈黴菌ATCC 13400 壯觀鏈黴菌ATCC 27465 η 小孢硬束黴(Stvsanus microsporus) ATCC 2833 總狀共頭黴ATCC 18192 η 雅致枝黴 (Thamnidium elegans) ATCC 18191 梨狀薩摩斯泰樂菌ATCC 8992 y tr y 梭孢殼ATCC 13807 n 綠色木黴 (Trichoderma viride^ ATCC 26802 η 粉紅單端孢ATCC 12543 tr y y/n 可可輪枝孢ATCC 12474 y tr tr 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 實例1 8 根據上述的一般方法,測試各種培養物將雄留烯二酮生 物轉化成1 1 α - #垔基雄甾晞二酮的效力。7 B V. Description of the invention (188) Printed by fComomona testosteroni) (Searle) ATCC 11996 Corynespora mandshurica ATCC 16718 yyy Brachytium eryngii ATCC yyy 8688a ATCC yyy 3655 Elegant gram silver bacterium ATCC yyy 9245 Curvularia sp. ATCC 22921 nyy / n Curvularia sp. ATCC 12071 ynn Searle tr nn ATCC 11011 Epidermococcus hermicella ATCC yyy 12722 HEpicoccum tr tr tr orvzae) ATCC 12724 Fusarium oxysporum ATCC 7601 tr ) ATCC 10097 Tococcus ovum ATCC 22822 y yUV? Y Chlorella parasite IMI 109891 yyy Lipomvces n lipofer, ATCC 10792 iMelanospora omata tr nn (Please read the precautions on the back first (Fill in this page) -191- This paper size applies to China National Standard (CNS) A4 (210X 297mm) ) 593305 5. Description of invention (189) Employees' cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs of the People's Republic of China. ATCC 26180 Mortierella aureus ATCC 42613 yyn White mold ATCC 1027a η White mold ATCC 4605 tr yy Mycobacterium sporum ATCC 6842 Warts P. aeruginosa ATCC 9095 tr tr y Searle n tr n ATCC 12674 Searle yyn Agrobacterium coral ATCC 19070 n Pseudomonas aeruginosa ATCC 46579 nyn Penicillium chrysogenum ATCC 9480 n Penicillium sp.ATCC 24550 yyy / n Penicillium purpuratum ATCC 46581 tr yy Aso-Oerlikhiomyces ATCC tr y tr 6651 Mycelium canine ATCC 26150 n tr tr Brachyspira (Thvcomvces yyy / n blakesleeanus, Mycobacterium ATCC 12231 yyy / n Rhizopogonus. Rhizococcus sp. ATCC 11145 tr yn Rhizoctonia sp. ATCC 6227b n E.coccus ATCC 14887 n tr n E.coccus ATCC 21329 tr tr n (Please read the note on the back first Please fill in this page for more details) -192- This paper size is applicable to China National Standard (CNS) A4 specification (210X297mm) 593305 V. Description of invention (19〇) Economy Printed by the Consumer Standards Cooperative of the Central Bureau of Standards of China Affinis Septorto Mesa η yUV? Y / n iSeptomvxa affinis) ATCC 6737 Two-color staphylococcus ATCC 12672 yyy / n Streptomyces californicus ATCC 15436 η% Streptomyces senecio fStreptomvces cinereocrocatus) ATCC 3443 Streptomyces azure ATCC 10147 η Streptomyces striatus ATCC 25453 Streptomyces freundii ATCC 10745 η Grey key mold psychrophile η fStreptomvces griseus subsp. Eriseus) ATCC 13968 Gray Streptomyces ATCC 11984 η Streptomyces hairui (Please read the notes on the back before filling in this page. Order ^ 1. -193-This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) 593305 kl B7 V. Description of the invention (191) fStreptomvces hvdro genans ) ATCC 19631 Streptococcus hygroscopicus ATCC 27438 yyy Streptomyces lilacinus Panlab 105 η oligospore chain Mold ATCC 25489 η Streptomyces spp. ATCC 25489 η tr tr Streptomyces roseus ATCC 13400 Streptomyces magnificentus ATCC 27465 η Stvsanus microsporus ATCC 2833 Conidial cephalosporin ATCC 18192 η Thamnidium elegans) ATCC 18191 Tyrosoma pyriformis ATCC 8992 y tr y Clostridium sp. ATCC 13807 n Trichoderma viride ^ ATCC 26802 η Monomonospora pink ATCC 12543 tr yy / n Cocoa verticillium ATCC 12474 y tr tr Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) Example 1 8 According to the general method described above, test various cultures to bioconvert androstenedione to 1 1 α- # 垔 基 andosterone dione potency.

基本上以在實例4中描述的方法,製備褐黃麴菌NRRL -194- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ 297公釐1 593305 A7 _________B7 五、發明説明(192) 405 (ATCC 1 8 5 00);黑麴菌 ATCC 1 1 394;小巢狀麴菌 ATCC 1 1 267;酒麴菌ATCC 11145 ;葡枝酒麴菌ATCC 6227b ;粉紅單端孢A T C C 12519和ATCC 8685每一種的工 作細胞銀行。以得自工作細胞銀行的孢子懸浮液(丨毫升)來 接種具有在表1 8中所列之組成的生長培養基(5 〇毫升),並 置於怔7皿相中’在怪溫相中精者在2 6 C下大約2 0小時的發 酵作用,來製備種子培養物。以200 rpm之速率攪拌該恆 溫箱。 利用每種微生物各一等份(2毫升)的種子培養物,來接種 含有表1 5之生長培養基(3 0毫升)的轉化燒瓶。利用每種培 養物接種兩個燒瓶,總共1 6個。在3 6 °C下將雄甾晞二酮 300亳克)溶解於甲醇(6毫升)中,並將該溶液〇·5毫升之等 份導入每個燒瓶中。通常在實例6中描述的條件下進行生物 轉化作用4 8小時。在4 8小時後收集肉湯的試樣,並如同實 例1 7以醋酸乙酯萃取。藉著蒸發濃縮醋酸乙酯,並藉著薄 層層析法分析試樣,以便決定是否出現具有類似1 1 α _幾基 雄甾烯二酮標準物(Sigma Chemical Co·,St. Louis)之層析滿 度的產物。結果顯示在表3 6中。以M +&quot;表示陽性的纟士果。 表36 雄留缔-一酉同至1 1 α -經基雄留婦一*酉同的生物轉化作用 培養物 A T C C編號 培養基 TLC結果 酒麴菌 11145 CSL 匍枝酒麴菌 6227b CSL + 小巢狀麴菌 11267 CSL + -195- 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210'乂297公釐) 593305 A7 B7 五、發明説明( 193 黑麴菌 11394 CSL + 褐黃麵菌 NRRL 405 CSL + 褐黃麴菌 1 8500 CSL + 粉紅單端孢 125 19 CSL + 粉紅單端孢 86 85 CSL + 烯二酮中產生具有像11 羥基雄留埽二酮標準物一樣之Rf 値的化合物。 M濟部中央標準局員工消費合作社印裂 藉著上述的相同程序,再度測試揭黃麴菌NRRL 4〇5 (ATCC 18500),並分離培養產物,藉著正相矽膠管柱層析 法,利用甲醇作爲溶劑來純化之。藉著薄層層析法分析溶 離份。TLC板爲Whatman K6F矽膠60埃,1(^2〇的大小, 25 0微米厚度。溶劑系統爲甲醇:氣仿,父95體積/體積。藉 著LC-MS和NMR分光計分析結晶狀的產物和n羥基^ 络烯二酮標準物。兩種化合物產生相同的外觀和分子量。 實例1 9 測試各種微生物將美克斯雷諾轉化成旧.禮基美克斯雷 諾的效力。按照在表34中的描述來製備本實例之發酵培養 基。 發酵條件和分析方法與實例17中的相同。tlc板和溶劑 系統與實例18中描述的相同。層析分析的原理如下:iH 減吴克斯雷諾和U ^^基康雷諾具有相同的層析滿度。 «&lt;&amp;广-基康田諾和9^禮基康雷諾顯示出與11 “ -趣基雄 田’希二酮和u厂羥基雄留埽二酮相同的滿度模式。因此η (請先閱讀背面之注意事項再填寫本頁) 訂 ^1. Μ氏張尺度適财關家 -196- 593305 7 Β 五、發明説明(194) 經濟部中央標準局員工消費合作社印掣 卢-羥基美克斯雷諾應該具有像9 α -羥基康雷諾一樣的淌度 。因此,將從生長培養基中萃取出的化合物,對作爲標準 物之9α-羥基康雷諾進行分析。結果顯示在表37中。 表37 從美克斯雷諾形成11/?-羥基美克斯雷諾之數據的摘要 微生物 培養基1 斑點特徵2 藍色梨頭黴ATCC6647 M,S 強 黑麴菌ATCC 16888 S,P 弱(S)?(P) 蠶攩t菌ATCC7159 P 強 蠶黴菌ATCC 13144 s,p ?,? 葡萄座腔菌IMI 038560 弱 短刺小克銀漢黴ATCC 8688a S,p 強 刺孢小克銀漢黴ATCC 3655 S,p 強 雅致小克銀漢黴ATCC 9245 s,p 強 魯那特彎孢ATCC 12017 s 強 卵形孢球托黴ATCC 22822 s,p 強 展青黴ATCC 24550 S,p 強 產紫音黴ATCC 46581 s,p 強 阿索-歐里維克髓黴IFO 6651 s,p 弱 馬赤球菌ATCC 14887 M 弱 紅色糖多孢菌ATCC 11635 M,SF 弱 吸水鏈黴菌ATCC 27438 M,SF 強 淺绛紅鏈黴菌ATCC 25489 M? SF 弱 雅致枝黴ATCC 18191 S,P 弱 梨狀薩摩斯泰樂菌ATCC 8992 S,P 弱 粉紅單端孢ATCC 12543 P,S 弱(p),?(s) (請先閱讀背面之注意事項再填寫本頁) -197- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) 593305 A7Basically, the method described in Example 4 was used to prepare Pseudomonas flavus NRRL-194- This paper size applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm 1 593305 A7 _________B7 V. Description of the invention (192) 405 ( (ATCC 1 8 5 00); black fungus ATCC 1 1 394; small nest fungus ATCC 1 1 267; wine bacterium fungus ATCC 11145; Working cell bank. A spore suspension (丨 ml) obtained from the working cell bank was used to inoculate a growth medium (50 ml) having the composition listed in Table 18 and placed in a 7-dish phase. Warm-phase spermatozoons ferment for about 20 hours at 26 C to prepare seed cultures. Stir the incubator at 200 rpm. Use an aliquot (2 ml) of each seed culture of each microorganism to Inoculate a transformation flask containing the growth medium (30 ml) of Table 15. Inoculate two flasks with each culture, for a total of 16. Dissolve androgens dione 300 g at 36 ° C) in Methanol (6 ml), and the solution was 0.5 ml Parts introduced into each flask. The biotransformation is usually carried out under the conditions described in Example 6 for 48 hours. A sample of the broth was collected after 48 hours and extracted with ethyl acetate as in Example 17. Ethyl acetate was concentrated by evaporation, and the sample was analyzed by thin-layer chromatography to determine whether a layer with a similar standard of 1 1 α _ few androstenedione dione (Sigma Chemical Co., St. Louis) appeared. Analytical product of fullness. The results are shown in Table 36. M + &quot; is a positive fruit. Table 36: Male and female associations-one-to-one to 1 1 α-total androgenous one-to-one biotransformation culture ATCC numbering medium TLC results Saccharomyces cerevisiae 11145 CSL Saccharomyces cerevisiae 6227b CSL + small nested tadpole Bacteria 11267 CSL + -195- Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) This paper size applies to China National Standard (CNS) A4 (210 '乂 297 mm) 593305 A7 B7 V. Description of the invention (193 Black fungus 11394 CSL + Pseudomonas flavus NRRL 405 CSL + Pseudomonas flavus 1 8500 CSL + Pink monospore 125 19 CSL + Pink monospore 86 85 CSL + ketene A compound with Rf 値 like the standard of 11-hydroxyandrostadione was produced in the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs of the People's Republic of China. Using the same procedure described above, the test was carried out to expose the fungus NRRL 40.5 (ATCC 18500), and the culture product was separated, purified by normal-phase silica gel column chromatography, using methanol as a solvent, and analyzed by thin layer chromatography. The TLC plate was Whatman K6F Silicone 60 Angstrom, 1 (^ 20 size, 250 micron Thickness. The solvent system was methanol: aerosol, parent 95 vol / vol. Analysis of the crystalline product and n-hydroxy ^ complexedione standard by LC-MS and NMR spectrometer. Both compounds gave the same appearance and molecular weight Example 19 The various microorganisms were tested for their effectiveness in converting Mexrenault to old. Ricci Mexrenault. The fermentation medium of this example was prepared as described in Table 34. Fermentation conditions and analysis methods were the same as in Example 17. The same. The tlc plate and the solvent system are the same as described in Example 18. The principle of the chromatographic analysis is as follows: iH minus Reynolds and U ^ Conconnol have the same chromatographic fullness. «&Lt; &amp; 广- Ji Kang Tian Nuo and 9 ^ Li Ji Kang Renuo show the same full-scale mode as 11 "-Kiji Tian Tian 'hexadione and u factory hydroxyandrostadione. Therefore η (Please read the precautions on the back before Fill out this page) Order ^ 1. M's Zhang scale suitable financial Guanjia -196- 593305 7 Β V. Description of the invention (194) Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs Consumer Cooperative India-Hydroxy Max Reynolds should have something like 9 α-Hydroxy Conreno has the same mobility. Therefore, the The compounds extracted from the growth medium were analyzed for 9α-hydroxyconoxeno as a standard. The results are shown in Table 37. Table 37 Summary of data for the formation of 11 /?-Hydroxymaxox Reynolds from Max Reynolds Microbial culture medium 1 Spot characteristics 2 P. aeruginosa ATCC6647 M, S strong black fungus ATCC 16888 S, P weak (S)? (P) silkworm chlamydia ATCC7159 P strong silk fungus ATCC 13144 s, p?,? Staphylococcus aureus IMI 038560 Weak short spiny Pleurotus eryngii ATCC 8688a S, p strong Escherichia sp. Microemulsion ATCC 3655 S, p strong elegant Pleurotus eryngii ATCC 9245 s, p. Lunatatus ATCC 12017 s T. oviparus ATCC 22822 s, p. Penicillium ATCC 24550 S, p. Purpureus ATCC 46581 s, p. Aso-Ourlikii mycobacterium IFO 6651 s, p. Marcescens ATCC 14887 M Saccharomyces faecalis ATCC 11635 M, SF Streptomyces faecalis ATCC 27438 M, SF Streptomyces spp. ATCC 25489 M? SF Mycobacterium sp. ATCC 18191 S, P ATCC 8992 S, P weak pink monotetra ATCC 12543 P, S weak (p) ,? (s) (Please read the notes on the back before filling out this page) -197- This paper size applies to China National Standard (CNS) A4 (210X297 mm) 593305 A7

經濟部中央標準局員工消費合作社印f =謬勒-喜頓 P = PYG(腺/酵母萃取物/葡萄糖) s =大豆粗粉 s F ==大豆粗粉加甲酸酯 2?=與無受酶質對照組之差異不確定 這些數據暗示在本表中所列的大部份生物,可從美克斯 雷諾產生類似或與1 1々-羥基美克斯雷諾相同的產物。 tAH 2 〇 計劃1:步驟2:製備5,R(5,從),7,/?-20,_胺基十六氳-U, /?-羥基_10’a,13, α _二甲基·3,,5_二氧螺[呋喃-2(3h), 17、(511’)-[7,4]亞甲幷[411]環戊[&amp;]菲]-5,-腈。 在50加侖的玻璃-襯裡反應器内裝入61 _2升(5 7 8公斤)的 DMF,接著再裝入23· 5公斤11-羥基康雷諾1,並加以攪拌 。在該混合物中加入7.1公斤的氣化鋰,攪拌該混合物2〇分 鐘,裝入16.9克丙酮氰醇,接著裝入5.1公斤的三乙胺。將 該混合物加熱至8 5 °C,並維持在該溫度下1 3 -1 8小時。在 反應之後加入3 5 3升的水,接著加入5.6公斤的碳酸氫鈉。 將該混合物冷卻至0°C,移至200加侖的玻璃-襯裡反應器中 ,並以1 3 0公斤之6 · 7 %次氣酸鈉溶液使其慢慢地中止。過 濾產物並以3x40升一份的水沖洗。得到21.4公斤的產物晞胺。 -198- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) f請先閱讀背面之注意事項再填寫本頁) -訂· 593305 A7 B7 五、發明説明(196Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs f = Mueller-Hidden P = PYG (gland / yeast extract / glucose) s = soybean meal s F == soybean meal and formate 2? = Without acceptance The difference in the enzymatic control group is uncertain. These data suggest that most of the organisms listed in this table can produce products similar to or the same as 1 1 々-hydroxymaxex Renault. tAH 2 〇 Plan 1: Step 2: Preparation of 5, R (5, from), 7, /?-20, _aminohexadecyl-U, /?-hydroxy_10'a, 13, α_dimethyl 3,5,5-dioxo [furan-2 (3h), 17, (511 ')-[7,4] methylenefluorene [411] cyclopenta [&amp;] phenanthrene] -5, -nitrile. A 50-gallon glass-lined reactor was charged with 61 _2 liters (578 kg) of DMF, followed by 23.5 kg of 11-hydroxyconoreno 1 and stirred. To the mixture was added 7.1 kg of lithium vaporized, and the mixture was stirred for 20 minutes, charged with 16.9 g of acetone cyanohydrin, and then charged with 5.1 kg of triethylamine. The mixture was heated to 85 ° C and maintained at this temperature for 1 3 to 1 8 hours. After the reaction, 3 5 3 liters of water was added, followed by 5.6 kg of sodium bicarbonate. The mixture was cooled to 0 ° C, transferred to a 200-gallon glass-lined reactor, and stopped slowly with 130 kg of a 6.7% sodium hypoxia solution. The product was filtered and rinsed with 3x40 liter portions of water. 21.4 kg of product amidine were obtained. -198- This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) f Please read the notes on the back before filling out this page)-Order · 593305 A7 B7 V. Invention Description (196

LICK DMF, EI3N, 丙酮氯醇 β5 0, 8-15 h 步驟1LICK DMF, EI3N, Acetochlorohydrin β5 0, 8-15 h Step 1

KK

實例2 1 計劃1:步驟2:製備4,S(4’^〇,7’從-十六氫-11’從-羥基-10·点,13* 々·二甲基-3’,5,20’-二氧螺[呋喃-2(3H),17*/? -[4,7]甲基幷-[17H]環戊[a]菲]·5*/?(2’Η)_ 腈。 在200加侖的玻璃-襯裡反應器中裝入50公斤烯胺2、大 約445升之0.8Ν稀氫氣酸和75升甲醇。將該混合物加熱至 8 0 °C 5小時,冷卻至0 °C 2小時。過濾固體產物,得到3 6.5 公斤的無水產物二酮。 〇 Q (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製Example 2 1 Scheme 1: Step 2: Preparation of 4, S (4 '^ 〇, 7' from -hexadecane-11 'from -hydroxy-10 · point, 13 * 々 · dimethyl-3', 5, 20'-Dioxo [furan-2 (3H), 17 * /?-[4,7] methylpyrene- [17H] cyclopenta [a] phenanthrene] · 5 * /? (2'Η) _ nitrile A 200 gallon glass-lined reactor was charged with 50 kg of enamine 2, approximately 445 liters of 0.8 N dilute hydrogen acid and 75 liters of methanol. The mixture was heated to 80 ° C for 5 hours and cooled to 0 ° C. 2 hours. The solid product was filtered to obtain 3 6.5 kg of anhydrous dione. 〇Q (Please read the precautions on the back before filling this page) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs

HCIf QH3〇Hr HaO »OeCr 5h ____________1 步驟2HCIf QH3〇Hr HaO »OeCr 5h ____________1 Step 2

計劃1 :步驟3 A :製備1 1 a,1 7江-二羥基_ 3 _氧代孕甾-4 -烯_ 7泛,2 1 _二羧酸氫甲酯,r -内酯0 -199- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 593305 A7 B7 五、發明説明(197) ^' (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 將4-頸、5-升的有底燒瓶,裝設機械攪拌器、具有氮氣 進入管之均壓添加漏斗、溫度計和帶有起泡器之冷凝器。 起泡器經由聚乙烯管連接到兩個2升的汽水閥,第一個是空 的,並安置以便預防在第二個汽水閥中之物質(1升濃縮的 次氣酸鋼溶液)的反-抽吸,而進入反應容器中。將二酉同 H79.50克;[重量並未對純度進行修正,純度爲85%])加 至燒瓶中的3升甲醇中。在漏斗中放置2 5 %甲醇系之甲醇鈉 溶液(64.83克),並逐滴加入,在氮氣下攪拌1〇分鐘。在加 成作用元成後’將橘黃色的混合物加熱至迴流2 〇小時。在 這段期間後,通過添加漏斗將167毫升的4N Hci逐滴加至 仍在迴流的反應混合物中(警告:HCN在此時放出!)。該反 應混合物顏色變淡’變成淡金橘色。然後以接取頭來代替 冷凝器’並藉著蒸餾移除1 · 5升的甲醇,同時經由漏斗以蒸 館之速度將1 · 5升的水加入燒瓶中。將該反應混合物冷卻至 周圍溫度,並以2·25升爲一等份的二氣甲烷萃取兩次。以 7 5 0毫升一等份之冰冷的飽和N a C 1溶液、1 N N a Ο Η連續沖 洗混合的萃取物,並再度以飽和的N a C 1沖洗。將有機層覆 以硫酸鈉脱水過夜、過濾,並在眞空中滅少體積至大約2 5 〇 毫升。加入甲苯(3 0 0毫升),並在減低的壓力下汽提殘餘的 二氯甲烷,在這段期間内產物開始在燒瓶的壁上形成白色 的固體。將燒瓶的内容物冷卻過夜,並藉著過滤移出固體 。以2 5 0毫升甲苯沖洗,並以2 5 0毫升一等份之乙醚沖洗兩 次,並在眞空漏斗上脱水,得到5 8 · 4 9克的白色固體,由 HPLC得知純度爲97.3%。當濃縮母液時,獲得額外6.76 -200- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 經濟部中央標準局員工消費合作社印製 593305 A7 -*-----------B7_____ 五、發明説明(198) 克’純度爲77. 1 %的產物。總產量,純度調整爲78%。 列 2 3 十里]1.步·|^3Β:將11 α,i7沈-二經基-3 -氧代孕甾-4-婦- 7α,21-二羧酸氫甲酯,r -内酯轉變爲17α-羥基-11沒-( 甲、醯基)氧代-3-氧代孕甾-4-烯- 7π,21-二複酸氫甲酯, r -内酯。 如同在上個實例中來裝備5 -升四頸的燒瓶,除了在起泡 器之前沒有裝設捕捉系統之外。將丨3 8.7 0克之含量的羥基 酉旨加至燒瓶中,接著加入1 425毫升二氯甲烷,並在氮氣下 攪拌。利用鹽/冰浴將反應混合物冷卻至-5 °C。迅速地加入 甲垸磺醯氣(5 1.15克,0.447莫耳),接著慢慢地逐滴加入 在225毫升二氣甲烷中之三乙胺(54.37克)。調整需要大約 3 0分鐘的加成作用,以便使該反應的溫度不會昇高到大約5 °C。在加成作用後持續攪拌1小時,並將反應内容物移至 12 -升的分離漏斗中。在其中加入2100毫升的二氣甲烷。 以700毫升爲一等份之冰冷的in、HC1、IN、NaOH和飽 和的N a C 1水溶液,連續沖洗該溶液。混合含水的沖洗液, 並以3 500毫升二氯甲烷反萃取。在9-升的水罐中混合有機 沖洗液,在其中加入5 0 0克的中性礬土,活性等級11,和 5 0 0克的無水硫酸鈉。將罐中的内容物徹底混合3 0分鐘並 過濾之。取出濾液在眞空中脱水,得到樹脂狀的黃色泡朱 。將其溶解於350毫升二氯甲烷中,攪掉並逐滴加入1800 毫升乙醚。調整加入的速率,以便使大約一半的乙醚在3 0 分鐘内被加入。在已經加入大約7 5 0毫升之後,產物開始分 -201- i紙張尺度適用中酬家標準(CNS ) A4規格(210^297公襲) (請先閱讀背面之注意事項再填寫本頁) 1«Scheme 1: Step 3 A: Preparation of 1 1 a, 1 7 Jiang-dihydroxy_ 3 _oxoprogestin-4 -en-7 pan, 2 1 _ hydrogen dicarboxylic acid methyl ester, r-lactone 0 -199- This paper size applies to Chinese National Standard (CNS) A4 (210X 297 mm) 593305 A7 B7 V. Invention Description (197) ^ '(Please read the notes on the back before filling this page) Employees of the Central Standards Bureau of the Ministry of Economic Affairs The cooperative prints a 4-necked, 5-liter bottomed flask equipped with a mechanical stirrer, a pressure equalization addition funnel with a nitrogen inlet tube, a thermometer, and a condenser with a bubbler. The bubbler was connected to two 2 litre soda valves via a polyethylene tube. The first was empty and was placed to prevent reversal of the substance in the second soda valve (1 litre of concentrated subacid steel solution). -Aspirate while entering the reaction vessel. Dioxin was H79.50 g; [weight was not corrected for purity, 85% purity]) was added to 3 liters of methanol in the flask. A 25% methanol-based sodium methoxide solution (64.83 g) was placed in the funnel, added dropwise, and stirred under nitrogen for 10 minutes. After the addition of the additive, the orange mixture was heated to reflux for 20 hours. After this period, 167 ml of 4N Hci was added dropwise to the reaction mixture still refluxing by the addition funnel (warning: HCN was released at this time!). The reaction mixture became pale 'to a pale kumquat. Then a condenser was used instead of the condenser &apos; and 1.5 litres of methanol was removed by distillation, while 1.5 litres of water was added to the flask via a funnel at the speed of a steamhouse. The reaction mixture was cooled to ambient temperature and extracted twice with 2.25 liters of two gas methane. 750 ml aliquots of ice-cold saturated Na C 1 solution and 1 N N a 0 Η were used to continuously wash the mixed extracts, and then washed again with saturated Na C 1. The organic layer was dehydrated with sodium sulfate overnight, filtered, and reduced in volume to approximately 250 ml. Toluene (300 ml) was added and the residual dichloromethane was stripped under reduced pressure, during which time the product began to form a white solid on the walls of the flask. The contents of the flask were cooled overnight and the solids were removed by filtration. Rinse with 250 ml of toluene and rinse twice with 250 ml aliquots of diethyl ether and dehydrate on an empty funnel to obtain 58.8 g of a white solid. The purity by HPLC is 97.3%. When the mother liquor is concentrated, get an additional 6.76 -200- This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7-* -------- --- B7_____ V. Description of the invention (198) grams of product with a purity of 77.1%. Total yield, purity adjusted to 78%. Column 2 3 Shili] 1. Step · | ^ 3Β: convert 11 α, i7 Shen-diazonyl-3 -oxoprogesterone-4-w-7-7,21-dihydrogen methyl ester, r -lactone It is 17α-hydroxy-11-methyl- (methyl, fluorenyl) oxo-3-oxopregest-4-ene-7π, 21-di double hydrogen methyl ester, and r-lactone. Equipped with a 5-liter four-necked flask as in the previous example, except that no capture system was installed before the bubbler. Add 38.7 g of hydroxy hydrazone to the flask, then add 1 425 ml of dichloromethane and stir under nitrogen. The reaction mixture was cooled to -5 ° C using a salt / ice bath. Methanesulfonium trioxide (5 1.15 g, 0.447 mol) was added quickly, followed by the dropwise addition of triethylamine (54.37 g) in 225 ml of digas methane. The adjustment requires approximately 30 minutes of addition so that the temperature of the reaction does not rise to approximately 5 ° C. After the addition, stirring was continued for 1 hour, and the reaction contents were transferred to a 12-liter separation funnel. To this was added 2100 ml of digas methane. 700 ml of ice-cold in, HC1, IN, NaOH, and saturated Na C 1 aqueous solution were used to continuously rinse the solution. The aqueous rinse was mixed and back-extracted with 3 500 ml of dichloromethane. An organic rinsing solution was mixed in a 9-liter water tank, and 500 g of neutral alumina, an activity level of 11, and 500 g of anhydrous sodium sulfate were added thereto. The contents of the jar were thoroughly mixed for 30 minutes and filtered. The filtrate was taken out and dehydrated in the air to obtain a resinous yellow bubble. It was dissolved in 350 ml of dichloromethane, stirred off and 1800 ml of ether was added dropwise. The rate of addition was adjusted so that about half of the ether was added in 30 minutes. After about 750 ml has been added, the product begins to be divided into -201-i paper size applicable to the CNS A4 specification (210 ^ 297 public attack) (Please read the precautions on the back before filling this page) 1 «

、1T 593305 A7 ____ B7 五、發明説明(199) 離出結晶狀之固體。在1 0分鐘内加入剩餘的乙醚。藉著過 濾移出固體’並以2升乙醚沖洗濾餅,在5 〇 t的眞空烘箱中 脱水過夜,得到144.61克(88%)幾乎白色的固體,熔點 149-150C。以該方式製備之物質,通常由hPLc得知純度 爲98-9 9 %(面積%)。在一個過程中,獲得具有熔點爲153_ 153.5°C之物質,由HPLC決定其純度爲99 5 〇/〇。 實例2 4 計劃1:步驟3&lt;^:方法八:製備17沈-羥基_3-氧代孕甾_4,9-(1 1) - 缔-7 α,21- —竣奴風甲酉旨,内酉旨。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 按照第二個實例來裝設1 -升的四頸燒瓶。在燒瓶中加入 甲酸(250¾升)和乙酸酐(62毫升),並在氮氣下攪拌。加入 甲酸鉀(6 · 1 7克),並利用油浴將反應混合物加熱至4 〇 之 内部溫度(稍後重覆至7 0 °C有較佳的結果)丨6小時。在丨6小 時之後,加入甲磺酸鹽丄,並將内部溫度昇高到丨〇 〇 t。持 續加熱並攪拌2小時,隨後在眞空中,在旋轉式汽化器上移 除溶劑。將殘餘物與500毫升冰水一起攪拌丨5分鐘,然後 以5 00亳升爲一等份之醋酸乙酯萃取兩次。混合有機相,並 以冰冷的2 5 0愛'等份之飽和的氯化鋼溶液(兩次)、1 n 氫氧化鋼溶液連續沖洗,再以飽和的氯化鈉溶液沖洗。然 後將有機相覆以硫酸鈉脱水、過濾,並在眞空中脱水,得 到黃白色的泡沫,當其與刮杓接觸時會使玻璃成爲霧狀。 形成14.65克的粉末,分析其爲82· 1 %的I、7 4%的^_和 5·7%的(藉著HPLC定出之面積%)。 ίΜ_25 -202- 本紙張尺錢财國_料(CNS) 210&gt;&lt;297公釐) 593305 A7 B7 五、發明説明(200 經濟部中央標準局員工消費合作社印製 計劃1 :步驟3 C :方法B ··製備1 7 α ·羥基-氧代孕留 4,9(11)-二晞-7沈,21_二羧酸氫甲酯,厂-内酷。 按照在上文的實例來裝設5 -升的四頭燒瓶,並加入 223.26克乙酸和41.37克乙酸鈉,並在氮氣下攪摔。利用 油浴,將該混合物加熱至1 0 0 °C之内部溫度。加入甲續酸鹽 (1 2 3 · 6 5克),並持續加熱3 0分鐘。在該期間結束時,停止 加熱並加入2 0 0毫升的冰水。溫度降至4 0 °C,並持續擾摔j 小時,隨後將反應混合物慢慢地倒入在5-升燒瓶中之丨5升 的冰水中。分離出像樹膠油狀之產物。將該油溶解於丨升的 醋酸乙醋中,並以冰冷飽和的氣化鋼溶液、1 ]S[氫氧化鈉和 最後再以飽和的氣化鈉溶液各1升來沖洗。將有機相覆以硫 酸鈉脱水並過滤之。在眞空中將濾液脱水,得到瓦解成樹 膠油的泡沫。將其與乙醚一起研製數次,最後終於固化。 過濾固體並以更多的乙醚沖洗,得到79.59克黃白色的固體 。這包括7 0 · 4 %想要的A 9 ’11烯酯i、1 2 · 3 %的△ 11,12晞酯 炎、1 0 · 8 %的7 α,9 π -内酯2_和5 · 7 %未反應的瓦。 實例2 6 計劃1 :步驟3D··合成9,1 1 α -環氧 17從-羥基-3_氧代孕 甾_4_晞-7“,21_二羧酸氫甲酯,r-内酯。 將4-頸有套層的500毫升反應器,裝設機械攪拌器、冷凝 器/起泡器、溫度計和具有氮氣進入管之添加漏斗。在反應 器中裝入在83毫升二氯甲烷中之8.32克粗製的晞酯,並在 氮氣下攪掉。在其中加入4·〇2克二價的磷酸鉀’接著是12 毫升的三氯乙腈。使外部的冷卻水經由反應器套層流動, -203 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) —爹. -、\呑. Γ 593305 A7 B7 五、發明説明(201) (請先閱讀背面之注意事項再填寫本頁} 並將該反應混合物冷卻至8 °C。在1 〇分鐘的期間内,在添加 漏斗中加入36毫升30%的過氧化氫。在加成作用完成後, 一開始爲淡黃色的反應混合物幾乎都轉變成無色。在整個 加成作用中’反應混合物維持在9 ± 1 °C,並持續攪;摔過夜( 總共2 3小時)。在反應混合物中加入二氯甲燒(1 5 〇毫升), 並將全部的内容物加至大約2 5 0毫升的冰水中。以丨5 〇毫升 馬一等份之一氣甲纪萃取二次。以4 0 0毫升冰冷的3 %亞硫 酸鈉溶液沖洗混合的二氣甲烷萃取物,以便分解任何殘餘 的過氧化物。接著以3 00毫升冰冷的in氫氧化鈉沖洗,4〇〇 耄升冰冷的1 N氫氯酸沖洗,最後再以4 〇 〇毫升鹽水沖洗。 將有機相覆以硫酸鑊脱水、過濾,並以8 〇毫升二氯甲燒沖 洗濾餅。在眞空中移除溶劑,得到9 · 1 0克淡黃色固體狀的 粗製產物。從大約2 5毫升2 - 丁酮中使其再結晶,得到5.5 2 克幾乎白色的結晶。最後從丙酮(大約5 0毫升)中再結晶, 得到3 · 1 6克長針狀的結晶,熔點2 4 1 - 2 4 3 Ό。 實例2 7 計劃1 _·步驟3 :選擇1 :從4f S(4f α ),7,以-十六氫-1 i丨從-經 經濟部中央標準局員工消費合作社印製 基-10’/?,13’々-二甲基-3,,5,20,-二氧代螺[呋喃_2(3^1), 17· -[4,7]甲基幷[17H]環戊[a]菲]-5, (2,H)·腈到 9,11 α -環氧-17 α -幾基-3-氧代孕留-4-晞- 7α,21-二叛酸 氫甲酯,r-内酯。 將二酮(20克)裝入乾淨和無水的反應器中,接著加入820 毫升的MeOH和17_6毫升的25% NaOMe/MeOH溶液。將 該反應混合物加熱至迴流條件(大約6 7 °C ) 1 6 - 2 0小時。利 -204- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(202 ) 用40毫升的4N HCH吏產物驟冷。在大氣壓下藉著蒸餾作用 移除溶劑。加入100毫升甲苯,並藉著與甲苯一起共沸蒸餘 和除殘餘的甲醇。在濃縮後,將粗製的幾基g旨i溶解於2 〇 6 *升的二氯甲烷中,並冷卻至〇 °C。加入甲烷磺醯氯(5亳升 )’接著慢慢地加入10.8毫升三乙胺。攪拌該產物4 5分鐘。 藉著眞空蒸麵移除溶劑,得到粗製的甲續酸鹽i。 在分離無水的反應器中,加入5.93克甲酸钟、240毫升 甲酸’接著加入118毫升乙酸Sf。將該混合物加熱至7〇 °c 4 小時。 將甲酸混合物加至上文製備之濃縮的甲磺酸鹽溶液L中。 將該混合物加熱至9 5 - 1 0 5 °C 2小時。將產生的混合物冷卻 至5 0 °C,並藉著在5 〇 °C下之眞空蒸餾作用移除揮發性的成 份。使產物分布在2 7 5毫升醋酸乙酯和2 7 5毫升水之間。利 用137毫升醋酸乙醋反萃取液層,以240毫升冰冷的in氫氧 化鈉溶液沖洗,然後以1 2 0毫升飽和的N aC Π中洗。在相分 離之後,在眞空蒸餾下濃縮有機層,得到粗製的烯酯。 將產物溶解於1 8 0毫升的二氣甲燒中,並冷卻至〇到1 5 °C 。加入8·68克磷酸氫二钾,接著加入2.9毫升三氯乙腈。在 3分鐘的期間内,將78毫升30%過氧化氫溶液加至該混合物 中。在0-15 °C下攪拌該反應混合物6-24小時。在反應之後 ’分離出兩相混合物。以1 2 6毫升3 %的亞硫酸鋼溶液、 126亳升0.5N的氫氧化鈉溶液、126毫升1N的氫氯酸和 1 2 6亳升的1 〇 %鹽水沖洗有機層。將產物覆以無水的硫酸鍰 脱水,或在矽藻土上過濾,並藉著在大氣壓下蒸餾移除溶 -205- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁} 1«· 593305 A7 B7 —-— ______________—----—五、發明説明(203 ) 劑二氯甲烷。使產物從甲基乙基酮中形成結晶兩次,得到 7.2克的艾皮樂雷諾。 0 〇1T 593305 A7 ____ B7 V. Description of the invention (199) A crystalline solid is isolated. The remaining ether was added over 10 minutes. The solid was removed by filtration and the filter cake was rinsed with 2 liters of ether and dehydrated in a 50 t emptied oven overnight to obtain 144.61 g (88%) of an almost white solid with a melting point of 149-150C. The substances prepared in this way usually have a purity of 98-99.9% (area%) from hPLc. In one process, a substance with a melting point of 153-153.5 ° C was obtained, and its purity was determined by HPLC to be 99 5 0 / 〇. Example 2 4 Plan 1: Step 3 &lt; ^: Method 8: Preparation of 17-hydroxy_3-oxoprogesterone_4,9- (1 1)-Di-7-7,21 --- Intrinsic purpose. Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page). Set up a 1-liter four-necked flask according to the second example. Add formic acid (250 ¾ liters) and acetic anhydride (62 ml) to the flask and stir under nitrogen. Potassium formate (6.17 g) was added and the reaction mixture was heated to an internal temperature of 40 using an oil bath (repeat to 70 ° C later for better results) for 6 hours. After 6 hours, the sulfonium mesylate was added and the internal temperature was raised to 00 t. Continue to heat and stir for 2 hours, then remove the solvent on a rotary evaporator in the air. The residue was stirred with 500 ml of ice-water for 5 minutes, and then extracted twice with 500 liters of an equal portion of ethyl acetate. The organic phases were mixed and washed continuously with ice-cold 250 aliquots of saturated steel chloride solution (twice), 1 n steel hydroxide solution, and then with a saturated sodium chloride solution. The organic phase is then dehydrated with sodium sulfate, filtered, and dehydrated in the air to obtain a yellow-white foam, which makes the glass misty when it comes into contact with scraping. A 14.65 g powder was formed and analyzed as 82.1% I, 74% ^ _ and 5.7% (area% determined by HPLC). ίΜ_25 -202- This paper rule money country_material (CNS) 210 &gt; &lt; 297 mm) 593305 A7 B7 V. Description of invention (200 Printed by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 1: Step 3 C: Method B ·· Preparation 1 7 α · Hydroxy-oxopregnancy 4,9 (11) -dihydrazone-7shen, 21_dihydrogen methyl ester, factory-inner cool. Install according to the example above 5 -A four-headed flask, and 223.26 g of acetic acid and 41.37 g of sodium acetate were added and stirred under nitrogen. Using an oil bath, the mixture was heated to an internal temperature of 100 ° C. The formate salt (1 2 3 · 65 g), and continue heating for 30 minutes. At the end of the period, stop heating and add 200 ml of ice water. The temperature drops to 40 ° C, and continues to disturb for j hours, then The reaction mixture was slowly poured into 5 liters of ice water in a 5-liter flask. The product was isolated as a gum oil. This oil was dissolved in liters of ethyl acetate and gasified with ice-cold saturation. The steel solution, 1] S [sodium hydroxide and finally 1 liter of saturated sodium gas solution was used for washing. The organic phase was dehydrated with sodium sulfate and filtered. The filtrate was dehydrated in the air to obtain a foam that disintegrated into gum oil. It was triturated with ether several times and finally solidified. The solid was filtered and rinsed with more ether to obtain 79.59 g of a yellow-white solid. This included 7 0 · 4% desired A 9 '11 enester i, 1 2 · 3% △ 11,12 acetonitis, 10 · 8% 7 α, 9 π-lactone 2_ and 5 · 7% unreacted Example 2 6 Scheme 1: Step 3D ·· Synthesis of 9,1 1 α-Epoxy 17 from -Hydroxy-3_oxoprogesterone_4_ 晞 -7 ", 21_dihydrogen methyl ester, r -Lactone. A 4-necked 500 ml reactor was equipped with a mechanical stirrer, condenser / foamer, thermometer, and addition funnel with nitrogen inlet tube. The reactor was charged with 83 ml of two 8.32 grams of crude methyl ester in methyl chloride and stirred off under nitrogen. To this was added 4.02 grams of divalent potassium phosphate 'followed by 12 ml of trichloroacetonitrile. External cooling water was passed through the reactor jacket Layer flow, -203 This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page) —Dad.-, \ Γ 593305 A7 B7 V. Description of the invention (201) (Please read the notes on the back before filling out this page} and cool the reaction mixture to 8 ° C. Add 36 to the addition funnel over a period of 10 minutes. Ml of 30% hydrogen peroxide. After the addition is complete, the reaction mixture that was light yellow in the beginning almost turned into colorless. The reaction mixture was maintained at 9 ± 1 ° C throughout the addition and continued to stir; Fall overnight (23 hours in total). Dichloromethane (150 ml) was added to the reaction mixture, and the entire contents were added to about 250 ml of ice water. It was extracted twice with a 500 ml portion of horses. Rinse the mixed digas methane extract with 400 ml of ice-cold 3% sodium sulfite solution to break down any remaining peroxide. Then rinse with 300 ml of ice-cold in sodium hydroxide, 400 l of ice-cold 1 N hydrochloric acid, and finally with 400 ml of saline. The organic phase was dehydrated with tritium sulfate, filtered, and the filter cake was washed with 80 ml of dichloromethane. The solvent was removed in the air to obtain 9.10 g of crude product as a pale yellow solid. It was recrystallized from about 25 ml of 2-butanone to give 5.5 2 g of almost white crystals. Finally, it was recrystallized from acetone (about 50 ml) to obtain 3.16 g of long needle-like crystals with a melting point of 2 4 1-2 4 3 Ό. Example 2 7 Plan 1 _ · Step 3: Option 1: From 4f S (4f α), 7, to -hexadecane-1 i 丨 from-printed by the Consumer Consumption Cooperative of the Central Standard Bureau of the Ministry of Economic Affairs-10 '/ ?, 13'fluorene-dimethyl-3,5,20, -dioxospiro [furan_2 (3 ^ 1), 17 ·-[4,7] methylfluorene [17H] cyclopenta [a ] Philippine] -5, (2, H) · Nitrile to 9,11 α-Epoxy-17 α-Equil-3-oxogesterin-4-hydrazone-7α, 21-dimethanoate, r -Lactone. A diketone (20 g) was charged into a clean and anhydrous reactor, followed by 820 ml of MeOH and 17-6 ml of a 25% NaOMe / MeOH solution. The reaction mixture was heated to reflux conditions (approximately 67 ° C) for 16 to 20 hours. Li-204- This paper size applies Chinese National Standard (CNS) A4 (210X297 mm) 593305 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (202) 40N 4N HCH official product cold. The solvent was removed by distillation at atmospheric pressure. 100 ml of toluene was added and the residual methanol was removed by azeotropic distillation with toluene. After concentrating, the crude glycine was dissolved in 206 * L of dichloromethane and cooled to 0 ° C. Methanesulfonyl chloride (5 liters) was added followed by slowly adding 10.8 ml of triethylamine. The product was stirred for 4 5 minutes. The solvent was removed by emptying the steamed noodles to obtain the crude formate i. In a separate anhydrous reactor, 5.93 g of formic acid bell, 240 ml of formic acid 'were added, followed by 118 ml of Sf acetate. The mixture was heated to 70 ° C for 4 hours. The formic acid mixture was added to the concentrated mesylate solution L prepared above. The mixture was heated to 95-105 ° C for 2 hours. The resulting mixture was cooled to 50 ° C and the volatile components were removed by air distillation at 50 ° C. The product was distributed between 275 ml of ethyl acetate and 275 ml of water. The layer was extracted with 137 ml of ethyl acetate, washed with 240 ml of ice-cold in sodium hydroxide solution, and then washed with 120 ml of saturated NaCII. After phase separation, the organic layer was concentrated under vacuum distillation to obtain a crude ene ester. The product was dissolved in 180 ml of dichloromethane and cooled to 0 to 15 ° C. 8.68 g of dipotassium hydrogen phosphate were added, followed by 2.9 ml of trichloroacetonitrile. Over a period of 3 minutes, 78 ml of a 30% hydrogen peroxide solution was added to the mixture. The reaction mixture is stirred at 0-15 ° C for 6-24 hours. After the reaction, the two-phase mixture was separated. The organic layer was washed with 126 ml of a 3% sulfurous acid steel solution, 126 ml of a 0.5N sodium hydroxide solution, 126 ml of 1N hydrochloric acid, and 126 ml of a 10% saline solution. Dehydrate the product with anhydrous tritium sulfate, or filter on diatomaceous earth, and remove the solvent by distillation under atmospheric pressure. -205- This paper size applies to China National Standard (CNS) A4 (210X297 mm) (please Read the notes on the back before filling in this page} 1 «· 593305 A7 B7 —-— ______________ —---- — V. Description of the invention (203) Dichloromethane. The product will form crystals from methyl ethyl ketone Twice, 7.2 grams of Epileur Reynolds were obtained. 0 〇

(請先閱讀背面之注意事項再填寫本頁j 經濟部中央標準局員工消費合作社印製 實例2 8 計劃1:步驟3:選擇2:不需中間物,i,S(4,沈),7, α -十六 氫-1 1’從-羥基-10丨冷,13, /? ·二甲基-3f,5,20f-三氧代螺[ 呋喃- 2(3H),17’/? - [4,7]甲基幷[17H]環戊[&amp;]菲]-5, (2’H)-腈轉變爲9,11α -環氧_17從-經基-3 -氧代孕甾·4 -埽 -7泛,21-二羧酸氫曱酯,r,内酯。 將4-頸5-升的圓底燒瓶裝設機械攪拌器、帶有氮氣進入 管的添加漏斗、溫度計和帶有附接到次氯酸鈉洗滌器之起 泡器的冷凝器。將二酮(8 3 · 2 0克)加至燒瓶中之3.0 5升甲醇 中。在添加漏斗中裝入6785克25〇/〇(重量:重量〕在甲醇中 之甲醇鈉落液。在氮氣下攪拌,並在15分鐘内,將甲醇化 物逐滴加至燒瓶中。出現暗橘/黃色的淤漿。將該反應混合 物加熱至迴流20小時,並逐滴加入175毫升4N氫氣酸,同 時繼續迴流(警告,在該操作時會放出HCN!)。以接取頭來 -206 -(Please read the precautions on the back before filling in this page. Example of printing by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 2 8 Plan 1: Step 3: Option 2: No intermediates required, i, S (4, Shen), 7 , α-Hexadecyl-1 1′-Hydroxy-10 丨 Cold, 13, /? dimethyl-3f, 5,20f-trioxospiro [furan-2 (3H), 17 '/?- [4,7] Methylpyrene [17H] cyclopenta [&amp; phenanthrene] -5, (2'H) -nitrile converted to 9,11α-epoxy-17 from -Cyclo-3 -oxoprogesterone · 4-Pyrene-7-pan, 21-dihydrobiethyl ester, r, lactone. A 4-neck 5-liter round bottom flask was equipped with a mechanical stirrer, an addition funnel with a nitrogen inlet tube, a thermometer, and a There is a condenser with a bubbler attached to a sodium hypochlorite scrubber. A diketone (83.20 g) is added to 3.0 5 liters of methanol in a flask. Into an addition funnel is charged 6785 g of 25/0 ( Weight: Weight] Sodium methoxide in methanol falls. Stir under nitrogen and add the methanolate dropwise to the flask over 15 minutes. A dark orange / yellow slurry appears. The reaction mixture is heated to reflux 20 hours, and 175 ml of 4N hydrogen acid was added dropwise while continuing to reflux (alarm When this operation will be released HCN) to acess head -206! -

593305 A7 _______B7 五、發明説明(204 ) 代替迴流冷凝器,並藉著蒸餾移除丨.6升的甲醇,同時以與 蒸餾速率相配合的速率,經由漏斗逐滴加入16升的1〇%氯 化鈉水溶液。將該反應混合物冷卻至周圍溫度,並以2.2 $ ^ 等份之一氣甲燒萃取兩次。以冰冷的750毫升一等份之 1 N氫氧化鈉和飽和的氯化鈉溶液沖洗混合的萃取物。藉著 在一大氣壓下與甲醇一起共沸蒸餘使有機層脱水,至終體 積1升(爲了分析移出全部的〇 · 5 %)。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 將濃縮的有機溶液(經基酯)加回到如同前文裝設,但是沒 有H CN捕捉器的原始反應燒瓶中。將燒瓶冷卻至,並加 入30.7克甲烷磺醯氣,並在氮氣下攪拌。將添加漏斗裝入 3 2 · 6 5克的三乙胺,在丨5分鐘的期間内將其逐滴加入,保 持溫度在5 °C。持續攪拌2小時,同時使該反應混合物回溫 至周圍溫度。製備包含25 0克Dowex 50 W X 8·100酸性離子 叉換樹脂之管柱,並在使用前以250毫升水、250毫升甲醇 和5 0 0毫升二氣甲烷沖洗。使該反應混合物流下該管柱並收 集之。製備新的管柱並重覆前文的程序。製備包含Dowexl X 8-200鹼性離子交換樹脂之第三個25〇克的管柱,並像上 述酸性樹脂的處理一樣預先處理之。使該反應混合物流下 該管柱並收集之。製備第四個驗性樹脂之管柱,並再度使 反應混合物流下該管柱,並收集之。通過每個管柱,接著 使2 5 0毫升二氣甲烷沖洗管柱,每次通過需要大約1 〇分鐘 。將溶劑沖洗液與反應混合物輪合,並在眞空下使體積減 少到大約5 0 0毫升,移出2 %以供質量管理。再將殘餘物減 少到終體積1 5 0亳升(粗製之甲磺酸鹽溶液)。 -207- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公襲]&quot;&quot;&quot;&quot; 經濟部中央榡準局員工消費合作社印製 593305 A7 _______B7 五、發明説明(205 ) 在原始的5-升反應裝置中加入960毫升甲酸、472毫升乙 酸酐和2 3 · 7 0克甲酸鉀。在氮氣下攪拌並將該混合物加熱至 7 0 °C 1 6小時。然後將溫度增加至1 〇 0 °C,並在3 0分鐘内經 由添加漏上加入粗製的甲磺酸鹽溶液。因爲將二氯甲烷蒸 餾出反應混合物之外,溫度降至8 5 °C。在已經完全移除之 後,使溫度攀昇回到1 〇 〇 °C,並維持2 · 5小時。將該反應混 合物冷卻至4 0 °C,並在壓力下移除甲酸,直到已經達到最 少的攪拌體積(大約150毫升)爲止。將殘餘物冷卻至周圍溫 度’並加入3 7 5毫升二氯甲燒。以冰冷的1升爲一份的飽和 乳化鈉溶液、1 N碳酸鋼沖洗經過稀釋的殘餘物,並再度以 氣化鈉溶液沖洗。將有機相覆以硫酸鎂(1 5 〇克)脱水並過濾 之’得到暗紅棕色的溶液(粗製之晞酯溶液)。 將4 -頸有套層之1升反應器裝設機械攪拌器、冷凝器/起 泡器、溫度計和帶有氮氣進入管的添加漏斗。在反應器中 裝入在6 0 0毫升二氣甲烷中之粗製的烯酯溶液(估計爲6 〇克) ’並在氮氣下擅;摔。在其中加入24.0克二價的鱗酸部,接 著加入8 7亳升三氣乙腈。使外部冷卻水流過反應器之套層 ’並將遠反應混合物冷卻至1 0 °C。在添加漏斗中加入1 4 7 毫升30%的過氧化氳,並3〇分鐘内混合。在完成加成作用 之後’最初暗紅棕色的反應混合物轉變成淡黃色。在整個 加成作用期間,將反應混合物維持在10 土 1°C,並持續授拌 過夜(總共2 3小時)。分離出相位,並以1 2 〇毫升爲一份之二 氣甲:萃取含水的邵份兩次。然後加入2 1 〇亳升3 %亞硫酸 鋼溶液,沖洗混合的有機相。在藉著澱粉/碘試紙得知,有 -208- 本紙張尺度適用中國國家標準(CNS ) M規格(21〇X 297公釐) (請先閲讀背面之注意事項再填寫本頁) 訂 593305 A7 —__Β7 ____ 五、發明説明(206 ) ~~ 機和含水部份不含過氧化物之後,重覆該步驟兩次。以2 j 〇 亳升爲一等份之1 Ν氫氧化鈉、1 Ν氫氣酸連續沖洗有機相, 最後再以鹽水沖洗兩次。以共沸之方式將有機相脱水,至 體積約爲1 0 0毫升,加入新鮮的溶劑(2 5 0毫升),並以共滞 之方式蒸餾至1 〇 〇毫升,在眞空中移除殘餘的溶劑,得到 5 7 · 〇 5克樹膠狀黃色泡沫狀之粗製產物。將一部份(5 1 . 〇 1 克)進一步脱水至恆重44.3克,並藉著HPLC定量分析。分 析爲 2 7.1 % E P X。 實例2 9 在氮氣下將11從_羥基雄甾烯二酮(429.5克)和甲苯磺酸 水合物(7.1)裝入反應燒瓶中。在該反應器中加入乙醇 (2 · 5 8升),並將所得的溶液冷卻至5 °C。在1 5分鐘的期間内 ,在0到1 5 °C下將原甲酸三乙酯(3 3 4.5克)加至該溶液中。 在完成原甲酸三乙酯之加成作用後,將反應混合物回溫至 40°C,並達到該溫度2小時,隨後使溫度昇高到迴流,並在 迴流下使該反應持續額外的3小時。在眞空下冷卻該反應混 合物,並在眞空下移除溶劑,產生3 -乙氧雄留-3,5 -二烯_ 1 7 -酮0 f例3 0 -從1 1 α -輕基康雷語形成烯胺 (請先閱讀背面之注意事項再填寫本頁)593305 A7 _______B7 V. Description of the invention (204) Replace the reflux condenser and remove 丨 .6 liters of methanol by distillation. At the same time, add 16 liters of 10% chlorine dropwise through the funnel at a rate compatible with the distillation rate. Aqueous sodium solution. The reaction mixture was cooled to ambient temperature, and extracted twice with a gaseous distillate of 2.2 $ ^ aliquots. Rinse the combined extracts with ice-cold 750 ml aliquots of 1 N sodium hydroxide and saturated sodium chloride solution. The organic layer was dehydrated by azeotropic distillation with methanol at atmospheric pressure to a final volume of 1 liter (the entire 0.5% was removed for analysis). Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) Add the concentrated organic solution (based on esters) back to the installation as before, but without the original response of the H CN trap In the flask. The flask was cooled to 30.7 g of methanesulfonium, and stirred under nitrogen. The addition funnel was charged with 3,2.5 grams of triethylamine, which was added dropwise over a period of 5 minutes, keeping the temperature at 5 ° C. Stirring was continued for 2 hours while warming the reaction mixture to ambient temperature. Prepare a column containing 250 grams of Dowex 50 W X 8.100 acid ion ion exchange resin and rinse with 250 ml of water, 250 ml of methanol, and 500 ml of digas methane before use. The reaction mixture was allowed to flow down the column and collected. Prepare a new column and repeat the previous procedure. A third 250-gram column containing Dowexl X 8-200 basic ion-exchange resin was prepared and pre-treated as in the case of the acid resin described above. The reaction mixture was allowed to flow down the column and collected. A fourth test resin column was prepared, and the reaction mixture was again flowed down the column and collected. Pass each column, followed by flushing the column with 250 ml of digas methane. Each pass takes approximately 10 minutes. The solvent rinsing solution was combined with the reaction mixture, and the volume was reduced to about 500 ml under emptying, and 2% was removed for quality management. The residue was reduced to a final volume of 150 liters (crude mesylate solution). -207- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 public attack) &quot; &quot; &quot; 960 ml of formic acid, 472 ml of acetic anhydride and 2 3 · 70 g of potassium formate were added to the original 5-liter reaction apparatus. Stir under nitrogen and heat the mixture to 70 ° C for 16 hours. Then increase the temperature to 100 ° C, and the crude methanesulfonate solution was added via the drain over 30 minutes. Since dichloromethane was distilled out of the reaction mixture, the temperature dropped to 8 5 ° C. After it had been completely removed After that, the temperature was ramped back to 100 ° C and maintained for 2.5 hours. The reaction mixture was cooled to 40 ° C and the formic acid was removed under pressure until the minimum stirring volume (about 150 ml) had been reached ). Cool the residue to ambient temperature 'and add 3 7 5 ml of dichloromethane. Rinse the diluted residue with ice-cold 1 liter saturated sodium emulsified solution, 1 N carbon steel and rinse again. Rinse with vaporized sodium solution. The organic phase was dehydrated with magnesium sulfate (150 g) and filtered to obtain a dark reddish brown solution (crude methyl ester solution). A 4-necked 1-liter reactor was equipped with a mechanical stirrer and condensed / Bubbler, thermometer and addition funnel with nitrogen inlet tube. The reactor was charged with a crude olefinic ester solution (estimated at 60 g) in 600 ml of digas methane 'and under nitrogen Break; add 24.0 grams of divalent scaly acid section, and then add 87 7 liters of trigas acetonitrile. Pass external cooling water through the jacket of the reactor and cool the remote reaction mixture to 10 ° C. In Add 147 ml of 30% osmium peroxide to the addition funnel and mix within 30 minutes. After the addition is complete, the 'initial dark reddish brown reaction mixture turns to pale yellow. During the entire addition, the reaction mixture is Maintain at 10 ° C and 1 ° C overnight and continue to stir overnight (total of 23 hours). Separate the phases and use 120 ml as a portion of the gas cylinder: extract the water-containing portion twice. Then add 2 1 〇 亳 L 3% sulfurous acid steel solution, rinse mixed organic .According to the starch / iodine test paper, there are -208- This paper size is applicable to the Chinese National Standard (CNS) M specification (21〇X 297 mm) (Please read the precautions on the back before filling this page) Order 593305 A7 —__ Β7 ____ V. Description of the invention (206) ~~ After the machine and the water-containing part do not contain peroxide, repeat this step twice. Use 2 j 〇 亳 to make 1 aliquot of 1N sodium hydroxide, 1 The organic phase was continuously flushed with N-hydrogen acid and finally washed twice with brine. The organic phase is dehydrated azeotropically to a volume of about 100 ml. Fresh solvent (250 ml) is added and distilled to a 100 ml volume in a stagnant manner. The residual The solvent gave 57.05 g of a crude product as a yellow foam in the form of a gum. A portion (51.01 g) was further dehydrated to a constant weight of 44.3 g and quantitatively analyzed by HPLC. Analyzed as 2 7.1% EPX. Example 2 9 A reaction flask was charged with 11-hydroxyandrostenedione dione (429.5 g) and toluenesulfonic acid hydrate (7.1) under nitrogen. Ethanol (2.88 liters) was charged into the reactor, and the resulting solution was cooled to 5 ° C. Triethyl orthoformate (3 3 4.5 g) was added to the solution over a period of 15 minutes at 0 to 15 ° C. After the addition of triethyl orthoformate was completed, the reaction mixture was warmed to 40 ° C and reached this temperature for 2 hours, then the temperature was raised to reflux, and the reaction was continued under reflux for an additional 3 hours . The reaction mixture was cooled under vacuum and the solvent was removed under vacuum to produce 3-ethoxyandrost-3,5-diene_ 1 7-one 0 f Example 3 0 -from 1 1 α -Lightyl Conrad Enamines (please read the notes on the back before filling this page)

經濟部中央標準局員工消費合作社印製 0 0Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 0 0

本紙張尺度適用中國國家標準(CNS ) Α4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印繁 593305 A7 — __Β7 五、發明説明(207 ) 將氰化鈉(1·72克)置於25亳升、裝有機械攪拌器的%頸燒 瓶中。加入水(2.1毫升)並加熱攪拌該混合物,直到固體溶 解爲止。加入二甲基甲醯胺(15亳升),接著加入丨丨從·羥基 康雷諾(5 · 0克)。在該混合物中加入水(〇 · 4亳升)和硫酸 (1 · 4 9克)的混合物。將該混合物加熱至8 52.5小時,在此 時HPLC分析顯示已完全轉變爲產物。將反應混合物冷卻至 室溫。加入硫酸(0.83克),並攪拌該混合物一個半小時。 將反應混合物加至在冰浴中冷卻的6 〇毫升水中。以3毫升 DMF和5毫升水沖洗燒瓶。攪拌該淤漿4〇分鐘並過滤之。 以4 0毫升水沖洗滤餅兩次’並在6 〇 °C的眞空烘箱中脱水過 夜,產生11從-羥基烯胺,也就是5,化(5,從),7,;5_胺基十六 氫-羥基-10·沒,13’α -二甲基·3',5 -二氧代螺[呋喃- 2(3Η),17’從(5’11)-[7,4]亞甲幷[411]環戊|&gt;]菲]_5,-腈 (4·9克)。 實例3 1-11 羥基康雷諾轉變爲二西同 〇 ηThis paper size applies to China National Standard (CNS) A4 (210X 297 mm) Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, Yin Fan 593305 A7 — __Β7 5. Description of the invention (207) Sodium cyanide (1.72 g) In a 25-litre% neck flask equipped with a mechanical stirrer. Water (2.1 ml) was added and the mixture was stirred with heating until the solids dissolved. Add dimethylformamide (15 liters), followed by hydroxycono Reno (5.0 g). To this mixture was added a mixture of water (0.4 liters) and sulfuric acid (1.49 g). The mixture was heated to 8 52.5 hours, at which time HPLC analysis showed complete conversion to the product. The reaction mixture was cooled to room temperature. Sulfuric acid (0.83 g) was added, and the mixture was stirred for one and a half hours. The reaction mixture was added to 60 ml of water cooled in an ice bath. Rinse the flask with 3 ml DMF and 5 ml water. The slurry was stirred for 40 minutes and filtered. Rinse the filter cake twice with 40 ml of water and dehydrate in an air oven at 60 ° C overnight to produce 11-hydroxyenamine, which is 5, hydrazine (5, from), 7, 5-amino group Hexadecyl-hydroxy-10 · di, 13'α-dimethyl · 3 ', 5-dioxospiro [furan-2 (3Η), 17' from (5'11)-[7,4] sub Formamidine [411] cyclopentane | &gt;] phenanthrene] -5, -nitrile (4.9g). Example 3 Conversion of 1-11 Hydroxyl Cononol to Dicyto

-210- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)-210- This paper size applies to Chinese National Standard (CNS) Α4 specification (210X297 mm) (Please read the precautions on the back before filling this page)

593305 A7 經濟部中央標準局員工消費合作社印製 B7五、發明説明(208 ) 燒瓶中。加入水(1 · 2 6毫升)並稍微加熱燒瓶,以便使固體 溶解。加入二甲基乙醯胺[或二甲基甲醯胺](9亳升),接著 加入11 π -羥基康雷諾(3·0克)。在反應燒瓶中加入硫酸 (0 · 4 7克)和水(0 · 2 5毫升)的混合物,同時加以檀拌。將該 混合物加熱至95 °C2小時。HPLC分析指出反應已經完成。 加入硫酸(0.27毫升),並攪拌該混合物30分鐘。導入額外 的水(25毫升)和硫酸(〇.90毫升),並攪摔反應混合物16小 時。然後在冰浴中將該混合物冷卻至5 - 1 〇 °C。藉著通過燒 結玻璃濾器過濾來分離固體,接著以水(2〇亳升)沖洗兩次 。固體的二酮,也就是4丨S(4丨沈),7丨沈·十六氫_u丨羥基 -1〇’々,13’卢-二甲基-3’,5,2〇,-二氧代螺[呋喃-2(311), 44,7]甲基幷[17Η]環戊[a]菲]-5,卢(2,Η)_腈,在眞 空烘箱中脱水,產生3 · 0克的固體。實例3 2 將在甲醇(1〇〇毫升)中,以實例31中描述之方法產製的 5 · 0克二酮的懸浮液加熱至迴流,並在丨分鐘内加入2 5 %在 甲醇(5.8晕升)直翁之甲醇鈉溶液。該混合物變成均質的。 在1 5分鐘之後,出現沉澱物。將混合物加熱至迴流,並在 大約4小時之後再度變成均質的。持續加熱至迴流,總共 23.5小時,並加入4.〇n HC1(1()毫升)。藉著蒸餾移除總 共60毫升在甲醇中的氰化氫溶液。在15分鐘内,在蒸餾殘 :物物f加入水(57毫升)。在加入水的期間内,該溶液的 /皿度昇呵至81.5 C,並藉著蒸餾移除額外的4毫升氰化氫/ 甲醇溶液。在水的加成作用完成之後,㈣合物變成雲霧 211 -593305 A7 Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs B7 V. Invention Description (208) Flask. Add water (1.26 ml) and heat the flask slightly to dissolve the solid. Dimethylacetamide [or dimethylformamide] (9 liters) was added, followed by 11 π-hydroxyconreno (3.0 g). In a reaction flask, a mixture of sulfuric acid (0.47 g) and water (0.25 ml) was added, while sandalwood was added. The mixture was heated to 95 ° C for 2 hours. HPLC analysis indicated that the reaction was complete. Sulfuric acid (0.27 ml) was added and the mixture was stirred for 30 minutes. Introduce additional water (25 ml) and sulfuric acid (0.90 ml) and stir the reaction mixture for 16 hours. The mixture was then cooled to 5-10 ° C in an ice bath. The solid was separated by filtration through a frit glass filter, followed by washing twice with water (20 liters). The solid diketone is 4 丨 S (4 丨 sink), 7 丨 sink · hexadecane_u 丨 hydroxyl-10′々, 13′lu-dimethyl-3 ′, 5,2〇,- Dioxospiro [furan-2 (311), 44,7] methylpyrene [17Η] cyclopenta [a] phenanthrene] -5, Lu (2, Η) _nitrile, dehydrated in a vacuum oven to produce 3 0 g of solid. Example 3 2 A suspension of 5.0 g of diketone produced in the method described in Example 31 in methanol (100 ml) was heated to reflux, and 25% methanol (5.8 Halo) NaOH's sodium methoxide solution. The mixture became homogeneous. After 15 minutes, a precipitate appeared. The mixture was heated to reflux and became homogeneous again after about 4 hours. Continue heating to reflux for a total of 23.5 hours and add 4.0 n HC1 (1 () ml). A total of 60 ml of hydrogen cyanide solution in methanol was removed by distillation. Water (57 ml) was added to the distillation residue f within 15 minutes. During the addition of water, the pH of the solution rose to 81.5 C, and an additional 4 ml of hydrogen cyanide / methanol solution was removed by distillation. After the addition of water is complete, the admixture becomes a cloud 211-

(讀先閱讀背面之注意事項再填寫本頁) 1«· 訂 p i n am A7(Read the precautions on the back before filling in this page) 1 «· Order p i n am A7

593305 五、發明説明(2〇9) 狀,並移除熱源。攪拌該混合物3 · 5小時,而產物慢慢地形 成結晶。過濾懸浮液,並以水沖洗收集到的固體,在漏斗 上以i氣蒸氣將其脱水,並在9 2 °C (2 ό以水銀計)下脱水1 6 J時,知到2 · 9 8克灰_白色的固體。該固體爲9 1.4 %的輕基 酯,也就是11 α,17α_二羥基_3_氧代孕留烯-7沈,2卜 二羧酸氫甲酯,r内酯,產量爲56.1 〇/〇。 實例3 3 將以實例3 1中描述之方法製備的二酮,裝入裝設有溫度 計、迪安-斯塔克分水器和機械攪拌器之清潔無水的3_頸反 應燒瓶中。在室溫(2 2。(:)下將甲醇(2 4毫升)裝入該反應器 中’並攪拌所得的淤漿5分鐘。將2 5重量❻/〇之在甲醇(5 2.8 笔升)中的甲醇鈉溶液裝入該反應器中,並在室溫下攪拌該 混合物10分鐘,在這段期間,反應混合物變成淡棕色澄清 的溶液,並觀察到輕微的放熱(2_3 °C)。控制添加的速率, 避免瓶的溫度超過3 0 °C。隨後將該混合物加熱至迴流條件( 大約6 7 C )’並在迴流下持續1 6小時。然後取試樣並藉著 Η P L C分析轉化作用。在迴流下持續反應,直到殘餘的二酮 不超過二酮裝載量的3 %。在迴流期間,在反應瓶中裝入的 4Ν HC1(120毫升),導致HCN的產生,可在洗滌器中使其 中止。 在反應結束之後,在大氣壓下將9 0 - 9 5 %的甲醇溶劑蒸餾 出反應混合物之外。在蒸餾期間,液面上的溫度變化從6 7 -7 5 °C,並在拋棄之前,先以苛性鹼和漂白劑處理含有η c N 的餾出液。在移除甲醇之後,將反應混合物冷卻至室溫, • 212- 本紙張尺度適用中國國家標準(CNS ) Α4規格(21〇&gt;&lt;297公釐) (請先閱讀背面之注意事項再填寫本頁) 丨« 、1Τ 經濟部中央標準局員工消費合作社印製 593305 經濟部中央標準局員工消費合作社印製 A7 __________B7 五、發明説明(210) 當將該混合物冷卻至4 0 - 4 5 °C的範園内時,固體產物開始沉 澱。在25°C下,可視需要含有5重量%的碳酸氫鈉(12〇〇亳 升)水溶液裝到已經冷卻的淤漿中,然後將所得的混合物冷 卻至0 C大約1小時。碳酸氫鋼的處理,可有效地從反應混 合物中排除剩下未反應的二酮。在〇 °C下攪拌該淤漿2小時 ’完成沉澱和結晶作用,隨後藉著過濾移出固體產物,並 以水(1 0 0毫升)沖洗濾餅。在8 0 - 9 0 °C的2 6,,水銀眞空下將 產物脱水至恆重。在脱水之後,水份含量低於〇 2 5重量0/〇 。經過調節之莫耳產量約爲7 7 - 8 0重量%。 實例3 4 使根據實例31製備之二酮(1當量)與甲醇鈉(4·8當量), 在甲醇溶劑中,在碘化鋅(1當量)的存在下反應。根據在本 文中描述的萃取過程,或是其中排除二氣甲烷萃取作用、 鹽水和苛性鹼沖洗,以及硫酸鈉脱水步驟的非_萃取過程, 來處理該反應產物。在非-萃取過程中,以5重量%的碳酸氫 鈉溶液來代替甲苯。 實例3 5 將藉著實例34製備之羥基酯(ι·97克)與四氫呋喃(20毫升 )混合,並將所得的混合物冷卻至·7〇Ό。加入磺醯氯(0.8 毫升)’並攪拌該混合物3 0分鐘,隨後加入咪π坐(1 . 3克)。 將反應混合物回溫至室溫,並攪拌額外的2小時。然後以二 氣甲燒晞釋該混合物,並以水萃取之。濃縮有機層,得到 粗製的晞酯(丨.97克)。藉著HPLCZ分析粗製產物的少量試 樣。分析顯示9,1 1 -鏈烯:1 1,1 2 -鏈晞:7,9 -内酯之比例爲 -213- 本紙張尺度適财_家轉(CNS ) M規格(2淑297公襲) (請先閱讀背面之注意事項再填寫本頁) 訂_ 經濟部中央標準局員工消費合作社印製 593305 A7 __ _____B7___ 五、發明説明(211 ) 75·5:7·2:17·3。將該過程混合成一個步驟,導入釋離基並 將其從導入晞酯之9,1 1 -鏈稀結構中除去,也就是反應爲續 醯氯引起式V之經基酯的1 1從-經基,被鹵化物代替,接著 疋△ - 9,1 1結構之脱鹵化氫的反應。因此未使用強酸(像是 甲酸)或諸如乙酸酐之類的乾燥劑,而完成了烯酯的形成。 也排除了另一個過程產生一氧化碳的迴流步驟。 實例3 6 將藉著實例34製備之羥基酯(20克)和二氯甲烷(400毫升 )加至裝有機械揽拌器、添加漏斗和熱電偶之清潔無水的三· 頸圓底燒瓶中。在周圍溫度下攪拌所得的混合物,直到獲 得完全的溶液爲止。利用冰浴將該溶液冷卻至5。(:。將甲烷 續醯氯(5亳升)迅速地加至含有羥基酯之ch2C12溶液中, 接著慢慢地逐滴加入三乙胺(1 〇 _ 8毫升)。調節加入速度以 便使反應溫度下超過5 °C。該反應爲極地放熱的;因此需要 冷卻。在大約5°C下攪拌該反應混合物1小時。當反應完成 時(HPLC和TLC分析),在大約〇°C的26水銀眞空下濃縮該 混合物,直到它變成黏稠的淤漿爲止。以CH2C12( 1 60毫升 )稀釋所得的淤漿,並在大約〇 X:的2 6水銀眞空下濃縮該混 合物’獲得一濃縮物。發現該濃縮物(其中R3 = H,且-A-A 和- B- B-爲- CH2_CH2 -之式IV的甲磺酸鹽產物,也就是11 α,17 二羥基·3·氧代孕甾-4-烯-7江,21·二羧酸氫甲酯 ’ Γ -内酯至17α -羥基- lla_(甲磺醯基)氧代-3 -氧代孕甾 -4 ·晞_ 7 α,2 1 -二羧酸氫甲酯,,-内酯)的純度爲 8 2 % (Η P L C面積°/〇)。不需分離,直接在下一個反應中使用 214- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210x297公釐1 &quot; (請先閱讀背面之注意事項再填寫本頁)593305 5. Description of the invention (209) and remove the heat source. The mixture was stirred for 3.5 hours while the product slowly formed crystals. The suspension was filtered, and the collected solid was washed with water, dehydrated on the funnel with i gas vapor, and dehydrated at 9 2 ° C (2 mer mercury) for 1 6 J, 2 · 9 8 Gram _ white solid. The solid was 9 1.4% of a light-based ester, that is, 11 α, 17α_dihydroxy_3_oxopregnene-7 precipitate, 2 methyl hydrogen dicarboxylate, and lactone. The yield was 56.1 〇 / 〇 . Example 33 The diketone prepared in the manner described in Example 31 was charged into a clean, anhydrous 3-necked reaction flask equipped with a thermometer, a Dean-Stark trap, and a mechanical stirrer. Methanol (24 ml) was charged into the reactor at room temperature (2 2. (:) and the resulting slurry was stirred for 5 minutes. 25 weight ❻ / 〇 in methanol (5 2.8 pen liters) Sodium methoxide solution was charged into the reactor, and the mixture was stirred at room temperature for 10 minutes, during which time the reaction mixture became a light brown clear solution, and a slight exotherm (2_3 ° C) was observed. Control The rate of addition avoids the temperature of the bottle exceeding 30 ° C. The mixture is then heated to reflux conditions (approximately 6 7 C) 'and maintained at reflux for 16 hours. Then samples are taken and the conversion is analyzed by Η PLC The reaction is continued under reflux until the residual diketone does not exceed 3% of the diketone loading. During the reflux, the 4N HC1 (120 ml) filled in the reaction bottle, resulting in the generation of HCN, can be in the scrubber Stop it. After the reaction is completed, 90-95% of the methanol solvent is distilled out of the reaction mixture at atmospheric pressure. During the distillation, the temperature of the liquid surface changes from 6 7 -7 5 ° C, and at Before disposal, treat with caustic and bleach containing η c N Distillate. After removing the methanol, cool the reaction mixture to room temperature. • 212- This paper size applies Chinese National Standard (CNS) A4 specification (21〇 &gt; &lt; 297mm) (Please read the Note: Please fill in this page again) 丨 «Printed by 1T Printed by the Consumers 'Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 593305 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economics A7 __________B7 V. Description of the invention (210) When the mixture is cooled to 40- At 45 ° C, the solid product began to precipitate. At 25 ° C, if necessary, an aqueous solution containing 5% by weight sodium bicarbonate (12,000 liters) was charged into the cooled slurry, and the obtained slurry was then charged. The mixture was cooled to 0 C for about 1 hour. The treatment of bicarbonate steel can effectively remove the unreacted diketone from the reaction mixture. Stir the slurry at 0 ° C for 2 hours to complete the precipitation and crystallization. The solid product was then removed by filtration, and the filter cake was rinsed with water (100 ml). The product was dehydrated to constant weight at 80-90 ° C at 26 ° C, with mercury emptied. After dehydration, the water Content is less than 0 2 5 weight 0 / 〇. The adjusted Mohr yield is about 7 7-80 weight%. Example 3 4 The diketone (1 equivalent) and sodium methoxide (4 · 8 equivalent) prepared according to Example 31 were prepared in methanol. The solvent is reacted in the presence of zinc iodide (1 equivalent). According to the extraction process described herein, or where digas methane extraction is excluded, brine and caustic washing, and non-extraction of the sodium sulfate dehydration step Process to treat the reaction product. In the non-extraction process, a 5% by weight sodium bicarbonate solution was used in place of toluene. Example 3 5 The hydroxy ester (1 · 97 g) prepared by Example 34 was mixed with tetrahydrofuran (20 ml), and the resulting mixture was cooled to 70 ° F. Sulfachloro (0.8 ml) was added and the mixture was stirred for 30 minutes, followed by acetone (1.3 g). The reaction mixture was warmed to room temperature and stirred for an additional 2 hours. The mixture was then degassed with dichloromethane and extracted with water. The organic layer was concentrated to give crude ethyl ester (.97 g). A small sample of the crude product was analyzed by HPLCZ. The analysis shows that the ratio of 9,1 1 -alkene: 1 1,1 2 -chain 晞: 7,9 -lactone is -213- The paper size is suitable for wealth_ 家 转 (CNS) M size (2 Shu 297 public attack ) (Please read the notes on the back before filling this page) Order _ Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 __ _____B7___ V. Description of the invention (211) 75 · 5: 7 · 2: 17 · 3. This process is mixed into one step, introducing a release group and removing it from the 9,1 1 -chain dilute structure introduced into the fluorenyl ester, that is, the reaction is to continue the fluorenyl chloride to cause the 1 1 from the transester of the formula V from- The radical is replaced by a halide, followed by a dehydrohalogenation reaction of the structure 疋 Δ-9,11. The use of strong acids (such as formic acid) or desiccants such as acetic anhydride is therefore not used, and the formation of ene esters is completed. It also precludes another process from generating a reflux step of carbon monoxide. Example 36 6 The hydroxyester (20 g) and dichloromethane (400 ml) prepared in Example 34 were added to a clean, anhydrous three-necked round bottom flask equipped with a mechanical stirrer, addition funnel, and thermocouple. The resulting mixture was stirred at ambient temperature until a complete solution was obtained. The solution was cooled to 5 using an ice bath. (:. Methane dichloromethane (5 liters) was quickly added to the ch2C12 solution containing the hydroxy ester, and then triethylamine (10-8 ml) was slowly added dropwise. The addition speed was adjusted so that the reaction temperature The temperature was above 5 ° C. The reaction was polar exothermic; therefore cooling was required. The reaction mixture was stirred at about 5 ° C for 1 hour. When the reaction was complete (HPLC and TLC analysis), the mercury was emptied at about 0 ° C at 26 ° C. The mixture was concentrated until it became a viscous slurry. The resulting slurry was diluted with CH2C12 (160 ml), and the mixture was concentrated under approximately 2 × mercury at approximately 0 ×: to obtain a concentrate. The concentrate was found Concentrate (where R3 = H, and -AA and -B-B- are -CH2_CH2-a mesylate product of formula IV, which is 11 α, 17 dihydroxy · 3 · oxopregn-4-ene- 7 Jiang, 21 · hydrogen methyl dicarboxylate 'Γ-lactone to 17α -hydroxy- lla_ (methylsulfonyl) oxo-3 -oxoprogesterone-4 · 晞 _ 7 α, 2 1 -dicarboxylic acid Hydrogen methyl ester, -lactone) has a purity of 8 2% (Η PLC area ° / 〇). No separation is required, and 214- paper is used directly in the next reaction. Scale applicable Chinese National Standard (CNS) Α4 size (210x297 mm 1 &quot; (Please read the Notes on the back to fill out this page)

593305 A7 B7 五、發明説明(212) 該物質。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 將甲酸鉀(4.7克)、甲酸(16毫升)和乙酸酐(8毫升, 0.084莫耳)加至裝有機械攪拌器、冷凝器、熱電偶和加熱 罩之清潔無水的反應器中。將所得的溶液加熱至7 〇 X:,並 攪拌大約4 - 8小時。乙酸酐的添加是放熱的,並產生氣體 (C Ο),以致於需調節加入的速率以便控制溫度和氣體的產 生(壓力)。製備活性消去劑的反應時間,依賴在該反應中水 存在的量而定(甲酸和甲酸鉀分別含有大約3 _ 5 %的水)。消 去反應對水存在的量很敏感;如果有&gt; 〇 ·丨〇/❶的水(K F ),則 7,9 -内酯不純的程度將會增加。從終產物中不易移除副產 物。當顯示KF &lt; 0 · 1 %水時,會使活性消去劑移至在先前步 驟中製備之甲磺酸鹽的濃縮物(〇 · 〇 7 〇莫耳)中。將所得的溶 液加熱至9 5 C ’並蒸館掉揮發性物質,在迪安斯塔克分水 器中收集。當揮發性物質的放出停止時,以冷凝器來代替 迪安斯塔克分水器,並加熱反應混合物至9 5 額外的1小時 °當完成時(丁1^和11?1^(:分析;&lt;〇.1%起始物質),將内容 物冷卻至50°(:,並開始眞空蒸餾(26以水銀計/50。(:)。將該 混合物濃縮成黏稠的淤漿,然後冷卻至周圍溫度。以醋酸 乙酯(137毫升)稀釋所得的淤漿,並攪拌該溶液15分鐘,再 以水(137毫升)稀釋。分離出層次,並以醋酸乙酯(7〇毫升) 再萃取下方的液層。以鹽水溶液(丨2 〇毫升)沖洗混合的醋酸 乙酯溶液一次’並以冰冷的1 N N a Ο Η溶液(各1 2 0毫升)沖 洗兩次。測量液層的ρ Η値,如果剩下沖洗液之ρ η値&lt; 8, 再度沖洗有機層。當剩下之沖洗液的ρ Η値&gt; 8時,以鹽水溶 -215- G氏張尺度適用中關家標準(CNS ) Μ規格⑺GX297公董) 一 593305 Α7 Β7 五、發明説明(213) 液(1 2 0毫升)沖洗醋酸乙酯層一次,並利用5 0 °C的水浴,藉 著旋轉汽化作用濃縮至無水。所得的烯酯,固體產物,也 就是17 π-羥基-3-氧代孕甾- 4,9(11)-二烯-7 α,21·二羧酸 氫甲酯,内酯,重92克(77莫耳0/〇之產量)。 將按照實例3 4製備之羥基酯(1 〇 〇克;〇 · 2 2莫耳)裝入裝設 有機械攪拌器、添加漏斗和熱電偶的2升3-頸之圓底燒瓶中 ’使用帶有自動溫度控制的循環冷卻浴。在反應之前使燒 瓶脱水,因爲甲烷磺醯氯對水有敏感性。 經濟部中央榡準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 、-S'一口 將二氣甲烷(1升)裝入燒瓶中,並在攪拌之下使羥基酯溶 解於其中。將該溶液冷卻至〇 °C,並經由添加漏斗將甲燒續 酶氯(25毫升;0.32莫耳)裝入燒瓶中。經由添加漏斗將三 乙胺(50毫升;〇.59莫耳)裝入該反應器中,並以額外的二 氯甲:fe ( 3 4毫升)沖洗該漏斗。加入三乙胺是高度放熱的。 在攪拌和冷卻之下的添加時間約爲1〇分鐘。將裝入的混合 物冷卻至〇°C,並保持在該溫度下額外的45分鐘,在這段期 間内,該反應燒瓶的液面上空間充滿氮氣。然後藉著薄層 層析法和高效率液體層析法來分析該反應混合物的試樣, 檢查反應的完成。隨後在〇°C下攪拌該混合物額外的3〇分鐘 ,並再度檢查反應的一成。在分析顯示該反應大體上已完 成之時;在0°C,在26”水銀眞空下將溶劑二氣甲烷汽提。 餾出物之氣相層析分析指出有甲烷磺醯氯和三乙胺的存在 。隨後將二氣甲烷(800毫升)中入反應器中,並在〇_ΐ5 π 之溫度範圍下,攪拌所得的混合物5分鐘。再度乃 -216-593305 A7 B7 5. Description of the invention (212) The substance. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs (please read the notes on the back before filling this page). Add potassium formate (4.7g), formic acid (16ml) and acetic anhydride (8ml, 0.084mol) to the container. Clean, anhydrous reactors with mechanical stirrers, condensers, thermocouples and heating hoods. The resulting solution was heated to 70 ×: and stirred for about 4-8 hours. The addition of acetic anhydride is exothermic and generates a gas (CO), so that the rate of addition needs to be adjusted in order to control the temperature and gas generation (pressure). The reaction time for the preparation of the active elimination agent depends on the amount of water present in the reaction (formic acid and potassium formate each contain approximately 3-5% water). The elimination reaction is sensitive to the amount of water present; if &gt; 〇 · 丨 〇 / ❶ water (K F), the degree of 7,9-lactone impureness will increase. It is not easy to remove by-products from the end product. When KF &lt; 0.1% water is shown, the active elimination agent is moved to the mesylate concentrate (0.07 mol) prepared in the previous step. The resulting solution was heated to 95 C 'and the volatiles were evaporated off and collected in a Dean Stark trap. When the evolution of volatile substances ceases, replace the Dean Stark trap with a condenser and heat the reaction mixture to 9 5 additional 1 hour ° When completed (Ding 1 ^ and 11? 1 ^ (: analysis &Lt; 0.1% starting material), the contents were cooled to 50 ° (:, and empty distillation was started (26 as mercury / 50. (:). The mixture was concentrated to a viscous slurry and then cooled To ambient temperature. The resulting slurry was diluted with ethyl acetate (137 ml), and the solution was stirred for 15 minutes, then diluted with water (137 ml). The layers were separated and re-extracted with ethyl acetate (70 ml). The lower liquid layer. Rinse the mixed ethyl acetate solution once with saline solution (20 ml) and rinse twice with ice-cold 1 NN a 0 Η solution (120 ml each). Measure the pH of the liquid layer Alas, if the remaining rinse solution ρ η 値 &lt; 8, the organic layer is rinsed again. When the remaining rinse solution ρ Η 値 &gt; 8 is used, the salt solution -215- G's Zhang scale applies the Zhongguanjia standard (CNS) M specifications (GX297 public director) 593305 Α7 Β7 V. Description of the invention (213) Liquid (120 ml) Rinse the ethyl acetate layer once and use a water bath at 50 ° C to concentrate it to dryness by rotary evaporation. The resulting enester, solid product, is 17 π-hydroxy-3-oxoprogesterone-4,9 ( 11) -Diene-7 α, 21 · dihydrogen methyl ester, lactone, weighing 92 g (77 mol 0/0 yield). A hydroxy ester (1000 g; 〇 · 2 2 mol) into a 2-liter 3-necked round bottom flask equipped with a mechanical stirrer, addition funnel and thermocouple 'using a circulating cooling bath with automatic temperature control. The flask was dehydrated before the reaction Because methanesulfonyl chloride is sensitive to water. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page). Into the flask, and dissolve the hydroxyester therein with stirring. The solution was cooled to 0 ° C., and the formazan enzyme chloride (25 ml; 0.32 mol) was charged into the flask via an addition funnel. The funnel was charged with triethylamine (50 ml; 0.59 mol) into the reactor with additional dichloromethane: f e (34 ml) rinse the funnel. The addition of triethylamine is highly exothermic. The addition time under stirring and cooling is about 10 minutes. The charged mixture is cooled to 0 ° C and maintained at this temperature. During the additional 45 minutes, during this period, the liquid surface space of the reaction flask was filled with nitrogen. Then, a sample of the reaction mixture was analyzed by thin layer chromatography and high-efficiency liquid chromatography to check the reaction. Finished. The mixture was then stirred at 0 ° C for an additional 30 minutes, and the reaction was checked for 10% again. When analysis showed that the reaction was substantially complete; the solvent was removed at 0 ° C under 26 "mercury Two-gas methane stripping. Gas chromatography analysis of the distillate indicated the presence of methanesulfonyl chloride and triethylamine. Subsequently, digas methane (800 ml) was charged into the reactor, and the resulting mixture was stirred at a temperature range of 0 to ΐ5π for 5 minutes. Once again -216-

經濟部中央標準局員工消費合作社印製 593305 A7 B7 五、發明説明(214) 在26&quot;水銀眞空下將溶劑汽提,得到其中113爲11,-A-A-和 -B-B -爲- CH2-CH2_,且R1爲甲氧羰基之式IV的甲磺酸鹽 。該產物之純度爲約9 0 - 9 5面積%。 欲製備消去劑,在分隔的無水反應器中混合甲酸鉀(23.5 克;0.28莫耳)、甲酸(80毫升)和乙酸酐(40毫升)。將甲酸 和乙酸酐抽吸至反應器中,並在加入乙酸酐期間,維持溫 度下超過4 0 °C。將消去劑混合物加熱至7 0 Ό,以便從反應 系統中清除水份。繼續該反應直到藉著F i s h e r分析,測定 水份含量低於〇 · 3重量%爲止。然後將消去劑溶液移至含有 如上述製備之濃縮粗製之鉀磺酸鹽溶液的反應器中。將所 得的混合物加熱至最大的溫度9 5 °C,並收集揮發性餾出物 ,直到不再產生更多的揮發物爲止。在大約9 〇 °C時停止蒸 餾。在蒸餾作用完成時,在95 °C下攪拌該反應混合物額外 的2小時,並以薄層層析法檢查反應的完成。當該反應完成 時,將反應器冷卻至5 0 °C,並在5 0 Ό的2 6,,水銀眞空下, 從反應混合物中移出甲酸和溶劑。將該濃縮物冷卻至室溫 ’隨後導入醋酸乙酯(688毫升),並攪拌醋酸乙酯與濃縮物 的混合物1 5分鐘。在此時導入1 2 %的鹽水溶液(6 8 8毫升) ’以便協助將可溶於水之雜質從有機相中移出。然後容許 該相沉降2 0分鐘。將液層移至另一個容器,並在其中裝入 額外含量的醋酸乙酯(350毫升),液層的反萃取在30分鐘内 完成,隨後容許該相沉降,並與醋酸乙酯層混合。在該混 合的醋酸乙酯層中,裝入飽和的氯化鈉溶液(6〇〇毫升),並 進行擾摔3 0分鐘。然後容許該相沉降。移出液層。完成額 -217- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 B7 V. Description of the invention (214) The solvent was stripped under 26 &quot; mercury air, and 113 was 11, -AA- and -BB-was-CH2-CH2_ And R1 is a mesylate salt of formula IV. The purity of this product is about 90-95% by area. To prepare the elimination agent, potassium formate (23.5 g; 0.28 mol), formic acid (80 ml) and acetic anhydride (40 ml) were mixed in a separate anhydrous reactor. Formic acid and acetic anhydride were pumped into the reactor and maintained at a temperature above 40 ° C during the addition of acetic anhydride. The elimination agent mixture was heated to 70 ° F to remove water from the reaction system. This reaction was continued until the moisture content was determined to be less than 0.3% by weight based on the F i s hr analysis. The elimination solution is then transferred to a reactor containing a concentrated crude potassium sulfonate solution prepared as described above. The resulting mixture was heated to a maximum temperature of 95 ° C and the volatile distillates were collected until no more volatiles were produced. Distillation was stopped at about 90 ° C. When the distillation was complete, the reaction mixture was stirred at 95 ° C for an additional 2 hours, and the completion of the reaction was checked by thin layer chromatography. When the reaction was complete, the reactor was cooled to 50 ° C and the formic acid and solvent were removed from the reaction mixture at 50 ° F, 26 ° C, and 100% mercury. The concentrate was cooled to room temperature 'followed by introduction of ethyl acetate (688 ml), and the mixture of ethyl acetate and the concentrate was stirred for 15 minutes. A 12% saline solution (6.88 ml) was introduced at this time to assist in removing water-soluble impurities from the organic phase. The phase was then allowed to settle for 20 minutes. The liquid layer was transferred to another container and charged with an additional amount of ethyl acetate (350 ml). The back extraction of the liquid layer was completed within 30 minutes, then the phase was allowed to settle and mixed with the ethyl acetate layer. The mixed ethyl acetate layer was charged with a saturated sodium chloride solution (600 ml), and was stirred for 30 minutes. The phase was then allowed to settle. Remove the liquid layer. Completion amount -217- This paper size applies to Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page)

593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(215) 外的氣化鈉(6 0 0毫升)的沖洗作用。從第二次剩下的沖洗液 中分離出有機相。然後在攪拌之下,以1N的氫氧化鈉(600 見升)沖洗有機相3 0分鐘。使該相沉降3 0分鐘,並移出液層 。檢查液層的p Η値,發現它&gt; 7。利用飽和的氯化鋼(6 〇 〇毫 升),更進一步地沖洗1 5分鐘。最後在5 0 X:的2 6 ’,水銀眞空 下濃縮有機相,並藉著過濾回收產物。在脱水後,最終的 產物是泡沫狀棕色的固體。在4 5 °C的減低壓力下,再進一 步脱水24小時,產生95.4克的烯酯產物,其分析爲68.8 % 。對於起始幾基酯和最後的烯酯,修正的莫耳產量爲 74.4% 〇 實例3 8 重覆實例3 7之程序,除了藉著以離子交換樹脂處理反應 溶液’免除了多重沖洗的步驟。鹼性氧化鋁或鹼性二氧化 石夕。在表3 8中列出以鹼性二氧化矽處理的條件。發現這些 處理,每個均有效地移除了雜質,不需實例4 4的多重沖洗 作用。 -218- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)593305 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the invention (215) Rinsing effect of sodium carbonate (600 ml). The organic phase was separated from the second remaining rinse. The organic phase was then rinsed with 1N sodium hydroxide (600 liters) with stirring for 30 minutes. The phase was allowed to settle for 30 minutes and the liquid layer was removed. Check the p 层 of the liquid layer and find it &gt; 7. Rinse even further for 15 minutes using saturated chlorinated steel (600 ml). Finally, the organic phase was concentrated at 50 x: 2 6 ', mercury was emptied, and the product was recovered by filtration. After dehydration, the final product was a foamy brown solid. Further dehydration for 24 hours at a reduced pressure of 45 ° C yielded 95.4 g of an enester product, which was 68.8% analyzed. For the first few esters and the last enester, the modified Moire yield was 74.4%. Example 3 8 The procedure of Example 37 was repeated, except that the multiple rinse step was eliminated by treating the reaction solution with an ion exchange resin. Basic alumina or alkaline dioxide. The conditions for treatment with basic silica are listed in Tables 38 and 8. It was found that each of these treatments effectively removed impurities without requiring the multiple flushing effect of Example 44. -218- This paper size applies to Chinese National Standard (CNS) A4 (210X297 mm) (Please read the precautions on the back before filling this page)

593305 A7 B7 五、發明説明(216 因子 驗性氧化銘 給定値 2克/125克產物 表3 8 貫*驗目的 利用驗性氧化鋁處理反應混 合物,以便移除Et3N · HC1 鹽,並排除了 IN NaOH和 1NHC1的沖洗 關键結果 產量爲93% 驗性二氧化矽 2克/125克產物 利用較便宜的鹼性二氧化矽 處理反應混合物,以便移除 Et3N · HC1鹽,並排除了 1N NaOH和1NHC1的沖洗 產量爲95% (請先閱讀背面之注意事項再填寫本頁)593305 A7 B7 V. Description of the invention (216 factor oxidative oxidative factor given 2 g / 125 g of product Table 3 8) * The purpose of the test is to treat the reaction mixture with experimental alumina in order to remove the Et3N · HC1 salt and exclude IN The key result of washing with NaOH and 1NHC1 is 93% yield. 2 g / 125 g of oxidative silica. The reaction mixture was treated with cheaper alkaline silica to remove the Et3N · HC1 salt and exclude 1N NaOH and The washing output of 1NHC1 is 95% (Please read the precautions on the back before filling this page)

實例3 9 在100亳升的反應器中,混合乙酸鉀(4克)和三氟乙酸 (42.5毫升)。以控制使溫度在添加期間低於30 °C的速度’ 加入三氟乙酸酐(9 · 5毫升)。然後將該溶液加熱至3 〇 C 3 〇分 鐘,以便提供可用來將式IV之甲讀酸鹽轉變成式11之烯醋 的消去劑。 將預先形成之TF A/TF A酐消去劑加至先前製備之式1V的 甲磺酸鹽溶液中。將所得的混合物加熱至4 0 C 4 · 5小時’足 期以T L· C或H P L· C檢查轉化的程度。當反應完成時,將該混 合物移至1 ·頸燒瓶中,並在減低的壓力下,在室溫(2 2 C ) 下濃縮至無水。在該混合物中加入醋酸乙酯(1 3 7耄升),以 便獲得固相物質的完全溶解,隨後加入水/鹽水混合物(1 3 7 毫升),並攪拌所得的兩相混合物1 0分鐘。然後谷淬相位分 -219- 本紙張尺度適用中國國家標準(CNS ) A4規格(210'〆297公釐) 訂 經濟、郅中央榡準局員工消費合作衽印製 593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(217) 離2 0分鐘。鹽水的強度爲2 4重量%。使液相與額外量的醋 酸乙酯(6 8亳升)接觸,並攪拌如此製備之兩相混合物丨〇分 鐘’隨後容許其靜置丨5分鐘,使相位分離,混合得自兩次 萃取作用的醋酸乙酯層,並以2 4重量。/()的鹽水(丨2 〇毫升)、 另一等份之24重量%的鹽水(60毫升)、1N的氫氧化鈉溶液 (1 5 0毫升)和另一份的鹽水(6 〇毫升)沖洗。在加入每個液相 之後,攪拌該混合物1 〇分鐘,並容許靜置1 5分鐘以便分離 之。在減低的壓力下,在4 5 °C下,利用水吸氣器將所得的 溶液濃縮至無水。藉著HP LC分析固態產物(8.09克),並發 現其包括8 3 · 4面積%的晞酯,2 · 4 5面積%的1 1,1 2 -鏈烯, 1 · 5 %的7,9 ·内酯和1 . 1 〇/〇未反應的甲磺酸鹽。 實例4 0 將具有在先前實例23中製備之結構的甲磺酸鹽(1.〇克)、 乙酸異丙晞酯(1〇克)和對-甲苯磺酸(5毫克)放置在50毫升 燒瓶中,並加熱至90°C,加以攪拌。在5小時之後,將該混 合物冷卻至2 5 °C,並在眞空中,在1 〇毫米汞柱下濃縮。將 殘餘物溶解於CH2C12(20毫升)中,並以5%含水的Example 39 In a 100-liter reactor, potassium acetate (4 g) and trifluoroacetic acid (42.5 ml) were mixed. Trifluoroacetic anhydride (9.5 ml) was added at a rate that controlled the temperature below 30 ° C during the addition. The solution was then heated to 30 C30 minutes to provide a scavenger that could be used to convert the formate salt of formula IV to the enolate of formula 11. The pre-formed TF A / TF A anhydride eradicating agent was added to the previously prepared mesylate solution of Formula 1V. The resulting mixture was heated to 40 C 4 · 5 hours' for a period of T L · C or HP L · C to check the degree of conversion. When the reaction was complete, the mixture was transferred to a 1-necked flask and concentrated under reduced pressure at room temperature (2 2 C) to dryness. To this mixture was added ethyl acetate (137 ml) to obtain complete dissolution of the solid phase material, followed by the addition of a water / brine mixture (137 ml) and the resulting two-phase mixture was stirred for 10 minutes. Then Gu Que phase points -219- This paper size applies Chinese National Standards (CNS) A4 specifications (210'〆297mm) Ordering economy, 郅 Central Bureau of Standards and Staff Consumption Cooperation 衽 Printing 593305 Staffing of Central Standards Bureau of Ministry of Economic Affairs Cooperative printed A7 B7 V. Description of invention (217) 20 minutes away. The strength of the brine was 24% by weight. The liquid phase was brought into contact with an additional amount of ethyl acetate (68 liters) and the two-phase mixture thus prepared was stirred for 0 minutes' and then allowed to stand for 5 minutes to separate the phases and the mixture was obtained from two extractions The ethyl acetate layer was 2 to 4 by weight. / () Of saline (20 ml), another aliquot of 24% by weight saline (60 ml), 1N sodium hydroxide solution (150 ml), and another portion of saline (60 ml) rinse. After each liquid phase was added, the mixture was stirred for 10 minutes and allowed to stand for 15 minutes to separate it. Under reduced pressure, the resulting solution was concentrated to dryness using a water aspirator at 45 ° C. The solid product (8.09 g) was analyzed by HP LC, and it was found to include 8 3 · 4 area% of fluorenyl ester, 2 · 4 5 area% of 1, 1, 2 -alkene, 1 · 5% of 7, 9 -Lactone and 1.1 0/0 unreacted mesylate. Example 40 0 A mesylate (1.0 g), isopropylacetate (10 g) and p-toluenesulfonic acid (5 mg) having the structure prepared in the previous Example 23 were placed in a 50 ml flask Medium and heat to 90 ° C and stir. After 5 hours, the mixture was cooled to 25 ° C and concentrated in the air under 10 mm Hg. Dissolve the residue in CH2C12 (20 mL) and hydrate with 5% water.

NaHC03沖洗。在眞空中濃縮ch2C12層,得到1.47克黃褐 色的油。使該物質從CH2C12/Et20中再結晶,得到〇·50克 式IV(Z)之烯醇乙酸酯。 將該物質加至先前已加熱至1〇〇 °C的乙酸鋼(0.12克)和乙 酸(2 · 0毫升)的混合物中,並加以攪摔。在6 〇分鐘之後,將 混合物冷卻至25°C,並以dChpO毫升)稀釋。以水(2〇 毫升)沖洗該溶液,並覆以MgS04脱水。藉著過濾移除乾燥 -220- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁)NaHC03 rinse. The ch2C12 layer was concentrated in the air to obtain 1.47 g of a yellow-brown oil. This material was recrystallized from CH2C12 / Et20 to obtain 0.50 g of enol acetate of formula IV (Z). This material was added to a mixture of steel acetate (0.12 g) and acetic acid (2.0 ml) previously heated to 100 ° C and stirred. After 60 minutes, the mixture was cooled to 25 ° C and diluted with dChp (0 ml). The solution was rinsed with water (20 ml) and dried over MgS04. Remove dryness by filtration -220- This paper size applies to Chinese National Standard (CNS) A4 (210X 297mm) (Please read the precautions on the back before filling this page)

經濟部中央標準局員工消費合作社印繁 593305 A7 B7 五、發明説明(218) 劑,並在眞空中濃縮濾液,得到0 · 4克想要的9,1 1 -鏈埽, IV(Y)。該粗產物含有低於2 %的7,9-内酯雜質。 實例4 1 -甲磺酸鹽在D M S Ο中的熱消去作用Employees' Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs, Yin Fan 593305 A7 B7 V. Description of the invention (218) agent, and the filtrate was concentrated in the air to obtain 0.4 g of the desired 9,1 1 -chain, IV (Y). The crude product contained less than 2% of 7,9-lactone impurities. Example 4 Thermal elimination of 1-mesylate in D M S Ο

將在燒瓶中之2克甲磺酸鹽和5毫升D M S 0的混合物加熱 至80°C22.4小時。該反應混合物的HPLC分析顯示未檢測 到起始物質。在該反應中加入水(1 〇毫升),並以二氣甲燒 萃取沉澱物三次。以水沖洗混合的二氯甲燒層,覆以硫酸 鎂脱水並濃縮之,得到烯酯。 實例4 2 在50¾升梨形燒瓶中,將正在搅拌的固體狀之式η a晞 酯(1.07克,分析含有74·4%的晞酯)、三氯乙醯胺(〇.32克 )和磷酸氫二鉀(0.70克),與二氣甲烷(15.0毫升〇混合。獲 待&amp;清的么液。經由吸移管,在1分鐘的期間内加入過氧化 氫(30重量% ; 5·〇亳升)。在室溫下攪拌所得的混合物6小 時’在此時Η P L C分析顯示在該反應混合物中,環氧美克斯 雷諾對晞酯之比例約爲丨:1。在該反應混合物中加入額外的 -221- 本紙張尺度適用中國國家榡準(CNS ) A4規格(2Η)χ 297公釐1 ~ — (請先閱讀背面之注意事項再填寫本頁} -訂 593305 經濟部中央標準局員工消費合作社印製 A7 B7 -—~ ~—--^ 五、發明説明(219) 三氯乙醯胺(0.3 2克),並在攪拌下繼續反應8小時以上,之 後顯示剩下的晞酯比例已經降至1 〇 %。加入額外的三氯乙 醯胺(0 · 0 8克),並容許該反應混合物靜置過夜,此時相對 於在該混合物中的環氧美克斯雷諾,剩下未反應的烯酯僅 有5 %。 實例4 3 將式11A之晞醋(5.4克;分析含有7 4.4 %晞酯)加至1 〇 〇 毫升反應器中。在該烯酯中加入兩者皆爲固體形式的三氯 乙醯胺(4·9克)和磷酸氫二鉀(3.5克),接著加入二氯甲烷 (5 0毫升)。將該混合物冷卻至1 5 °C,並在1 〇分鐘的期間内 加入3 0%過氧化氫(25克)。容許該反應混合物回到20°C, 並在該溫度下攪拌6小時,在此時藉著HPLC檢查轉化作用 。定出剩下的烯酯低於1重量%。 將該反應混合物加至水(1 0 0毫升)中,容許相位分離,並 移出二氣甲烷層。在二氯甲烷層中加入氫氧化鈉(0 · 5 N ; 50¾升)。在20分鐘後,容許相位分離,並在二氯甲燒層中 加入HC1(0.5N ; 50毫升),隨後容許相位分離,並以飽和 的鹽水(5 0毫升)沖洗有機相。將二氯甲燒層覆以無水的硫 酸鑊脱水,並移除溶劑。獲得白色的固體(5 · 7克)。將含水 的氫氧化鈉層酸化並萃取之,萃取處理獲的額外〇 · 2克的產 物。環氧美克斯雷諾的產量爲90.2%。 實例4 4 以在實例4 3中描述的方法將式11A之晞酯轉化成環氧美克 斯雷語,但具有下列之差異:一開始裝入的包括晞目旨(5.4克 -222- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) f請先閱讀背面之注意事項再填寫本頁j -訂- 593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(220 ) ,分析含有74.4 %之烯酯)、三氯乙醯胺(3.3克)和磷酸氫 二鉀(3.5克)。加入過氧化氫溶液(12.5毫升)。在20 °C下經 營該反應過夜。隨後HPLC顯示晞酯有90%轉化成環氧美克 斯雷諾。加入額外的三氯乙醯胺(3.3克)和30 %過氧化氫 (5.0毫升),並進行該反應額外的6小時,在此時以晞酯之 裝載量爲基礎,僅有2%殘餘的晞酯。在按照實例43中的描 述處理之後,產生5.71克的環氧美克斯雷諾。 實例4 5 以在實例43中描述的一般方法,將式IIA之烯酯轉化成環 氧美克斯雷諾。在本實例的反應中,晞酯之裝載量爲5.4 ( 分析含有74.4 %的晞酯),三氯乙醯胺之裝載量爲4.9克, 過氧化氫之裝載量爲25克,磷酸氫二鉀之裝載量爲3.5克。 反應在2 0 C下進行1 8小時。殘餘的晞酯低於2 %。在處理後 產生5.71克的環氧美克斯雷諾。 實例4 6 以在實例4 3中描述的方法將式11A之晞酯轉化成環氧美克 斯雷諾,在本實例中之反應溫度爲2 8 °C。在反應器中物質 之裝載量包括烯酯(2.7克),三氯乙醯胺(2.5克),磷酸氫 二鉀(1.7克),過氧化氫(17.0克)和二氯甲烷(5〇亳升)。在 4小時反應之後,以晞酯裝載量爲基礎,未反應之晞酯僅有 2%。在按照實例43描述的處理之後,獲得3.0克的環氧美 克斯雷諾。 實例4 7 將式11A之缔酯(1 7克;分析含有7 2 %的晞酯)溶解於二氯 -223 - 本紙張尺度適用中國國家標準(CNS ) A4描枝f 輅、 (請先閱讀背面之注意事項再填寫本頁} 、一呑 丁 593305 A7 B7__ 五、發明説明(221) 甲烷(1 5 0毫升)中,隨後在緩慢的攪拌下加入三氯乙醯胺 (1 4 · 9克)。將該混合物的溫度調整到2 5 °C,並在4 0 0 r p m 的攪拌下,在該晞酯受酶質的溶液中攪拌在水(1 〇 · 6毫升) 中之磷酸氫二鉀(10.6克)的溶液。在3-5分鐘的期間内,在 受酶質/磷酸/三氯乙醯胺的溶液中加入過氧化氫(3 0重量% 之溶液;6 9 · 4毫升)。未觀察到放熱或氧氣的放出。在2 5 °C 下,以400 rpm攪摔如此製備之反應混合物1 8.5小時。在 整個反應過程中均未觀察到氧氣的放出。以水(69.4毫升) 稀釋該反應混合物,並以大約250 rpm攪拌該混合物15分 鐘。對於此操作不需控制溫度,其大體上在室溫(任何在5 -2 5 °C之範圍内的溫度均是可接受的)下經營。容許液層和有 機層分離,並移出較低的二氣甲燒層。 經濟部中央標準局員工消費合作社印繁 (請先閱讀背面之注意事項再填寫本頁) 在250 rpm的攪捽速率下,以二氣甲烷(69.4毫升)反萃 取液層1 5分鐘。容許分離出層次,並移出較低的二氯甲燒 層。對液層(177克;pH = 7)進行過氧化氫的測定。結果 (1 2 · 2 %)顯示在反應中僅消耗了 〇 · 〇 4 3 4莫耳的過氧化氫, 爲0 · 0 3 0 7莫耳的鏈烯。利用少量體積的二氣甲烷反應萃取 ,足以確定沒有環氧美克斯雷諾喪失在液層中。利用第二 次大量的二氣甲燒萃取證實該結果,在該萃取作用中僅回 收了三氣乙醯胺。 將得自上述萃取作用之混合的二氯甲烷溶液混合,並以 大約2 5 0 r p m之速率,以3重量%的亞硫酸鈉溶液(1 2 2毫升 )沖洗至少1 5分鐘。在擅;摔期間結束時,觀察到陰性的澱粉 碘試驗(KI試紙;未觀察到顏色;在陽性的試驗中,紫色表 -224- I紙張尺度適用中國國家榡準(CNS ) A4規格(210X297公釐)~'' 593305 A7 B7 五、發明説明(222 ) 示過氧化物的存在)。 容許液層和有機層分離,並移出較低的二氯甲烷層。拋 棄液層(pH = 6)。注意到加入亞硫酸鈉溶液可引起輕微的放 熱,以致於應該在溫度控制之下添加。 以大約25 0 rpm的速率,並在15_25 t的溫度範圍下 (pH=12-13),利用〇·5Ν氫氧化鈉(61毫升)沖洗二氣甲燒 相4 5分鐘。在該過程中移除衍生自三氯乙醯胺的雜質。將 鹼性含水的溶離份酸化,接著以二氯甲烷萃取,證實有非 苇少量的%氧美克斯雷諾在該操作中喪失。 在250 rpm之攪拌速率下,在i5-25°C的溫度範圍下,以 〇·1Ν的氫氯酸(61亳升)沖洗二氣甲烷相! 5分鐘。然後容許 分離出層次,移出較低的二氯甲烷層,並再度在25〇 rpm ,1 5 - 2 5 C的溫度範圍下,以1 〇重量%的含水氯化鈉(6 1毫 升)沖洗15分鐘。再次容許分離出層次,並移出有機層。通 過Solkafloc的墊子過濾有機層,然後在減低的壓力下蒸發 至無水。利用6 5 °C之水浴溫度使其完全脱水。獲得灰白色 的固體(17.9 5克),並進行HPLC分析。分析含有環氧美克 斯雷諾6 6 · 0 5 %。關於該反應之經過調整的莫耳產量爲 9 3 · 1 0/〇 〇 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 將產物溶解於熱的甲基乙基酮(189毫升)中,並在大氣壓 下蒸餾所得的溶液,直到已經移除9 5毫升的酮溶劑爲止。 將溫度降至5 0 °C時產物形成結晶。在5 0 °C下持續攪掉1小 時。然後將溫度降至2 0 - 2 5 °C,並持續再攪拌2小時。過濾 固體並以MEK(24毫升)沖洗,並將固體脱水至恆重9.98克 -225- 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(223 ) ,藉著HPLC分析,其含有93.63 %的環氧美克斯雷諾。將 該產物再度溶解於熱的MEK(106毫升)中,並在壓力下通 過1 0微米之線形濾器過濾該熱溶液。利用額外的1 8毫升 MEK沖洗,並在大氣壓下蒸餾經過過濾的MEK溶液。直到 已經移除5 3毫升溶劑爲止。將溫度降至5 0 °C,此時產物形 成結晶;並在5 0 t下持續攪摔1小時。然後將溫度降至2 〇 -2 5 C ’並在該溫度下持續再授拌2小時。過濾固體產物,並 以Μ E K (1 8毫升)沖洗。將固體產物脱水至怔重8.3 2克,經 過定量HPLC分析,其含有99.6%的環氧美克斯雷諾。最後 在脱水時喪失的低於1.0%。根據在本實例中之反應和處理 ’環氧美克斯雷諾的總產量爲6 5 · 8 %。該總產量反映9 3 % 的反應產量,7 8 · 9 %的最初之結晶作用回收率,和89 · 5 % 的再結晶回收率。 皇例4 8-式IIΑ利用甲苯的環氬化作用 以在實例46中描述的一般方法,將式na之烯酯轉化成艾 皮樂雷諾,除了使用甲苯作爲溶劑之外。將物質裝入反應 器中的裝載量,包括晞酯(2·7克)、三氣乙醯胺(2·5克)、 磷酸氫二鉀(1.7克)、過氧化氫(17〇克)和曱苯(5()毫升)。 容許該反應放熱至2 8°C,並在4小時中完成。將所得的三相 混合物冷卻至1 5 °C,過濾,以水沖洗,並在眞空中脱水, 得到2.5克的產物。 實例4 9 - 9 · 1 1 -二烯酮% i氧化作用 在一升的3頸燒瓶中,將命名爲χνιΙΑ(其中_a_a_和-B_ B-均爲- CH2-CH2-之化合物χνπ”々化合物(4〇 67克)溶 -226 - 本紙張尺度適家標準(CNS ) (請先閲讀背面之注意事項再填寫本頁)A mixture of 2 g of mesylate and 5 ml of D M S 0 in the flask was heated to 80 ° C for 22.4 hours. HPLC analysis of the reaction mixture showed that no starting material was detected. To the reaction was added water (10 ml), and the precipitate was extracted three times with dichloromethane. The mixed dichloromethane layer was washed with water, covered with magnesium sulfate, dehydrated, and concentrated to obtain an olefinic ester. Example 4 2 In a 50¾ liter pear-shaped flask, a stirring solid of the formula η a 晞 ester (1.07 g, analysis containing 74.4% fluorenyl ester), trichloroacetamide (0.32 g) and Dipotassium hydrogen phosphate (0.70 g) was mixed with digas methane (15.0 ml.) To obtain &amp; clear solution. Hydrogen peroxide (30% by weight; 5 · 〇) was added over a period of 1 minute via a pipette.亳 liter). The resulting mixture was stirred at room temperature for 6 hours. At this time, PLC analysis showed that in the reaction mixture, the ratio of epoxy mexrenol to ethyl ester was about 丨: 1. In this reaction mixture Add extra -221- This paper size applies to China National Standards (CNS) A4 (2mm) x 297mm 1 ~ — (Please read the precautions on the back before filling this page}-Order 593305 Central Bureau of Standards, Ministry of Economic Affairs A7 B7 printed by employee consumer cooperatives ----- ~~ ------ ^ V. Description of the invention (219) Trichloroacetamide (0.3 2 g), and continue to react for more than 8 hours under stirring, after which the remaining ethyl ester is displayed The proportion has been reduced to 10%. Add additional trichloroacetamide (0.88 g) and allow the reaction The mixture was allowed to stand overnight, at which time only 5% of the unreacted ene ester was left relative to the epoxy mexenolide in the mixture. Example 4 3 A vinegar of formula 11A (5.4 g; analysis containing 7 4.4) % Ethyl ester) was added to a 100 ml reactor. To this ene ester were added trichloroacetamide (4.9 g) and dipotassium hydrogen phosphate (3.5 g) both in solid form, followed by Dichloromethane (50 ml). The mixture was cooled to 15 ° C and 30% hydrogen peroxide (25 g) was added over a period of 10 minutes. The reaction mixture was allowed to return to 20 ° C, and Stir at this temperature for 6 hours, at which time the conversion was checked by HPLC. The remaining enester was determined to be less than 1% by weight. The reaction mixture was added to water (100 ml), and phase separation was allowed, The methane layer was removed. Sodium hydroxide (0.5 N; 50¾ liters) was added to the dichloromethane layer. After 20 minutes, phase separation was allowed, and HC1 (0.5N; 50 ml), then phase separation was allowed, and the organic phase was washed with saturated saline (50 ml). Dehydrate with anhydrous sulphuric acid and remove the solvent. A white solid (5.7 g) was obtained. The aqueous sodium hydroxide layer was acidified and extracted, and an additional 0.2 g of the product obtained by the extraction treatment. Epoxime The yield of Xrenox was 90.2%. Example 4 4 The methyl ester of formula 11A was converted to epoxy Mexray in the manner described in Example 43, but with the following differences: The initial loading included 晞Purpose (5.4g-222- This paper size applies to Chinese National Standard (CNS) A4 specifications (210X297mm) f Please read the notes on the back before filling out this page j-order-593305 Employee Consumer Cooperatives, Central Standards Bureau, Ministry of Economic Affairs A7 B7 was printed. 5. Description of the invention (220). Analysis of 74.4% of enols), trichloroacetamide (3.3 g) and dipotassium hydrogen phosphate (3.5 g). Add hydrogen peroxide solution (12.5 ml). The reaction was run overnight at 20 ° C. Subsequent HPLC showed that 90% of the fluorene esters were converted to epoxymaxex Renault. Additional trichloroacetamide (3.3 g) and 30% hydrogen peroxide (5.0 ml) were added and the reaction was carried out for an additional 6 hours. At this time, based on the loading of methyl ester, only 2% of the residual Ester. After treatment as described in Example 43, 5.71 grams of epoxy Mexanol was produced. Example 4 5 Using the general method described in Example 43, the enol of formula IIA was converted to epoxy mexrenol. In the reaction of this example, the loading of fluorenyl ester is 5.4 (analytical content of 74.4% of fluorenyl ester), the loading of trichloroacetamide is 4.9 g, the loading of hydrogen peroxide is 25 g, and dipotassium hydrogen phosphate The loading capacity is 3.5 grams. The reaction was carried out at 20 C for 18 hours. Residual ethyl ester was less than 2%. After the treatment, 5.71 g of epoxy Mex Renault was produced. Example 4 6 The fluorene ester of formula 11A was converted to epoxy mexanol in the manner described in Example 43. The reaction temperature in this example was 28 ° C. The loadings of the substances in the reactor included enester (2.7 g), trichloroacetamide (2.5 g), dipotassium hydrogen phosphate (1.7 g), hydrogen peroxide (17.0 g) and dichloromethane (50 g) Rise). After 4 hours of reaction, the unreacted fluorene ester was only 2% based on the fluorene ester loading. After the treatment as described in Example 43, 3.0 g of epoxy Mexanol was obtained. Example 4 7 Dissolve the associative ester of formula 11A (17 g; analysis contains 72% fluorenyl ester) dissolved in dichloro-223-This paper is in accordance with Chinese National Standard (CNS) A4, description f 辂, (Please read first Note on the back page, please fill in this page} 、 Yinding Ding 593305 A7 B7__ V. Description of the invention (221) Methane (150 ml), then add trichloroacetamide (1 4 · 9 g) under slow stirring ). The temperature of the mixture was adjusted to 25 ° C, and the potassium dibasic phosphate was stirred in water (10.6 ml) in a solution of the acetamyl esterase with stirring at 400 rpm. (10.6 g) solution. Hydrogen peroxide (30% by weight solution; 69.4 ml) was added to the enzymatic / phosphoric acid / trichloroacetamide solution over a period of 3-5 minutes. No exotherm or evolution of oxygen was observed. The reaction mixture thus prepared was stirred at 400 rpm for 1 8.5 hours at 25 ° C. No evolution of oxygen was observed throughout the reaction. Dilute with water (69.4 ml) The reaction mixture, and the mixture was stirred at about 250 rpm for 15 minutes. No temperature control was required for this operation, Generally operates at room temperature (any temperature in the range of 5-2 5 ° C is acceptable). The liquid layer and the organic layer are allowed to separate, and the lower two-gas-fired layer is removed. Central Ministry of Economic Affairs Standard Bureau staff consumer cooperatives Yinfan (please read the precautions on the back before filling this page) at 250 rpm stirring rate, back extract the liquid layer with methane (69.4 ml) for 15 minutes. The layers are allowed to separate, The lower dichloromethane layer was removed. The liquid layer (177 g; pH = 7) was measured for hydrogen peroxide. The results (12.2%) showed that only 0.004 was consumed in the reaction. Moore's hydrogen peroxide is 0. 0 3 0 7 Moore's alkene. Using a small volume of two-gas methane reaction extraction is sufficient to determine that no epoxy mexanol is lost in the liquid layer. The result was confirmed by the two-gas methyl alcohol extraction, and only the three-gas acetamide was recovered in the extraction. The mixed dichloromethane solution obtained from the above extraction was mixed and mixed at a rate of about 250 rpm at 3% by weight sodium sulfite solution (122 ml) rinse for at least 15 minutes At the end of the fall period, a negative starch iodine test was observed (KI test paper; no color was observed; in a positive test, the purple table-224-I paper size was applicable to China National Standard (CNS) A4 specification (210X297 (Mm) ~ '' 593305 A7 B7 V. Description of the invention (222) shows the existence of peroxide). Allow the liquid layer and the organic layer to separate and remove the lower methylene chloride layer. Discard the liquid layer (pH = 6) . Note that the addition of sodium sulfite solution can cause a slight exotherm so that it should be added under temperature control. At a rate of about 250 rpm and at a temperature range of 15-25 t (pH = 12-13), the digas phase was washed with 0.5N sodium hydroxide (61 ml) for 4 5 minutes. Amine derived from trichloro-acetyl remove impurities in the process. The alkaline aqueous fraction was acidified, followed by extraction with dichloromethane, and it was confirmed that a small amount of% oxmex Reynolds was lost during the operation. At a stirring rate of 250 rpm, in the temperature range of i5-25 ° C, rinse the digas methane phase with 0.1N hydrochloric acid (61 liters)! 5 minutes. The layers were then allowed to separate, the lower methylene chloride layer was removed, and rinsed again at 1050% by weight aqueous sodium chloride (61 ml) at a temperature range of 25 rpm and 15-25 C. minute. The layers are again allowed to separate and the organic layer is removed. The organic layer was filtered through a pad of Solkafloc and evaporated to dryness under reduced pressure. Use a water bath temperature of 65 ° C to completely dehydrate it. An off-white solid (17.9 5 g) was obtained and analyzed by HPLC. The analysis contained epoxy Mexyl Reynolds 66.05%. The adjusted Mohr output for this reaction is 9 3 · 10/00 printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page). Dissolve the product in hot methyl Ethyl ketone (189 ml) and the resulting solution was distilled at atmospheric pressure until 95 ml of the ketone solvent had been removed. The product crystallized when the temperature was reduced to 50 ° C. Stir off at 50 ° C for 1 hour. Then reduce the temperature to 20-25 ° C and continue stirring for another 2 hours. Filter the solids and rinse them with MEK (24 ml), and dehydrate the solids to a constant weight of 9.98 g -225- This paper size applies to China National Standard (CNS) A4 specifications (210 × 297 mm) 593305 Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economy Preparation of A7 B7 V. Description of the invention (223). By HPLC analysis, it contained 93.63% epoxy Mexanol. The product was redissolved in hot MEK (106 ml) and the hot solution was filtered under pressure through a 10 micron linear filter. Rinse with an additional 18 ml of MEK and distill the filtered MEK solution at atmospheric pressure. Until 5 3 ml of solvent has been removed. The temperature was reduced to 50 ° C, at which time the product formed crystals; and it was continuously stirred at 50 t for 1 hour. The temperature was then lowered to 20-2 5 C 'and stirring was continued for another 2 hours at this temperature. The solid product was filtered and rinsed with MEK (18 mL). The solid product was dehydrated to a weight of 8.32 g, and was analyzed by quantitative HPLC, and contained 99.6% epoxy mexrenol. Finally, less than 1.0% was lost during dehydration. According to the reaction and treatment in this example, the total production of epoxy Mexileau is 65. 8%. This total yield reflects a reaction yield of 93%, an initial crystallization recovery of 78.9%, and a recrystallization recovery of 89.5%. Example 4 8-Formula IIA utilizes cyclic argonization of toluene In the general method described in Example 46, the alkenyl ester of formula na was converted to apirenaline, except that toluene was used as a solvent. Loading capacity of the substance into the reactor, including methyl esters (2.7 grams), trigas acetamide (2.5 grams), dipotassium hydrogen phosphate (1.7 grams), hydrogen peroxide (170 grams) And toluene (5 () ml). The reaction was allowed to exotherm to 28 ° C and was completed in 4 hours. The resulting three-phase mixture was cooled to 15 ° C, filtered, rinsed with water, and dehydrated in the air to obtain 2.5 g of product. Example 4 9-9 · 1 1 -dienone% i oxidation in a one liter 3-necked flask will be named χνιΙΑ (where _a_a_ and -B_ B- are both -CH2-CH2- compounds χνπ " 々Compound (4067g) Soluble-226-IKEA Standard (CNS) for this paper (Please read the precautions on the back before filling this page)

593305 A7 B7 五、發明説明(224 ) 解於二氯甲烷(250毫升)中,並藉著外部的冰鹽混合物將其 冷卻。加入磷酸二鉀(22.5克)和三氣乙腈(83.5克),並將 該混合物冷卻至2 °C,隨後在1小時的期間内,慢慢地加入 3 0 %過氧化氫(2 0 0克)。在1 2 °C下攪拌該反應混合物8小時 ’並在室溫下擾拌1 4小時。取出一滴有機層,並檢查任何 起始的晞酮,發現&lt; 〇 · 5 %。加入水(4 0 0毫升),攪拌1 5分 鐘,並分離出層次。連續以2 0 0毫升碘化鉀(1 〇 % )、2 0 0毫 升硫代硫酸鈉(1 0 % )和1 〇 〇毫升飽和的碳酸氫鈉溶液沖洗有 機層,並每次均分離出層次。將有機層覆以無水的硫酸鎂 脱水,並濃縮之,產生粗製的環氧化物(4 1克)。使產物從 醋酸乙酯:二氣甲烷中再結晶,得到1 4 · 9克的純物質。 實例5 0 -式X V11A利用間·氣過氧苯甲酸的環氧化作用 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 將化合物XVIIA(18.0克)溶解於250毫升的二氯甲烷中 ,並冷卻至1 0 °C。在攪捽之下,於1 5分鐘的期間内加入固 體的間-氯過苯甲酸(5 0 - 6 0 %純度,2 1 · 8 6克)。並未觀察到 溫度的昇高。攪拌該反應混合物3小時,並檢查二晞_的存 在。以亞硫酸鈉(10%)、氫氧化鈉溶液(0.5 N)、氫氣酸溶 液(5 %)連續處理該反應混合物,且最後以5 〇毫升飽和的鹽 水溶液處理。在利用硫酸鎂脱水並蒸發之後,得到17 64克 環氧化物,可直接在下一個步驟中使用。發現該產物含有 拜耳-維格利(Baeyer-Villiger)氧化產物,可藉著與醋酸乙醋 一起研製,接著從二氯甲烷中形成結晶將其移除。就5〇〇克 的規模而言,依據經常的處理方式,過濾已沉澱的間-氯過 苯甲酸。 -227- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 經濟部中央標準局員工消費合作社印製 593305 A7 ____B7 五、發明説明(225 ) 實例5 1 -組合物XVIIA利用三氣乙gi胺之環 將化合物XVII A(2克)溶解於25毫升的二氣甲垸中。加 入三氣乙醯胺(2克)、磷酸二鉀(2克)。在室溫下攪拌,加 入30%過氧化氫(10毫升),並持續攪拌18小時,產生過氧 化物(1 · 6 3克)。未形成拜耳·維格利氧化產物。 實例5 2 將氫氧化鉀(5 6.3 9克;1 005.03毫莫耳;3·〇〇當量)裝入 2000毫升燒瓶中,並在周圍溫度下與二甲亞砜(75〇〇毫升 )一起形成淤漿。將符合式XX之三晞酮(其中R3爲Η,且_Α· Α -和- Β- Β-分別爲- CH2-CH2-)(100.00 克;335.01 亳莫耳 ;1·〇〇當量)與THF(95 6.0毫升)一起裝入燒瓶中。將三甲 基銃甲基硫酸鹽(126.14克;670.02毫莫耳;2·〇〇當量)裝 入燒瓶中,並將所得的混合物加熱至迴流,8 〇到8 5 °C !小 時。藉著HPLC檢查17-螺氧亞甲基的轉化。在眞空下從反 應混合物中汽提大約1升的THF,隨後在30分鐘的期間内裝 入水(460毫升),同時將反應混合物冷卻至丨5°C。過滤所得 的混合物,並以2 0 0毫升爲一等份的水沖洗固態環氧乙燒之 產物兩次。觀察產物是高度結晶狀的,並可輕易地完成過 濾作用。隨後在眞空下,在4 0 °C下將產物脱水。分離出 104.6克3 -甲基烯醇烯△-5,6,9,11,_17_環氧乙烷類固醇產 物。 實例5 3 在氮氣掩蓋下將乙醇鈉(41.94克;616.25毫莫耳;1.90 當量)裝入無水的5〇〇毫升反應器中。在反應器中裝入乙醇 -228- 本紙張尺度適用中國國家標準(CNS ) A4規格(21〇X297公釐) (請先閲讀背面之注意事項再填寫本頁) -訂 593305 經濟部中央標準局員工消費合作社印製 A7 五、發明説明( 226 ) (27〇·9毫升),並使甲醇銅在乙醇中形成淤漿。將丙二酸二 乙酉旨U 03.90克;64 8.6 8毫莫耳;2·〇〇當量)裝入該聚I ’隨後加入以實例52描述之方法製備的環氧乙燒類固醇 U 04.60克;324.34毫莫耳;i.oo當量),並將所得的混合 物加熱至迴流,也就是80-85。(:。持續加熱4小時,隨後藉 著H PLC檢查反應的完成。在30分鐘的期間内,在該反應 混合物中裝入水(3 3 7.86毫升),同時將該混合物冷:至^ °C。持續攪掉30分鐘,然後過濾反應淤漿,產生包含細粒 非晶形之粉末的滤餅。以水(各200亳升)沖洗濾餅兩^,隨 後在周圍溫度的眞空下將其脱水。分離出丨33 ·8克的3_甲基 烯醇醚△5,6,9,11-17-螺内酯-2 1-甲氧羰基中間物。土 實例5 4 將按照實例53產製之3·甲基烯醇醚-a ^7·螺 内酉旨-21-甲氧窥基中間物(式Χνιπ,其中R3爲η,且-A- Α -和- Β_Β -分別爲- CH2_CH2_ ; 133.80 克;313.68 毫莫 耳;1 ·〇〇當量),與氣化鈉(27.50克;470.52亳莫耳; 1·50^ι)、一甲基甲醯胺(7〇9愛升)和水(5毫升)一起在才覺 拌下裝入2000毫升的反應器中。將所得的混合物加熱至迴 流,138-142°C3小時,隨後藉著HPlc檢查該反應混合物 的反應冗成。隨後在3 0分鐘的期間内,將水加至該混合物 中’同時將該混合物冷卻至丨5 X:。持續攪拌3 〇分鐘,隨後 過滤該反應於漿,回收像濾餅狀之非晶形的固態反應產物 。沖洗該濾餅兩次(2 0 0亳升等份的水),之後將其脱水。將 產物3 -甲基烯醇醚_ 1 7 -螺内酯脱水,得到9丨.6克(8 2 · 3 °/〇產 -229- 本紙張尺度it财關家標準(CNS ) A4規格(2^1^董) (讀先閱讀背面之注意事項再填寫本頁)593305 A7 B7 V. Description of the invention (224) Dissolved in dichloromethane (250 ml) and cooled by an external ice-salt mixture. Dipotassium phosphate (22.5 g) and trigas acetonitrile (83.5 g) were added, and the mixture was cooled to 2 ° C, and then 30% hydrogen peroxide (200 g) was slowly added over a period of 1 hour. ). The reaction mixture was stirred at 12 ° C for 8 hours' and stirred at room temperature for 14 hours. A drop of the organic layer was removed and checked for any starting fluorenone, and was found to be &lt; 0.5%. Add water (400 ml), stir for 15 minutes, and separate the layers. The organic layer was washed successively with 200 ml of potassium iodide (100%), 200 ml of sodium thiosulfate (10%), and 100 ml of a saturated sodium bicarbonate solution, and the layers were separated each time. The organic layer was dried over anhydrous magnesium sulfate and concentrated to give a crude epoxide (41 g). The product was recrystallized from ethyl acetate: digas methane to give 14.9 g of pure material. Example 5 0-Formula X V11A Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs using the epoxidation of m-peroxy benzoic acid In 250 ml of dichloromethane and cooled to 10 ° C. Under stirring, solid m-chloroperbenzoic acid (50-60% purity, 21 · 86 g) was added over a period of 15 minutes. No increase in temperature was observed. The reaction mixture was stirred for 3 hours and checked for the presence of dioxin. The reaction mixture was continuously treated with sodium sulfite (10%), sodium hydroxide solution (0.5 N), and hydrogen acid solution (5%), and finally treated with 50 ml of a saturated saline solution. After dehydration with magnesium sulfate and evaporation, 17 64 g of epoxide was obtained, which was used directly in the next step. The product was found to contain a Bayer-Villiger oxidation product, which could be removed by trituration with ethyl acetate and subsequent formation of crystals from dichloromethane. For a 500 g scale, the precipitated m-chloroperbenzoic acid was filtered according to the usual treatment. -227- This paper size applies Chinese National Standard (CNS) A4 (210X 297mm) Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 593305 A7 ____B7 V. Description of the Invention (225) Example 5 1-Composition XVIIA The ring of acetylamine was used to dissolve compound XVII A (2 g) in 25 ml of digas formamidine. Add trigas acetamide (2 g) and dipotassium phosphate (2 g). Stir at room temperature, add 30% hydrogen peroxide (10 ml), and continue stirring for 18 hours to produce peroxides (1.63 g). No Bayer Vegley oxidation products were formed. Example 5 2 Potassium hydroxide (5 6.39 g; 1 005.03 millimoles; 3,000 equivalents) was charged into a 2000 ml flask and formed with dimethyl sulfoxide (750,000 ml) at ambient temperature. Slurry. Tristrione (where R3 is Η, and _Α · Α-and-Β- Β- are -CH2-CH2-, respectively) (100.00 g; 335.01 mol; 1.0 eq.) And THF (95 6.0 ml) was charged into the flask together. Trimethylphosphonium methyl sulfate (126.14 g; 670.02 mmol; 2,000 equivalents) was charged into a flask, and the resulting mixture was heated to reflux at 80 to 85 ° C for one hour. The conversion of 17-spirooxymethylene was checked by HPLC. Approximately 1 liter of THF was stripped from the reaction mixture under vacuum, and then water (460 ml) was charged over a period of 30 minutes while the reaction mixture was cooled to 5 ° C. The resulting mixture was filtered, and the solid ethylene oxide product was washed twice with 200 ml aliquots of water. It was observed that the product was highly crystalline and could easily complete the filtration. The product was then dehydrated at 40 ° C under vacuum. 104.6 g of 3-methylenolene delta-5,6,9,11, _17_ ethylene oxide steroid product was isolated. Example 53 Under a nitrogen blanket, sodium ethoxide (41.94 g; 616.25 mmoles; 1.90 equivalents) was charged into an anhydrous 500 ml reactor. Load ethanol into the reactor-228- This paper size applies to Chinese National Standard (CNS) A4 (21 × 297 mm) (Please read the precautions on the back before filling this page)-Order 593305 Central Bureau of Standards, Ministry of Economic Affairs Employee Consumer Cooperative printed A7 V. Invention Description (226) (270.9 ml) and made copper methoxide into a slurry in ethanol. 03.90 g of malonyl malonate U; 64 8.6 8 mmoles; 2.000 equivalents) was charged into the poly I 'followed by the addition of ethylene oxide steroid U 04.60 g prepared by the method described in Example 52; 324.34 Millimoles; i.oo equivalent), and the resulting mixture was heated to reflux, that is 80-85. (: Continue heating for 4 hours, then check the completion of the reaction by H PLC. During the 30 minute period, fill the reaction mixture with water (3 3 7.86 ml) while cooling the mixture: to ^ ° C The stirring was continued for 30 minutes, and then the reaction slurry was filtered to produce a filter cake containing fine-grained amorphous powder. The filter cake was rinsed with water (200 liters each) for 2 ^, and then dehydrated under ambient air. 33 · 8 g of 3-methylenol ether △ 5,6,9,11-17-spirolactone-2 1-methoxycarbonyl intermediate was isolated. Example 5 4 3 · produced according to Example 53 Methenol ether-a ^ 7 · spironyl- 21-methoxyl intermediate (Formula Xνιπ, where R3 is η, and -A- Α-and-Β_Β-are-CH2_CH2_; 133.80 g; 313.68 millimoles; 1.0 eq.), With sodium vaporization (27.50 g; 470.52 mol; 1.50 μm), monomethylformamide (7.09 liters), and water (5 ml ) Put together into a 2000-ml reactor with caustic agitation. The resulting mixture was heated to reflux at 138-142 ° C for 3 hours, and then the reaction mixture of the reaction mixture was checked by HPlc for redundancy. Then in a period of 30 minutes, water was added to the mixture 'while the mixture was cooled to 5 X :. Stirring was continued for 30 minutes, and then the reaction slurry was filtered to recover amorphous cake-like amorphous The reaction product in a solid state. The filter cake was rinsed twice (200 liter aliquots of water), and then dehydrated. The product 3-methylenol ether_ 17 -spirolactone was dehydrated to obtain 91.6 g ( 8 2 · 3 ° / 〇Production-229- This paper standard It Finance Standard (CNS) A4 Specification (2 ^ 1 ^ Dong) (Read the precautions on the back before filling in this page)

593305 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(227 ) 量;9 6面積%分析)。 實例5 5 將根據實例5 4產製的晞醇醚(9丨· 6 〇克;2 5 8 · 3 6毫莫耳; 1·〇〇當量)、乙醇(250毫升)、乙酸(250毫升)和水(250亳 升)裝入2 0 0 0毫升反應器中,並將所得的於漿加熱至迴流2 小時。在3 0分鐘内的期間内,將水(6 〇 〇毫升)裝入,同時將 該反應混合物冷卻至1 5 °C。隨後過濾反應淤漿,並以水 (2 00毫升一等份)沖洗濾餅兩次。然後將濾餅脱水;分離出 84.4克產物3-酮△ 5,6,9,1 1-1 7-螺内酯(式XVII之化合物 ,其中 R3 爲 Η,且-A_A_*_b_b_ 爲 _Ch2_CH2-;產量 9 5.9%) 〇 實例5 6 將化合物XVIIA(1公斤;2.81莫耳)與四氯化碳(3_2升) 一起裝入2 2升的4 -頸燒瓶中。將N _溴-琥珀醯亞胺(5 3 8克) 加至該混合物中,接著加入乙腈(3·2升)。將所得的混合物 加熱至迴流,並維持在68°C之迴流溫度下大約3小時,產生 澄清橘色的溶液。在加熱5小時之後,溶液轉成暗色。在6 小時之後移除熱源,並對該反應混合物採樣。在眞空下汽 提溶劑,並在仍留在底部的殘餘物中加入醋酸乙酯(6升)。 攪拌所得的混合物,隨後加入5 %碳酸氫鈉溶液(4升),並 攪拌該混合物1 5分鐘,隨後容許相位沉降。移出液層,並 將飽和的鹽水溶液(4升)導入混合物中,然後攪拌15分鐘。 再度分離相位,並在眞空下汽提有機層,產生黏稠的淤漿 。然後加入二甲基甲醯胺(4升),並持續汽提至罐溫度爲55 -230- 本紙張尺度適用中國國家標準(CNS ) A4規格(210'〆297公釐) (請先閱讀背面之注意事項再填寫本頁) 丁 593305 A7 B7 五、發明説明(228 ) C。容許仍留在底部的靜置過夜,並加入daBCO(330克) 和溴化鋰(2 4 3克)。然後加熱該混合物至7 〇 X:。在一個半小 時之後加熱,取出液態層析法之試樣,並在3.5 〇個小時之 後加熱,加入額外的DABCO (40克)。在4.5小時之後加熱 ’將水(4升)導入並將所得的混合物冷卻至1 5 °C。過濾該淤 漿,並以水(3升)沖洗濾餅,並在濾器上脱水過夜。將濕的 濾餅(978克)裝回22升的燒瓶内,並加入二甲基甲醯胺(7 升)。將如此產製之混合物加熱至1 〇 5 °C,在此時濾餅已完 全溶解於該溶液中。移除熱源,並攪掉在燒瓶中的混合物 ,再冷卻之。將冰水應用於反應器的套層中,並將反應器 中的混合物冷卻至1 4 °C,並持續2小時。過濾所得的淤漿, 並以2 · 5升一等份的水沖洗兩次。在眞空下將濾餅脱水過夜 。獲得5 10克的淡棕色固體產物。 實例5 7 在2升4 -頸的燒瓶中裝入:按照實例4 9、5 0或5 1產製之 9,11-環氧康雷諾(100.00克;282.1毫莫耳;ΐ·〇〇當量)、 二曱基曱醯胺(650.0毫升)、氯化鋰(30.00克·,707.7毫莫 耳;2.51當量)和丙酮氰醇(72.04克;77.3毫升;846.4毫 莫耳;3 · 0 0當量)。以機械方式揽摔所得的懸浮液,並以四 甲基胍(4 5.49克;49.6毫升;395.0毫莫耳,· 1.4〇當量)。 然後利用水冷的冷凝器和乾冰冷凝器(在丙_中填滿乾冰 &gt; 過 濾該系統,以避免HCN的逃脱。排氣管線從乾冰冷凝器通 過。進入填充過量許多之含氯漂白劑的洗滌器内。將該混 合物加熱至80°C。 -231- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 、τ 經濟部中央標準局員工消費合作社印製 經濟部中央標準局員工消費合作社印製 593305 A7 B7 五、發明説明(229 ) ' 在1 8小時之後,獲得暗紅-掠色的溶液,將其冷卻至室、w 並攪拌之。在冷卻的過程中,將氮氣噴射到該溶液中,以 便利用通入在洗務器中之漂白劑的’排氣管線移除殘餘的 HCN。在2小時之後,以乙酸(72克)處理該溶液,並擾掉 3 0分鐘。然後將粗製之混合物倒入冰水(2升)中,並加以才覺 拌。再進一步以10%含水的HC1(400亳升)處理經過授摔的 懸浮液,並攪拌1小時。然後過濾該混合物,得到暗碑紅色 的固體(7 3克),將濾液置於4升的分液漏斗中,並以二氣甲 烷(3x800毫升)萃取;混合有機層,並以水(2\2升)反萃取 。在具it中丨展縮· 一氣甲燒;谷液’传到6 1克暗紅色的油。 在容許含水的沖洗溶離份放置過夜之後,出現相當多的 沉殺物。藉著過濾收集沉澱物,並測定其爲純的產物晞胺 (14.8克)。 在將原始的紅色固體(7 3克)脱水之後,藉著HPLC分析, 並確定其主要成份爲9,11-環氧晞胺。HPLC進一步顯示該 烯胺是獲自二氯甲烷處理之紅色油的主要成份。計算該埽 胺之莫耳產量爲46 %。 實例5 8 將根據實例5 7製備之9,1 1 -環氧晞胺(4.6 0 0克; 0·011261莫耳;ι·〇〇當量)導入1〇〇〇毫升的圓底燒瓶中。 在該混合物中加入甲醇(3〇〇毫升)和〇·5重量%的含水HC1 (1 9 2耄升),隨後將其迴流丨7小時。隨後在眞空下移除甲醇 ’使留在罐中之物質的量減少到5 〇毫升,並引起白色沉澱 物形成。在該於漿中加入水(1〇〇毫升),隨後將其過濾,產 -232- 本紙張尺度適用中國國ϋ^^ϋΤΤΐ〇Χ297公釐) (請先閱讀背面之注意事項再填寫本頁) -^衣· 593305 A7 B7 五、發明説明(230 ) ~ 生白色的固體餅,以水沖洗三次。產生3·747克固體狀的 9,1 1-環氧二酮產物(8ι·3%)。 實例5 9 將根據實例5 8製備之環氧二酮(2 〇 〇毫克;〇 · 4 9毫莫耳) 懸浮於甲醇(3亳升)中,並在該混合物中加入1,8 -二氮二環 [5·4·〇]十一碳_7-#(DBU)。當在迴流下加熱24小時時, 茲混合物變成均質的。然後在3 0°C下,在旋轉式汽化器上 將其濃縮至無水,並使殘餘物分布在二氯甲烷和3.〇n HC1 之間。碟縮有機相,產生黃色的固體(丨9 3毫克),’確定其爲 2 2重量%之環氧美克斯雷諾。產量爲2 〇 %。 (請先閱讀背面之注意事項再填寫本頁)593305 Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Amount of Invention Description (227); 96% Analysis by Area). Example 5 5 Methanol ether (9 丨 · 60 g; 2 58 · 36 mmol; 1.0 equivalent) produced according to Example 5 4, ethanol (250 ml), acetic acid (250 ml) Water and water (250 liters) were charged into a 2000 ml reactor, and the resulting slurry was heated to reflux for 2 hours. Over a period of 30 minutes, water (600 ml) was charged while the reaction mixture was cooled to 15 ° C. The reaction slurry was then filtered and the filter cake was washed twice with water (200 ml aliquots). The filter cake was then dehydrated; 84.4 grams of the product 3-ketone △ 5,6,9,1 1-1 7-spirolactone (a compound of formula XVII, where R3 is fluorene and -A_A _ * _ b_b_ is _Ch2_CH2-; yield 9 5.9%) Example 5 6 Compound XVIIA (1 kg; 2.81 moles) was charged together with carbon tetrachloride (3_2 liters) into a 22 liter 4-neck flask. N-bromo-succinimide (538 grams) was added to the mixture, followed by acetonitrile (3.2 liters). The resulting mixture was heated to reflux and maintained at a reflux temperature of 68 ° C for about 3 hours, resulting in a clear orange solution. After heating for 5 hours, the solution turned dark. The heat source was removed after 6 hours and the reaction mixture was sampled. The solvent was stripped under vacuum and ethyl acetate (6 liters) was added to the residue remaining on the bottom. The resulting mixture was stirred, then a 5% sodium bicarbonate solution (4 liters) was added, and the mixture was stirred for 15 minutes, after which time the phase was allowed to settle. The liquid layer was removed and a saturated saline solution (4 liters) was introduced into the mixture, followed by stirring for 15 minutes. The phases were separated again, and the organic layer was stripped under the air, resulting in a thick slurry. Then add dimethylformamide (4 liters), and continue stripping to a tank temperature of 55 -230- This paper size applies to China National Standard (CNS) A4 specifications (210'〆297 mm) (Please read the back first (Notes on this page, please fill out this page) Ding 593305 A7 B7 V. Description of the invention (228) C. Allow to stand still at the bottom overnight and add daBCO (330 g) and lithium bromide (243 g). The mixture was then heated to 70X :. After one and a half hours of heating, remove the liquid chromatography sample and heat it after 3.5 hours, add additional DABCO (40 g). After 4.5 hours heating ′ water (4 liters) was introduced and the resulting mixture was cooled to 15 ° C. The slurry was filtered and the filter cake was rinsed with water (3 liters) and dehydrated on the filter overnight. The wet cake (978 g) was returned to a 22-liter flask and dimethylformamide (7 liters) was added. The mixture thus produced was heated to 105 ° C, at which point the filter cake was completely dissolved in the solution. Remove the heat source and stir off the mixture in the flask before cooling. Ice water was applied to the jacket of the reactor, and the mixture in the reactor was cooled to 14 ° C for 2 hours. The resulting slurry was filtered and rinsed twice with 2.5 l aliquots of water. The cake was dehydrated overnight under emptiness. 5 10 g of light brown solid product are obtained. Example 5 7 A 2 liter 4-necked flask was charged with 9,11-epoxy Conreno (100.00 g; 282.1 millimoles; ΐ0.00 equivalent) manufactured according to Example 4, 9, 50, or 51. ), Dimethylamidamine (650.0 ml), lithium chloride (30.00 g ·, 707.7 mmol; 2.51 equivalent) and acetone cyanohydrin (72.04 g; 77.3 ml; 846.4 mmol); 3.0 0 equivalent ). The resulting suspension was mechanically shaken with tetramethylguanidine (4 5.49 g; 49.6 ml; 395.0 millimoles, 1.40 equivalents). Then use a water-cooled condenser and a dry ice condenser (fill the dry ice in C_) to filter the system to avoid the escape of HCN. The exhaust line passes through the dry ice condenser. It enters the washing with a lot of chlorine bleach The mixture is heated to 80 ° C. -231- This paper size applies Chinese National Standard (CNS) A4 specification (210X297 mm) (Please read the precautions on the back before filling this page), τ Central of the Ministry of Economy Printed by the Consumer Bureau of the Standards Bureau Printed by the Central Consumers Bureau of the Ministry of Economy 593305 A7 B7 5. Description of the invention (229) '' After 18 hours, obtain a dark red-grass solution, cool it to the chamber, w and Stir. During cooling, sparg nitrogen into the solution to remove residual HCN using the 'exhaust line' of the bleach in the scrubber. After 2 hours, acetic acid (72 g ) Treat the solution and stir for 30 minutes. Then pour the crude mixture into ice water (2 liters) and mix it. Then treat with 10% water containing HC1 (400 liters). Overhang The mixture was stirred for 1 hour. The mixture was then filtered to obtain a dark red solid (73 g). The filtrate was placed in a 4 liter separatory funnel and extracted with methane (3x800 ml); the organic layers were mixed , And back extraction with water (2 \ 2 liters). In it it 丨 stretched and simmered in one gas; the grains' passed to 6 1 g of dark red oil. After allowing the water-containing rinses to stand overnight, it appeared Quite a lot of slaughter. The precipitate was collected by filtration and determined to be the pure product amidine (14.8 g). After dehydrating the original red solid (73 g), it was analyzed by HPLC and determined. The main ingredient is 9,11-epoxidamine. HPLC further showed that the enamine was the main component of the red oil obtained from the dichloromethane treatment. The molar yield of the amidine was calculated to be 46%. Example 5 8 According to the example 9,11 1-epoxidamine (4.60 g; 0.011261 mole; 1.00 equivalent) prepared in 5 7 was introduced into a 1000 ml round bottom flask. To this mixture was added methanol ( 300 ml) and 0.5% by weight of aqueous HC1 (192 ml), which was subsequently refluxed. 7 The subsequent removal of methanol under empty space reduced the amount of material remaining in the tank to 50 ml and caused the formation of a white precipitate. Water (100 ml) was added to the slurry, which was subsequently filtered , Product-232- This paper size is applicable to the country of China ^^ ΐΤΤΤ〇〇297297 mm) (Please read the precautions on the back before filling out this page)-^ · 593305 A7 B7 V. Description of the invention (230) ~ Raw white Rinse the solid cake three times with water. This gave 3.747 g of the 9,1 1-epoxydione product (8 m · 3%) as a solid. Example 5 9 An epoxy diketone (200 mg; 0.49 mmol) prepared according to Example 5 8 was suspended in methanol (3 ml), and 1,8-diazine was added to the mixture. Bicyclic [5 · 4 · 〇] undecyl_7-# (DBU). When heated under reflux for 24 hours, the mixture becomes homogeneous. It was then concentrated to dryness on a rotary evaporator at 30 ° C and the residue was distributed between dichloromethane and 3.0 n HC1. The organic phase was shrunk to give a yellow solid (93 mg), which was identified to be 22% by weight of epoxy Mexanol. The yield is 20%. (Please read the notes on the back before filling this page)

艾皮樂雷諾 經濟部中央標準局員工消費合作社印製 實例6 0 在懸浮於1.5毫升甲醇中的1〇〇毫克二酮中,加入1〇微升 (0.18當量)25% (重量/重量)在甲醇中之甲醇鈉的溶液。將 該溶液加熱至迴流。在30分鐘後,無二酮殘留,並出現5_ -233 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29?公釐)Printed by the Consumers Cooperative of the Central Bureau of Standards of the Ministry of Economics of Epilele, printed by Example 60 0. To 100 mg of dione suspended in 1.5 ml of methanol, add 10 μl (0.18 equivalent) of 25% (w / w) in A solution of sodium methoxide in methanol. The solution was heated to reflux. After 30 minutes, no diketone remained and 5_ -233 appeared-This paper size is in accordance with China National Standard (CNS) A4 (210X29? Mm)

經濟部中央標準局員工消費合作社印掣 593305 A7 B7___ 五、發明説明(231) 氰基酯。在該混合物中加入4 6微升2 5 % (重量/重量)在甲醇 中之甲醇鈉的溶液。將該混合物加熱至迴流2 3小時,在此 時由Η P L C判斷,主要的產物爲艾皮樂雷諾。 〇 〇 在懸浮於30毫升無水甲醇中的2克二酮中,加入0.34毫 升的三乙胺。將該懸浮液加熱至迴流4 _ 5小時。在2 5 °C下攪 拌該混合物1 6小時。過濾所得的懸浮液,得到1 .3克白色固 體狀之5-氰基酯。 在懸浮於80毫升甲醇中的6·6克二酮中,加入2.8毫升的 三乙胺。將該混合物加熱至迴流4小時,並以2 5 χ攪拌8 8小 時,在這段期間中產物從溶液中形成結晶。過濾接著以甲 醇沖洗,得到5·8克白色粉末狀的氰基酯。使該物質從氯仿 /甲醇中再結晶,得到31克結晶狀之物質,由HpLc得知其 爲均質的。 &lt; 由上又彳寸知,將看到達到數個本發明之目標,並獲得其 他有利的結果。 〃 以上又的組成和過程,可進行各種變化,而不違背本發 明之範圍’企圖將所有包含在上文之説明中,並顯示在^ (請先閲讀背面之注意事項再填寫本頁)Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs 593305 A7 B7___ 5. Description of the Invention (231) Cyanoester. To this mixture was added 46 microliters of a 25% (w / w) solution of sodium methoxide in methanol. The mixture was heated to reflux for 23 hours, at which point the main product was Epileleno, as judged by ΗPLC. To 2 g of diketone suspended in 30 ml of anhydrous methanol, 0.34 ml of triethylamine was added. The suspension was heated to reflux for 4-5 hours. The mixture was stirred at 25 ° C for 16 hours. The resulting suspension was filtered to obtain 1.3 g of 5-cyanoester as a white solid. To 6.6 g of diketone suspended in 80 ml of methanol, 2.8 ml of triethylamine was added. The mixture was heated to reflux for 4 hours and stirred for 8 8 hours at 25 x during which time the product formed crystals from the solution. Filtration followed by rinsing with methanol gave 5.8 g of cyanoester as a white powder. This material was recrystallized from chloroform / methanol to obtain 31 g of a crystalline material, which was found to be homogeneous from HpLc. &lt; As can be seen from the above, it will be seen that several objects of the present invention have been achieved and other advantageous results obtained. 〃 The above composition and process can be changed in various ways without violating the scope of the present invention ', and it is intended to include all of the above descriptions and display them ^ (Please read the precautions on the back before filling this page)

-234--234-

593305 A7 B7五、發明説明(232 )錄之圖片中的事件,解釋爲作爲例證的,而沒有限制的意思。 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 -235 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)593305 A7 B7 V. The events in the pictures recorded in the description of the invention (232) are to be interpreted as illustrations, without limitation. (Please read the notes on the back before filling this page) Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs -235-This paper size applies to China National Standard (CNS) A4 (210X297 mm)

Claims (1)

593305 第08611δ698號專利中請案 g 中文申請專利範圍替換本(92年9月)漂593305 Patent No. 08611δ698 Requested g Chinese Patent Application Replacement (September 1992) 1. 一種製備3 -酮- 7α_烷氧羰基取代之Δ_4,5_類固醇的方 法’其包括使燒基化試劑與4,5_二氫.5,7_内酉旨類固醇受 酶質,在鹼的存在下反應,該内酯受酶質在3_碳位置處 以酮或二烷氧基取代,且更包括了下列部份: ?( 7). 其中C(5)代表該受酶質之類固醇結構的5_碳位置,而 C (7)代表7-碳·位置。 2. 根據中請專利範圍第丨項之方法,其中該類轉受酶質包 括2和或不飽和的核心結構’更包括:9,&quot;_環氧化物或 其W驅物;且在17_碳處的取代基係選自包括螺内酯、酮 或其他螺内酯之前驅物。 3. 根據中請專利範圍第2項之方法,其中該類固醇受酶質及 邊方法所製備之類固醇,係在丨7•位置處以符合式 XXXIII之螺内酯取代基取代,1. A method for preparing a 3 -keto-7α_alkoxycarbonyl-substituted Δ_4,5_ steroid ', which comprises making the alkylating reagent and 4,5_dihydro. 5,7_ intrinsic steroid subject to enzymes, In the presence of a base, the lactone is substituted by a ketone or dialkoxy at the 3-carbon position of the enzyme, and further includes the following: (7). Where C (5) represents the enzyme The 5-carbon position of the steroid structure, and C (7) represents the 7-carbon position. 2. The method according to item 丨 of the patent application, wherein the type of transzyme includes 2 and or unsaturated core structures, and further includes: 9, &quot; _epoxide or its precursor; and 17 The substituent at the carbon is selected from the group consisting of spirolactone, ketone, or other spirolactone precursors. 3. The method according to item 2 of the patent claim, wherein the steroid is substituted by enzymatic and steroid-prepared steroids at the 7-7 position with a spironolactone substituent in accordance with formula XXXIII, XXXIII 〇 4. 5. 6. 根據申請專利範圍第!項之方法,其包括17_鲖結構。 根據申請專利範圍第”貝之方法,其中該内酯受酶質包括 3 - —燒氧基取代基。 根據申請專利範圍第!項之方法,其中使該5,7•内醋與燒XXXIII 〇 4. 5. 6. According to the scope of patent application! The method of the item, which includes a 17_ 鲖 structure. The method according to the scope of the patent application, wherein the lactone is enzymatic substance including a 3-alkoxy substituent. According to the method of the scope of the patent application, the method of item 5,7 593305 A8 B8 C8 D8593305 A8 B8 C8 D8 基鹵在驗的存在下反應。 •内酯類固醇化合物的方法,該内 來取代之,並包括下列結構: 7. —種製備4,5-二氫_5,7_内酯類固 酯類固醇在3 _碳處以酮來取代之,The base halide reacts in the presence of the test. • A method for lactone steroid compounds, which replaces the lactone, and includes the following structure: 7. — A method for preparing 4,5-dihydro-5,7_lactone steroid steroids is replaced by ketones at 3 carbons , 其中C ( 5 )代表該内酯化合物之類固醇結構的5 _碳位置, 而C(7)代表7 -碳位置, 該方法包括:_ 將氰基取代的類固醇轉化成7 -羧酸,隨後再將7 _羧酸再 轉化成5,7 -内酯。 8·根據申請專利範圍第7項之方法,其中該受酶質包括3 _ 酉同-Δ-4,5-7-羧基類固醇,並形成包括3_二烷氧基-5,7-内醋之縮酮中間物,在酸性的條件下將該3 _二烷氧基_ 5,7 -内酯水解’形成3 -酮-5,7·内酉旨。 9· 一種製備符合式Π之化合物的方法:Where C (5) represents the 5-carbon position of the steroid structure of the lactone compound, and C (7) represents the 7-carbon position, the method includes:-converting a cyano-substituted steroid to a 7-carboxylic acid, followed by The 7-carboxylic acid is reconverted to 5,7-lactone. 8. The method according to item 7 of the scope of patent application, wherein the enzymatic substance includes 3 _ iso-Δ-4,5-7-carboxy steroid, and forms including 3-dialkoxy-5,7-lactone The ketal intermediate is hydrolyzed to form 3-keto-5,7 · lactone under acidic conditions. 9. · A method for preparing a compound according to formula Π: 其中 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 593305 A8 B8 C8Of which, this paper size applies to China National Standard (CNS) Α4 size (210 X 297 mm) 593305 A8 B8 C8 -A_A-代表基團 _chr4_chr5或 cr4 = cr5_ R代表阿法(alPha)_方位的低級烷氧羰基或羥羰基; R 、R及R5選自包括氫、鹵素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, ^-:6-代表基團&lt;111^〇:1111、或1或/3-方位之基團: R6 i~CH, III 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 、酸基、幾烷基、烷氧烷基、羥羰基、烷基、烷氧 羰基、醯氧烷基、氰基、芳氧基,且 R和R分別選自包括氳、卣素、低碳數燒氧基、醯 基、見基、燒氧燒基、經黢基、燒基、虎氧黢基 、驗氧燒基、氰基、芳氧基,或是R8和R9 —起包含 一蚊壞或雜環之結構,或是R8或R9與R6或R7—起包 含一碳環或雜環結構,融合成五環之D環, 該方法包括: 藉著水解作用,接著在鹼的存在下與烷基化試劑反應, 將式EI化合物烷基化,該式EI化合物具有下列結構: -3 593305 A8 B8 C8 ______D8 六、申請專利範圍-A_A- represents a group _chr4_chr5 or cr4 = cr5_ R represents a lower alkoxycarbonyl or hydroxycarbonyl group of alpha (alPha); R, R, and R5 are selected from the group consisting of hydrogen, halogen, hydroxyl, low-carbon alkyl, Low carbon number alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, aryloxy, ^-: 6- representative group &lt; 111 ^ 〇: 1111, or 1 or / 3-position Groups: R6 i ~ CH, III where R6 and R7 are selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, acid group, hexaalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, Alkoxyalkyl, cyano, and aryloxy, and R and R are respectively selected from the group consisting of fluorene, fluorene, low-carbon alkoxy, fluorenyl, amido, alkoxy, fluorenyl, alkynyl, Tiger oxenyl, oxygen test, cyano, aryloxy, or R8 and R9 together contain a mosquito or heterocyclic structure, or R8 or R9 and R6 or R7 contain a carbocyclic or Heterocyclic structure, fused into a five-ring D ring, the method includes: by hydrolysis, followed by reaction with an alkylating agent in the presence of a base, alkylating a compound of formula EI, the compound of formula EI has the following structure : -3 593305 A8 B8 C8 ______D8 6. Scope of patent application ΞΙ 其中-Α-Α-、R3、R8、R9和-Β-Β_如同上文之定義,且r 17 為(^至(:4烷基。 10. —種製備符合式11 C之化合物的方法:ΞΙ wherein -Α-Α-, R3, R8, R9, and -Β-Β_ are as defined above, and r 17 is (^ to (: 4 alkyl). 10. a method: IIC 其中 -Α-Α -代表基團- CHR4-CHR5 -或 _cR4 = CR5· R1代表阿法(alpha)-方位的低級烷氧羰基或羥羰基; R3、R4及R5選自包括氫、齒素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, R26為Ci至C4烷基; -B-B-代表基團-CHR6-CHR7_或α _或心方位之基團: -4 593305IIC where -Α-Α- represents a group-CHR4-CHR5-or _cR4 = CR5 · R1 represents an alpha (lower) alkoxycarbonyl or hydroxycarbonyl group; R3, R4 and R5 are selected from the group consisting of hydrogen, Element, hydroxy, low-carbon alkyl, low-carbon alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, aryloxy, R26 is Ci to C4 alkyl; -BB- represents a group -CHR6-CHR7_ or α _ or cardiac group: -4 593305 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羧基、醯氧烷基、氰基、芳氧基, 該方法包括: 藉著水解作用’接著在鹼的存在下與烷基化試劑反應, 將式E化合物燒基化,該式E化合物具有下列結構:Where R6 and R7 are selected from the group consisting of hydrogen, halogen, low-carbon alkoxyfluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarboxy, fluorenylalkyl, cyano, and aryloxy The method includes: by hydrolysis' followed by reaction with an alkylating agent in the presence of a base, the compound of formula E is alkylated, and the compound of formula E has the following structure: 其中_A-A-、R3和_Β_Β·如同上文之定義,且R17為(^至 C 4 fe 基。 11 · 一種製備符合式E之化合物的方法: 〇Wherein _A-A-, R3 and _Β_Β are as defined above, and R17 is a ^ to C 4 fe group. 11 · A method for preparing a compound according to formula E: 〇 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) ^J 593305 A8 B8 C8 D8 々、申請專利範圍 其中 _Α_Α·代表基團 _(:ΗΙ14-ί:ΠΙ15-或·CR^^CR5- R3、R4及R5選自包括氫、鹵素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, R17為&lt;^至(:4烷基; -B-B-代表基團-CHR6-CHR7-或α-或沒-方位之基團:This paper size applies to China National Standard (CNS) A4 specification (210 X 297 mm) ^ J 593305 A8 B8 C8 D8 ^^ CR5- R3, R4 and R5 are selected from the group consisting of hydrogen, halogen, hydroxyl, low-carbon alkyl, low-carbon alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, and aryloxy, R17 is &lt; ^ to (: 4 alkyl; -BB- represents a group -CHR6-CHR7- or α- or non-azimuth group: 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷·基、烷氧 羰基、醯氧烷基、氰基、芳氧基, 該方法包括: 在鹼金屬li化物的存在下,將符合式D Ε 2之化合物熱裂 解,該式D E 2之化合物具有下列結構:Wherein R6 and R7 are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkynyl, alkoxycarbonyl, fluorenylalkyl, cyano, Aryloxy, the method includes: thermally cracking a compound conforming to formula DE 2 in the presence of an alkali metal liide, the compound of formula DE 2 having the following structure: 其中R 為Ci至C4燒基’且- 、r17和- B- B· 如同上文之定義。 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 A8 B8 C8 D8Wherein R is Ci to C4 alkyl, and-, r17 and -B-B are as defined above. This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 593305 A8 B8 C8 D8 種製備符合式DE2之化合物的方法:A method for preparing compounds according to formula DE2: 其中 -A_A_ 代表基團 _CHR、chr5_ 或 cr4 = cr5_ R R及R選自包括氫、自素、羥基、低碳數烷基 低蚊數烷氧基、每烷基、烷氧烷基、經羰基、氰 基、芳氧基, R17和R12分別選自c^c4烷基; 代表基團_CHr6_chr7_或^或^ •方位之基團:Where -A_A_ represents the group _CHR, chr5_ or cr4 = cr5_ RR and R is selected from the group consisting of hydrogen, autogen, hydroxyl, low-carbon alkyl, low-mosquito alkoxy, per-alkyl, alkoxyalkyl, carbonyl , Cyano, aryloxy, R17 and R12 are respectively selected from c ^ c4 alkyl; Representative group _CHr6_chr7_ or ^ or ^ • Orientation group: 其中R6和R7分別選自包括氫、函素、低碳數烷氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羰基、醯氧烷基、氰基、芳氧基, 該方法包括: 在驗的存在下,將式DE 1之化合物與丙二酸二烷基酯縮 合,該式D E 1之化合物具有下列結構: 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A BCD 々、申請專利範圍Wherein R6 and R7 are respectively selected from the group consisting of hydrogen, functional elements, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, fluorenylalkyl, cyano, Aryloxy, the method comprises: condensing a compound of formula DE 1 with a dialkyl malonate in the presence of a test, the compound of formula DE 1 having the following structure: The Chinese paper standard (CNS) applies to this paper A4 size (210 X 297 mm) 593305 8 8 8 8 A BCD 々, patent application scope 0 DE1 其中-A-A-、R3、R17和-B-B-如同上文之定義。 13. —種製備符合式DE 1之化合物的方法:0 DE1 where -A-A-, R3, R17 and -B-B- are as defined above. 13. A method for preparing a compound according to formula DE 1: 其中 -A-A-代表基團- CHR4-CHR5-或-CR4 = CR5- R3、R4及R5選自包括氫、鹵素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, R17為Ci至C4烷基; -B-B-代表基團-CHR6-CHR7-或α -或/3-方位之基團, -8- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 A8 B8 C8 D8 六、申請專利範圍Where -AA- represents a group-CHR4-CHR5- or -CR4 = CR5- R3, R4 and R5 are selected from the group consisting of hydrogen, halogen, hydroxyl, low-carbon alkyl, low-carbon alkoxy, hydroxyalkyl, alkane Oxyalkyl, hydroxycarbonyl, cyano, aryloxy, R17 is Ci to C4 alkyl; -BB- represents the group -CHR6-CHR7- or α- or / 3-azimuth group, -8- this paper Standards apply to China National Standard (CNS) A4 specifications (210 X 297 mm) 593305 A8 B8 C8 D8 工1工 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 、酿基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羰基、醯氧烷基、氰基、芳氧基, 該方法包括: 該式 =二下 =化合物域内錄鹽反應R6 and R7 are selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, alkynyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, alkoxyalkyl, and cyano Group, aryloxy group, the method includes: the formula = two times = salt recording reaction in the compound domain D 其中、R3和如同上文之定装 14. 一種製備符合式d之化合物的方法: 巧D wherein, R3 and the same as above 14. A method for preparing a compound according to formula d: D -9-D -9- 593305593305 其中 -A-Λ-代表基團- CHR4-CHR5-或-CR4 = CR5- R 、R及R5選自包括氫、鹵素、輕基、低石炭數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, R17為Ci至c4烷基; -B-B-代表基團-chr6-CHR7_或α-或/5-方位之基團: %_/R7 .I 1 1 C H C Η 2 C H —- III 其中R和R分別選自包括氫、卣素、低碳數燒氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羰基、醯氧烷基、氰基、芳氧基, 讀方法包括: 將式C之化合物水解成7 α -羧酸,並在酸性條件下與原 甲酸三烷基酯反應,該式C之化合物具有下列結構: R3Where -A-Λ- represents a group-CHR4-CHR5- or -CR4 = CR5- R, R and R5 are selected from the group consisting of hydrogen, halogen, light group, low carbon number alkyl group, low carbon number alkoxy group, and hydroxyalkane Group, alkoxyalkyl group, hydroxycarbonyl group, cyano group, aryloxy group, R17 is Ci to c4 alkyl group; -BB- represents group -chr6-CHR7_ or α- or / 5-azimuth group:% _ / R7 .I 1 1 CHC Η 2 CH —- III where R and R are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, and alkyl , Alkoxycarbonyl, alkoxyalkyl, cyano, aryloxy, and the reading method includes: hydrolyzing a compound of formula C to a 7 α-carboxylic acid, and reacting with trialkyl orthoformate under acidic conditions, the formula The compound of C has the following structure: R3 c 其中- Α-Α-、R3 ' R17和-Β-Β-如同上文之定義。 -10- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) A8 B8 C8 D8 申請專利範圍 15·—種製備符合式I之化合物的方法: R3 R80c wherein-Α-Α-, R3 'R17 and -Β-Β- are as defined above. -10- This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) A8 B8 C8 D8 Application scope of patent 15 · —A method for preparing compounds conforming to formula I: R3 R80 其中 _Α·Α-代表基團-CHRLCHr5 或 cr4==cr5_ R3、R4及R5選自包括氫、齒素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, R26為c^c4烷基; -B-B-代表基團_CHr6_chr7•或或方位之基團: —_ C Η —^ C Η 2 ~~ C Η — III 其中R和R7分別選自包括氫、鹵素、低碳數燒氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 窥基、Sat氧纟元基、氣基、芳氧基,且 R80和R90分別選自r&gt;r9 ’或r8〇和r90 一起形成酮 R8和R9分別選自包括氫、_素、低碳數燒氧基、酿 基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧羰基 、驗氧烷基、氰基、芳氧基,或是…和尺9 一起包含 -11 - 593305 8 8 8 8 ABCD 六、申請專利範圍 一峡%或雜環之結構,或是R8*R9與r6*r7 一起包 含一碳環或雜環結構,融合成五環之D環, 該方法包括: 藉著在驗的存在下與烷基化試劑反應,將式A 2丨丨之化 合物:fe基化’該式A 2 1 1之化合物具有下列結構:Where _Α · Α- represents the group -CHRLCHr5 or cr4 == cr5_ R3, R4 and R5 are selected from the group consisting of hydrogen, halo, hydroxyl, low-carbon alkyl, low-carbon alkoxy, hydroxyalkyl, alkoxy Alkyl, hydroxycarbonyl, cyano, aryloxy, R26 is c ^ c4 alkyl; -BB- represents the group _CHr6_chr7 • or a group of orientation: —_ C Η — ^ C Η 2 ~~ C Η — III wherein R and R7 are selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxy, Sat oxonyl, Gas group, aryloxy group, and R80 and R90 are selected from r> r9 'or r80 and r90 together to form a ketone. R8 and R9 are respectively selected from the group consisting of hydrogen, hydrogen, low carbon number alkoxy group, alcohol group, hydroxyalkane Group, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, oxyalkyl, cyano, aryloxy, or ... Contains -11-593305 8 8 8 8 ABCD with rule 9 Structures with a range of 1% or a heterocyclic ring, or R8 * R9 and r6 * r7 together containing a carbocyclic or heterocyclic structure, fused into a pentacyclic D ring, the method includes: Base The reaction agent, the compound of the formula A 2 Shushu: Fe group of 'Compound A 2 1 1 of the formula has the following structure: 0 [A211] 其中^^-、{^、^^、尺⑻和^-^如同上文之定義, 且R17為(^至(:4烷基。 16. —種製備符合式IE之化合物的方法: 〇0 [A211] wherein ^^-, {^, ^^, ruler, and ^-^ have the same meanings as defined above, and R17 is (^ to (: 4 alkyl groups). 16. A method for preparing compounds conforming to formula IE Method: 〇 其中 -八-八-代表基團-〇11114-0:11115-或&lt;114 = 〇115- -12- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 8 8 8 8 A BCD 六、申請專利範園 R3、R4及R5選自包括氳、4素 ' ^ ^ ^ ^ ^ ^ , 、 羥基、低碳數烷羞 低妷數烷虱基、羥烷基、境 基、芳氧基, …基、幾羰基、# R26為c 1至c4烷基; - B-B-代表基團-CHR6_CHR7〇t 及α-或冷_方位之基團: R6 • C Η · —— C Η - III 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羧基、醯氧烷基、氰基、芳氧基, 該方法包括: 藉著在鹼的存在下與烷基化試劑反應,將式2丨丨之化合 物烷基化,該式2 1 1之化合物具有下列結構:Of which -eight-eight-represents a group-〇11114-0: 11115- or &lt; 114 = 〇115- -12- This paper size applies the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 8 8 8 8 A BCD VI. Patent application Fanyuan R3, R4 and R5 are selected from the group consisting of fluorene, 4 primes, ^ ^ ^ ^ ^ ^, hydroxy, low carbon number, low carbon number, alkyl group, hydroxyalkyl group, environmental group , Aryloxy, ... group, carbonyl group, # R26 is c 1 to c4 alkyl group;-BB- represents the group -CHR6_CHR70 and the α- or cold-positioned group: R6 • C Η · —— C Η-III wherein R6 and R7 are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarboxy, alkoxyalkyl, and cyano This method includes: alkylating a compound of formula 2 丨 by reacting with an alkylating agent in the presence of a base, and the compound of formula 2 1 1 has the following structure: [211] 其中- A- A-、R3和- B- B-如同上文之足我。 17. —種製備符合式2 1 1之化合物的方法: 13- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 A8 B8 C8 D8 六、申請專利範圍[211] Of which-A- A-, R3 and-B- B- are as good as above. 17. —A method for preparing a compound conforming to formula 2 1 1: 13- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 593305 A8 B8 C8 D8 6. Scope of patent application -八-八_代表基團 _chr4-chr5·或_cr4 = cr5· R 、R及R5選自包括氫、鹵素、觀基、低碳數燒基 、低竣數燒氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, -3-6-代表基團_(:111^(:]^7_或(:1:_或/3-方位之基團: R6-Eight-eight-representing group _chr4-chr5 · or _cr4 = cr5 · R, R and R5 are selected from the group consisting of hydrogen, halogen, guanyl, low carbon number alkynyl, low number alkynyl, hydroxyalkyl , Alkoxyalkyl, hydroxycarbonyl, cyano, aryloxy, -3-6- represents the group _ (: 111 ^ (:) ^ 7_ or (: 1: _ or / 3-azimuth group: R6 C Η — C Η 2 — R7 CH IU 其中R6和R7分別選自包括氫、函素、低碳數烷氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羰基、醯氧烷基、氰基、芳氧基, R8/和R9G分別選自R8*R9 ,或尺8〇和r9G 一起形成酮 R和R分別選自包括氫、齒素、低碳數烷氧基、醯 土罗工k基、k氧燒基、輕羰基、虎基、虎氧羰基 、醯氧烷基、氰基、芳氧基,或是R8和R9 —起包含 一碳環或雜環之結構,或是R8或R9與R6或R7—起包 -14- 工尺度通用中國國家標準董τ 593305 A8 B8 C8C Η — C Η 2 — R7 CH IU where R6 and R7 are respectively selected from the group consisting of hydrogen, halo, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, and alkoxy Carbonyl, alkoxyalkyl, cyano, aryloxy, R8 / and R9G are respectively selected from R8 * R9, or chiral 80 and r9G together to form a ketone. R and R are respectively selected from the group consisting of hydrogen, dentin, and lower alkane Oxy, arsenite, k-based, k-oxyalkyl, light carbonyl, oxo, oxocarbonyl, oxoalkyl, cyano, aryloxy, or R8 and R9 together contain a carbocyclic or heterocyclic The structure of the ring, or R8 or R9 and R6 or R7-from the contract -14- GM China National Standard τ 593305 A8 B8 C8 D8 含一蚊環或雜環結構,融合成五環之D環, 該方法包括: 將式2 1 〇 &lt;化合物氧化,該式2 1 0之化合物具有下列結 構:D8 contains a mosquito ring or heterocyclic structure and is fused into a five-ring D ring. The method includes: oxidizing a compound of formula 2 10 &lt; the compound of formula 2 10 has the following structure: [A210] 其中-A-A-、 -B_B-、R3、R8G和R90如同上文之定義。 18·根據申請專利範圍第17項之方法,其中該R8和R9包括 X代表兩個氫原子、氧代或=s, Y1和Y2 —起代表氧橋_〇-,或 Y1代表羥基,且 Y2代表經基、低碳數烷基,或如果X代表Η],也可代表 燒酸氧基。 19·根據申請專利範圍第18項之方法,其中R8和R9包括[A210] wherein -A-A-, -B_B-, R3, R8G, and R90 are as defined above. 18. The method according to item 17 of the scope of patent application, wherein R8 and R9 include X representing two hydrogen atoms, oxo or = s, Y1 and Y2 together represent an oxygen bridge _〇-, or Y1 represents a hydroxyl group, and Y2 Represents a mesityl group, a lower carbon number alkyl group, or if X represents fluorene], it may also represent an acid oxy group. 19. Method according to item 18 of the scope of patent application, wherein R8 and R9 include 20’種製備符合下式之化合物的方法:20 ’methods for preparing compounds [A211] 其中 -A-A-代表基團- CHR4-CHR5-*_CR4 = CR5- R 、R及R選自包括氫、鹵素、經基、低碳數烷基 低奴數板氧基、每燒基、燒氧燒基、藉羧基、氰 基、芳氧基, θ -B-B-代表基團-CHR6-CHR7-或α·或/5-方位之基團: R6 一· -C Η 一 C Η 2-C Η 一 III 其中R6和R7分別選自包括氫、商素、低碳數烷氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 致基、B盡氧纟元基、氣基、芳氧基,且 R8和R9分別選自包括氫、卣素、低碳數烷氧基、醯 基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧羰基 、醯氧烷基、氰基、芳氧基,或是R8和R9 一起包含 一碳環或雜環之結構,或是尺8或119與116或117一起包 -16- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公董) 593305[A211] where -AA- represents a group-CHR4-CHR5-* _ CR4 = CR5-R, R and R are selected from the group consisting of hydrogen, halogen, meridian, low-carbon alkyl, low-sulphonic plate oxygen, per-alkyl group , Oxyalkyl, carboxyl, cyano, aryloxy, θ -BB- represents the group -CHR6-CHR7- or α · or / 5-azimuth group: R6-· -C Η -C Η 2 -C Η 一 III in which R6 and R7 are respectively selected from the group consisting of hydrogen, quotient, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxygenic group, and B An oxo group, an oxo group, and an aryloxy group, and R8 and R9 are respectively selected from the group consisting of hydrogen, halogen, alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, Alkoxycarbonyl, alkoxyalkyl, cyano, aryloxy, or a structure in which R8 and R9 together contain a carbocyclic or heterocyclic ring, or a rule of 8 or 119 and 116 or 117 together Applicable to China National Standard (CNS) A4 specification (210 X 297 public directors) 593305 含一碳環或雜環結構 該方法包括: 融合成五環之D環, 使式A 2 0 9之3 _酉同_ $ 反應,該式A209C之 ,7 -半縮醛中間物與過氧化物氧 化合物符合下式: 化劑Containing a carbocyclic or heterocyclic structure, the method includes: fused into a five-ring D ring, and reacting the formula A 2 0 9-3 __ with _ $, the formula A209C, the 7-hemal acetal intermediate and peroxidation The oxygen compound conforms to the following formula: [A209C] 其中- r&gt; 8 -f ^ Q 、 R、R和R如同上文之定義。 21.根據申請專利範圚!, 軛圍弟20項之方法,其中該R8和R9包括 /CV7),Μ,,(°Η2)2 . c - X X代表兩個氫原子、氧代或=s, Y和Y2 —起代表氧橋·〇-,或 γ 1代表#i基,且 Y2代表羥基、低碳數烷基,或如果χ代表h2,也可代 烷醯氧基。 22.根據中請專利範圍第21項之方法,其中該R8和R9包括 0 ΊΙ -17 - ^張尺度11^^家標準(CNS) A4規格(觀297公爱)&quot;~: ----~. 593305 8 8 8 8 A BCD 申請專利範圍 23· —種製備符合下式之化合物的方法[A209C] wherein-r &gt; 8 -f ^ Q, R, R, and R are as defined above. 21. According to the patent application Fan! The method of yoke 20 items, wherein the R8 and R9 include / CV7), M ,, (° Η2) 2. C-XX represents two hydrogen atoms, oxo or = s, Y and Y2 together represent oxygen The bridge ·-, or γ 1 represents a #i group, and Y 2 represents a hydroxyl group, a lower carbon number alkyl group, or if χ represents h 2, an alkylalkoxy group may also be substituted. 22. The method according to item 21 of the patent application, wherein the R8 and R9 include 0 Ί -17-^ Zhang standard 11 ^ Home Standard (CNS) A4 specifications (View 297 public love) &quot; ~: --- -~. 593305 8 8 8 8 A BCD patent application scope 23 · —A method for preparing a compound conforming to the following formula Ο—— OH [A210] 其中 -A-A-代表基團- CHR4-CHR5·或-CR4 = CR5-R3、R4及R5選自包括氫、鹵素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, -B-B-代表基團-CHR6-CHR7-或[或/3-方位之基團: R6 • CH — CH, -CH IU 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羰基、醯氧烷基、氰基、芳氧基,且 R8G和R9G分別選自和r9,或尺8〇和尺9() 一起形成酮 R和R分別選自包括氫、齒素、低碳數燒氧基、酿 基、經燒基、烷氧烷基、羥羰基、烷基、烷氧羰基 -18- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 A8 B8 C8〇—— OH [A210] where -AA- represents a group-CHR4-CHR5 · or -CR4 = CR5-R3, R4 and R5 are selected from the group consisting of hydrogen, halogen, hydroxyl, low-carbon alkyl, and low-carbon alkoxy , Hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, aryloxy, -BB- represents the group -CHR6-CHR7- or [or / 3-azimuth group: R6 • CH — CH,- CH IU where R6 and R7 are selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, alkoxyalkyl, and cyano And aryloxy, and R8G and R9G are respectively selected from the group consisting of r9, or ruler 80 and ruler 9 () to form a ketone. R and R are respectively selected from the group consisting of hydrogen, tooth element, low carbon number alkoxy group, brewer group, and Alkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl-18-This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) 593305 A8 B8 C8 、驢氧烷基、氰基、芳氧基,或是R8和R9 —起包含 一蚊裱或雜環之結構,或是R8或R9與R6或R7—起包 含一奴%或雜環結構,融合成五環之D環, 該方法包括: 使式A 2 0 9 C之3 -酮5,7 -半縮醛中間物與過氧化物氧化劑 反應,該式A209C之化合物符合下式:, Donkey oxyalkyl, cyano, aryloxy, or R8 and R9 together contain a mosquito frame or heterocyclic structure, or R8 or R9 and R6 or R7 together contain a slave% or heterocyclic structure, Fusion into a five-ring D ring, the method includes: reacting a 3-keto 5,7-hemiacetal intermediate of formula A 2 0 9 C with a peroxide oxidant. The compound of formula A209C conforms to the following formula: [A209C] 其中-Α·Α_、-B-B-、R3、R8和R9如同上文之定義。 24·根據申請專利範圍第23項之方法,其中該R8和R9包括 7)丨丨丨丨丨(CH2) 2 · X代表兩個氫原子、氧代或=S, Y1和Y2 —起代表氧橋_〇-,或 γ 1代表羥基,且 Y2代表羥基、低碳數烷基,或如果X代表h2,也可代表 烷醯氧基。 25.根據申請專利範圍第24項之方法,其中該R8和R9包括 -19-本紙張尺度適用中國國家標準(CNS) A4規格(21〇 x邠7公釐) 593305 8 8 8 8 A BCD 申請專利範圍 0 II 26. —種製備符合下式之化合物的方法 其中[A209C] wherein -A · A_, -B-B-, R3, R8, and R9 are as defined above. 24. The method according to item 23 of the scope of patent application, wherein the R8 and R9 include 7) 丨 丨 丨 丨 丨 (CH2) 2 · X represents two hydrogen atoms, oxo or = S, Y1 and Y2 together represent oxygen The bridge _〇-, or γ 1 represents a hydroxyl group, and Y 2 represents a hydroxyl group, a lower carbon number alkyl group, or if X represents h 2, it may also represent an alkoxy group. 25. The method according to item 24 of the scope of patent application, wherein the R8 and R9 include -19- this paper size applies the Chinese National Standard (CNS) A4 specification (21 × x7 mm) 593305 8 8 8 8 A BCD application Patent scope 0 II 26.-A method for preparing a compound according to the following formula R90 [A209] -A-A-代表基團- CHR、CHR5-或-CR4 = CR5- R3、R4及R5選自包括氫、鹵素、羥基、低碳數烷J 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、鲁 基、芳氧基, -B-B·代表基團-CHR6-CHR7-或α-或/5-方位之基團, R6 -C Η — C Η 2 — C Η - 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧』 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷聋 談基、醯氧烷基、氰基、芳氧基,且 R80和R9G分別選自尺8和以,*r8(^r9G 一起形成酮 R8和R9分別選自包括氫、鹵素、低碳數烷氧基、商 基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧羰3 -20 - 本紙張尺度適财酬家鮮(CNH^格(⑽x 297公董) 593305 8 8 8 8 A B c D 申請專利範圍 、驢氧fe基、氯基、芳氧基,或是R8和R9 —起包含 一碳環或雜環之結構,或是R8或R9與R6或R7—起包 含一碳環或雜環結構,融合成五環之D環, 且-Ε·Ε·選自包括: \1 XLII: XLIV OR· I ,c— 2 ; XLV 和 R o——c R ίο ——R XL VI ο XLVII .21 C一CR -21 - 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 593305 A8 , . B8 C8 D8 六、申請專利範圍 R21、R22和R23分別選自氫、烷基、齒素、硝基和 氰基、且R24選自包括氫和低碳數烷基, 該方法包括: 將符合式A2 0 8之化合物水解R90 [A209] -AA- represents a group-CHR, CHR5- or -CR4 = CR5- R3, R4 and R5 are selected from the group consisting of hydrogen, halogen, hydroxyl, low-carbon alkane J, low-carbon alkoxy, hydroxyalkane , Alkoxyalkyl, hydroxycarbonyl, rudi, aryloxy, -BB · represents a group -CHR6-CHR7- or α- or / 5-azimuth group, R6 -C Η — C Η 2 — C Η-where R6 and R7 are selected from the group consisting of hydrogen, halogen, low-carbon alkoxy ', fluorenyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkanoyl, alkoxyalkyl, cyano Group, aryloxy group, and R80 and R9G are respectively selected from the group of 8 and 1, * r8 (^ r9G together form a ketone. R8 and R9 are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy group, commercial group, hydroxyalkyl , Alkoxyalkyl, Hydroxycarbonyl, Alkyl, Alkoxycarbonyl 3 -20-This paper is suitable for wealth and money (CNH ^ 格 (⑽x 297 公 董) 593305 8 8 8 8 AB c D Oxyfe, chloro, aryloxy, or R8 and R9 together contain a carbocyclic or heterocyclic structure, or R8 or R9 and R6 or R7 contain a carbocyclic or heterocyclic structure, fused into D ring of five rings, and -Ε · Ε · is selected from the group consisting of: \ 1 X LII: XLIV OR · I, c—2; XLV and Ro—c R ίο ——R XL VI ο XLVII .21 C—CR -21-This paper size applies to China National Standard (CNS) A4 specification (210X 297 Mm) 593305 A8,. B8 C8 D8 6. The scope of patent applications R21, R22 and R23 are selected from hydrogen, alkyl, halo, nitro and cyano, respectively, and R24 is selected from the group consisting of hydrogen and low-carbon alkyl, The method includes: hydrolyzing a compound conforming to formula A208 [A208] 其中 _Α_Α_、_Β·Β_、·Ε_Ε_、R3、R8〇 和 R90 如同上文 之定義,烷基或R19 0·基團一起形成〇,〇-氧 伸燒基橋;及 烷基。 27. —種製備符合下式之化合物的方法:[A208] wherein _Α_Α_, _Β · Β_, · Ε_Ε_, R3, R80, and R90 have the same meanings as defined above, and the alkyl or R19 0 · groups together form a 0,0-oxyl-extension group bridge; and an alkyl group. 27. A method for preparing a compound according to the following formula: [A205] 其中 -A-A-代表基團- CHR4-CHR5-或-CR4 = CR5- -22- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A BCD R3、R4及R5選自包括氫、鹵幸、〜 ^ 羥基、低碳數烷基 、低碳數烷氧基、輕烷基、烷轰 也虱虼基、羥羰基、氰 基、芳氧基, 團: R6 -C Η — C Η 2 ~ 丨_ C Η - III 其中R和R7分別選·自包括氫、函素、低碳數燒氧基 、酉盛基―、經貌基、貌氧燒基、幾黢基、燒基、貌氧 羰基、醯氧烷基、氰基、芳氧基,且 基或R19 0 -基團一起形成〇,〇 -氧伸燒 基橋;及 烷基。 其中-E-E-選自包括:[A205] where -AA- represents the group-CHR4-CHR5- or -CR4 = CR5- -22- This paper size applies to China National Standard (CNS) A4 specifications (210 X 297 mm) 593305 8 8 8 8 A BCD R3, R4, and R5 are selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl, lower alkoxy, light alkyl, alkyl, hydroxycarbonyl, cyano, and aryloxy Group: R6 -C Η — C Η 2 ~ 丨 _ C Η-III, where R and R7 are selected and selected from the group consisting of hydrogen, functional element, low carbon number alkoxy group, 酉 盛 基 ―, mesomorphic group, and morphological oxygen An alkyl group, an alkyl group, an alkyl group, an alkyloxycarbonyl group, an alkyloxyalkyl group, a cyano group, an aryloxy group, and an alkyl group or an R19 0-group together form a 0,0-oxyalkylene bridge; and an alkyl group. Where -E-E- is selected from the group consisting of: XLIH XLIV R - -c // R I 2 o-c-R V L X R 〇——c R. I c ——R XLVI 23 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 593305 8 8 8 8 A BCD ^、申請專利範圍 和 〇 2, XLVII R21、R22和R23分別選自氫、烷基、自素、硝基和氰基 ,R24選自氫和低碳數烷基, 該方法包括: 使符合式204之化合物與低碳數醇類和酸反應,該式2〇4 之化合物具有下列之結構: 9XLIH XLIV R--c // RI 2 ocR VLXR 〇——c R. I c ——R XLVI 23 This paper size applies to China National Standard (CNS) A4 (210 x 297 mm) 593305 8 8 8 8 A BCD ^, the scope of application for patents and 〇2, XLVII R21, R22 and R23 are respectively selected from hydrogen, alkyl, autogen, nitro and cyano, and R24 is selected from hydrogen and low-carbon alkyl. The method includes: The compound of formula 204 reacts with a lower carbon number of alcohols and acids. The compound of formula 204 has the following structure: 9 OH [A204] 其中_A-A_、-B-B_、-E-E-、R3和R19如同上文之定義 28· —種製備符合下式之化合物的方法:OH [A204] where _A-A_, -B-B_, -E-E-, R3 and R19 are as defined above. 28 ·-A method for preparing a compound according to the formula: [A204] 其中 -24 本紙張尺度適用中國國家標準(CMS) A4規格(210 x 297公釐) 593305 8 8 8 8 A BCD 申請專利範圍 -A-A-代表基團- CHR4-CHR5-或-CR4 = CR5- R3、R4及R5選自包括氫、齒素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, -B-B-代表基團·ΟΗΙ16·(:ΗΙ17_或α -或冷-方位之基團: R6 III 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羰基、醯氧烷基、氰基、芳氧基,且 尺19為CrCU烷基或R19 0 -基團一起形成0,0-氧伸烷 基橋; 其中-E-E-選自包括: .22 \1 XL: I C- XL IV OR2呼 XLV R O 1C R n c IR 25 X I 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A B c D 申請專利範圍 和 XLVII R21、R22和R23分別選自氫、烷基、鹵素、硝基和氰基 ,R24選自氫和低碳數烷基, 該方法包括: 將符合式2 0 3之化合物水解,該式2 0 3之化合物具有下列 之結構: .[A204] Among which -24 paper sizes are applicable to Chinese National Standard (CMS) A4 specifications (210 x 297 mm) 593305 8 8 8 8 A BCD patent application scope -AA- representative group-CHR4-CHR5- or -CR4 = CR5- R3, R4 and R5 are selected from the group consisting of hydrogen, halogen, hydroxy, low-carbon alkyl, low-carbon alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, and aryloxy,- BB- represents a group of ΟΗΙ16 · (: ΗΙ17_ or α- or cold-azimuth group: R6 III wherein R6 and R7 are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, and hydroxyalkyl , Alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, alkoxyalkyl, cyano, and aryloxy, and the 19 is a CrCU alkyl or R19 0-group together to form 0,0-oxyalkylene Base bridge; where -EE- is selected from the following: .22 \ 1 XL: I C- XL IV OR2 Call XLV RO 1C R nc IR 25 XI This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ) 593305 8 8 8 8 AB c D patent application scope and XLVII R21, R22 and R23 are respectively selected from hydrogen, alkyl, halogen, nitro and cyano, and R24 is selected from hydrogen and low-carbon alkyl, The method comprises: hydrolyzing a compound conforming to the formula 230, the compound having the following structure: [A203] 其中- A- A-、-B-B-、-E-E-、R3和R18如同上文之定義’及 尺“為匕-匕烷基或R18 Ο基團一起形成〇,〇-氧伸烷基橋 〇 29. —種製備符合下式之化合物的方法:[A203] in which-A- A-, -BB-, -EE-, R3 and R18 are as defined above and the rule "is a d-alkyl group or a R18 group together to form a 〇-〇-oxyalkylene基 桥 〇29. — A method for preparing a compound according to the following formula: [A204] -26-本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 593305 8 8 8 8 A B c D 々、申請專利範圍 其中 -A-A-代表基團_(:11114-(:^1115-或-CR4 = CR5- R3、R4及R5選自包括氫、鹵素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, -B-B-代表基團-CHR6-CHR7-或α -或/3-方位之基團: R6[A204] -26- This paper size applies to Chinese National Standard (CNS) A4 specification (210X 297 mm) 593305 8 8 8 8 AB c D 々, the scope of patent application where -AA- represents the group _ (: 11114- ( : ^ 1115- or -CR4 = CR5- R3, R4 and R5 are selected from the group consisting of hydrogen, halogen, hydroxyl, low-carbon alkyl, low-carbon alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyanide Group, aryloxy group, -BB- represents a group -CHR6-CHR7- or α- or / 3-azimuth group: R6 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 、醯基、輕燒基、燒氧燒基、談基、燒基、燒氧 羰基、醯氧烷基、氰基、芳氧基,且 其中-E-E-選自包括: R21 R22 \1丨 C-C—— / ) p23 XLIIIWherein R6 and R7 are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, lightly burned, oxyhalo, alkynyl, alkynyl, alkoxycarbonyl, alkoxyalkyl, cyano, and aromatic. Oxygen, and -EE- is selected from the group consisting of: R21 R22 \ 1 丨 CC—— /) p23 XLIII XLIVXLIV -27- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 ABCD 六、申請專利範圍 OR \1 和 XLVI XLVII R18為C^C:4烷基,或.Ru〇_基團一起形成〇,〇_氧基押 燒基橋’ R21、分別選自氫、燒基、卣素、舜 基和氰基,R2·4選自氫和低碳數烷基, 該方法包括: 藉著在酸性條件下’在原甲酸鹽的存在下,與鏈燒醇及 應,來保濩付合式A2〇1之化合物的酮取代基,該式 之化合物具有下列結構:-27- This paper size is in accordance with Chinese National Standard (CNS) A4 (210 X 297 mm) 593305 8 8 8 8 ABCD VI. Patent application scope OR \ 1 and XLVI XLVII R18 are C ^ C: 4 alkyl, or .Ru〇_ group together to form a 〇, 〇_ oxy alkynyl bridge 'R21, respectively selected from hydrogen, alkynyl, halogen, synyl and cyano, R2 · 4 is selected from hydrogen and lower carbon alkyl The method comprises: protecting the keto substituent of the compound of the formula A2O1 by reacting with the chain alcohol and the reactant in the presence of an orthoformate under acidic conditions, the compound of the formula having the following structure: [A201] 藉此 其中-A-A-、-B-B-、_E_E_*R3和如同上文之定義 產生符合式2 0 2之3 -稀醇酸中間物· 28 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) -------- 593305 A8 B8 C8 D8 申請專利範圍[A201] From this, -AA-, -BB-, _E_E_ * R3 and as defined above are used to produce a 3-dilute alkyd intermediate that conforms to the formula 2 0 2 · 28 This paper applies the Chinese National Standard (CNS) A4 Specifications (210 X 297 mm) -------- 593305 A8 B8 C8 D8 [A202] 其中-八-八-、-;8-;6-、-£-丑-、尺3如同上文之定義,及1118為 C「C4烷基或R18 O基團.一起形成0,0-伸烷基橋;及將該 式202之化合物還原,以產生符合式Α203之化合物:[A202] wherein -eight-eight-,-; 8-; 6-,-£ -ugly-, ruler 3 are as defined above, and 1118 is a C, C4 alkyl or R18 O group. Together, it forms 0, 0-alkylene bridge; and reducing the compound of formula 202 to produce a compound conforming to formula A203: [Α203] 其中-Α-Α-,-Β-Β-,-Ε-Ε-,R3及R18係如上所定義;及 將符合式Α203之化合物水解,藉此製造式Α204之化合 物。 30. —種製備符合下式之化合物的方法:[Α203] wherein -Α-Α-, -Β-Β-, -Ε-Ε-, R3 and R18 are as defined above; and a compound conforming to formula A203 is hydrolyzed to thereby produce a compound of formula A204. 30. A method for preparing a compound according to the following formula: CHO [A203] -29- 本紙張尺度適用中國國家標準(CNS) Α4規格(210 X 297公釐) 593305 8 8 8 8 A BCD 申請專利範圍 其中 -A-A-代表基團- CHR4-CHR5-或-CR4 = CR5- R3、R4及R5選自包括氫、函素、羥基、低碳數烷基 、低碳數烷氧基、羥烷基、烷氧烷基、羥羰基、氰 基、芳氧基, -B-B-代表基團-CHR6-CHR7-或α -或/3 -方位之基團: R6 III 其中R6和R7分別選自包括氫、鹵素、低碳數烷氧基 、醯基、羥烷基、烷氧烷基、羥羰基、烷基、烷氧 羰基、醯氧烷基、氰基、芳氧基,且 其中-Ε_Ε-選自包括: 22 \1 XLI:CHO [A203] -29- This paper size applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 593305 8 8 8 8 A BCD patent application scope where -AA- represents the group-CHR4-CHR5- or- CR4 = CR5- R3, R4 and R5 are selected from the group consisting of hydrogen, halo, hydroxyl, low-carbon alkyl, low-carbon alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, and aryloxy , -BB- represents a group -CHR6-CHR7- or α- or / 3-azimuth group: R6 III wherein R6 and R7 are respectively selected from the group consisting of hydrogen, halogen, low-carbon alkoxy, fluorenyl, and hydroxyalkane Group, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, alkoxyalkyl, cyano, aryloxy, and -E_Ε- is selected from the group consisting of: 22 \ 1 XLI: XLIV XLV XLVI -30- 本紙張尺度適用中國國家標準(CNS) A4規格(210 χ 297公釐) 593305 A8 B8 C8 D8 六、申請專利範圍 和 ^CR21 XLVII R18為烷基,或是在C-17處的R18〇-基團一起形 成〇,〇-氧基伸烷基橋,R21、R22和R23分別選自氫、烷 基、鹵素、硝基和氰基,R24選自氫和低碳數燒基, 該方法包括: 將符合式A202之化合物.還原··XLIV XLV XLVI -30- This paper size applies to Chinese National Standard (CNS) A4 (210 x 297 mm) 593305 A8 B8 C8 D8 VI. Patent application scope and CR21 XLVII R18 is alkyl, or C-17 The R18〇- groups at the same position together form a 0,0-oxyalkylene bridge, R21, R22 and R23 are respectively selected from hydrogen, alkyl, halogen, nitro and cyano, and R24 is selected from hydrogen and low carbon number The method includes: reducing a compound conforming to Formula A202. [A202] 其中-A-A-、-B-B-、-E-E-、R3和R18如同上文之定義。 3 1 ·根據申請專利範圍第9至3 0項中任一項之方法,其中r3為 氫,-A-A-代表基團-CHR4-CHR5_,_Β·Β·代表基團 -CHR6-CHR7。 32·根據申請專利範圍第31項之方法,其中R4,r5,尺6及尺7 各為氫。 項之方法,其中R3 ’ _B-B•代表基图 33·根據申請專利範圍第26至30項中任一 為氫,-A-A-代表基團-CHR4-CHR5--CHR6-CHR7, -31 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 A8 B8 C8 D8 六、申請專利範圍 R4,R5,R6及R7各為氫,及-Ε·Ε-係選自下列 及[A202] wherein -A-A-, -B-B-, -E-E-, R3 and R18 are as defined above. 31. The method according to any one of claims 9 to 30 in the scope of the patent application, wherein r3 is hydrogen, -A-A- represents a group -CHR4-CHR5_, and _Β · Β · represents a group -CHR6-CHR7. 32. The method according to item 31 of the scope of patent application, wherein R4, r5, ruler 6 and ruler 7 are each hydrogen. Method, in which R3′_B-B • represents the base figure 33. According to any one of the 26th to 30th scope of the patent application, it is hydrogen, and -AA- represents the group -CHR4-CHR5--CHR6-CHR7, -31- This paper size applies to Chinese National Standard (CNS) A4 specifications (210 X 297 mm) 593305 A8 B8 C8 D8 Six, the scope of patent applications R4, R5, R6 and R7 are each hydrogen, and -E · Ε- is selected from the following and XLIIIXLIII XLVII 素、硝基和 其中R21、R22’和R23分別選自氫、烷基、鹵 氰基。 34.—種式D之化合物, 〇XLVII, nitro and R21, R22 'and R23 are selected from hydrogen, alkyl and halocyano, respectively. 34.-a compound of formula D, Ό -32- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 A8 B832 -32- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 593305 A8 B8 本紙張尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 593305 8 8 8 8 A B c D 六、申請專利範圍 0This paper size is in accordance with Chinese National Standard (CNS) A4 (210X 297 mm) 593305 8 8 8 8 A B c D 6. Scope of patent application 0 38.—種式F之化合物, ο 4 2 式 種38.—Compounds of formula F, ο 4 2 其中-A-A-代表基團-CH2-CH2·或-CH=CH-。 39.根據申請專利範圍第38項之化合物,其具有下式 〇Wherein -A-A- represents the group -CH2-CH2 · or -CH = CH-. 39. The compound according to item 38 of the application, which has the following formula: 物 合 化 之 -34- 本紙浪尺度適用中國國家標準(CNS) A4規格(210X 297公釐) 593305 8 8 8 8 A BCD 々、申請專利範圍Physicochemical -34- The paper scale is applicable to Chinese National Standard (CNS) A4 specifications (210X 297 mm) 593305 8 8 8 8 A BCD 々 Scope of patent application 其中-A-A-代表基團-CH2-CH2-或-CH=CH-;以及R80與R90各 自為羥基或羥基羰基烷基或共同形成酮或代表以下基團 〇Where -A-A- represents the group -CH2-CH2- or -CH = CH-; and R80 and R90 are each a hydroxyl group or a hydroxycarbonylalkyl group or form a ketone or represent the following groups. 41.根據申請專利’範圍第40項之化合物,其具有下式41. The compound according to item 40 of the scope of patent application, which has the formula 〇 42.—種式2 1 0之化合物,〇 42.—A compound of formula 2 10, -35- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A B c D 申請專利範圍 其中-A-A-代表基團-CH2-CH2-或-CH=CH_ ;以及R8G與R9G各 自為羥基或羥基羰基烷基或共同形成酮或代表以下基團 〇 U 43 .根據申請專利範圍第4 2項之化合物,其具有下式-35- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 593305 8 8 8 8 AB c D The scope of patent application where -AA- represents the group -CH2-CH2- or -CH = CH_ And R8G and R9G are each a hydroxyl group or a hydroxycarbonyl alkyl group or form a ketone or represent the following group. 43. The compound according to item 42 of the scope of patent application, which has the following formula 44. 一種式209之化合物44. A compound of formula 209 -36- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A B c D 申請專利範圍 其中-A-A-代表基團-CH2_CH2-或-CH=CH-;以及R8G與R90各 自為羥基或羥基羰基烷基或共同形成酮或代表以下基團 〇-36- This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 593305 8 8 8 8 AB c D. The scope of patent application is -AA- represents the group -CH2_CH2- or -CH = CH-; And R8G and R90 are each a hydroxyl group or a hydroxycarbonyl alkyl group or together form a ketone or represent the following groups. C(17) 以及-E - E -係選自以下基團 JCM——CHj- XLIII. 〉C XLIV, OH、I :CH—CH- XLV, OH XLVI, 及 &gt;Δη- XLVII45·根據申請專利範圍第44項之化合物,其具下式 37- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 A8 B8 C8C (17) and -E-E- are selected from the group JCM——CHj- XLIII.〉 C XLIV, OH, I: CH—CH- XLV, OH XLVI, and &gt; Δη- XLVII45 · According to the patent application The 44th scope compound has the following formula: 37- This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 593305 A8 B8 C8 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 593305 A8 B8 C8 D8 申請專利範圍 &gt; Η-CH2 ^C=CH- OH、I CH—CH一 XL IV, XLV, OH -CH, XLVI. 及This paper size applies to China National Standard (CNS) A4 (210 x 297 mm) 593305 A8 B8 C8 D8 Patent application scope &gt; Η-CH2 ^ C = CH- OH, I CH-CH-XL-IV, XLV, OH -CH, XLVI. And A ?CH— XLVII 〇47.根據申請專利範圍第4 6項之化合物,其具有下式 HacA? CH- XLVII 〇 47. According to the scope of application of the 46th patent compound, which has the following formula Hac 48.—種式207之化合物, -39 - 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A BCD 申請專利範圍48.—Compound of Formula 207, -39-This paper size applies to Chinese National Standard (CNS) A4 (210 X 297 mm) 593305 8 8 8 8 A 207 其中-A-A-代表基團-CH2-CH2-或-CH=CH- ; R19 為 烷 基或尺190-基_團共同形成0,0-氧烷撐橋;R2G為CVC4烷基;R25 為(^至山烷基「以及-E-E-係選自以下基團: CH-—CH:, XLIII, 及 &gt; =CH- OH 〉H—L OH ^X—CH2 &gt;Δη- XLIV, XLV, XLVI, XL VII -40- 本紙張尺度適用中國國家標準(CNS) A4規格(210 x 297公釐) 593305 8 8 8 8 A B c D 申請專利範圍 49.根據申請專利範圍第4 8項之化合物,其具有下式 〇207 where -AA- represents the group -CH2-CH2- or -CH = CH-; R19 is an alkyl group or a 190-group-group to form a 0,0-oxoalkylene bridge; R2G is a CVC4 alkyl group; R25 is (^ To alkylene "and -EE- are selected from the following groups: CH --- CH :, XLIII, and &gt; = CH-OH> H-L OH ^ X-CH2 &gt; Δη- XLIV, XLV, XLVI, XL VII -40- This paper size applies to Chinese National Standard (CNS) A4 (210 x 297 mm) 593305 8 8 8 8 AB c D Application scope of patent 49. According to the 48th compound of the scope of patent application, It has the following formula. 50.—種式206之化合物50.- Compound of Formula 206 206 其中-A-A-代表基團-CH2-CH2-或-CH=CH- ; R19為(^至匕烷 基或R190-基團共同形成0,0-氧烷撐橋;烷基;以 及-E-E-係選自以下基團: XLIII, -CH2 ;C=CH- XLIV, -41 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A BCD 六、申請專利範圍 及 OH、I CH._-.CH· XLV, OH -CH2 XLVI, XLVII ο 5 51.根據申請專利範圍第 項之化合物,其具有下式 H3CO-HjCO'206 where -AA- represents the group -CH2-CH2- or -CH = CH-; R19 is (^ to alkyl or R190- groups together to form a 0,0-oxyalkylene bridge; alkyl; and -EE -It is selected from the following groups: XLIII, -CH2; C = CH- XLIV, -41 This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210 X 297 mm) 593305 8 8 8 8 A BCD VI. Application Patent scope and OH, I CH ._-. CH · XLV, OH-CH2 XLVI, XLVII ο 5 51. The compound according to the item in the scope of patent application, which has the following formula H3CO-HjCO ' 〇CHa 52.—種式2 0 5之化合物〇CHa 52.—a compound of the formula 205 205 42 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A BCD 申請專利範圍 其中-A-A-代表基團-CH2-CH2-或-CH=CH- ; R19為(^至匕烷 基或R190-基團共同形成0,0-氧烷撐橋;烷基;以 及-E-E-係選自以下基團: _CH, XLIII, =CH- XLIV, OH、I /CH—CH_ • XLV, OH 二 0-Cha* XLVI, 及 Λ feH- XLVII 53.根據申請專利範圍第52項之化合物,其具有下式205 42 This paper size applies Chinese National Standard (CNS) A4 specification (210 X 297 mm) 593305 8 8 8 8 A BCD patent application scope where -AA- represents the group -CH2-CH2- or -CH = CH-; R19 is an alkyl group or R190- group that together forms a 0,0-oxoalkylene bridge; an alkyl group; and -EE- is selected from the group: _CH, XLIII, = CH- XLIV, OH, I / CH—CH_ • XLV, OH di 0-Cha * XLVI, and Λ feH- XLVII 53. The compound according to item 52 of the scope of patent application, which has the following formula -43 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A BCD 々、申請專利範圍 54.—種式2 04之化合物,-43 This paper size is applicable to Chinese National Standard (CNS) A4 specification (210 X 297 mm) 593305 8 8 8 8 A BCD 々, patent application scope 54.— compound of formula 2 04, 4 ο 2 其中-A-A-代表基團-CH2-CH2-或 _CH=CH- ; R19 為 CiSC4 烷 基或R190-基—團共同形成0,0-氧烷撐橋;以及-E-E-係選自以 下基團 Η —-C H2 - XLIII, :CH_ XLIV, \ I CH*—Ch..... XLV, OH X-ch2_ XLVI, 及 醒工 44 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A BCD 六、申請專利範圍 5 5.根據申請專利範圍第54項之化合物,其具有下式4 ο 2 where -AA- represents the group -CH2-CH2- or _CH = CH-; R19 is CiSC4 alkyl or R190- group-groups together to form a 0,0-oxoalkylene bridge; and -EE- system selection From the following groups Η —-C H2-XLIII,: CH_ XLIV, \ I CH * —Ch ..... XLV, OH X-ch2_ XLVI, and Xinggong 44 This paper applies the Chinese National Standard (CNS) A4 Specifications (210 X 297 mm) 593305 8 8 8 8 A BCD VI. Patent Application Range 5 5. The compound according to item 54 of the patent application range has the following formula 56.—種式2 0 3之化合物, R156.—A compound of formula 203, R1 8 R1 3 ο 2 其中-A-A-代表基團-CH2-CH2-或-CH=CH- ; R18為(^至匕烷基 或在C-17之或R180-基團共同形成0,0-氧烷撐橋;以及-E-E-係選自以下基團: / rCH-CH2- XLIII, &gt; :CH· XLIV, -45- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐) 593305 8 8 8 8 A B c D 申請專利範園 OH XLV, 、I ^CH—CH- Oh -ch2- XLVI( 及 XLVII 57·根據申請專利範圍第56項之化合物,其具有下式8 R1 3 ο 2 where -AA- represents the group -CH2-CH2- or -CH = CH-; R18 is (^ to alkyl or C-17 or R180- groups together to form 0,0-oxygen Alkylene bridge; and -EE- is selected from the following groups: / rCH-CH2- XLIII, &gt;: CH · XLIV, -45- This paper size applies to China National Standard (CNS) A4 (210 X 297 mm) ) 593305 8 8 8 8 AB c D Patent application park OH XLV, ^ CH-CH- Oh-ch2- XLVI (and XLVII 57. According to the 56th patent application, it has the following formula -46 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)-46 This paper size applies to China National Standard (CNS) A4 (210 X 297 mm)
TW86118698A 1996-12-11 1997-12-11 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein TW593305B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3331596P 1996-12-11 1996-12-11

Publications (1)

Publication Number Publication Date
TW593305B true TW593305B (en) 2004-06-21

Family

ID=21869706

Family Applications (2)

Application Number Title Priority Date Filing Date
TW86118698A TW593305B (en) 1996-12-11 1997-12-11 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
TW92125191A TWI244483B (en) 1996-12-11 1997-12-11 Intermediates useful in processes for preparation of 9,11-epoxy steroids

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW92125191A TWI244483B (en) 1996-12-11 1997-12-11 Intermediates useful in processes for preparation of 9,11-epoxy steroids

Country Status (4)

Country Link
AR (1) AR010768A1 (en)
RU (1) RU2261865C2 (en)
TW (2) TW593305B (en)
ZA (1) ZA9711038B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114456952A (en) * 2022-02-22 2022-05-10 昆明理工大学 Chrysosporium and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111471668B (en) * 2020-02-28 2022-05-24 浙江工业大学 Nitrilase mutant and application thereof in preparation of 1-cyanocyclohexylacetic acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114456952A (en) * 2022-02-22 2022-05-10 昆明理工大学 Chrysosporium and application thereof
CN114456952B (en) * 2022-02-22 2023-04-14 昆明理工大学 Chrysosporium and application thereof

Also Published As

Publication number Publication date
TWI244483B (en) 2005-12-01
AR010768A1 (en) 2000-07-12
TW200400956A (en) 2004-01-16
ZA9711038B (en) 1999-01-25
RU2261865C2 (en) 2005-10-10

Similar Documents

Publication Publication Date Title
CA2273343C (en) Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
US6335441B1 (en) 5β-cyano-substituted steroid compounds
WO1998025948A9 (en) Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
US20080027237A1 (en) Processes for preparations of 9,11-epoxy steroids and intermediates useful therein
TW593305B (en) Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
CA2347346C (en) Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olefinic double bonds
KR100506007B1 (en) Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
AU744223B2 (en) Process for the epoxidation of olefinic double bonds
CA2550659A1 (en) Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
CA2553379A1 (en) Processes for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds
IL158857A (en) Processes for preparation of steroids and intermediates useful therein

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees